<SEC-DOCUMENT>0001615774-19-007324.txt : 20190509
<SEC-HEADER>0001615774-19-007324.hdr.sgml : 20190509
<ACCEPTANCE-DATETIME>20190508201027
ACCESSION NUMBER:		0001615774-19-007324
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		47
CONFORMED PERIOD OF REPORT:	20190331
FILED AS OF DATE:		20190509
DATE AS OF CHANGE:		20190508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANAVEX LIFE SCIENCES CORP.
		CENTRAL INDEX KEY:			0001314052
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				208365999
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37606
		FILM NUMBER:		19808419

	BUSINESS ADDRESS:	
		STREET 1:		51 W 52ND STREET,
		STREET 2:		7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019-6163
		BUSINESS PHONE:		800-689-3939

	MAIL ADDRESS:	
		STREET 1:		51 W 52ND STREET,
		STREET 2:		7TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019-6163

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Thrifty Printing Inc.
		DATE OF NAME CHANGE:	20050111
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>s118023_10q.htm
<DESCRIPTION>FORM 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 16pt"><B>FORM
10-Q</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Mark
One)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9746;
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the quarterly period ended: <B><U>March 31, 2019</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9744; TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the transition period from _____to _____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File Number: <U>001-37606</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>ANAVEX
LIFE SCIENCES CORP.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Nevada</U></B></FONT></TD>
    <TD STYLE="width: 50%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>98-0608404</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction
    of</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation or
    organization)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="width: 24%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>51
    West 52<SUP>nd</SUP> Street, 7<SUP>th</SUP> Floor, New York, NY USA 10019</B></FONT></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal
    executive offices) (Zip Code)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>1-844-689-3939</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
telephone number, including area code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>N/A</U></B><BR>
(Former name, former address and former fiscal year, if changed since last report)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9746;
&nbsp;Yes &#9744; No</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive
Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9746;
&nbsp;Yes &#9744; No</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo;,
&ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 27%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</FONT></TD>
    <TD STYLE="width: 3%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="width: 41%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 26%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer</FONT></TD>
    <TD STYLE="width: 3%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9746;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting
    company</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9746;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth
    company</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&#9744; Yes &#9746; &nbsp;No</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities Registered Pursuant to Section&nbsp;12(b) of the
Act:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding: 1.5pt; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Title of Each Class</FONT></TD>
    <TD STYLE="padding: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Trading Symbol</FONT></TD>
    <TD STYLE="padding: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Name of Each Exchange on Which Registered</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.5pt; text-align: center; width: 12%"><FONT STYLE="font-size: 10pt">Common Stock</FONT></TD>
    <TD STYLE="padding: 1.5pt; text-align: center; width: 12%"><FONT STYLE="font-size: 10pt">Par Value</FONT></TD>
    <TD STYLE="padding: 1.5pt; width: 12%"><FONT STYLE="font-size: 10pt">$0.001</FONT></TD>
    <TD STYLE="padding: 1.5pt; width: 1%">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: center; width: 31%"><FONT STYLE="font-size: 10pt">AVXL</FONT></TD>
    <TD STYLE="padding: 1.5pt; text-align: center; width: 1%">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; text-align: center; width: 31%"><FONT STYLE="font-size: 10pt">NASDAQ Stock Market LLC</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">APPLICABLE
ONLY TO CORPORATE ISSUERS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
the number of shares outstanding of each of the issuer&rsquo;s classes of common stock, as of the latest practicable date: 49,115,137
shares of common stock outstanding as of May 8, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>TABLE
OF CONTENTS </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="width: 90%; text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a001_v1">PART I - FINANCIAL INFORMATION</A></FONT></TD>
    <TD STYLE="width: 10%; text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a002_v1">Item 1. FINANCIAL STATEMENTS</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a003_v1">Item 2. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">2</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a004_v1">Item 3. Quantitative and Qualitative Disclosures about Market Risks</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a005_v1">Item 4. Controls and Procedures</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a006_v1">PART II &ndash; OTHER INFORMATION</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a007_v1">Item 1. Legal Proceedings</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a008_v1">Item 1A. Risk Factors</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a009_v1">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a010_v1">Item 3. Defaults Upon Senior Securities</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a011_v1">Item 4. Mine Safety Disclosures</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT>6</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a012_v1">Item 5. Other Information</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a013_v1">Item 6. Exhibits</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in">&nbsp;</TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; padding-left: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#a014_v1">SIGNATURES</A></FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">ii</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a001_v1"></A>PART
I - FINANCIAL INFORMATION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a002_v1"></A>Item
1. FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black"><B>ANAVEX LIFE
SCIENCES CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">INTERIM CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="color: Black"><B>ANAVEX
LIFE SCIENCES CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="color: Black">INTERIM
CONDENSED CONSOLIDATED BALANCE SHEETS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="color: Black">March
31, 2019 and September 30, 2018</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">March
    31</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">September
    30,</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2019</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">(Unaudited)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Assets</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Current</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Cash
    and cash equivalents</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">19,457,845</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">22,930,638</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Sales
    tax recoverable</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">76,160</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">40,171</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Prepaid
    expenses</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">849,642</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,251,798</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Deferred
    costs</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">151,133</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">101,133</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid; padding-left: 0.125in"><FONT STYLE="color: Black">Deposits
    - short term</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">15,000</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">20,549,780</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">24,323,740</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Deposits</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">52,396</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Total
    Assets</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">20,549,780</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">24,376,136</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Liabilities and Stockholders&rsquo;
    Equity</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Current</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Accounts
    payable and accrued liabilities</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">6,370,604</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,884,626</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Total
    Liabilities</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">6,370,604</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">3,884,626</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Commitments - Note 5</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Capital stock</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Authorized:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="color: Black">100,000,000 common shares,
    par value $0.001 per share</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Issued
    and outstanding:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="color: Black">48,173,241 common shares</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in"><FONT STYLE="color: Black">(September 30, 2018
    - 45,933,472)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">48,175</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">45,935</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Additional paid-in capital</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">138,696,975</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">129,377,542</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Subscriptions receivable</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(292,700</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Accumulated deficit</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(124,273,274</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(108,931,967</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Total
    Stockholders&rsquo; Equity</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">14,179,176</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">20,491,510</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Total
    Liabilities and Stockholders&rsquo; Equity</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">20,549,780</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">24,376,136</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">See Accompanying Notes to Condensed
Consolidated Interim Financial Statements</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black"><B>ANAVEX
LIFE SCIENCES CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">For
the three and six months ended March 31, 2019 and 2018<BR>
(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">Three months
    ended March 31,</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">Six months
    ended March 31,</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2019</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2019</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Operating expenses</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">General and
    administrative</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,061,251</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,489,450</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,822,559</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,887,253</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Research
    and development</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">6,078,786</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">3,245,023</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">11,790,996</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">5,939,335</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Total operating expenses</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,140,037</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(4,734,473</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(15,613,555</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,826,588</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Other income (expenses)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Grant income</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">74,527</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">149,055</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Interest income, net</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">51,465</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">28,647</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">130,265</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">59,023</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Foreign
    exchange gain (loss), net</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">54,199</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(18,337</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">49,693</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(6,358</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Total
    other income, net</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">180,191</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">10,310</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">329,013</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">52,665</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Net loss before provision
    for income taxes</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(7,959,846</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(4,724,163</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(15,284,542</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,773,923</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Income
    tax expense</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(48,048</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(27,861</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(56,765</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(37,266</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Net
    loss and comprehensive loss</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(8,007,894</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(4,752,024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(15,341,307</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(8,811,189</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Loss per share</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Basic
    and diluted</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(0.17</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(0.11</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(0.33</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(0.20</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Weighted average number of shares outstanding</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Basic
    and diluted</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">47,134,686</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">44,545,523</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">46,726,649</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">44,210,591</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">See
Accompanying Notes to Condensed Consolidated Interim Financial Statements</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black"><B>ANAVEX
LIFE SCIENCES CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black"><B>INTERIM
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">For
the six months ended March 31, 2019 and 2018 <BR>
(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2019</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2018</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Cash Flows used in Operating
    Activities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Net loss</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(15,341,307</FONT></TD><TD STYLE="width: 1%; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,811,189</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Adjustments to reconcile
    net loss to net cash used in operations:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Stock-based
    compensation</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,960,139</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,347,681</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Changes in non-cash working
    capital balances related to operations:</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Sales
    tax recoverable</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(35,989</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">4,737</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in"><FONT STYLE="color: Black">Prepaid
    expenses and deposits</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">402,156</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">185,268</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Deposits</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">37,396</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.125in; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Accounts
    payable and accrued liabilities</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">2,485,978</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(167,597</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Net cash used in operating
    activities</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,491,627</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(6,441,100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Cash Flows provided by Financing
    Activities</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Issuance of common shares</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">5,068,834</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">4,688,370</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Deferred
    financing charges</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(50,000</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(30,943</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Net cash provided by financing
    activities</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">5,018,834</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">4,657,427</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Decrease in cash and cash
    equivalents during the period</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(3,472,793</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(1,783,673</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Cash
    and cash equivalents, beginning of period</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">22,930,638</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">27,440,257</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Cash
    and cash equivalents, end of period</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">19,457,845</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">25,656,584</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">See Accompanying Notes to Condensed Consolidated Interim Financial Statements</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black"><B>ANAVEX
LIFE SCIENCES CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">INTERIM
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS&rsquo; EQUITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">For
the three and six months ended March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD COLSPAN="13" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Common
                                         Stock</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Additional</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Common</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Paid-in</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Shares
                                         to be</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Accumulated</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Par
                                         Value</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Deficit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black"><U>Three months ended March 31, 2019 and 2018</U></FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Balance, January 1, 2019</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">46,887,056</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">46,888</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">133,438,276</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(116,265,380</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">17,219,784</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Shares issued under purchase
    agreement</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Purchase shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,279,592</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,279</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,365,555</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(292,700</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,074,134</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Commitment shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">6,047</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(7</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="color: Black">Shares
    issued pursuant to     cashless exercise of warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">546</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Share based compensation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,893,152</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,893,152</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Net loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,007,894</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8,007,894</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Balance,
    March 31, 2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">48,173,241</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">48,175</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">138,696,975</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(292,700</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(124,273,274</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-top: Black 1pt solid; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">14,179,176</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Balance, January 1, 2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">44,421,992</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">44,423</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">121,038,635</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(95,537,723</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">25,545,335</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Shares issued under purchase
    agreement</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Purchase shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">150,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">151</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">459,699</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">459,850</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Commitment shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">826</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Shares issued pursuant to
    cashless exercise of options</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">970</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Share based compensation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,225,696</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,225,696</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Net
    loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(4,752,024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(4,752,024</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Balance,
    March 31, 2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">44,573,788</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">44,575</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">122,724,029</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(100,289,747</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">22,478,857</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">See Accompanying Notes to Condensed
Consolidated Interim Financial Statements</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black"><B>ANAVEX
LIFE SCIENCES CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">INTERIM
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS&rsquo; EQUITY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">For
the three and six months ended March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD COLSPAN="13" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Common
                                         Stock</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Additional</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Common</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Paid-in</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Shares
                                         to be</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Accumulated</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Par
                                         Value</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Deficit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Total</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black"><U>Six months ended March 31, 2019 and 2018</U></FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Balance, October 1, 2018</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">45,933,472</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">45,935</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">129,377,542</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(108,931,967</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="width: 8%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">20,491,510</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Shares issued under purchase
    agreement</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Purchase shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,229,592</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,229</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">5,359,305</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(292,700</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">5,068,834</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Commitment shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">9,631</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(10</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.125in; padding-left: 0.125in"><FONT STYLE="color: Black">Shares issued pursuant to
    cashless exercise of warrants</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">546</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Share based compensation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,960,139</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">3,960,139</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Net
    loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(15,341,307</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(15,341,307</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Balance,
    March 31, 2019</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">48,173,241</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">48,175</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">138,696,975</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(292,700</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(124,273,274</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">14,179,176</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Balance, October 1, 2017</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">43,330,817</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">43,332</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">115,689,221</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(91,478,558</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">24,253,995</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Shares issued under purchase
    agreement</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Purchase shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,233,580</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1,234</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">4,687,136</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">4,688,370</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in"><FONT STYLE="color: Black">Commitment shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">8,421</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(8</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">Shares issued pursuant to
    cashless exercise of options</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">970</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">(1</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">Share based compensation</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,347,681</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="color: Black">2,347,681</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">Net
    loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(8,811,189</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid"><FONT STYLE="color: Black">(8,811,189</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">Balance,
    March 31, 2018</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">44,573,788</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">44,575</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">122,724,029</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">(100,289,747</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="color: Black">22,478,857</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="color: Black">See
Accompanying Notes to Condensed Consolidated Interim Financial Statements&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">Anavex Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">Notes to the Condensed Consolidated
Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">(Unaudited)</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 42pt; text-align: left"><FONT STYLE="color: Black">Note 1</FONT></TD><TD><FONT STYLE="color: Black"><U>Business Description and Basis of Presentation</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify;"><FONT STYLE="color: Black">Business</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; "><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify"><FONT STYLE="color: Black">Anavex
Life Sciences Corp. (the &ldquo;Company&rdquo;) is a clinical stage biopharmaceutical company engaged in the development of differentiated
therapeutics by applying precision medicine to central nervous system (&ldquo;CNS&rdquo;) diseases with high unmet need. Anavex
analyzes genomic data from clinical studies to identify biomarkers, which select patients that will receive the therapeutic benefit
for the treatment of neurodegenerative and neurodevelopmental diseases. The Company&rsquo;s lead compound ANAVEX&reg;2-73 is being
developed to treat Alzheimer&rsquo;s disease, Parkinson&rsquo;s disease and potentially other central nervous system diseases,
including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked
gene, methyl-CpG-binding protein 2 (&ldquo;MECP2&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Basis
of Presentation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 42.55pt"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">These
unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&ldquo;SEC&rdquo;) and accounting principles generally accepted in the United States of America
(&ldquo;US GAAP&rdquo;) for interim reporting. Accordingly, certain information and note disclosures normally included in the
annual financial statements in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.
In the opinion of management, the disclosures are adequate to make the information presented not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">These
accompanying unaudited interim condensed consolidated financial statements reflect all adjustments, consisting of normal recurring
adjustments, which in the opinion of management are necessary for fair presentation of the information contained herein. The consolidated
balance sheet as of September 30, 2018 was derived from the audited annual financial statements but does not include all disclosures
required by US GAAP. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction
with the audited consolidated financial statements and notes thereto included in the Company&rsquo;s annual report on Form 10-K
for the year ended September 30, 2018 filed with the SEC on December 12, 2018. The Company follows the same accounting policies
in the preparation of interim reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Operating
results for the six months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year
ending September 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Liquidity</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">All
of the Company&rsquo;s potential drug compounds are in the clinical development stage and the Company cannot be certain that its
research and development efforts will be successful or, if successful, that its potential drug compounds will ever be approved
for sales to pharmaceutical companies or generate commercial revenues. To date, we have not generated any revenues from our operations.
The Company expects the business to continue to experience negative cash flows for the foreseeable future and cannot predict when,
if ever, our business might become profitable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">Anavex Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">Notes to the Condensed Consolidated
Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">(Unaudited)</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 42.55pt"><FONT STYLE="color: Black">Note 1</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="color: Black"><U>Business Description and Basis of Presentation</U> &ndash; (continued)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
Company believes that its existing cash and cash equivalents, along with existing financial commitments from third parties, will
be sufficient to meet its cash commitments for at least the next eighteen months after the date that these condensed consolidated
interim financial statements are issued. The process of drug development can be costly, and the timing and outcomes of clinical
trials is uncertain.&nbsp;The assumptions upon which the Company has based its estimates are routinely evaluated and may be subject
to change.&nbsp;The actual amount of the Company&rsquo;s expenditures will vary depending upon a number of factors including but
not limited to the design, timing and duration of future clinical trials, the progress of the Company&rsquo;s research and development
programs and the level of financial resources available. The Company has the ability to adjust its operating plan spending levels
based on the timing of future clinical trials.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
Company will need to raise additional capital in order to continue to fund operations and fully fund later stage clinical development
programs. Such capital may not be available on commercially acceptable terms, if at all. The Company believes that it will be
able to obtain additional working capital to fund future operations through current financing commitments from third parties,
or through other arrangements; however, there can be no assurance that such additional financing, if available, can be obtained
on terms acceptable to the Company.&nbsp;&nbsp;If the Company is unable to obtain such additional financing, future operations
would need to be scaled back.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">Use
of Estimates</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and
expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset
valuations, asset impairment, stock-based compensation and loss contingencies. The Company bases its estimates and assumptions
on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs
and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&rsquo;s estimates. To the extent there are material differences between the estimates and the actual
results, future results of operations will be affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">Anavex Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">Notes to the Condensed Consolidated
Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: Black">(Unaudited)</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42.55pt"><FONT STYLE="color: Black">Note 1</FONT></TD>
    <TD><FONT STYLE="color: Black"><U>Business Description and Basis of Presentation</U> &ndash; (continued)</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">Principles
of Consolidation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">These
consolidated financial statements include the accounts of Anavex Life Sciences Corp. and its wholly-owned subsidiaries, Anavex
Australia Pty Limited, a company incorporated under the laws of Australia, Anavex Germany GmbH, a company incorporated under the
laws of Germany, and Anavex Canada Ltd., a company incorporated under the laws of the Province of Ontario, Canada. All inter-company
transactions and balances have been eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">Fair
Value Measurements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
fair value hierarchy under GAAP is based on three levels of inputs, of which the first two are considered observable and the last
unobservable, that may be used to measure fair value which are the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify; width: 0.55in"><FONT STYLE="color: Black">Level 1 -</FONT>&nbsp;</TD>
    <TD><FONT STYLE="color: Black">quoted prices (unadjusted) in active markets for identical assets or liabilities;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -40.5pt"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="white-space: nowrap; width: 0.55in; text-align: right"><FONT STYLE="color: Black">Level 2 -&nbsp;</FONT></TD><TD><FONT STYLE="color: Black"> observable
inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical
or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose
significant value drivers are observable; and</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -40.5pt"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 72pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; text-align: justify; width: 0.55in"><FONT STYLE="color: Black">Level 3 -&nbsp;</FONT></TD>
    <TD><FONT STYLE="color: Black">assets and liabilities whose significant value drivers are unobservable by little or no market activity
and that are significant to the fair value of the assets or liabilities.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -40.5pt"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
book value of cash and cash equivalents and accounts payable and accrued liabilities approximate their fair values due to the
short-term maturity of those instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">At
March 31, 2019 and September 30, 2018, the Company did not have any Level 3 assets or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black"><I>Basic
and Diluted Loss per Share</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; color: gray"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Basic
loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common
shares outstanding during the period. Diluted loss per common share is computed similar to basic loss per common share except
that the denominator is increased to include the weighted average number of all potentially dilutive securities convertible into
shares of common stock that were outstanding during the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">As
of March 31, 2019, loss per share excludes 7,655,850 (September 30, 2018 &ndash; 7,185,296) potentially dilutive common shares
related to outstanding options and warrants, as their effect was anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Anavex Life Sciences Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Notes to the Condensed Consolidated Interim Financial Statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">March 31, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Unaudited)</P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42.55pt"><FONT STYLE="color: Black">Note 2</FONT></TD>
    <TD><FONT STYLE="color: Black"><U>Recent Accounting Pronouncements</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black"><I>Recently
Adopted Accounting Pronouncements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">In
May 2014, the FASB and the International Accounting Standards Board (IASB) issued a converged standard on revenue recognition
from contracts with customers, ASU 2014-09 (Topic 606 and IFRS 15). This standard superseded nearly all existing revenue recognition
guidance. ASU 2014-09 is effective for the Company on a prospective basis beginning on October 1, 2018. The adoption of this standard
did not have a material impact for any period presented and the Company will apply this standard to all future revenues.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">In
May 2017, the FASB issued ASU No. 2017-09, &ldquo;Compensation&ndash;Stock Compensation (Topic 718): Scope of Modification Accounting,&rdquo;
clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The
new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the
same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company
on a prospective basis beginning on October 1, 2018. The adoption of this standard did not have a material impact for any period
presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black"><I>Recent
Accounting Pronouncements Not Yet Adopted</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">In
February 2016, the FASB issued Accounting Standards Update No. 2016-02, <I>Leases</I>. The guidance would require lessees to recognize
most leases on their balance sheets as lease liabilities with corresponding right &ndash;of use assets. The guidance is effective
for annual and interim reporting periods beginning on or after December 15, 2018. The new guidance is effective for the Company
on a prospective basis beginning on October 1, 2019. The Company is currently evaluating the impact this guidance will have on
its financial condition, results of operations and cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">In
June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments
(&ldquo;ASU 2018-07&rdquo;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring
goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after
December 15, 2018, with early adoption permitted, but no earlier than the Company&rsquo;s adoption date of Topic 606. The new guidance
is effective for the Company beginning on October 1, 2019. The new guidance is required to be applied retrospectively with the
cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07 will
have on the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">Other
than noted above, the Company does not expect the adoption of recently issued accounting pronouncements to have a significant
impact on its results of operations, financial position or cash flow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; background-color: white"><FONT STYLE="color: Black"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Anavex Life Sciences Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Notes to the Condensed Consolidated Interim Financial Statements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">March 31, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Unaudited)</P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42.55pt"><FONT STYLE="color: Black">Note 3</FONT></TD>
    <TD><FONT STYLE="color: Black"><U>Other Income </U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Grant
Income</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Clinical
Study Grant</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">During
the year ended September 30, 2017, the Company was awarded grant funding in the amount of $597,886. The grant is being received
in equal quarterly installments over a period of two years beginning during the year ended September 30, 2018 in exchange for
a commitment to complete clinical testing for a therapeutic drug candidate for the treatment of Rett syndrome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
grant income is deferred when received and amortized to other income as the related research and development expenditures are
incurred. During the three and six months ended March 31, 2019, the Company recognized $74,527 and $149,055, respectively (2018:
$Nil and $Nil, respectively) of this grant on its statement of operations within grant income.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; background-color: white"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 42.55pt"><FONT STYLE="color: Black">Note 4</FONT></TD>
    <TD><FONT STYLE="color: Black"><U>Equity Offering Agreements</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Controlled
Equity Offering Sales Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">On
July 6, 2018, the Company entered into a Controlled Equity Offering&nbsp;Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with
Cantor Fitzgerald&nbsp;&amp; Co., as agent (&ldquo;Cantor Fitzgerald&rdquo;), pursuant to which the Company may offer and sell
shares of common stock, for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald (the
&ldquo;Offering&rdquo;).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">Upon
delivery of a placement notice based on the Company&rsquo;s instructions and subject to the terms and conditions of the Sales
Agreement, Cantor Fitzgerald may sell the Shares by methods deemed to be an &ldquo;at the market offering&rdquo; offering, in
negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices,
or by any other method permitted by law, including negotiated transactions, subject to the prior written consent of the Company.
The Company is not obligated to make any sales of Shares under the Sales Agreement. The Company or Cantor Fitzgerald may suspend
or terminate the offering of Shares upon notice to the other party, subject to certain conditions.&nbsp; Cantor Fitzgerald will
act as sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices and applicable
state and federal law, rules&nbsp;and regulations and the rules&nbsp;of Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">The
Company has agreed to pay Cantor Fitzgerald commissions for its services of acting as agent of up to 3.0% of the gross proceeds
from the sale of the Shares pursuant to the Sales Agreement.&nbsp; The Company has also agreed to provide Cantor Fitzgerald with
customary indemnification and contribution rights. At March 31, 2019, the Company had incurred $151,133 in legal and accounting
fees associated with the Sales Agreement. This amount is included in deferred financing charges at March 31, 2019 and is expected
to be reclassified to share capital upon issuance of shares under the Sales Agreement. At March 31, 2019, no shares have been
sold pursuant to the Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><FONT STYLE="color: Black">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to the Condensed Consolidated Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                            4</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Equity
                                         Offering Agreements</U> &ndash; Continued</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 21, 2015, the Company entered into a $50,000,000 purchase agreement (the &ldquo;2015 Purchase Agreement&rdquo;) with Lincoln
Park Capital Fund, LLC (&ldquo;Lincoln Park&rdquo;), pursuant to which the Company may sell and issue to Lincoln Park, and Lincoln
Park is obligated to purchase, up to $50,000,000 in value of its shares of common stock from time to time over a 36-month period
starting from the effective date of the respective registration statement, to September 6, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.35pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may direct Lincoln Park, at its sole discretion, and subject to certain conditions, to purchase up to 50,000 shares of
common stock on any business day, provided that at least one business day has passed since the most recent purchase. The amount
of a purchase may be increased under certain circumstances provided, however that Lincoln Park&rsquo;s committed obligation under
any single purchase shall not exceed $2,000,000. The purchase price of shares of common stock related to the future funding will
be based on the then prevailing market prices of such shares at the time of sales as described in the 2015 Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for entering into the 2015 Purchase Agreement, the Company issued to Lincoln Park 179,598 shares of common stock
as a commitment fee and agreed to issue up to 89,799 shares pro rata, when and if, Lincoln Park purchases at the Company&rsquo;s
discretion the $50,000,000 aggregate commitment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2019, the Company issued to Lincoln Park an aggregate of 2,239,223 (2018: 1,242,001) shares of
common stock under the Purchase Agreement, including 2,229,592 (2018: 1,233,580) shares of common stock for an aggregate purchase
price of $5,361,534 (2018: $4,688,370) and 9,631 (2018: 8,421) commitment shares. At March 31, 2019, an amount of $7,836,072 remained
available under the 2015 Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">At March 31, 2019, an amount of $292,700 (September 30, 2018: $0) was receivable under the Purchase Agreement in respect of
100,000 purchase shares and 526 commitment shares issued and outstanding. This amount was received subsequent to March 31,
2019.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.75pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.75pt 0pt 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.75pt 0pt 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to the Condensed Consolidated Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                             5</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commitments</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;
Litigation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to claims and legal proceedings that arise in the ordinary course of business. Such matters are inherently
uncertain, and there can be no guarantee that the outcome of any such matter will be decided favorably to the Company or that
the resolution of any such matter will not have a material adverse effect upon the Company&rsquo;s consolidated financial statements.
The Company does not believe that any of such pending claims and legal proceedings will have a material adverse effect on its
consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.75pt 0pt 16.2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
&nbsp;&nbsp;Share Purchase Warrants</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the status of the Company&rsquo;s outstanding share purchase warrants is presented below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.75pt 0pt 14.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Weighted</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Average</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Number of Shares</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Exercise Price</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 29%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, October 1, 2017</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">1,609,309</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2.66</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">350,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4.19</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(756,143</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.96</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">(524,787</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">)</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">3.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, September 30, 2018</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">678,379</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.87</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,250</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.68</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">(307,129</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">)</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">1.47</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance, March 31, 2019</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">370,000</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">4.03</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended March 31, 2019, the Company issued 546 shares in connection with the exercise of 1,250 share purchase warrants
on a cashless basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8in 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 15; Value: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8in 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8in 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to the Condensed Consolidated Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                            5</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commitments</U>
                                         &ndash; (Continued) </FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">c)&nbsp;&nbsp; Stock&ndash;based Compensation Plan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015
Stock Option Plan</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2015, the Company&rsquo;s board of directors approved a 2015 Omnibus Incentive Plan (the &ldquo;2015 Plan&rdquo;),
which provides for the grant of stock options and restricted stock awards to directors, officers, employees and consultants of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.7pt 0pt 18.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of our common shares reserved for issue under the plan is 6,050,553 shares, subject to adjustment in the event
of a change of the Company&rsquo;s capitalization. As a result of the adoption of the 2015 Plan, no further option awards will
be granted under any previously existing stock option plan. Stock option awards previously granted under the previously existing
stock option plans remain outstanding in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.75pt 0pt 18.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2015 Plan provides that it may be administered by the board of directors, or the board of directors may delegate such responsibility
to a committee. The exercise price will be determined by the board of directors at the time of grant shall be at least equal to
the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be
less than 110% of fair market value of the Company&rsquo;s shares of common stock on the grant date. Stock options may be granted
under the 2015 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may
be determined by the board, subject to earlier termination in accordance with the terms of the 2015 Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.55pt 0pt 18.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the status of Company&rsquo;s outstanding stock purchase options is presented below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 45.75pt 0pt 18.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Weighted</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Weighted</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Number of</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Average</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Average Grant</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Aggregate</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Shares</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Exercise Price</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">Date Fair Value</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">intrinsic value</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 29%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at October 1, 2017</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">5,092,030</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">4.13</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">5,280,544</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,730,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.71</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.09</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(164,280</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3.66</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">(150,833</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">)</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">1.18</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at September 30, 2018</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">6,506,917</TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">3.83</TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"></TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">2,353,088</TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,030,399</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2.45</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.97</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">(238,966</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">)</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">2.86</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at March 31, 2019</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">7,298,350</TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">3.67</TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"></TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double">$</TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double">3,642,978</TD><TD STYLE="text-align: left; border-bottom: Black 2.5pt double">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable at March 31, 2019</FONT></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">5,240,285</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">3.73</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid"></TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">2,976,021</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted market
price of the Company&rsquo;s stock for the options that were in-the-money at March 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60.05pt 0pt 4.75pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60.05pt 0pt 4.75pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 60.05pt 0pt 4.75pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
to the Condensed Consolidated Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 133.6pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                            5</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Commitments</U> &ndash;
                                         (Continued)</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
&nbsp;&nbsp;Stock&ndash;based Compensation Plan &ndash; (Continued)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three and six months ended March 31, 2019, the Company recognized stock-based compensation expense in connection with the
issuance and vesting of stock options in exchange for services. These amounts have been included in general and administrative
expenses and research and development expenses on the Company&rsquo;s statement of operations as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 57.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.7in">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Three months ended March 31,</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Six months ended March 31,</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; text-align: left">General and administrative</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">950,999</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">625,679</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2,006,587</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,197,041</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">942,153</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">600,017</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">1,953,552</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">1,150,640</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total share based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">1,893,152</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">1,225,696</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">3,960,139</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1pt solid">$</TD><TD STYLE="text-align: right; border-bottom: Black 1pt solid">2,347,681</TD><TD STYLE="text-align: left; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; margin-left: 0.7in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; margin-left: 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
amount of approximately $4,546,000 in stock-based compensation is expected to be recorded over the remaining term of such options
through June 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 64.75pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: justify; margin-bottom: 0pt; margin-left: 0.7in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following
weighted average assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 64.7pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2018</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; text-align: left">Risk-free interest rate</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">2.91</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">2.43</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Expected life of options (years)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.59</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.57</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Annualized volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">105.96</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112.23</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dividend rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0pt"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
                            6</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Subsequent
                                         Events</U></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to March 31, 2019,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company filed a Certificate of Amendment with the Secretary of State of Nevada to amend the Company&rsquo;s articles of incorporation
to authorize the issuance of 10,000,000 shares of preferred stock having a par value of $0.001 per share. The Board of Directors
of the Company shall have the authority to issue shares of preferred stock in one or more series and shall have the authority
to establish by duly appointed resolution such voting powers, designations, preferences, limitations and restrictions and relative
rights of the preferred shares it deems necessary or advisable.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 15, 2019, the Board approved, subject to stockholder approval, the 2019 Omnibus Incentive Plan (the &ldquo;2019 Plan&rdquo;)
and, on April 5, 2019, the 2019 Plan was approved the Company&rsquo;s stockholders. Under the terms of the 2019 Plan, 6,000,000
additional shares of Common Stock are available for issuance under the 2019 Plan, in addition to the shares available under the
2015 Plan. Any awards outstanding under the 2015 Plan or the Company&rsquo;s 2007 Stock Option Plan (the &ldquo;2007 Plan&rdquo;)
will remain subject to and be paid under the 2015 Plan or the 2007 Plan, respectively, and any shares subject to outstanding awards
under the 2015 Plan or the 2007 Plan that subsequently cease to be subject to such awards (other than by reason of settlement
of the awards in shares) will automatically become available for issuance under the 2019 Plan.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 17; Value: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Anavex
Life Sciences Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Notes
to the Condensed Consolidated Interim Financial Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March 31, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(Unaudited)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; font-style: normal; font-weight: normal">
<TD STYLE="width: 0in; font-style: normal; font-weight: normal"></TD><TD STYLE="width: 0.5in; text-align: left; font-style: normal; font-weight: normal"><FONT STYLE="font-weight: normal; font-style: normal">Note&nbsp;6</FONT></TD><TD STYLE="font-style: normal; font-weight: normal"><FONT STYLE="font-weight: normal; font-style: normal"><U>Subsequent
                                         Events</U> &ndash; Continued</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">iii)</TD><TD STYLE="text-align: justify">On May 3, 2019 (the &ldquo;Effective Date&rdquo;), the
Company entered into a Second Amendment to the Employment Agreement (the &ldquo;Amendment&rdquo;) with the Company&rsquo;s Chief
Executive Officer (the &ldquo;CEO&rdquo;) in his continuing capacity as Chief Executive Officer of the Company. The Amendment
amends the Employment Agreement by and between the Company and the CEO, effective July 5, 2013 (the &ldquo;Employment Agreement&rdquo;),
as amended, and extends the term of the Employment Agreement through July 5, 2022, unless earlier terminated <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
provided in the Amendment. Pursuant to the terms of the Amendment, the CEO shall receive an annual base salary of $550,000 and
is eligible to earn an annual cash target bonus for each whole or partial calendar year of twenty percent of his base salary.
Subject to the terms of the Amendment, the CEO will also receive on the Effective Date 750,000 options for shares of the Company&rsquo;s
common stock, one-third of which shall vest on each of July 5, 2020, July 5, 2021 and July 5, 2022. The options shall have an
exercise price equal to the closing price of the Company&rsquo;s common stock on the Effective Date.</FONT></TD>
</TR></TABLE>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"></P>

<!-- Field: Page; Sequence: 18; Options: NewSection; Value: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a003_v1"></A>Item
2. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-Looking
Statements</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Quarterly Report on Form 10-Q includes forward-looking statements. All statements other than statements of historical facts contained
in this Quarterly Report on Form 10-Q, including statements regarding our anticipated future clinical and regulatory milestone
events, future financial position, business strategy and plans and objectives of management for future operations, are forward-looking
statements. The words &ldquo;believe,&rdquo; &ldquo;may,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;intend,&rdquo; &ldquo;expect&rdquo; &ldquo;should,&rdquo; &ldquo;forecast,&rdquo; &ldquo;could,&rdquo; &ldquo;suggest,&rdquo;
&ldquo;plan&rdquo; and similar expressions, as they relate to us, are intended to identify forward-looking statements. Such forward-looking
statements include, without limitation, statements regarding:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to generate any revenue or to continue as a going concern;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to successfully conduct clinical and preclinical trials for our product candidates;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to raise additional capital on favorable terms;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to execute our research and development plan on time and on budget;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         products ability to demonstrate efficacy or an acceptable safety profile;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to obtain the support of qualified scientific collaborators;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability, whether alone or with commercial partners, to successfully commercialize any
                                         of our product candidates that may be approved for sale;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to identify and obtain additional product candidates;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         reliance on third parties in non-clinical and clinical studies;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to defend against product liability claims;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to safeguard against security breaches;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to obtain and maintain sufficient intellectual property protection for our product
                                         candidates;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to comply with our intellectual property licensing agreements;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to defend against claims of intellectual property infringement;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to comply with the maintenance requirements of the government patent agencies;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         ability to protect our intellectual property rights throughout the world;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         anticipated start dates, durations and completion dates of our ongoing and future clinical
                                         studies;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                         anticipated designs of our future clinical studies;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         anticipated future regulatory submissions and our ability to receive regulatory approvals
                                         to develop and market our product candidates; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 20.65pt; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 18pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                         anticipated future cash position.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have based these forward-looking statements largely on our current expectations and projections about future events, including
the responses we expect from the U.S. Food and Drug Administration, (&ldquo;FDA&rdquo;), and other regulatory authorities and
financial trends that we believe may affect our financial condition, results of operations, business strategy, preclinical and
clinical trials, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions
including without limitation the risks described in &ldquo;Risk Factors&rdquo; in Part I, Item 1A of our Annual Report on Form
10-K. These risks are not exhaustive. Other sections of this Quarterly Report on Form 10-Q include additional factors which could
adversely impact our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment.
New risk factors emerge from time to time and it is not possible for our management to predict all risk factors, nor can we assess
the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results
to differ materially from those contained in any forward-looking statements. You should not rely upon forward-looking statements
as predictions of future events. We cannot assure you that the events and circumstances reflected in the forward-looking statements
will be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Except
as required by applicable laws including the securities laws of the United States, we assume no obligation to update or supplement
forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<!-- Field: Page; Sequence: 19; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Quarterly Report on Form 10-Q, the terms &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; and &ldquo;Anavex&rdquo;
mean Anavex Life Sciences Corp., unless the context clearly requires otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Current Business</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by
applying precision medicine to central nervous system (&ldquo;CNS&rdquo;) diseases with high unmet need. Anavex analyzes genomic
data from clinical studies to identify biomarkers, which select patients that will receive the therapeutic benefit for the treatment
of neurodegenerative and neurodevelopmental diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
lead compound, ANAVEX<SUP>&reg;</SUP>2-73, is being developed to treat Alzheimer&rsquo;s disease, Parkinson&rsquo;s disease and
potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological
monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2 (&ldquo;MECP2&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total portfolio currently consists of five programs. To prioritize the allocation of our resources, we designate certain programs
as core programs and others as seed programs, and we currently have two core programs and three seed programs. Our core programs
are at various stages of clinical and preclinical development, in neurodegenerative and neurodevelopmental diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes key information about our programs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="img001_v1.jpg" ALT="(GRAPHIC)">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
has a portfolio of compounds varying in sigma-1 receptor (S1R) binding activities. The SIGMAR1 gene encodes the S1R protein, which
is an intracellular chaperone protein with important roles in cellular communication. S1R is also involved in transcriptional
regulation at the nuclear envelope and restores homeostasis and stimulates recovery of cell function when activated. In order
to validate the ability of our compounds to activate quantitatively the S1R, we performed in collaboration with Stanford University
a quantitative Positron Emission Tomography (PET) imaging scan in mice, which demonstrated a dose-dependent ANAVEX<SUP>&reg;</SUP>2-73
target engagement or receptor occupancy (RO) with S1R in the brain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="img002_v1.jpg" ALT="(GRAPHIC)">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: Red"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cellular
Homeostasis</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
diseases are possibly directly caused by chronic homeostatic imbalances or cellular stress of brain cells. In pediatric diseases
like Rett syndrome or infantile spasms, the chronic cellular stress is possibly caused by the presence of a constant genetic mutation.
In neurodegenerative diseases, such as Alzheimer&rsquo;s and Parkinson&rsquo;s diseases, chronic cellular stress is possibly caused
by age-correlated buildup of cellular insult and hence chronic cellular stress. Specifically, defects in homeostasis of protein
or ribonucleic acid (&ldquo;RNA&rdquo;) lead to the death of neurons and dysfunction of the nervous system. The spreading of protein
aggregates resulting in a proteinopathy, a characteristic finding in Alzheimer&rsquo;s and Parkinson&rsquo;s diseases that results
from disorders of protein synthesis, trafficking, folding, processing or degradation in cells. The clearance of macromolecules
in the brain is particularly susceptible to imbalances that result in aggregation and degeneration in nerve cells. For example,
Alzheimer&rsquo;s disease pathology is characterized by the presence of amyloid plaques, neurofibrillary tangles, which are aggregates
of hyperphosphorylated Tau protein that are a marker of other diseases known as tauopathies as well as inflammation of microglia.
With the SIGMAR1 activation through SIGMAR1 agonists like ANAVEX<SUP>&reg;</SUP>2-73, our approach is to restore cellular balance,
i.e. homeostasis. Therapies that correct defects in cellular homeostasis might have the potential to halt or delay neurodevelopmental
and neurodegenerative disease progression.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>ANAVEX</I></B><SUP>&reg;</SUP><B><I>2-73-specific
Biomarkers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
full genomic analysis of Alzheimer&rsquo;s disease (AD) patients treated with ANAVEX<SUP>&reg;</SUP>2-73 resulted in the identification
of actionable genetic variants. A significant impact of the genomic biomarkers SIGMAR1, the direct target of ANAVEX<SUP>&reg;</SUP>2-73
and COMT, a gene involved in memory function, on the drug response level was identified, leading to an early ANAVEX<SUP>&reg;</SUP>2-73-specific
biomarker hypothesis. It is expected that <I>excluding</I> patients with these two identified biomarker variants (approximately
10%-20% of the population) in prospective studies would identify approximately 80%-90% patients that would display clinically
significant improved functional and cognitive scores. The consistency between the identified DNA and RNA data related to ANAVEX<SUP>&reg;</SUP>2-73,
which are considered independent of AD pathology, as well as multiple endpoints and time-points, provides support for precision
medicine clinical development of ANAVEX<SUP>&reg;</SUP>2-73 by using genetic biomarkers identified within the study population
itself to target patients who are most likely to respond to ANAVEX<SUP>&reg;</SUP>2-73 treatment in AD as well as indications
like Parkinson&rsquo;s disease dementia (PDD) or Rett syndrome (RTT) in which ANAVEX<SUP>&reg;</SUP>2-73 is currently studied
or planned to be studied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Clinical
Studies Overview</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2016, we completed a Phase 2a clinical trial, consisting of PART A and PART B, which lasted a total of 57 weeks, for
ANAVEX<SUP>&reg;</SUP>2-73 in mild-to-moderate Alzheimer&rsquo;s patients. This open-label randomized trial met both primary and
secondary endpoints and was designed to assess the safety and exploratory efficacy of ANAVEX<SUP>&reg;</SUP>2-73 in 32 patients.
ANAVEX<SUP>&reg;</SUP>2-73 targets sigma-1 and muscarinic receptors, which have been shown in preclinical studies to reduce stress
levels in the brain believed to restore cellular homeostasis and to reverse the pathological hallmarks observed in Alzheimer&rsquo;s
disease. In October 2017, we presented positive pharmacokinetic (PK) and pharmacodynamic (PD) data from the Phase 2a study, which
established a concentration-effect relationship between ANAVEX<SUP>&reg;</SUP>2-73 and study measurements. These measures obtained
from all patients who participated in the entire 57 weeks include exploratory cognitive and functional scores as well as biomarker
signals of brain activity. Additionally, the study appears to show that ANAVEX<SUP>&reg;</SUP>2-73 activity is enhanced by its
active metabolite (ANAVEX19-144), which also targets the sigma-1 receptor and has a half-life approximately twice as long as the
parent molecule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2016, we received approval from the Ethics Committee in Australia to extend the Phase 2a clinical trial by an additional
108 weeks, which had been requested by patients and their caregivers. Subsequently, in May 2018, we received approval from the
Ethics Committee in Australia to further extend the Phase 2a extension trial for an additional two years. The two consecutive
trial extensions have allowed participants who completed the 52-week PART B of the study to continue taking ANAVEX<SUP>&reg;</SUP>2-73,
providing an opportunity to gather extended safety data for a cumulative time period of five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2018, we presented new long-term clinical data for ANAVEX<SUP>&reg;</SUP>2-73 in a presentation at the 2018 Clinical Trials
on Alzheimer&rsquo;s Disease (CTAD) Meeting. At 148 weeks into the five-year extended Phase 2a clinical study, data confirmed
a significant association between ANAVEX<SUP>&reg;</SUP>2-73 concentration and both exploratory functional and cognitive endpoints
as measured by the Alzheimer&rsquo;s Disease Cooperative Study-Activities of Daily Living&nbsp;(ADCS-ADL)&nbsp;evaluation and
the Mini Mental State Examination (MMSE), respectively. The cohort of patients treated with higher ANAVEX<SUP>&reg;</SUP>2-73
concentration maintained ADCS-ADL performance compared to the lower concentration cohort (p&lt;0.0001). As well, the patient cohort
with the higher ANAVEX<SUP>&reg;</SUP>2-73 concentration performed better at MMSE compared to the lower concentration cohort (p&lt;0.0008).
A significant impact on the drug response levels of both the SIGMAR1 (p&lt;0.0080) and COMT (p&lt;0.0014) genomic biomarkers,
identified and specified at week 57, was also confirmed over the 148-week period. Further, ANAVEX<SUP>&reg;</SUP>2-73 demonstrated
continued favorable safety and tolerability through 148 weeks.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
larger Phase 2b/3 double-blind, placebo-controlled study of ANAVEX<SUP>&reg;</SUP>2-73 in Alzheimer&rsquo;s disease commenced
in October 2018, which is independent of the ongoing Phase 2a extension study. The Phase 2b/3 study will enroll approximately
450 patients for 48 weeks, randomized 1:1:1 to two different ANAVEX<SUP>&reg;</SUP>2-73 doses or placebo. The trial is currently
taking place in Australia; however, North American sites may also be added. The ANAVEX<SUP>&reg;</SUP>2-73 Phase 2b/3 study design
incorporates genomic precision medicine biomarkers identified in the ANAVEX<SUP>&reg;</SUP>2-73 Phase 2a study. Primary and secondary
endpoints will assess safety and both cognitive and functional efficacy, measured through Alzheimer&rsquo;s Disease Assessment
Scale &ndash; Cognition (ADAS-Cog), ADCS-ADL and Clinical Dementia Rating &ndash; Sum of Boxes for cognition and function (CDR-SB).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, we presented positive preclinical data for ANAVEX<SUP>&reg;</SUP>2-73 in Rett syndrome, a rare neurodevelopmental
disease. The study was funded by the International Rett Syndrome Foundation (&ldquo;Rettsyndrome.org&rdquo;). In January 2017,
we were awarded a financial grant from Rettsyndrome.org of a minimum of $0.6 million to cover some of the costs of a multicenter
Phase 2 clinical trial of ANAVEX<SUP>&reg;</SUP>2-73 for the treatment of Rett syndrome. This award is being received in quarterly
instalments which commenced during fiscal 2018. Further, in March 2019, the Company commenced a Phase 2 clinical trial of ANAVEX<SUP>&reg;</SUP>2-73
for the treatment of Rett syndrome. The Phase 2 study is taking place in the United States and is a randomized double-blind, placebo-controlled
safety, tolerability, pharmacokinetic and efficacy study of oral liquid ANAVEX<SUP>&reg;</SUP>2-73 formulation to treat Rett syndrome.
Pharmacokinetic and dose findings will be investigated in a total of 15 patients over a 7-week treatment period including ANAVEX<SUP>&reg;</SUP>2-73-specific
genomic precision medicine biomarkers. All patients who participate in the study will be eligible to receive ANAVEX<SUP>&reg;</SUP>2-73
under a voluntary open label extension protocol. This study will be followed by a planned placebo-controlled safety and efficacy
evaluation of ANAVEX<SUP>&reg;</SUP>2-73 over a 3-month treatment period. Primary and secondary endpoints include safety as well
as Rett syndrome conditions such as cognitive impairment, motor impairment, behavioral symptoms and seizure activity. The ANAVEX<SUP>&reg;</SUP>2-73
Phase 2 Rett syndrome study design incorporates genomic precision medicine biomarkers identified in the ANAVEX<SUP>&reg;</SUP>2-73
Phase 2a Alzheimer&rsquo;s disease study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2016, we presented positive preclinical data for ANAVEX<SUP>&reg;</SUP>2-73 in Parkinson&rsquo;s disease, which demonstrated
significant improvements on all measures: behavioral, histopathological, and neuroinflammatory endpoints. The study was funded
by the Michael J. Fox Foundation. Additional data was announced in October 2017 from the model for experimental parkinsonism.
The data presented indicates that ANAVEX<SUP>&reg;</SUP>2-73 induces robust neurorestoration in experimental parkinsonism. The
encouraging results we have gathered in this model, coupled with the favorable profile of this compound in the Alzheimer&rsquo;s
disease trial, support the notion that ANAVEX<SUP>&reg;</SUP>2-73 is a promising clinical candidate drug for Parkinson&rsquo;s
disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2018, the Company initiated in Spain, a double-blind, randomized, placebo-controlled Phase 2 trial with ANAVEX<SUP>&reg;</SUP>2-73
in Parkinson&rsquo;s Disease Dementia (PDD), which will study the effect of the compound on both the cognitive and motor impairment
of Parkinson&rsquo;s disease. The Phase 2 study will enroll approximately 120 patients for 14 weeks, randomized 1:1:1 to two different
ANAVEX<SUP>&reg;</SUP>2-73 doses or placebo. The ANAVEX<SUP>&reg;</SUP>2-73 Phase 2 PDD study design incorporates genomic precision
medicine biomarkers identified in the ANAVEX<SUP>&reg;</SUP>2-73 Phase 2a study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Pipeline</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development pipeline includes ANAVEX<SUP>&reg;</SUP>2-73 currently in three different clinical studies, and several
compounds in different stages of pre-clinical study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
proprietary SIGMACEPTOR&trade; Discovery Platform produced small molecule drug candidates with unique modes of action, based on
our understanding of sigma receptors. Sigma receptors may be targets for therapeutics to combat many human diseases, both of neurodegenerative
nature, including Alzheimer&rsquo;s disease, as well as of neurodevelopmental nature, like Rett syndrome. When bound by the appropriate
ligands, sigma receptors influence the functioning of multiple biochemical signals that are involved in the pathogenesis (origin
or development) of disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compounds
that have been subjects of our research include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX<SUP>&reg;</SUP>2-73
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANAVEX<SUP>&reg;</SUP>2-73
may offer a disease-modifying approach in neurodegenerative and neurodevelopmental diseases by activation of sigma-1 receptors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Rett syndrome, administration of ANAVEX<SUP>&reg;</SUP>2-73 resulted in both significant and dose related improvements in an array
of behavioral paradigms in the MECP2 HET Rett syndrome disease model. In addition, in a further experiment sponsored by Rettsyndrome.org,
ANAVEX<SUP>&reg;</SUP>2-73 was evaluated in automatic visual response and respiration tests in 7-month old mice, an age at which
advanced pathology is evident. Vehicle-treated MECP2 mice demonstrated fewer automatic visual responses than wild-type mice. Treatment
with ANAVEX<SUP>&reg;</SUP>2-73 for four weeks significantly increased the automatic visual response in the MECP2 Rett syndrome
disease mouse. Additionally, chronic oral dosing daily for 6.5 weeks of ANAVEX<SUP>&reg;</SUP>2-73 starting at ~5.5 weeks of age
was conducted in the MECP2 HET Rett syndrome disease mouse model assessed the different aspects of muscular coordination, balance,
motor learning and muscular strengths, some of the core deficits observed in Rett syndrome. Administration of ANAVEX<SUP>&reg;</SUP>2-73
resulted in both significant and dose related improvements in an array of these behavioral paradigms in the MECP2 HET Rett syndrome
disease model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2019, the Company initiated a Phase 2 clinical trial of ANAVEX<SUP>&reg;</SUP>2-73 for the treatment of Rett syndrome. The
Phase 2 study is taking place in the United States and is a randomized double-blind, placebo-controlled safety, tolerability,
pharmacokinetic and efficacy study of oral liquid ANAVEX<SUP>&reg;</SUP>2-73 formulation to treat Rett syndrome. Pharmacokinetic
and dose finding will be investigated in a total of 15 patients over a 7-week treatment period using ANAVEX&reg;2-73-specific
genomic precision medicine biomarkers. All patients who participate in the study will be eligible to receive ANAVEX&reg;2-73 under
a voluntary open label extension protocol.&nbsp;This study is part of a planned Rett syndrome program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2016 and June 2016, the FDA granted Orphan Drug Designation to ANAVEX<SUP>&reg;</SUP>2-73 for the treatment of Rett syndrome
and infantile spasms, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
Parkinson&rsquo;s disease, data demonstrates significant improvements and restoration of function in a disease modifying animal
model of Parkinson&rsquo;s disease. Significant improvements were seen on all measures tested: behavioral, histopathological,
and neuroinflammatory endpoints. In July 2018 the Company received approval from the Spanish Agency for Medicinal Products and
Medical Devices (AEMPS), to initiate its Phase 2, double-blind, placebo-controlled 14-week trial of the safety and efficacy of
ANAVEX<SUP>&reg;</SUP>2-73 for the treatment of Parkinson&rsquo;s disease dementia. The Phase 2 study commenced in October 2018
and will involve approximately 120 patients, randomized 1:1:1 to two different ANAVEX<SUP>&reg;</SUP>2-73 doses or placebo, in
up to 24 clinical study sites.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
Alzheimer&rsquo;s disease (AD) animal models, ANAVEX<SUP>&reg;</SUP>2-73 has shown pharmacological, histological and behavioral
evidence as a potential neuroprotective, anti-amnesic, anti-convulsive and anti-depressive therapeutic agent, due to its potent
affinity to sigma-1 receptors and moderate affinities to M1-4 type muscarinic receptors. In addition, ANAVEX<SUP>&reg;</SUP>2-73
has shown a potential dual mechanism which may impact both amyloid and tau pathology. In a transgenic AD animal model Tg2576,
ANAVEX<SUP>&reg;</SUP>2-73 induced a statistically significant neuroprotective effect against the development of oxidative stress
in the mouse brain, as well as significantly increased the expression of functional and synaptic plasticity markers that is apparently
amyloid-beta independent. It also statistically alleviated the learning and memory deficits developed over time in the animals,
regardless of sex, both in terms of spatial working memory and long-term spatial reference memory.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the results of pre-clinical testing, we initiated and completed a Phase 1 single ascending dose (SAD) clinical trial of ANAVEX<SUP>&reg;</SUP>2-73.
In this Phase 1 SAD trial, the maximum tolerated single dose was defined per protocol as 55-60 mg. This dose is above the equivalent
dose shown to have positive effects in mouse models of AD. There were no significant changes in laboratory or electrocardiogram
(ECG) parameters. ANAVEX<SUP>&reg;</SUP>2-73 was well tolerated below the 55-60 mg dose with only mild adverse events in some
subjects. Observed adverse events at doses above the maximum tolerated single dose included headache and dizziness, which were
moderate in severity and reversible. These side effects are often seen with drugs that target CNS conditions, including AD.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ANAVEX<SUP>&reg;</SUP>2-73 Phase 1 SAD trial was conducted as a randomized, placebo-controlled study. Healthy male volunteers
between the ages of 18 and 55 received single, ascending oral doses over the course of the trial. Study endpoints included safety
and tolerability together with pharmacokinetic parameters. Pharmacokinetics includes the absorption and distribution of a drug,
the rate at which a drug enters the blood and the duration of its effect, as well as chemical changes of the substance in the
body. This study was conducted in Germany in collaboration with ABX-CRO, a clinical research organization that has conducted several
Alzheimer&rsquo;s disease studies, and the Technical University of Dresden.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2014, a Phase 2a clinical trial was initiated for ANAVEX<SUP>&reg;</SUP>2-73, which is being evaluated for the treatment
of Alzheimer&rsquo;s disease. The open-label randomized trial was designed to assess the safety and exploratory efficacy of ANAVEX<SUP>&reg;</SUP>2-73
in 32 patients with mild-to-moderate Alzheimer&rsquo;s disease. ANAVEX<SUP>&reg;</SUP>2-73 targets sigma-1 and muscarinic receptors,
which have been shown in preclinical studies to reduce stress levels in the brain believed to restore cellular homeostasis and
to reverse the pathological hallmarks observed in Alzheimer&rsquo;s disease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Phase 2a study met both primary and secondary objectives of the study.&nbsp;The 31-week&nbsp;preliminary exploratory&nbsp;safety
and&nbsp;efficacy data from the&nbsp;Phase 2a study of ANAVEX<SUP>&reg;</SUP>2-73 in Alzheimer&rsquo;s&nbsp;patients, with most
receiving also donepezil, the current standard of care, demonstrated&nbsp;favorable&nbsp;safety, maximum tolerated&nbsp;dose,
positive dose response, sustained efficacy response through 31 weeks for both cognitive and functional measures, as well as&nbsp;positive
unexpected therapeutic response events. ANAVEX<SUP>&reg;</SUP>2-73 continued to demonstrate a favorable adverse event (AE) profile&nbsp;through
31 weeks in a patient population of elderly Alzheimer&rsquo;s patients with varying degrees of physical fragility. The most common&nbsp;side
effects across all AE categories tended to be of mild severity grade 1 and were resolved with dose reductions that were&nbsp;anticipated
within the adaptive design of the study protocol.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
57 weeks, Alzheimer&rsquo;s patients taking a daily oral dose between 10mg and 50mg of ANAVEX<SUP>&reg;</SUP>2-73 was well tolerated.
There were no clinically significant treatment-related adverse events and no serious adverse events. Despite non-optimized dosing
of ANAVEX<SUP>&reg;</SUP>2-73 throughout the 57-week study, continued significant improvements from baseline of cognitive, functional
and behavioral scores in a group of patients were observed, respectively. This data was analyzed using refined mathematical modeling
methods in conjunction with the detailed pharmacokinetic (PK) information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2017, we presented positive PK and PD data from the Phase 2a study, which established a concentration-effect relationship
between ANAVEX<SUP>&reg;</SUP>2-73 and study measurements. These measures, obtained from all patients who participated in the
entire 57 weeks, include exploratory cognitive and functional scores as well as biomarker signals of brain activity. Additionally,
the study appears to show that ANAVEX<SUP>&reg;</SUP>2-73 activity is enhanced by its active metabolite (ANAVEX19-144), which
also targets the sigma-1 receptor and has a half-life approximately twice as long as the parent molecule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-specified
exploratory analyses included the cognitive (MMSE) and the functional (ADCS-ADL) changes from baseline. A continued stabilization
of both cognitive and functional measures in patients treated with ANAVEX<SUP>&reg;</SUP>2-73 was observed. This correlation was
positive within all measured scores (MMSE, ADCS-ADL, Cogstate, HAM-D and EEG/ERP).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2018, we presented the results of a genomic DNA and RNA evaluation of the participants in the Phase 2a study. More than 33,000
genes were analyzed using unbiased, data driven, machine learning, artificial intelligence (AI) system for analyzing DNA &amp;
RNA data in patients exposed to ANAVEX<SUP>&reg;</SUP>2-73. The analysis identified genetic variants that impacted response to
ANAVEX<SUP>&reg;</SUP>2-73, among them variants related to the Sigma-1 receptor (SIGMAR1), the target for ANAVEX<SUP>&reg;</SUP>2-73.
Results showed that study participants without the SIGMAR1 (rs1800866) variants, which is about 80 percent of the population worldwide,
demonstrated improved cognitive (MMSE) and the functional (ADCS-ADL) scores. The results from this evaluation may enable a precision
medicine approach, since these signatures can now be applied to neurological indications tested in clinical studies with ANAVEX<SUP>&reg;</SUP>2-73
including Alzheimer&rsquo;s disease, Parkinson&rsquo;s disease dementia and Rett syndrome.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANAVEX<SUP>&reg;</SUP>2-73
data presented met prerequisite information in order to progress into a Phase 2b/3 placebo-controlled study. On July 2, 2018,
the Human Research Ethics Committee in Australia approved the initiation of our Phase 2b/3, double-blind, randomized, placebo-controlled
48-week safety and efficacy trial of ANAVEX<SUP>&reg;</SUP>2-73 for the treatment of early Alzheimer&rsquo;s disease. This Phase
2b/3 study design incorporates inclusion of genomic precision medicine biomarkers identified in the ANAVEX<SUP>&reg;</SUP>2-73
Phase 2a study. The Phase 2b/3 study, which is expected to enroll approximately 450 patients, randomized 1:1:1 to either two different
ANAVEX<SUP>&reg;</SUP>2-73 doses or placebo, commenced in October 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
data also validates ANAVEX<SUP>&reg;</SUP>2-73 as a prospective platform drug for other neurodegenerative diseases beyond Alzheimer&rsquo;s
disease, Parkinson&rsquo;s disease or Rett syndrome, more specifically, epilepsy, infantile spasms, Fragile X syndrome, Angelman
syndrome, multiple sclerosis and, more recently, tuberous sclerosis complex (TSC). ANAVEX<SUP>&reg;</SUP>2-73 demonstrated significant
improvements in all of these indications in the respective preclinical animal models.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a study sponsored by the Foundation for Angelman Syndrome, ANAVEX<SUP>&reg;</SUP>2-73 was assessed in a mouse model for the development
of audiogenic seizures. The results indicated that ANAVEX<SUP>&reg;</SUP>2-73 administration significantly reduced audiogenic-induced
seizures. In a study sponsored by FRAXA Research Foundation regarding Fragile X syndrome, data demonstrated that ANAVEX<SUP>&reg;</SUP>2-73
restored hippocampal brain-derived neurotrophic factor (BDNF) expression to normal levels. BDNF under-expression has been observed
in many neurodevelopmental and neurodegenerative pathologies. BDNF signaling promotes maturation of both excitatory and inhibitory
synapses. ANAVEX<SUP>&reg;</SUP>2-73 normalization of BDNF expression could be a contributing factor for the positive data observed
in both neurodevelopmental and neurodegenerative disorders like Angelman and Fragile X syndromes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
data presented also indicates that ANAVEX<SUP>&reg;</SUP>2-73 demonstrates protective effects of mitochondrial enzyme complexes
during pathological conditions, which, if impaired, are believed to play a role in the pathogenesis of neurodegenerative and neurodevelopmental
diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
data on ANAVEX<SUP>&reg;</SUP>2-73 related to multiple sclerosis indicates that ANAVEX<SUP>&reg;</SUP>2-73 may promote remyelination
in multiple sclerosis disease. Further, data also demonstrates that ANAVEX<SUP>&reg;</SUP>2-73 provides protection for oligodendrocytes
(&ldquo;OL&rsquo;s&rdquo;) and oligodendrocyte precursor cells (&ldquo;OPC&rsquo;s&rdquo;), as well as central nervous system
neurons in addition to helping repair by increasing OPC proliferation and maturation in tissue culture.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2018, we presented preclinical data of ANAVEX<SUP>&reg;</SUP>2-73 in a genetic mouse model of tuberous sclerosis complex
(&ldquo;TSC&rdquo;). TSC is a rare genetic disorder characterized by the growth of numerous benign tumors in many parts of the
body with a high incidence of seizures. The new preclinical data demonstrates that treatment with ANAVEX<SUP>&reg;</SUP>2-73 significantly
increases survival and reduces seizures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX<SUP>&reg;</SUP>3-71</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANAVEX<SUP>&reg;</SUP>3-71
is a preclinical drug candidate with a novel mechanism of action via sigma-1 receptor activation and M1 muscarinic allosteric
modulation, which has been shown to enhance neuroprotection and cognition in Alzheimer&rsquo;s disease models. ANAVEX<SUP>&reg;</SUP>3-71
is a CNS-penetrable mono-therapy that bridges treatment of both cognitive impairments with disease modifications. It is highly
effective in very small doses against the major Alzheimer&rsquo;s hallmarks in transgenic (3xTg-AD) mice, including cognitive
deficits, amyloid and tau pathologies, and also has beneficial effects on inflammation and mitochondrial dysfunctions. ANAVEX<SUP>&reg;</SUP>3-71
indicates extensive therapeutic advantages in Alzheimer&rsquo;s and other protein-aggregation-related diseases given its ability
to enhance neuroprotection and cognition via sigma-1 receptor activation and M1 muscarinic allosteric modulation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
preclinical study examined the response of ANAVEX<SUP>&reg;</SUP>3-71 in aged transgenic animal models and showed a significant
reduction in the rate of cognitive deficit, amyloid beta pathology and inflammation with the administration of ANAVEX 3-71. In
April 2016, the FDA granted Orphan Drug Designation to ANAVEX<SUP>&reg;</SUP>3-71 for the treatment of Frontotemporal dementia
(FTD).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
pathological conditions ANAVEX<SUP>&reg;</SUP>3-71 demonstrated the formation of new synapses between neurons (synaptogenesis)
without causing an abnormal increase in the number of astrocytes. In neurodegenerative diseases such as Alzheimer&rsquo;s and
Parkinson&rsquo;s disease, synaptogenesis is believed to be impaired. Additional preclinical data presented also indicates that
in addition to reducing oxidative stress, ANAVEX<SUP>&reg;</SUP>3-71 demonstrates protective effects of mitochondrial enzyme complexes
during pathological conditions, which, if impaired, are believed to play a role in the pathogenesis of neurodegenerative and neurodevelopmental
diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX<SUP>&reg;</SUP>1-41</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANAVEX<SUP>&reg;</SUP>1-41
is a sigma-1 agonist. Pre-clinical tests revealed significant neuroprotective benefits (i.e., protects nerve cells from degeneration
or death) through the modulation of endoplasmic reticulum, mitochondrial and oxidative stress, which damages and impairs cell
viability. In addition, in animal models, ANAVEX<SUP>&reg;</SUP>1-41 prevented the expression of caspase-3, an enzyme that plays
a key role in apoptosis (programmed cell death) and loss of cells in the hippocampus, the part of the brain that regulates learning,
emotion and memory. These activities involve both muscarinic and sigma-1 receptor systems through a novel mechanism of action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preclinical
data presented also indicates that ANAVEX<SUP>&reg;</SUP>1-41 demonstrates protective effects of mitochondrial enzyme complexes
during pathological conditions, which, if impaired, are believed to play a role in the pathogenesis of neurodegenerative and neurodevelopmental
diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX<SUP>&reg;</SUP>1066</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANAVEX<SUP>&reg;</SUP>1066,
a mixed sigma-1/sigma-2 ligand is designed for the potential treatment of neuropathic and visceral pain. ANAVEX<SUP>&reg;</SUP>1066
was tested in two preclinical models of neuropathic and visceral pain that have been extensively validated in rats. In the chronic
constriction injury model of neuropathic pain, a single oral administration of ANAVEX<SUP>&reg;</SUP>1066 dose-dependently restored
the nociceptive threshold in the affected paw to normal levels while leaving the contralateral healthy paw unchanged. Efficacy
was rapid and remained significant for two hours. In a model of visceral pain, chronic colonic hypersensitivity was induced by
injection of an inflammatory agent directly into the colon and a single oral administration of ANAVEX<SUP>&reg;</SUP>1066 returned
the nociceptive threshold to control levels in a dose-dependent manner. Companion studies in rats demonstrated the lack of any
effects on normal gastrointestinal transit with ANAVEX<SUP>&reg;</SUP>1066 and a favorable safety profile in a battery of behavioral
measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
compounds are in the pre-clinical and clinical testing stages of development, and there is no guarantee that the activity demonstrated
in pre-clinical models will be shown in human testing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX<SUP>&reg;</SUP>1037
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANAVEX<SUP>&reg;</SUP>1037
is designed for the treatment of prostate and pancreatic cancer. It is a low molecular weight, synthetic compound exhibiting high
affinity for sigma-1 receptors at nanomolar levels and moderate affinity for sigma-2 receptors and sodium channels at micromolar
levels. In advanced pre-clinical studies, this compound revealed antitumor potential. It has also been shown to selectively kill
human cancer cells without affecting normal/healthy cells and also to significantly suppress tumor growth in immune-deficient
mice models. Scientific publications highlight the possibility that these ligands may stop tumor growth and induce selective cell
death in various tumor cell lines. Sigma receptors are highly expressed in different tumor cell types. Binding by appropriate
sigma-1 and/or sigma-2 ligands can induce selective apoptosis. In addition, through tumor cell membrane reorganization and interactions
with ion channels, our drug candidates may play an important role in inhibiting the processes of metastasis (spreading of cancer
cells from the original site to other parts of the body), angiogenesis (the formation of new blood vessels) and tumor cell proliferation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to identify and initiate discussions with potential strategic and commercial partners to most effectively advance our
programs and realize maximum shareholder value. Further, we may acquire or develop new intellectual property and assign, license,
or otherwise transfer our intellectual property to further our goals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Target Indications</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have developed compounds with potential application to two broad categories and several specific indications. including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Central
Nervous System Diseases</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alzheimer&rsquo;s
                                         disease &ndash; In 2018, an estimated 5.5 million Americans were suffering from Alzheimer&rsquo;s
                                         disease. The Alzheimer&rsquo;s Association<SUP>&reg;</SUP> reports that by 2025, 7.1
                                         million Americans will be afflicted by the disease, about a 29 percent increase from
                                         currently affected patients. Medications on the market today treat only the symptoms
                                         of Alzheimer&rsquo;s disease and do not have the ability to stop its onset or its progression.
                                         There is an urgent and unmet need for both a disease modifying cure for Alzheimer&rsquo;s
                                         disease as well as for better symptomatic treatments.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parkinson&rsquo;s
                                         disease &ndash; Parkinson&rsquo;s disease is a progressive disease of the nervous system
                                         marked by tremors, muscular rigidity, and slow, imprecise movement. It is associated
                                         with degeneration of the basal ganglia of the brain and a deficiency of the neurotransmitter
                                         dopamine. Parkinson&rsquo;s disease afflicts more than 10 million people worldwide, typically
                                         middle-aged and elderly people. The Parkinson&rsquo;s disease market is set to expand
                                         from $2.1 billion in 2014 to $3.2 billion by 2021, according to business intelligence
                                         provider GBI Research.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rett
                                         syndrome - Rett syndrome is a rare X-linked genetic neurological and developmental disorder
                                         that affects the way the brain develops, including protein transcription, which is altered
                                         and as a result leads to severe disruptions in neuronal homeostasis. It is considered
                                         a rare, progressive neurodevelopmental disorder and is caused by a single mutation in
                                         the MECP2 gene. Because males have a different chromosome combination from females, boys
                                         who have the genetic MECP2 mutation are affected in devastating ways. Most of them die
                                         before birth or in early infancy. For females who survive infancy, Rett syndrome leads
                                         to severe impairments, affecting nearly every aspect of the child&rsquo;s life; severe
                                         mental retardation, their ability to speak, walk and eat, sleeping problems, seizures
                                         and even the ability to breathe easily. Rett syndrome affects approximately 1 in every
                                         10,000-15,000 females.</FONT></TD></TR></TABLE>
<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depression
                                         - Depression is a major cause of morbidity worldwide according to the World Health Organization.
                                         Pharmaceutical treatment for depression is dominated by blockbuster brands, with the
                                         leading nine brands accounting for approximately 75% of total sales. However, the dominance
                                         of the leading brands is waning, largely due to the effects of patent expiration and
                                         generic competition.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Epilepsy
                                         - Epilepsy is a common chronic neurological disorder characterized by recurrent unprovoked
                                         seizures. These seizures are transient signs and/or symptoms of abnormal, excessive or
                                         synchronous neuronal activity in the brain. According to the Centers for Disease Control
                                         and Prevention, epilepsy affects 3.4 million Americans. Today, epilepsy is often controlled,
                                         but not cured, with medication that is categorized as older traditional anti-epileptic
                                         drugs and second generation anti-epileptic drugs. Because epilepsy afflicts sufferers
                                         in different ways, there is a need for drugs used in combination with both traditional
                                         anti-epileptic drugs and second generation anti-epileptic drugs. GBI Research estimates
                                         that the epilepsy market will increase to $4.5 billion by 2019.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuropathic
                                         Pain &ndash; We define neuralgia, or neuropathic pain, as pain that is not related to
                                         activation of pain receptor cells in any part of the body. Neuralgia is more difficult
                                         to treat than some other types of pain because it does not respond well to normal pain
                                         medications. Special medications have become more specific to neuralgia and typically
                                         fall under the category of membrane stabilizing drugs or antidepressants.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cancer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Malignant
                                         Melanoma - Predominantly a skin cancer, malignant melanoma can also occur in melanocytes
                                         found in the bowel and the eye. Malignant melanoma accounts for 75% of all deaths associated
                                         with skin cancer. The treatment includes surgical removal of the tumor, adjuvant treatment,
                                         chemo and immunotherapy, or radiation therapy. According to IMS Health the worldwide
                                         malignant melanoma market is expected to grow to $4.4 billion by 2022.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prostate
                                         Cancer &ndash; Specific to men, prostate cancer is a form of cancer that develops in
                                         the prostate, a gland in the male reproductive system. The cancer cells may metastasize
                                         from the prostate to other parts of the body, particularly the bones and lymph nodes.
                                         Drug therapeutics for prostate cancer are expected to increase to nearly $13.5 billion
                                         in 2024 according to Datamonitor Healthcare.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pancreatic
                                         Cancer - Pancreatic cancer is a malignant neoplasm of the pancreas. In the United States,
                                         approximately 55,000 new cases of pancreatic cancer will be diagnosed this year and approximately
                                         44,000 patients will die as a result of their cancer, according to the American Cancer
                                         Society. Sales predictions by GBI Research forecast that the market for the pharmaceutical
                                         treatment of pancreatic cancer in the United States and five largest European countries
                                         will increase to $2.9 billion by 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Patents,
Trademarks and Intellectual Property </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anavex
holds ownership or exclusive rights to four U.S. patents, nine U.S. patent applications, and various PCT or ex-U.S. patent applications
relating to our drug candidates, methods associated therewith, and to our research programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own one issued U.S. patent entitled &ldquo;ANAVEX<SUP>&reg;</SUP>2-73 and certain anticholinesterase inhibitors composition and
method for neuroprotection&rdquo; claims a composition of matter of ANAVEX&reg;2-73 directed to a novel and synergistic neuroprotective
compound combined with donepezil and other cholinesterase inhibitors.&nbsp; This patent is expected to expire in June 2034, absent
any patent term extension for regulatory delays. A related continuation application is also pending in the U.S. In addition, we
own one issued U.S. Patent with claims directed to methods of treating melanoma with a compound related to ANAVEX<SUP>&reg;</SUP>2-73.
This patent is expected to expire in February 2030, absent any patent term extension for regulatory delays.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to ANAVEX<SUP>&reg;</SUP>3-71, we own exclusive rights to two issued U.S. patents with claims respectively directed to
the ANAVEX<SUP>&reg;</SUP>3-71 compound and methods of treating various diseases including Alzheimer&rsquo;s with the same. These
patents are expected to expire in April 2030, and January 2030, respectively, absent any patent term extension for regulatory
delays. We also own exclusive rights to related patents or applications that are granted or pending in Australia, Canada, China,
Europe, Japan, Korea, New Zealand, Russia, and South Africa, and are expected to expire in January 2030.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also own other patent applications directed to enantiomers, formulations and uses that may provide additional protection for one
or more of our product candidates.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
regard patents and other intellectual property rights as corporate assets. Accordingly, we attempt to optimize the value of intellectual
property in developing our business strategy including the selective development, protection, and exploitation of our intellectual
property rights. In addition to filings made with intellectual property authorities, we protect our intellectual property and
confidential information by means of carefully considered processes of communication and the sharing of information, and by the
use of confidentiality and non-disclosure agreements and provisions for the same in contractor&rsquo;s agreements. While no agreement
offers absolute protection, such agreements provide some form of recourse in the event of disclosure, or anticipated disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property position, like that of many biomedical companies, is uncertain and involves complex legal and technical
questions for which important legal principles are unresolved. For more information regarding challenges to our existing or future
patents, see Item 1A &ldquo;Risk Factors.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
Highlights</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses for the second quarter of fiscal 2019 were $8.1 million, compared to $4.7 million for the comparable quarter in fiscal
2018. The operating expenses include an aggregate of $1.9 million, as compared to $1.2 million in second quarter fiscal 2018,
in non-cash charges related to the issuance and vesting of stock options. The increase in operating expenses is primarily attributable
to a $2.8 million increase in research and development expenses to $6.1 million in the second quarter of fiscal 2019, mainly due
to the commencement of three clinical studies for ANAVEX&reg;2-73, a Phase 2b/3 Alzheimer&rsquo;s disease clinical study, a Phase
2 Parkinson&rsquo;s disease dementia clinical study, and a Phase 2 Rett syndrome clinical study.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the second quarter of fiscal 2019 was $8.0 million, or $0.17 per share, as compared to $4.8 million, or $0.11 per share
in the comparative quarter of fiscal 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Results
of Operations</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">We
are in the development stage and have not earned any revenues since our inception and we do not anticipate earning any revenues
until we can establish an alliance with other companies to develop, co-develop, license, acquire or market our products.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal"><B>Three
and six months ended March 31, 2019 compared to three and six months ended March 31, 2018</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
Expenses</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
operating expenses for the second quarter of fiscal 2019 were $8.1 million, compared to $4.7 million for the second quarter of
fiscal 2018. Total operating expenses for the first half of fiscal 2019 were $15.6 million compared to $8.8 million for the same
period in fiscal 2018. This represents an increase of $3.4 million for the three-month period and $6.8 million for the six months
period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses have increased by $2.8 million to $6.1 million for the three months ended March 31, 2019, and by $5.9
million to $11.8 million for the six-month period ended March 31, 2019, as compared to the applicable prior year periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research
and development expenses includes approximately $3.1 million for the three-month period and $6.0 million for the six-month period
ended March 31, 2019 spent in connection with the clinical stage development of ANAVEX<SUP>&reg;</SUP>2-73. The increases were
associated with expenditures incurred in connection with the commencement of three clinical studies for ANAVEX<SUP>&reg;</SUP>2-73.
During the first half of fiscal 2019, the Company commenced a Phase 2b/3 clinical study for the treatment of Alzheimer&rsquo;s
disease, a Phase 2 study for the treatment of Parkinsons Disease Dementia and a Phase 2 study for the treatment of Rett syndrome.
In addition, the Company&rsquo;s Phase 2a extension study in Alzheimer&rsquo;s disease continued. Research and development expenses
include approximately $1.0 million for the three-month period and $1.9 million for the six-month period spent in preclinical development
activities for ANAVEX<SUP>&reg;</SUP>2-73 and ANAVEX<SUP>&reg;</SUP>3-71. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
income </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net amount of other income was $0.18 million as compared to $0.0 million for the three-month period ended March 31, 2019 and $0.3
million for the six-month period as compared to $0.05 million for the comparable six-month period in fiscal 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal 2019 we received $149,055 in grant income from the Rett Syndrome Foundation, which is being utilized towards the ANAVEX<SUP>&reg;</SUP>2-73
Phase 2 clinical study for Rett syndrome, which commenced in March 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity
and Capital Resources</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
Capital&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2018</FONT></TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 66%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Assets</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,549,780</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,323,740</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Liabilities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,370,604</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,884,626</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Working
    Capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,179,176</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,439,114</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
At March 31, 2019, we had $19.5 million in cash and cash equivalents, a decrease of $3.5 million from September 30, 2018. The
principal reason for this decrease is due to an increase in cash utilized in operations to $8.5 million, due to an increase in
clinical development activities, as described above, offset by cash received of $5.1 million from the issuance of shares of common
stock issued under the Purchase Agreement (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
Flows&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six
    months ended March 31,</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 66%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash flows used in operating activities</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,491,627</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,441,100</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    cash flows from financing activities</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,018,834</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,657,427</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Decrease
    in cash and cash equivalents during the period</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,472,793</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,783,673</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flow used in operating activities</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities for the first six months in fiscal 2019 was $8.5 million, compared to $6.4 million during the
comparable period during fiscal 2018. The principal reason for this increase in net cash used from operating activities in the
current period is due to the increase in operating expenses, particularly clinical development costs, as described above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
flow provided by financing activities</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
provided by financing activities for the first six months in fiscal 2019 was $5.0 million, attributable to cash received from
the issuance of common shares at various market prices under the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
provided by financing activities for the first six months in fiscal 2018 was $4.6 million, attributable to cash received from
the issuance of common shares at various market prices under the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Financing</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Controlled
Equity Offering Sales Agreement</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 6, 2018, we entered into a Controlled Equity Offering&nbsp;Sales Agreement (the &ldquo;Sales Agreement&rdquo;) with Cantor
Fitzgerald&nbsp;&amp; Co., as agent (&ldquo;Cantor Fitzgerald&rdquo;), pursuant to which we may offer and sell shares of common
stock, for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald (the &ldquo;At-the-Market
Offering&rdquo;).&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
delivery of a placement notice based on the Company&rsquo;s instructions and subject to the terms and conditions of the Sales
Agreement, Cantor Fitzgerald may sell shares of common stock by methods deemed to be an &ldquo;at the market offering&rdquo; offering,
in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices,
or by any other method permitted by law, including negotiated transactions, subject to the prior written consent of the Company.
We are not obligated to make any sales of shares under the Sales Agreement. We or Cantor Fitzgerald may suspend or terminate the
At-the-Market Offering upon notice to the other party, subject to certain conditions.&nbsp; Cantor Fitzgerald will act as sales
agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices and applicable state and
federal law, rules&nbsp;and regulations and the rules&nbsp;of Nasdaq.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed to pay Cantor Fitzgerald commissions for its services of acting as agent of up to 3.0% of the gross proceeds
from the sale of the Shares pursuant to the Sales Agreement.&nbsp; We have also agreed to provide Cantor Fitzgerald with customary
indemnification and contribution rights. To date, no shares of common stock have been sold pursuant to the Sales Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 21, 2015, we entered into a Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;) with Lincoln Park Capital Fund,
LLC (&ldquo;Lincoln Park&rdquo;), pursuant to which Lincoln Park committed to purchase up to $50,000,000 of our common stock.
Concurrently with the execution of the Purchase Agreement, we issued 179,598 shares of our common stock to Lincoln Park as a fee
for its commitment to purchase shares of our common stock under the Purchase Agreement and shall issue up to 89,799 shares pro
rata, when and if Lincoln Park purchases, at our discretion, the $50,000,000 aggregate commitment. The purchase shares that may
be sold pursuant to the Purchase Agreement may be sold by us to Lincoln Park at our discretion from time to time until September
6, 2019, 36 months after the SEC declared effective the related registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may direct Lincoln Park, at our sole discretion, and subject to certain conditions, to purchase up to 50,000 shares of common
stock on any business day, provided that at least one business day has passed since the most recent purchase. The amount of a
purchase may be increased under certain circumstances provided, however that Lincoln Park&rsquo;s committed obligation under any
single purchase shall not exceed $2,000,000. The purchase price of shares of common stock related to the future funding will be
based on the then prevailing market prices of such shares at the time of sales as described in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than our rights related to the At-the-Market Offering and the Lincoln Park financing, there can be no assurance that additional
financing will be available to us when needed or, if available, that it can be obtained on commercially reasonable terms. If we
are not able to obtain the additional financing on a timely basis, if and when it is needed, we will be forced to delay or scale
down some or all of our research and development activities or perhaps even cease the operation of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect that we will be able to continue to fund our operations through existing cash on hand and through equity and debt financing
in the future. If we raise additional financing by issuing equity securities, our existing stockholders&rsquo; ownership will
be diluted. Obtaining commercial loans, assuming those loans would be available, would increase our liabilities and future cash
commitments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal">Off-Balance
Sheet Arrangements</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; font-style: normal">We
have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial
condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital
resources that are material to our stockholders.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CRITICAL
ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
prepare our interim condensed consolidated financial statements in accordance with accounting principles generally accepted in
the United States of America, and make estimates and assumptions that affect our reported amounts of assets, liabilities, revenue
and expenses, and the related disclosures of contingent liabilities. We base our estimates on historical experience and other
assumptions that we believe are reasonable in the circumstances. Actual results may differ from these estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
have been no significant changes in the critical accounting policies and estimates described in our Annual Report on Form 10-K
for the year ended September 30, 2018 as filed with the SEC on December 12, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECENT
ACCOUNTING PRONOUNCEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to Note 2 &ldquo;Recent Accounting Pronouncements&rdquo; in notes to our Interim Condensed Consolidated Financial Statements
included in this Form 10-Q.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a004_v1"></A>Item
3. Quantitative and Qualitative Disclosures about Market Risks.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a005_v1"></A>Item
4. Controls and Procedures.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
Controls and Procedures </B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain disclosure controls and procedures that are designed to provide reasonable assurance that material information required
to be disclosed in our periodic reports filed under the Exchange Act is recorded, processed, summarized, and reported within the
time periods specified in the SEC&rsquo;s rules and forms and to provide reasonable assurance that such information is accumulated
and communicated to our management, our chief executive officer and our principal financial officer, to allow timely decisions
regarding required disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
carried out an evaluation, under the supervision and with the participation of our management, including our principal executive
officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures,
as defined in Rule 13(a) 15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal
financial officer concluded that our disclosure controls and procedures were effective, as of March 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the quarter ended March 31, 2019, there were no changes in our internal control over financial reporting identified in management&rsquo;s
evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Form 10-Q that materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a006_v1"></A>PART
II &ndash; OTHER INFORMATION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a007_v1"></A>Item
1. Legal Proceedings.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
know of no material pending legal proceedings, other than ordinary routine litigation incidental to our business, to which our
company or our subsidiary is a party or of which any of their property is subject. There are no proceedings in which any of our
directors, officers or affiliates, or any registered or beneficial stockholder holding more than 5% of our shares, is an adverse
party or has a material interest adverse to our or our subsidiary&rsquo;s interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a008_v1"></A>Item
1A. Risk Factors.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the information set forth in this Form 10-Q, you should carefully review and consider the risk factors discussed in
&ldquo;Item 1A &ndash; Risk Factors&rdquo; in our Annual Report on Form 10-K for the fiscal year ended September 30, 2018 filed
with the SEC on December 12, 2018. These risks could materially and adversely affect our business, financial condition and results
of operations. The risks described in herein and in our Form 10-K are not the only risks we face. Our operations could also be
affected by additional factors that are not presently known to us or by factors that we currently consider immaterial to our business.
There have been no material changes in the significant factors that may affect our business and operations as described in &ldquo;Item
1A &ndash; Risk Factors&rdquo; of the Annual Report on Form 10-K for the fiscal year ended September 30, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a009_v1"></A>Item
2. Unregistered Sales of Equity Securities and Use of Proceeds.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the period covered by this Quarterly Report on Form 10-Q, we have not sold any equity securities that were not registered under
the Securities Act of 1933 that were not previously reported in a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a010_v1"></A>Item
3. Defaults Upon Senior Securities.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a011_v1"></A>Item
4. Mine Safety Disclosures</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><A NAME="a012_v1"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
5. Other Information.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 3, 2019 (the &ldquo;Effective Date&rdquo;),
the Company entered into a Second Amendment to the Employment Agreement (the &ldquo;Amendment&rdquo;) with the Company&rsquo;s
Chief Executive Officer (the &ldquo;CEO&rdquo;) in his continuing capacity as Chief Executive Officer of the Company. The Amendment
amends the Employment Agreement by and between the Company and the CEO, effective July 5, 2013 (the &ldquo;Employment Agreement&rdquo;),
as amended, and extends the term of the Employment Agreement through July 5, 2022, unless earlier terminated as provided in the
Amendment. Pursuant to the terms of the Amendment, the CEO shall receive an annual base salary of $550,000 and is eligible to earn
an annual cash target bonus for each whole or partial calendar year of twenty percent of his base salary. Subject to the terms
of the Amendment, the CEO will also receive on the Effective Date 750,000 options for shares of the Company&rsquo;s common stock,
one-third of which shall vest on each of July 5, 2020, July 5, 2021 and July 5, 2022. The options shall have an exercise price
equal to the closing price of the Company&rsquo;s common stock on the Effective Date.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a013_v1"></A>Item
6. Exhibits.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 12%; border: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    </B><BR>
    <B>Number </B></FONT></TD>
    <TD STYLE="width: 88%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
    <B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(3)
    </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Articles
    of Incorporation and Bylaws </B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1*</FONT></A></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles
    of Incorporation, as amended</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(31)
    </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule
    13a-14(a)/15(d)-14(a)Certifications</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex31-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</FONT></A></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex31-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Christopher Missling, PhD.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex31-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</FONT></A></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex31-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Sandra Boenisch</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(32)
    </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
    1350 Certifications</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex32-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1*</FONT></A></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex32-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certification of Christopher Missling, PhD and Sandra Boenisch.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><P STYLE="margin: 0pt 0"><B>(10)</B></P>


</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><P STYLE="margin: 0pt 0"><B>Material
                                         Contracts</B></P>


</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1*</FONT>


</A></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><A HREF="s118023_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Employment Agreement by and between Anavex Life Sciences Corp. and Christopher Missling,
PhD, dated May 3, 2019</FONT>


</A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(101)</B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>XBRL</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    INSTANCE DOCUMENT</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    TAXONOMY EXTENSION SCHEMA</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    TAXONOMY EXTENSION CALCULATION LINKBASE</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    TAXONOMY EXTENSION DEFINITION LINKBASE</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    TAXONOMY EXTENSION LABEL LINKBASE</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.75pt; padding-left: 5.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    TAXONOMY EXTENSION PRESENTATION LINKBASE</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Filed herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a014_v1"></A>SIGNATURES</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX
    LIFE SCIENCES CORP.</B></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Christopher
    Missling, PhD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    Missling, PhD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 8, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Sandra
    Boenisch</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandra
    Boenisch, CPA, CGA</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 8, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>s118023_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right">&nbsp;<B>&nbsp;</B></P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="s118023_ex3-1img01.jpg" ALT="">&nbsp;&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<IMG SRC="s118023_ex3-1img02.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="s118023_ex3-1img03.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="s118023_ex3-1img04.jpg" ALT=""></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<CENTER>
<DIV STYLE="border: BLACK 1pt solid; padding: 1% 2%; width: 96%; text-align: center">
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="s118023_ex3-1img05.jpg" ALT=""><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>
</DIV>
</CENTER>
<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>
<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>s118023_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 10.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECOND AMENDMENT TO</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">EMPLOYMENT AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Second Amendment to
Employment Agreement (the &ldquo;<B><U>Amendment</U></B>&rdquo;) is executed on this 3rd day of May 2019 (the &ldquo;<B><U>Effective
Date</U></B>&rdquo;), by and between <B>Christopher Missling, PhD</B> (hereinafter referred to as &ldquo;<B><U>Executive</U></B>&rdquo;)
and Anavex Life Sciences Corp. (&ldquo;<B><U>Employer</U></B>&rdquo; and, together with its subsidiaries, the &ldquo;<B><U>Company</U></B>&rdquo;)
and serves to amend that certain Employment Agreement dated June 27, 2013, as amended by that amended and restated first amendment
dated July 18, 2016, (the &ldquo;<B><U>Employment Agreement</U></B>&rdquo;) by and between Executive and the Company. Except as
otherwise provided herein in the Amendment, capitalized terms used in this Amendment shall have the same meanings given to them
in the Employment Agreement. <B>Executive</B> and <B>Company</B> are collectively referred to as the &ldquo;<B><U>Parties</U></B>&rdquo;
and singularly referred to as &ldquo;<B><U>Party</U></B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, Executive
currently is employed by the Company pursuant to the terms of the Employment Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Parties
desire to amend the Employment Agreement as described below, but to otherwise maintain in effect in full all other terms of the
Employment Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>,
for good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>AMENDMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U></U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">1.&nbsp;&nbsp;&nbsp;<B><U>ADOPTION
OF RECITALS</U></B>. The Parties adopt the above recitals as being true and correct, and they are incorporated herein as material
parts of this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">2.&nbsp;&nbsp;&nbsp;<B><U>SECTION 1</U></B>.
The Parties agree that Section 1 of the Employment Agreement shall be amended and restated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify">1. <U>Term</U>. The term of your employment hereunder shall
commence on July 5th, 2019 (the &ldquo;<U>Start Date</U>&rdquo;) and shall end on the earliest of (i) July 5th, 2022, (ii) the
date on which your employment is terminated by Company or you pursuant to Paragraph 10 or (iii) the date of your death or the date
of termination of your employment by reason of incapacity (determined in accordance with Paragraph 8) (the &ldquo;<U>Employment
Term</U>&rdquo;). The period from the Start Date until July 5th, 2022, regardless of any earlier termination, shall hereinafter
be referred to as the &ldquo;<U>Original Employment Term</U>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">3.&nbsp;&nbsp;&nbsp;<B><U>SECTION 3</U></B>.
The Parties agree that Section 3 of the Employment Agreement shall be amended and restated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">3. <U>Cash Compensation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 93pt; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 93pt; text-indent: -0.25in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;<U>Base Salary</U>.
In consideration for the services performed by you pursuant to this Agreement, the Company shall pay to you, and you will be entitled
to receive and hereby agree to accept, an initial annual base salary of $550,000, subject to increases in the discretion of the
Board or its Compensation Committee (&ldquo;<U>Base Salary</U>&rdquo;), payable in accordance with the Company&rsquo;s normal payroll
payment practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 93pt; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 93pt">The Compensation Committee of the Board (the &ldquo;<U>Compensation
Committee</U>&rdquo;) may review your salary at least annually and may increase (but not decrease) the Base Salary. The result
of any such review shall be reported to you by the Compensation Committee promptly after it occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 92.9pt; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 92.9pt; text-indent: -0.25in; text-align: justify">(b)&nbsp;&nbsp;&nbsp;<U>Annual
Bonus Compensation</U>. In addition to your Base Salary, during the Employment Term you shall be eligible to earn an annual cash
bonus for each whole or partial fiscal year during the Employment Term, (the &ldquo;<U>Bonus</U>&rdquo;). Commencing July 5th,
2019, your target bonus for each fiscal year during the Employment Term shall be twenty percent (20%) of annualized Base Salary,
as in effect on July 5th, 2019 of each applicable performance year; provided that the Compensation Committee may review your target
bonus at least annually and may increase (but not decrease) the target bonus. The result of any such annual review shall be reported
to you by the Compensation Committee promptly after it occurs. Your target bonus, as it may be so increased from time to time,
is referred to herein as the &ldquo;Target Bonus&rdquo;. As the actual amount payable to you as Bonus will be dependent upon the
achievement of certain performance goals, your actual Bonus may be less than, greater than or equal to the Target Bonus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 92.9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 92.9pt; text-indent: -0.25in; text-align: justify">(c)&nbsp;&nbsp;&nbsp;Your Bonus
for each whole fiscal year during the Employment Term, beginning with 2019, will be based upon achievement of one or more performance
goals established by the Compensation Committee, which may include individualized performance goals applicable uniquely to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">4.&nbsp;&nbsp;&nbsp;<B><U>SECTION 4</U></B>.
The Parties agree that Section 4 of the Employment Agreement shall be amended and restated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">4. <U>Stock Options</U>. In addition to your Base
Salary and Bonus, you shall receive the following stock option grants:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">(i)</TD><TD STYLE="text-align: justify">On May 3, 2019, you shall receive 750,000 of options
for shares of the Company&rsquo;s Common Stock, one-third of which shall vest on July 5, 2020, one-third of which shall vest on
July 5, 2021, and the remaining one-third shall vest on July 5, 2022.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Each such option shall have an exercise price equal to closing price
of the Common Stock on the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Upon a Change in Control, all previously granted but unvested stock
options shall vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">5.&nbsp;&nbsp;&nbsp;<B><U>FULL
FORCE AND EFFECT</U></B>. Except as expressly amended herein, all other terms and provisions of the Employment Agreement shall
remain in full force and effect and are hereby ratified and confirmed in all respects. The Parties mutually acknowledge and agree
that any and all other prior agreements, offer letters or contracts between Executive and the Company, are declared null and void
with no legal effect as of the date this Amendment is executed by the Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">6.&nbsp;&nbsp;&nbsp;<B><U>FURTHER
AMENDMENTS</U></B>. The Employment Agreement shall further be amended wherever appropriate to reflect the changes indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">7.&nbsp;&nbsp;&nbsp;<B><U>RIGHT
TO REVIEW AND TO SEEK COUNSEL</U>.</B> The Executive acknowledges that K&amp;L Gates LLP represents only the Company in this Amendment
and does not represent the interests of the Executive and has not advised the Executive in connection with this Amendment. The
Executive further acknowledges that he has had the opportunity to seek independent counsel and tax advice in connection with the
execution of this Amendment, and the Executive represents and warrants to the Company (a) that he has sought such independent counsel
and advice as he has deemed appropriate in connection with the execution hereof and the transactions contemplated hereby, and (b)
that he has not relied on any representation of the Company as to tax matters, or as to the consequences of the execution hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">8.&nbsp;&nbsp;&nbsp;<B><U>GOVERNING
LAW</U></B><U>.</U> This Amendment shall be governed and construed in accordance with the laws of the State of New York without
regard to conflicts of law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">9.&nbsp;&nbsp;&nbsp;<B><U>HEADINGS
AND CAPTIONS</U></B>. The titles and captions of paragraphs and subparagraphs contained in this Amendment are provided for convenience
of reference only, and shall not be considered terms or conditions of this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">10.&nbsp;&nbsp;<B><U>VALIDITY</U></B>.
The invalidity or unenforceability of any provision of this Amendment shall not affect the validity or enforceability of any other
provision of this Amendment, which shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">11.&nbsp;&nbsp;<B><U>COUNTERPARTS</U></B>.
This Amendment may be executed in one or more counterparts, by facsimile or electronically, each of which shall be deemed to be
an original but all of which together will constitute one and the same instrument. For purposes of legal enforcement of this Agreement
(i.e., by a court of law or equity or in arbitration), a copy or scanned version of this Agreement shall constitute an original.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0">[<I>Signature page follows</I>.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>,
the parties hereto have executed this Agreement on May 3, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE:</B></FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ANAVEX LIFE SCIENCES CORP.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CHRISTOPHER MISSLING, PHD</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 38%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&nbsp;Sandra Boenisch</FONT></TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="width: 36%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/&nbsp;Christopher Missling</FONT></TD>
    <TD STYLE="width: 11%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandra Boenisch</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Financial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>s118023_ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Christopher Missling, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. I have reviewed this Quarterly Report on Form 10-Q for the
three months ended March 31, 2019 of Anavex Life Sciences Corp. (the &ldquo;registrant&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. The registrant&rsquo;s other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&ndash;15(e) and 15d&ndash;15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a&ndash;15(f) and 15d&ndash;15(f)) for the registrant
and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(a) designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(b) designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(c) evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(d) disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. The registrant&rsquo;s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit
committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(a) all significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: May 8, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Christopher Missling, PhD</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Missling, PhD</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer, President and Secretary</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>s118023_ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 31.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I, Sandra Boenisch, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1. I have reviewed this Quarterly Report on Form 10-Q for the
three months ended March 31, 2019 of Anavex Life Sciences Corp. (the &ldquo;registrant&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4. The registrant&rsquo;s other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&ndash;15(e) and 15d&ndash;15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a&ndash;15(f) and 15d&ndash;15(f)) for the registrant
and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(a) designed such disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(b) designed such internal control over financial
reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(c) evaluated the effectiveness of the registrant&rsquo;s
disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(d) disclosed in this report any change in the registrant&rsquo;s
internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter that has materially
affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. The registrant&rsquo;s other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit
committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(a) all significant deficiencies and material weaknesses
in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: May 8, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/Sandra
    Boenisch</FONT></TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sandra Boenisch, CPA, CGA</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal Financial Officer, Treasurer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 20; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>s118023_ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the Quarterly Report of Anavex Life Sciences
Corp. (the &ldquo;Company&rdquo;) on Form 10-Q for the three months ended March 31, 2019 as filed with the Securities and Exchange
Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned, in the capacities and on the date indicated below, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of our knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(1) the Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">(2) the information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30.6pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
<TR STYLE="vertical-align: top">
    <TD>Dated: May 8, 2019</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/Christopher Missling, PhD</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Christopher Missling, PhD </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;Chief Executive Officer, President, Secretary </TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Executive Officer)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 38%; border-bottom: Black 1pt solid">/s/Sandra Boenisch</TD>
    <TD STYLE="width: 12%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Sandra Boenisch, CPA, CGA</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Principal Financial Officer, Treasurer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">(Principal Financial and Accounting Officer)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing certification is being furnished solely to accompany
the Report pursuant to 18 U.S.C. &sect; 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the
date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required
by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form
within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 21; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>

    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>avxl-20190331.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:avxl="http://anavex.com/20190331">
    <link:schemaRef xlink:href="avxl-20190331.xsd" xlink:type="simple" />
    <xbrli:context id="From2018-10-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2017-09-30_custom_ClinicalStudyGrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avxl:ClinicalStudyGrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-10-19to2015-10-21_custom_PurchaseAgreementMember_custom_LincolnParkCapitalFundLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avxl:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-10-19</xbrli:startDate>
        <xbrli:endDate>2015-10-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-05to2018-07-06_custom_EquityOfferingSalesAgreementMember_custom_CantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:EquityOfferingSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avxl:CantorFitzgeraldAndCoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-05</xbrli:startDate>
        <xbrli:endDate>2018-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_EquityOfferingSalesAgreementMember_custom_CantorFitzgeraldAndCoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:EquityOfferingSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avxl:CantorFitzgeraldAndCoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avxl:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">avxl:LincolnParkCapitalFundLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avxl:PurchaseWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_PurchaseWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avxl:PurchaseWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_PurchaseWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avxl:PurchaseWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_PurchaseWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avxl:PurchaseWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_PurchaseWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">avxl:PurchaseWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avxl:StockOptionPlan2015Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_StockOptionPlan2015Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avxl:StockOptionPlan2015Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_StockOptionPlan2015Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avxl:StockOptionPlan2015Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31_us-gaap_GeneralAndAdministrativeExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_us-gaap_ResearchAndDevelopmentExpenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_StockOptionPlan2015Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avxl:StockOptionPlan2015Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avxl:StockOptionPlan2015Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-04to2019-04-05_custom_OmnibusIncentive2019PlanMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">avxl:OmnibusIncentive2019PlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-04</xbrli:startDate>
        <xbrli:endDate>2019-04-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_custom_CommonSharesToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">avxl:CommonSharesToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-01_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2019-03-31_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-10-01to2018-09-30_custom_PurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:PurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-10-01</xbrli:startDate>
        <xbrli:endDate>2018-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-03_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-02to2019-05-03_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001314052</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">avxl:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-02</xbrli:startDate>
        <xbrli:endDate>2019-05-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2018-10-01to2019-03-31">ANAVEX LIFE SCIENCES CORP.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2018-10-01to2019-03-31">0001314052</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2018-10-01to2019-03-31">10-Q</dei:DocumentType>
    <dei:TradingSymbol contextRef="From2018-10-01to2019-03-31">AVXL</dei:TradingSymbol>
    <dei:DocumentPeriodEndDate contextRef="From2018-10-01to2019-03-31">2019-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2018-10-01to2019-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2018-10-01to2019-03-31">--09-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityCurrentReportingStatus contextRef="From2018-10-01to2019-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntitySmallBusiness contextRef="From2018-10-01to2019-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2018-10-01to2019-03-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2018-10-01to2019-03-31">false</dei:EntityExTransitionPeriod>
    <dei:EntityFilerCategory contextRef="From2018-10-01to2019-03-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2018-10-01to2019-03-31">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2018-10-01to2019-03-31">2019</dei:DocumentFiscalYearFocus>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2019-05-08" unitRef="Shares" decimals="INF">49115137</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="From2018-10-01to2019-03-31" unitRef="Shares" decimals="INF">7655850</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="From2017-10-01to2018-09-30" unitRef="Shares" decimals="INF">7185296</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <avxl:NonOperatingIncomeFromGrant contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">149055</avxl:NonOperatingIncomeFromGrant>
    <avxl:NonOperatingIncomeFromGrant contextRef="From2016-10-01to2017-09-30_custom_ClinicalStudyGrantMember" unitRef="USD" decimals="0">597886</avxl:NonOperatingIncomeFromGrant>
    <avxl:NonOperatingIncomeFromGrant contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">74527</avxl:NonOperatingIncomeFromGrant>
    <avxl:NonOperatingIncomeFromGrant contextRef="From2018-01-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:NonOperatingIncomeFromGrant contextRef="From2017-10-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:ValueOfSharesObligatedToPurchase contextRef="From2015-10-19to2015-10-21_custom_PurchaseAgreementMember_custom_LincolnParkCapitalFundLLCMember" unitRef="USD" decimals="0">50000000</avxl:ValueOfSharesObligatedToPurchase>
    <avxl:AgreementTerm contextRef="From2015-10-19to2015-10-21_custom_PurchaseAgreementMember_custom_LincolnParkCapitalFundLLCMember">P36M</avxl:AgreementTerm>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationDescription contextRef="From2015-10-19to2015-10-21_custom_PurchaseAgreementMember_custom_LincolnParkCapitalFundLLCMember">The Company may direct Lincoln Park, at its sole discretion, and subject to certain conditions, to purchase up to 50,000 shares of common stock on any business day, provided that at least one business day has passed since the most recent purchase. The amount of a purchase may be increased under certain circumstances provided, however that Lincoln Park&#8217;s committed obligation under any single purchase shall not exceed $2,000,000. The purchase price of shares of common stock related to the future funding will be based on the then prevailing market prices of such shares at the time of sales as described in the 2015 Purchase Agreement.</us-gaap:UnrecordedUnconditionalPurchaseObligationDescription>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2015-10-19to2015-10-21_custom_PurchaseAgreementMember_custom_LincolnParkCapitalFundLLCMember" unitRef="Shares" decimals="INF">179598</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">2239223</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-01-01to2018-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">1242001</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-04-04to2019-04-05_custom_OmnibusIncentive2019PlanMember_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-10-01to2019-03-31_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">292700</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-10-01to2018-09-30_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <avxl:NumberOfSharesObligatedToPurchaseProrataBasic contextRef="From2015-10-19to2015-10-21_custom_PurchaseAgreementMember_custom_LincolnParkCapitalFundLLCMember" unitRef="Shares" decimals="INF">89799</avxl:NumberOfSharesObligatedToPurchaseProrataBasic>
    <avxl:StockIssuedDuringPeriodSharesNewIssues4 contextRef="From2019-01-01to2019-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">2229592</avxl:StockIssuedDuringPeriodSharesNewIssues4>
    <avxl:StockIssuedDuringPeriodSharesNewIssues4 contextRef="From2018-01-01to2018-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">1233580</avxl:StockIssuedDuringPeriodSharesNewIssues4>
    <avxl:StockIssuedDuringPeriodSharesNewIssues4 contextRef="From2018-10-01to2019-03-31_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">100000</avxl:StockIssuedDuringPeriodSharesNewIssues4>
    <avxl:StockIssuedDuringPeriodValueNewIssues3 contextRef="From2019-01-01to2019-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">5361534</avxl:StockIssuedDuringPeriodValueNewIssues3>
    <avxl:StockIssuedDuringPeriodValueNewIssues3 contextRef="From2018-01-01to2018-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">4688370</avxl:StockIssuedDuringPeriodValueNewIssues3>
    <avxl:StockIssuedDuringPeriodSharesNewIssues3 contextRef="From2019-01-01to2019-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">9631</avxl:StockIssuedDuringPeriodSharesNewIssues3>
    <avxl:StockIssuedDuringPeriodSharesNewIssues3 contextRef="From2018-01-01to2018-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">8421</avxl:StockIssuedDuringPeriodSharesNewIssues3>
    <avxl:StockIssuedDuringPeriodSharesNewIssues3 contextRef="From2018-10-01to2019-03-31_custom_PurchaseAgreementMember" unitRef="Shares" decimals="INF">526</avxl:StockIssuedDuringPeriodSharesNewIssues3>
    <avxl:StockIssuedDuringPeriodValueNewIssues4 contextRef="From2019-01-01to2019-03-31_custom_LincolnParkCapitalFundLLCMember_custom_PurchaseAgreementMember" unitRef="USD" decimals="0">7836072</avxl:StockIssuedDuringPeriodValueNewIssues4>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">5068834</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-07-05to2018-07-06_custom_EquityOfferingSalesAgreementMember_custom_CantorFitzgeraldAndCoMember" unitRef="USD" decimals="0">50000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">4688370</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <avxl:PercentageOfGrossProceedsFromSales contextRef="From2018-10-01to2019-03-31_custom_EquityOfferingSalesAgreementMember_custom_CantorFitzgeraldAndCoMember" unitRef="Pure" decimals="INF">0.03</avxl:PercentageOfGrossProceedsFromSales>
    <us-gaap:LegalFees contextRef="From2018-10-01to2019-03-31_custom_EquityOfferingSalesAgreementMember_custom_CantorFitzgeraldAndCoMember" unitRef="USD" decimals="0">151133</us-gaap:LegalFees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2017-09-30_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">1609309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2018-09-30_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">678379</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2019-03-31_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">370000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod contextRef="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">350000</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod contextRef="From2018-10-01to2019-03-31" unitRef="Shares" decimals="INF">1250</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod contextRef="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">-756143</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod contextRef="From2018-10-01to2019-03-31_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">-1250</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod contextRef="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">-524787</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod contextRef="From2018-10-01to2019-03-31_custom_PurchaseWarrantsMember" unitRef="Shares" decimals="INF">-307129</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-09-30_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">2.66</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">2.87</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice>
    <avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-03-31_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">4.03</avxl:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice>
    <avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice contextRef="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">4.19</avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice>
    <avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">2.96</avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice>
    <avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">1.68</avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice>
    <avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice contextRef="From2017-10-01to2018-09-30_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">3.00</avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice>
    <avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice contextRef="From2018-10-01to2019-03-31_custom_PurchaseWarrantsMember" unitRef="USDPShares" decimals="INF">1.47</avxl:ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-09-30_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">5092030</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-09-30_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">6506917</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">7298350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-05-03_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember_srt_ChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF">750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">1730000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">1030399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">164280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">238966</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">150833</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-09-30_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">4.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-09-30_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">3.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">3.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">2.71</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">2.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">3.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">2.86</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">1.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2017-10-01to2018-09-30_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">2.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">1.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">5240285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="USDPShares" decimals="INF">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2017-09-30_custom_StockOptionPlan2015Member" unitRef="USD" decimals="0">5280544</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2018-09-30_custom_StockOptionPlan2015Member" unitRef="USD" decimals="0">2353088</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="USD" decimals="0">3642978</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="USD" decimals="0">2976021</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">3960139</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">1893152</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-03-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">950999</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-01-01to2018-03-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">625679</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-10-01to2019-03-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">2006587</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2017-10-01to2018-03-31_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="USD" decimals="0">1197041</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">942153</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-01-01to2018-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">600017</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2017-10-01to2018-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">1150640</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-10-01to2019-03-31_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="USD" decimals="0">1953552</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1225696</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">2347681</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2018-10-01to2019-03-31" unitRef="Pure" decimals="INF">0.0291</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2017-10-01to2018-03-31" unitRef="Pure" decimals="INF">0.0243</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-10-01to2019-03-31">P5Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-10-01to2018-03-31">P6Y6M25D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2018-10-01to2019-03-31" unitRef="Pure" decimals="INF">1.0596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2017-10-01to2018-03-31" unitRef="Pure" decimals="INF">1.1223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2018-10-01to2019-03-31" unitRef="Pure" decimals="INF">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2017-10-01to2018-03-31" unitRef="Pure" decimals="INF">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares contextRef="From2018-10-01to2019-03-31" unitRef="Shares" decimals="INF">546</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">546</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">546</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2019-03-31_custom_StockOptionPlan2015Member" unitRef="Shares" decimals="INF">6050553</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member">The exercise price will be determined by the board of directors at the time of grant shall be at least equal to the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be less than 110% of fair market value of the Company&#8217;s shares of common stock on the grant date.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2018-10-01to2019-03-31_custom_StockOptionPlan2015Member">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <avxl:RemainingAllocatedShareBasedCompensationExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">6020600</avxl:RemainingAllocatedShareBasedCompensationExpense>
    <us-gaap:Cash contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">22930638</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">19457845</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">27440257</us-gaap:Cash>
    <avxl:GeneralSalesTaxRecoverable contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">40171</avxl:GeneralSalesTaxRecoverable>
    <avxl:GeneralSalesTaxRecoverable contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">76160</avxl:GeneralSalesTaxRecoverable>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">1251798</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">849642</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">101133</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">151133</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:OtherShortTermInvestments contextRef="AsOf2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherShortTermInvestments contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">15000</us-gaap:OtherShortTermInvestments>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">24323740</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">20549780</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">52396</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Assets contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">24376136</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">20549780</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">3884626</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">6370604</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">3884626</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">6370604</us-gaap:LiabilitiesCurrent>
    <us-gaap:CommonStockValue contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">45935</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">48175</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">129377542</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">138696975</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:CommonStockSharesSubscriptions contextRef="AsOf2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockSharesSubscriptions contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-292700</us-gaap:CommonStockSharesSubscriptions>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">-108931967</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-124273274</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">20491510</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">14179176</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30" unitRef="USD" decimals="0">24253995</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31" unitRef="USD" decimals="0">22478857</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">46888</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">48175</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">43332</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">44575</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">133438276</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">138696975</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">115689221</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">122724029</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" decimals="0">-292700</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-116265380</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-124273274</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-91478558</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-100289747</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">44423</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">121038635</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-95537723</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">25545335</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">45935</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">129377542</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-09-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-108931967</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">17219784</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-09-30" unitRef="USD" decimals="0">24376136</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">20549780</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">45933472</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">48173241</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-09-30" unitRef="Shares" decimals="INF">45933472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">48173241</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">46887056</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">48173241</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">43330817</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">44573788</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">44421992</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-09-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">45933472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">3822559</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">2061251</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1489450</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">2887253</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">11790996</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">6078786</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">3245023</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">5939335</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">15613555</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">8140037</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">4734473</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">8826588</us-gaap:OperatingExpenses>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">130265</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">51465</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">28647</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">59023</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">49693</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">54199</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-18337</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-6358</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">329013</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">180191</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">10310</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">52665</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-15284542</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-7959846</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-4724163</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-8773923</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-15341307</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-8007894</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-4752024</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-8811189</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8007894</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-10-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8811189</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-4752024</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-10-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-15341307</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-10-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.33</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-10-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.2</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-10-01to2019-03-31" unitRef="Shares" decimals="INF">46726649</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">47134686</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-01-01to2018-03-31" unitRef="Shares" decimals="INF">44545523</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2017-10-01to2018-03-31" unitRef="Shares" decimals="INF">44210591</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:ShareBasedCompensation contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">3960139</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">2347681</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">35989</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-4737</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-402156</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-185268</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-37396</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets contextRef="From2017-10-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">2485978</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-167597</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-8491627</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-6441100</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">50000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">30943</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">5018834</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">4657427</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">-3472793</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">-1783673</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">19457845</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-03-31" unitRef="USD" decimals="0">25656584</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">5068834</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">3074134</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">459850</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">4688370</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1279</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1234</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3365555</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2017-10-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">4687136</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" decimals="0">-292700</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2017-10-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2017-10-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">151</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">459699</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-01-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2229</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5359305</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-10-01to2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" decimals="0">-292700</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-10-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1279592</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1233580</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">150000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2229592</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-01-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2017-10-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">7</avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">8</avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-7</avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2017-10-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-8</avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2019-01-01to2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2017-10-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2017-10-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-01-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">10</avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-10</avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">6047</avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">8421</avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">826</avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">9631</avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement>
    <avxl:CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement contextRef="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="Shares" xsi:nil="true" />
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2018-10-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2019-01-01to2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1</avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants>
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2018-10-01to2019-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedPursuantToCashlessExerciseOfWarrants contextRef="From2018-10-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2017-10-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</avxl:SharesIssuedUponExerciseOfWarrantsCashless>
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2017-10-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1</avxl:SharesIssuedUponExerciseOfWarrantsCashless>
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2017-10-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2017-10-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</avxl:SharesIssuedUponExerciseOfWarrantsCashless>
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1</avxl:SharesIssuedUponExerciseOfWarrantsCashless>
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2018-01-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedUponExerciseOfWarrantsCashless contextRef="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <avxl:SharesIssuedUponExerciseOfWarrantsCashlessInShares contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">970</avxl:SharesIssuedUponExerciseOfWarrantsCashlessInShares>
    <avxl:SharesIssuedUponExerciseOfWarrantsCashlessInShares contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">970</avxl:SharesIssuedUponExerciseOfWarrantsCashlessInShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">3960139</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">1893152</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1225696</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">2347681</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-10-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1893152</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-10-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2347681</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-10-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2017-10-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1225696</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-01-01to2018-03-31_custom_CommonSharesToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-10-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="From2018-10-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">3960139</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 42pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Note 1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Business&#13;    Description and Basis of Presentation&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Business&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Anavex&#13;Life Sciences Corp. (the &amp;#8220;Company&amp;#8221;) is a clinical stage biopharmaceutical company engaged in the development of differentiated&#13;therapeutics by applying precision medicine to central nervous system (&amp;#8220;CNS&amp;#8221;) diseases with high unmet need. Anavex&#13;analyzes genomic data from clinical studies to identify biomarkers, which select patients that will receive the therapeutic benefit&#13;for the treatment of neurodegenerative and neurodevelopmental diseases. The Company&amp;#8217;s lead compound ANAVEX&amp;#174;2-73 is&#13;being developed to treat Alzheimer&amp;#8217;s disease, Parkinson&amp;#8217;s disease and potentially other central nervous system diseases,&#13;including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked&#13;gene, methyl-CpG-binding protein 2 (&amp;#8220;MECP2&amp;#8221;).&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basis&#13;of Presentation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 42.55pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;These&#13;unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the&#13;Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) and accounting principles generally accepted in the United States of America&#13;(&amp;#8220;US GAAP&amp;#8221;) for interim reporting. Accordingly, certain information and note disclosures normally included in the&#13;annual financial statements in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.&#13;In the opinion of management, the disclosures are adequate to make the information presented not misleading.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;These&#13;accompanying unaudited interim condensed consolidated financial statements reflect all adjustments, consisting of normal recurring&#13;adjustments, which in the opinion of management are necessary for fair presentation of the information contained herein. The consolidated&#13;balance sheet as of September 30, 2018 was derived from the audited annual financial statements but does not include all disclosures&#13;required by US GAAP. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction&#13;with the audited consolidated financial statements and notes thereto included in the Company&amp;#8217;s annual report on Form 10-K&#13;for the year ended September 30, 2018 filed with the SEC on December 12, 2018. The Company follows the same accounting policies&#13;in the preparation of interim reports.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Operating&#13;results for the six months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year&#13;ending September 30, 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Liquidity&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;All&#13;of the Company&amp;#8217;s potential drug compounds are in the clinical development stage and the Company cannot be certain that its&#13;research and development efforts will be successful or, if successful, that its potential drug compounds will ever be approved&#13;for sales to pharmaceutical companies or generate commercial revenues. To date, we have not generated any revenues from our operations.&#13;The Company expects the business to continue to experience negative cash flows for the foreseeable future and cannot predict when,&#13;if ever, our business might become profitable.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company believes that its existing cash and cash equivalents, along with existing financial commitments from third parties, will&#13;be sufficient to meet its cash commitments for at least the next eighteen months after the date that these condensed consolidated&#13;interim financial statements are issued. The process of drug development can be costly, and the timing and outcomes of clinical&#13;trials is uncertain.&amp;#160;The assumptions upon which the Company has based its estimates are routinely evaluated and may be subject&#13;to change.&amp;#160;The actual amount of the Company&amp;#8217;s expenditures will vary depending upon a number of factors including but&#13;not limited to the design, timing and duration of future clinical trials, the progress of the Company&amp;#8217;s research and development&#13;programs and the level of financial resources available. The Company has the ability to adjust its operating plan spending levels&#13;based on the timing of future clinical trials.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company will need to raise additional capital in order to continue to fund operations and fully fund later stage clinical development&#13;programs. Such capital may not be available on commercially acceptable terms, if at all. The Company believes that it will be&#13;able to obtain additional working capital to fund future operations through current financing commitments from third parties,&#13;or through other arrangements; however, there can be no assurance that such additional financing, if available, can be obtained&#13;on terms acceptable to the Company.&amp;#160;&amp;#160;If the Company is unable to obtain such additional financing, future operations&#13;would need to be scaled back.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Use&#13;of Estimates&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect&#13;the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and&#13;expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset&#13;valuations, asset impairment, stock-based compensation and loss contingencies. The Company bases its estimates and assumptions&#13;on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the&#13;results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs&#13;and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially&#13;and adversely from the Company&amp;#8217;s estimates. To the extent there are material differences between the estimates and the actual&#13;results, future results of operations will be affected.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Principles&#13;of Consolidation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;These&#13;consolidated financial statements include the accounts of Anavex Life Sciences Corp. and its wholly-owned subsidiaries, Anavex&#13;Australia Pty Limited, a company incorporated under the laws of Australia, Anavex Germany GmbH, a company incorporated under the&#13;laws of Germany, and Anavex Canada Ltd., a company incorporated under the laws of the Province of Ontario, Canada. All inter-company&#13;transactions and balances have been eliminated.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair&#13;Value Measurements&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value hierarchy under GAAP is based on three levels of inputs, of which the first two are considered observable and the last&#13;unobservable, that may be used to measure fair value which are the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 72pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 0.55in; white-space: nowrap; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;    1 -&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;quoted prices (unadjusted) in active markets&#13;    for identical assets or liabilities;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 63pt"&gt;&lt;/td&gt;&lt;td style="width: 40.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 72pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 0.55in; white-space: nowrap; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;    2 -&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;observable inputs other than Level 1, quoted&#13;    prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities&#13;    in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are&#13;    observable; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 63pt"&gt;&lt;/td&gt;&lt;td style="width: 40.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 72pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 0.55in; white-space: nowrap; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;    3 -&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;assets and liabilities whose significant value&#13;    drivers are unobservable by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;tr style="vertical-align: top"&gt;&#13;&lt;td style="width: 63pt"&gt;&lt;/td&gt;&lt;td style="width: 40.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;book value of cash and cash equivalents and accounts payable and accrued liabilities approximate their fair values due to the&#13;short-term maturity of those instruments.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;At&#13;March 31, 2019 and September 30, 2018, the Company did not have any Level 3 assets or liabilities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Basic&#13;and Diluted Loss per Share&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&#13;loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common&#13;shares outstanding during the period. Diluted loss per common share is computed similar to basic loss per common share except&#13;that the denominator is increased to include the weighted average number of all potentially dilutive securities convertible into&#13;shares of common stock that were outstanding during the period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of March 31, 2019, loss per share excludes 7,655,850 (September 30, 2018 &amp;#8211; 7,185,296) potentially dilutive common shares&#13;related to outstanding options and warrants, as their effect was anti-dilutive.&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 42.55pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Note 2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Recent&#13;    Accounting Pronouncements&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Recently&#13;Adopted Accounting Pronouncements&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2014, the FASB and the International Accounting Standards Board (IASB) issued a converged standard on revenue recognition&#13;from contracts with customers, ASU 2014-09 (Topic 606 and IFRS 15). This standard superseded nearly all existing revenue recognition&#13;guidance. ASU 2014-09 is effective for the Company on a prospective basis beginning on October 1, 2018. The adoption of this standard&#13;did not have a material impact for any period presented and the Company will apply this standard to all future revenues.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2017, the FASB issued ASU No. 2017-09, &amp;#8220;Compensation&amp;#8211;Stock Compensation (Topic 718): Scope of Modification Accounting,&amp;#8221;&#13;clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The&#13;new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the&#13;same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company&#13;on a prospective basis beginning on October 1, 2018. The adoption of this standard did not have a material impact for any period&#13;presented.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements Not Yet Adopted&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2016, the FASB issued Accounting Standards Update No. 2016-02, &lt;i&gt;Leases&lt;/i&gt;. The guidance would require lessees to recognize&#13;most leases on their balance sheets as lease liabilities with corresponding right &amp;#8211;of use assets. The guidance is effective&#13;for annual and interim reporting periods beginning on or after December 15, 2018. The new guidance is effective for the Company&#13;on a prospective basis beginning on October 1, 2019. The Company is currently evaluating the impact this guidance will have on&#13;its financial condition, results of operations and cash flows.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments&#13;(&amp;#8220;ASU 2018-07&amp;#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring&#13;goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after&#13;December 15, 2018, with early adoption permitted, but no earlier than the Company&amp;#8217;s adoption date of Topic 606. The new&#13;guidance is effective for the Company beginning on October 1, 2019. The new guidance is required to be applied retrospectively&#13;with the cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07&#13;will have on the consolidated financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&#13;than noted above, the Company does not expect the adoption of recently issued accounting pronouncements to have a significant&#13;impact on its results of operations, financial position or cash flow.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <avxl:OtherIncomeDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 42.55pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Note 3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Other&#13;    Income &lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Grant&#13;Income&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Clinical&#13;Study Grant&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the year ended September 30, 2017, the Company was awarded grant funding in the amount of $597,886. The grant is being received&#13;in equal quarterly installments over a period of two years beginning during the year ended September 30, 2018 in exchange for&#13;a commitment to complete clinical testing for a therapeutic drug candidate for the treatment of Rett syndrome.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;grant income is deferred when received and amortized to other income as the related research and development expenditures are&#13;incurred. During the three and six months ended March 31, 2019, the Company recognized $74,527 and $149,055, respectively (2018:&#13;$Nil and $Nil, respectively) of this grant on its statement of operations within grant income.&lt;/font&gt;&lt;/p&gt;</avxl:OtherIncomeDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;summary of the status of the Company&amp;#8217;s outstanding share purchase warrants is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 45.75pt 0 14.2pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number&#13;    of Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise&#13;    Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 40%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance,&#13;    October 1, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,609,309&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;350,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(756,143&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(524,787&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, September&#13;    30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;678,379&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.68&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(307,129&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance,&#13;    March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;370,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;summary of the status of Company&amp;#8217;s outstanding stock purchase options is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 45.75pt 0 18.95pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 90%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number&#13;    of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Average&#13;    Grant&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Aggregate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise&#13;    Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Date&#13;    Fair Value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;intrinsic&#13;    value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 20%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding&#13;    at October 1, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,092,030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,280,544&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="white-space: nowrap; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,730,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(164,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(150,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding&#13;    at September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,506,917&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,353,088&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,030,399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.97&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(238,966&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding&#13;    at March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,298,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,642,978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercisable&#13;    at March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,240,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,976,021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;These&#13;amounts have been included in general and administrative expenses and research and development expenses on the Company&amp;#8217;s&#13;statement of operations as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.3pt 0 57.4pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 80%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Three&#13;    months ended March 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Six months&#13;    ended March 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 20%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;General&#13;    and administrative&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;950,999&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;625,679&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,006,587&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,197,041&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Research and development&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;942,153&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;600,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,953,552&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,150,640&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,893,152&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,225,696&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,960,139&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,347,681&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-04-01_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-04-01_us-gaap_SubsequentEventMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Recently&#13;Adopted Accounting Pronouncements&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2014, the FASB and the International Accounting Standards Board (IASB) issued a converged standard on revenue recognition&#13;from contracts with customers, ASU 2014-09 (Topic 606 and IFRS 15). This standard superseded nearly all existing revenue recognition&#13;guidance. ASU 2014-09 is effective for the Company on a prospective basis beginning on October 1, 2018. The adoption of this standard&#13;did not have a material impact for any period presented and the Company will apply this standard to all future revenues.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2017, the FASB issued ASU No. 2017-09, &amp;#8220;Compensation&amp;#8211;Stock Compensation (Topic 718): Scope of Modification Accounting,&amp;#8221;&#13;clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The&#13;new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the&#13;same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company&#13;on a prospective basis beginning on October 1, 2018. The adoption of this standard did not have a material impact for any period&#13;presented.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements Not Yet Adopted&lt;/i&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2016, the FASB issued Accounting Standards Update No. 2016-02, &lt;i&gt;Leases&lt;/i&gt;. The guidance would require lessees to recognize&#13;most leases on their balance sheets as lease liabilities with corresponding right &amp;#8211;of use assets. The guidance is effective&#13;for annual and interim reporting periods beginning on or after December 15, 2018. The new guidance is effective for the Company&#13;on a prospective basis beginning on October 1, 2019. The Company is currently evaluating the impact this guidance will have on&#13;its financial condition, results of operations and cash flows.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments&#13;(&amp;#8220;ASU 2018-07&amp;#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring&#13;goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after&#13;December 15, 2018, with early adoption permitted, but no earlier than the Company&amp;#8217;s adoption date of Topic 606. The new&#13;guidance is effective for the Company beginning on October 1, 2019. The new guidance is required to be applied retrospectively&#13;with the cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07&#13;will have on the consolidated financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&#13;than noted above, the Company does not expect the adoption of recently issued accounting pronouncements to have a significant&#13;impact on its results of operations, financial position or cash flow.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2018-10-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following&#13;weighted average assumptions:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 64.7pt 0 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 54%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk-free&#13;    interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.91&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life of options&#13;    (years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Annualized volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;105.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2018-09-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2018-10-01to2019-03-31" unitRef="USD" decimals="0">56765</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">48048</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">27861</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="From2017-10-01to2018-03-31" unitRef="USD" decimals="0">37266</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <avxl:EquityOfferingAgreementsTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 42.55pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Note 4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Equity&#13;    Offering Agreements&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Controlled&#13;Equity Offering Sales Agreement&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;July 6, 2018, the Company entered into a Controlled Equity Offering&amp;#160;Sales Agreement (the &amp;#8220;Sales Agreement&amp;#8221;) with&#13;Cantor Fitzgerald&amp;#160;&amp;#38; Co., as agent (&amp;#8220;Cantor Fitzgerald&amp;#8221;), pursuant to which the Company may offer and sell&#13;shares of common stock, for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald (the&#13;&amp;#8220;Offering&amp;#8221;).&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Upon&#13;delivery of a placement notice based on the Company&amp;#8217;s instructions and subject to the terms and conditions of the Sales&#13;Agreement, Cantor Fitzgerald may sell the Shares by methods deemed to be an &amp;#8220;at the market offering&amp;#8221; offering, in&#13;negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices,&#13;or by any other method permitted by law, including negotiated transactions, subject to the prior written consent of the Company.&#13;The Company is not obligated to make any sales of Shares under the Sales Agreement. The Company or Cantor Fitzgerald may suspend&#13;or terminate the offering of Shares upon notice to the other party, subject to certain conditions.&amp;#160; Cantor Fitzgerald will&#13;act as sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices and applicable&#13;state and federal law, rules&amp;#160;and regulations and the rules&amp;#160;of Nasdaq.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company has agreed to pay Cantor Fitzgerald commissions for its services of acting as agent of up to 3.0% of the gross proceeds&#13;from the sale of the Shares pursuant to the Sales Agreement.&amp;#160; The Company has also agreed to provide Cantor Fitzgerald with&#13;customary indemnification and contribution rights. At March 31, 2019, the Company had incurred $151,133 in legal and accounting&#13;fees associated with the Sales Agreement. This amount is included in deferred financing charges at March 31, 2019 and is expected&#13;to be reclassified to share capital upon issuance of shares under the Sales Agreement. At March 31, 2019, no shares have been&#13;sold pursuant to the Offering.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase&#13;Agreement&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 21, 2015, the Company entered into a $50,000,000 purchase agreement (the &amp;#8220;2015 Purchase Agreement&amp;#8221;) with Lincoln&#13;Park Capital Fund, LLC (&amp;#8220;Lincoln Park&amp;#8221;), pursuant to which the Company may sell and issue to Lincoln Park, and Lincoln&#13;Park is obligated to purchase, up to $50,000,000 in value of its shares of common stock from time to time over a 36-month period&#13;starting from the effective date of the respective registration statement, to September 6, 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company may direct Lincoln Park, at its sole discretion, and subject to certain conditions, to purchase up to 50,000 shares of&#13;common stock on any business day, provided that at least one business day has passed since the most recent purchase. The amount&#13;of a purchase may be increased under certain circumstances provided, however that Lincoln Park&amp;#8217;s committed obligation under&#13;any single purchase shall not exceed $2,000,000. The purchase price of shares of common stock related to the future funding will&#13;be based on the then prevailing market prices of such shares at the time of sales as described in the 2015 Purchase Agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;consideration for entering into the 2015 Purchase Agreement, the Company issued to Lincoln Park 179,598 shares of common stock&#13;as a commitment fee and agreed to issue up to 89,799 shares pro rata, when and if, Lincoln Park purchases at the Company&amp;#8217;s&#13;discretion the $50,000,000 aggregate commitment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the three months ended March 31, 2019, the Company issued to Lincoln Park an aggregate of 2,239,223 (2018: 1,242,001) shares of&#13;common stock under the Purchase Agreement, including 2,229,592 (2018: 1,233,580) shares of common stock for an aggregate purchase&#13;price of $5,361,534 (2018: $4,688,370) and 9,631 (2018: 8,421) commitment shares. At March 31, 2019, an amount of $7,836,072 remained&#13;available under the 2015 Purchase Agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;At&#13;March 31, 2019, an amount of $292,700 (September 30, 2018: $0) was receivable under the Purchase Agreement in respect of 100,000&#13;purchase shares and 526 commitment shares issued and outstanding. This amount was received subsequent to March 31, 2019.&lt;/font&gt;&lt;/p&gt;</avxl:EquityOfferingAgreementsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-align: left; width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Note&#13;    6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Subsequent&#13;    Events&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Subsequent&#13;to March 31, 2019,&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;i)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The Company filed&#13;    a Certificate of Amendment with the Secretary of State of Nevada to amend the Company&amp;#8217;s articles of incorporation to&#13;    authorize the issuance of 10,000,000 shares of preferred stock having a par value of $0.001 per share. The Board of Directors&#13;    of the Company shall have the authority to issue shares of preferred stock in one or more series and shall have the authority&#13;    to establish by duly appointed resolution such voting powers, designations, preferences, limitations and restrictions and&#13;    relative rights of the preferred shares it deems necessary or advisable.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;ii)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On January 15, 2019,&#13;    the Board approved, subject to stockholder approval, the 2019 Omnibus Incentive Plan (the &amp;#8220;2019 Plan&amp;#8221;) and, on&#13;    April 5, 2019, the 2019 Plan was approved the Company&amp;#8217;s stockholders. Under the terms of the 2019 Plan, 6,000,000 additional&#13;    shares of Common Stock are available for issuance under the 2019 Plan, in addition to the shares available under the 2015&#13;    Plan. Any awards outstanding under the 2015 Plan or the Company&amp;#8217;s 2007 Stock Option Plan (the &amp;#8220;2007 Plan&amp;#8221;)&#13;    will remain subject to and be paid under the 2015 Plan or the 2007 Plan, respectively, and any shares subject to outstanding&#13;    awards under the 2015 Plan or the 2007 Plan that subsequently cease to be subject to such awards (other than by reason of&#13;    settlement of the awards in shares) will automatically become available for issuance under the 2019 Plan.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;i)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On May 3, 2019 (the&#13;    &amp;#8220;Effective Date&amp;#8221;), the Company entered into a Second Amendment to the Employment Agreement (the &amp;#8220;Amendment&amp;#8221;)&#13;    with the Company&amp;#8217;s Chief Executive Officer (the &amp;#8220;CEO&amp;#8221;) in his continuing capacity as Chief Executive Officer&#13;    of the Company. The Amendment amends the Employment Agreement by and between the Company and the CEO, effective July 5, 2013&#13;    (the &amp;#8220;Employment Agreement&amp;#8221;), as amended, and extends the term of the Employment Agreement through July 5, 2022,&#13;    unless earlier terminated as provided in the Amendment. Pursuant to the terms of the Amendment, the CEO shall receive an annual&#13;    base salary of $550,000 and is eligible to earn an annual cash target bonus for each whole or partial calendar year of twenty&#13;    percent of his base salary. Subject to the terms of the Amendment, the CEO will also receive on the Effective Date 750,000&#13;    options for shares of the Company&amp;#8217;s common stock, one-third of which shall vest on each of July 5, 2020, July 5, 2021&#13;    and July 5, 2022. The options shall have an exercise price equal to the closing price of the Company&amp;#8217;s common stock&#13;    on the Effective Date.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LaborAndRelatedExpense contextRef="From2019-05-02to2019-05-03_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember_srt_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">550000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights contextRef="From2019-05-02to2019-05-03_us-gaap_SubsequentEventMember_custom_EmploymentAgreementMember_srt_ChiefExecutiveOfficerMember">one-third of which shall vest on each of July 5, 2020, July 5, 2021 and July 5, 2022.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <us-gaap:CommitmentsDisclosureTextBlock contextRef="From2018-10-01to2019-03-31">&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="text-align: left; width: 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Note&#13;    5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Commitments&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;a)&amp;#160;&amp;#160;&#13;Litigation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company is subject to claims and legal proceedings that arise in the ordinary course of business. Such matters are inherently&#13;uncertain, and there can be no guarantee that the outcome of any such matter will be decided favorably to the Company or that&#13;the resolution of any such matter will not have a material adverse effect upon the Company&amp;#8217;s consolidated financial statements.&#13;The Company does not believe that any of such pending claims and legal proceedings will have a material adverse effect on its&#13;consolidated financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;b)&#13;&amp;#160;&amp;#160;Share Purchase Warrants&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;summary of the status of the Company&amp;#8217;s outstanding share purchase warrants is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number&#13;    of Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise&#13;    Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 53%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance,&#13;    October 1, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,609,309&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;350,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(756,143&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(524,787&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance, September&#13;    30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;678,379&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.87&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.68&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(307,129&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.47&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Balance,&#13;    March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;370,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.03&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the six months ended March 31, 2019, the Company issued 546 shares in connection with the exercise of 1,250 share purchase warrants&#13;on a cashless basis.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;c)&amp;#160;&amp;#160;&#13;Stock&amp;#8211;based Compensation Plan&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2015&#13;Stock Option Plan&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 18, 2015, the Company&amp;#8217;s board of directors approved a 2015 Omnibus Incentive Plan (the &amp;#8220;2015 Plan&amp;#8221;),&#13;which provides for the grant of stock options and restricted stock awards to directors, officers, employees and consultants of&#13;the Company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;maximum number of our common shares reserved for issue under the plan is 6,050,553 shares, subject to adjustment in the event&#13;of a change of the Company&amp;#8217;s capitalization. As a result of the adoption of the 2015 Plan, no further option awards will&#13;be granted under any previously existing stock option plan. Stock option awards previously granted under the previously existing&#13;stock option plans remain outstanding in accordance with their terms.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;2015 Plan provides that it may be administered by the board of directors, or the board of directors may delegate such responsibility&#13;to a committee. The exercise price will be determined by the board of directors at the time of grant shall be at least equal to&#13;the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be&#13;less than 110% of fair market value of the Company&amp;#8217;s shares of common stock on the grant date. Stock options may be granted&#13;under the 2015 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may&#13;be determined by the board, subject to earlier termination in accordance with the terms of the 2015 Plan.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;A&#13;summary of the status of Company&amp;#8217;s outstanding stock purchase options is presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 90%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number&#13;    of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Average&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Average&#13;    Grant&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Aggregate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercise&#13;    Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Date&#13;    Fair Value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;intrinsic&#13;    value&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 35%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding&#13;    at October 1, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,092,030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,280,544&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,730,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.71&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.09&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(164,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(150,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding&#13;    at September 30, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,506,917&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.83&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,353,088&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,030,399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.97&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(238,966&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.86&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding&#13;    at March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,298,350&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.67&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,642,978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.5pt double; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercisable&#13;    at March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,240,285&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,976,021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted market&#13;price of the Company&amp;#8217;s stock for the options that were in-the-money at March 31, 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;the three and six months ended March 31, 2019, the Company recognized stock-based compensation expense in connection with the&#13;issuance and vesting of stock options in exchange for services. These amounts have been included in general and administrative&#13;expenses and research and development expenses on the Company&amp;#8217;s statement of operations as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 90%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Three&#13;    months ended March 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Six months&#13;    ended March 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 36%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;General&#13;    and administrative&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;950,999&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;625,679&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,006,587&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 13%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,197,041&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Research and development&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;942,153&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;600,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,953,552&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,150,640&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total share based compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,893,152&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,225,696&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,960,139&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,347,681&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;An&#13;amount of approximately $4,546,000 in stock-based compensation is expected to be recorded over the remaining term of such options&#13;through June 2021.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following&#13;weighted average assumptions:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left; width: 54%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Risk-free&#13;    interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.91&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; width: 20%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.43&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected life of options&#13;    (years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.59&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.57&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: rgb(204,238,255); vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Annualized volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;105.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="background-color: white; vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividend rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:CommitmentsDisclosureTextBlock>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>avxl-20190331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:avxl="http://anavex.com/20190331" elementFormDefault="qualified" targetNamespace="http://anavex.com/20190331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://anavex.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" id="InterimCondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" id="InterimCondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" id="InterimCondensedConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" id="InterimCondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" id="InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity">
	  <link:definition>00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" id="BusinessDescriptionAndBasisOfPresentation">
	  <link:definition>00000007 - Disclosure - Business Description and Basis of Presentation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/RecentAccountingPronouncements" id="RecentAccountingPronouncements">
	  <link:definition>00000008 - Disclosure - Recent Accounting Pronouncements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/OtherIncome" id="OtherIncome">
	  <link:definition>00000009 - Disclosure - Other Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/EquityOfferingAgreements" id="EquityOfferingAgreements">
	  <link:definition>00000010 - Disclosure - Equity Offering Agreements</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/Commitments" id="Commitments">
	  <link:definition>00000011 - Disclosure - Commitments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000012 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/RecentAccountingPronouncementsPolicies" id="RecentAccountingPronouncementsPolicies">
	  <link:definition>00000013 - Disclosure - Recent Accounting Pronouncements (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/CommitmentsTables" id="CommitmentsTables">
	  <link:definition>00000014 - Disclosure - Commitments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" id="BusinessDescriptionAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000015 - Disclosure - Business Description and Basis of Presentation (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/OtherIncomeDetailsNarrative" id="OtherIncomeDetailsNarrative">
	  <link:definition>00000016 - Disclosure - Other Income (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" id="EquityOfferingAgreementsDetailsNarrative">
	  <link:definition>00000017 - Disclosure - Equity Offering Agreements (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/CommitmentsDetails" id="CommitmentsDetails">
	  <link:definition>00000018 - Disclosure - Commitments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/CommitmentsDetails1" id="CommitmentsDetails1">
	  <link:definition>00000019 - Disclosure - Commitments (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/CommitmentsDetails2" id="CommitmentsDetails2">
	  <link:definition>00000020 - Disclosure - Commitments (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/CommitmentsDetails3" id="CommitmentsDetails3">
	  <link:definition>00000021 - Disclosure - Commitments (Details 3)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/CommitmentsDetailsNarrative" id="CommitmentsDetailsNarrative">
	  <link:definition>00000022 - Disclosure - Commitments (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://anavex.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000023 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="avxl-20190331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="avxl-20190331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="avxl-20190331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="avxl-20190331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <element id="avxl_NonOperatingIncomeFromGrant" name="NonOperatingIncomeFromGrant" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ValueOfSharesObligatedToPurchase" name="ValueOfSharesObligatedToPurchase" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_AgreementTerm" name="AgreementTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_NumberOfSharesObligatedToPurchaseProrataBasic" name="NumberOfSharesObligatedToPurchaseProrataBasic" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_StockIssuedDuringPeriodSharesNewIssues4" name="StockIssuedDuringPeriodSharesNewIssues4" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_StockIssuedDuringPeriodValueNewIssues3" name="StockIssuedDuringPeriodValueNewIssues3" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_StockIssuedDuringPeriodSharesNewIssues3" name="StockIssuedDuringPeriodSharesNewIssues3" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_StockIssuedDuringPeriodValueNewIssues4" name="StockIssuedDuringPeriodValueNewIssues4" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_PercentageOfGrossProceedsFromSales" name="PercentageOfGrossProceedsFromSales" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" name="SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_RemainingAllocatedShareBasedCompensationExpense" name="RemainingAllocatedShareBasedCompensationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_GeneralSalesTaxRecoverable" name="GeneralSalesTaxRecoverable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" name="CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" name="CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" name="SharesIssuedPursuantToCashlessExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_SharesIssuedUponExerciseOfWarrantsCashless" name="SharesIssuedUponExerciseOfWarrantsCashless" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" name="SharesIssuedUponExerciseOfWarrantsCashlessInShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_OtherIncomeDisclosureTextBlock" name="OtherIncomeDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_EquityOfferingAgreementsTextBlock" name="EquityOfferingAgreementsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ClinicalStudyGrantMember" name="ClinicalStudyGrantMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_PurchaseAgreementMember" name="PurchaseAgreementMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_LincolnParkCapitalFundLLCMember" name="LincolnParkCapitalFundLLCMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_EquityOfferingSalesAgreementMember" name="EquityOfferingSalesAgreementMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_CantorFitzgeraldAndCoMember" name="CantorFitzgeraldAndCoMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_PurchaseWarrantsMember" name="PurchaseWarrantsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_StockOptionPlan2015Member" name="StockOptionPlan2015Member" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_OmnibusIncentive2019PlanMember" name="OmnibusIncentive2019PlanMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_CommonSharesToBeIssuedMember" name="CommonSharesToBeIssuedMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_EmploymentAgreementMember" name="EmploymentAgreementMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_EquityOfferingAgreementsAbstract" name="EquityOfferingAgreementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>avxl-20190331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://anavex.com/role/DocumentAndEntityInformation" xlink:href="avxl-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" xlink:href="avxl-20190331.xsd#BusinessDescriptionAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/RecentAccountingPronouncements" xlink:href="avxl-20190331.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/OtherIncome" xlink:href="avxl-20190331.xsd#OtherIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/EquityOfferingAgreements" xlink:href="avxl-20190331.xsd#EquityOfferingAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/Commitments" xlink:href="avxl-20190331.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/SubsequentEvents" xlink:href="avxl-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/RecentAccountingPronouncementsPolicies" xlink:href="avxl-20190331.xsd#RecentAccountingPronouncementsPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsTables" xlink:href="avxl-20190331.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:href="avxl-20190331.xsd#BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/OtherIncomeDetailsNarrative" xlink:href="avxl-20190331.xsd#OtherIncomeDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" xlink:href="avxl-20190331.xsd#EquityOfferingAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails" xlink:href="avxl-20190331.xsd#CommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails1" xlink:href="avxl-20190331.xsd#CommitmentsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails2" xlink:href="avxl-20190331.xsd#CommitmentsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails3" xlink:href="avxl-20190331.xsd#CommitmentsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetailsNarrative" xlink:href="avxl-20190331.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/SubsequentEventsDetailsNarrative" xlink:href="avxl-20190331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_GeneralSalesTaxRecoverable" xlink:label="loc_avxlGeneralSalesTaxRecoverable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_avxlGeneralSalesTaxRecoverable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherShortTermInvestments" xlink:label="loc_us-gaapOtherShortTermInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockSharesSubscriptions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NonOperatingIncomeFromGrant" xlink:label="loc_avxlNonOperatingIncomeFromGrant" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_avxlNonOperatingIncomeFromGrant" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:title="00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" xlink:title="00000007 - Disclosure - Business Description and Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/RecentAccountingPronouncements" xlink:title="00000008 - Disclosure - Recent Accounting Pronouncements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/OtherIncome" xlink:title="00000009 - Disclosure - Other Income" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/EquityOfferingAgreements" xlink:title="00000010 - Disclosure - Equity Offering Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/Commitments" xlink:title="00000011 - Disclosure - Commitments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/SubsequentEvents" xlink:title="00000012 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/RecentAccountingPronouncementsPolicies" xlink:title="00000013 - Disclosure - Recent Accounting Pronouncements (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsTables" xlink:title="00000014 - Disclosure - Commitments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:title="00000015 - Disclosure - Business Description and Basis of Presentation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/OtherIncomeDetailsNarrative" xlink:title="00000016 - Disclosure - Other Income (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" xlink:title="00000017 - Disclosure - Equity Offering Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails" xlink:title="00000018 - Disclosure - Commitments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails1" xlink:title="00000019 - Disclosure - Commitments (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails2" xlink:title="00000020 - Disclosure - Commitments (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails3" xlink:title="00000021 - Disclosure - Commitments (Details 3)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetailsNarrative" xlink:title="00000022 - Disclosure - Commitments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://anavex.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000023 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>avxl-20190331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://anavex.com/role/DocumentAndEntityInformation" xlink:href="avxl-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" xlink:href="avxl-20190331.xsd#BusinessDescriptionAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/RecentAccountingPronouncements" xlink:href="avxl-20190331.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/OtherIncome" xlink:href="avxl-20190331.xsd#OtherIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/EquityOfferingAgreements" xlink:href="avxl-20190331.xsd#EquityOfferingAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/Commitments" xlink:href="avxl-20190331.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/SubsequentEvents" xlink:href="avxl-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/RecentAccountingPronouncementsPolicies" xlink:href="avxl-20190331.xsd#RecentAccountingPronouncementsPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsTables" xlink:href="avxl-20190331.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:href="avxl-20190331.xsd#BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/OtherIncomeDetailsNarrative" xlink:href="avxl-20190331.xsd#OtherIncomeDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" xlink:href="avxl-20190331.xsd#EquityOfferingAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails" xlink:href="avxl-20190331.xsd#CommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails1" xlink:href="avxl-20190331.xsd#CommitmentsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails2" xlink:href="avxl-20190331.xsd#CommitmentsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails3" xlink:href="avxl-20190331.xsd#CommitmentsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetailsNarrative" xlink:href="avxl-20190331.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/SubsequentEventsDetailsNarrative" xlink:href="avxl-20190331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:title="00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommonSharesToBeIssuedMember" xlink:label="loc_avxlCommonSharesToBeIssuedMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_avxlCommonSharesToBeIssuedMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" xlink:label="loc_avxlCommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_avxlCommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" xlink:label="loc_avxlCommitmentSharesIssuedValueUndertermsOfPurchaseAgreement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_avxlCommitmentSharesIssuedValueUndertermsOfPurchaseAgreement_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" xlink:label="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrants_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:label="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedUponExerciseOfWarrantsCashless" xlink:label="loc_avxlSharesIssuedUponExerciseOfWarrantsCashless_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_avxlSharesIssuedUponExerciseOfWarrantsCashless_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" xlink:label="loc_avxlSharesIssuedUponExerciseOfWarrantsCashlessInShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_avxlSharesIssuedUponExerciseOfWarrantsCashlessInShares_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward_60" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" xlink:title="00000007 - Disclosure - Business Description and Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/RecentAccountingPronouncements" xlink:title="00000008 - Disclosure - Recent Accounting Pronouncements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/OtherIncome" xlink:title="00000009 - Disclosure - Other Income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/EquityOfferingAgreements" xlink:title="00000010 - Disclosure - Equity Offering Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/Commitments" xlink:title="00000011 - Disclosure - Commitments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/SubsequentEvents" xlink:title="00000012 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/RecentAccountingPronouncementsPolicies" xlink:title="00000013 - Disclosure - Recent Accounting Pronouncements (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsTables" xlink:title="00000014 - Disclosure - Commitments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:title="00000015 - Disclosure - Business Description and Basis of Presentation (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/OtherIncomeDetailsNarrative" xlink:title="00000016 - Disclosure - Other Income (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ClinicalStudyGrantMember" xlink:label="loc_avxlClinicalStudyGrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_avxlClinicalStudyGrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NonOperatingIncomeFromGrant" xlink:label="loc_avxlNonOperatingIncomeFromGrant_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlNonOperatingIncomeFromGrant_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" xlink:title="00000017 - Disclosure - Equity Offering Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingSalesAgreementMember" xlink:label="loc_avxlEquityOfferingSalesAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_avxlEquityOfferingSalesAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PurchaseAgreementMember" xlink:label="loc_avxlPurchaseAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_avxlPurchaseAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CantorFitzgeraldAndCoMember" xlink:label="loc_avxlCantorFitzgeraldAndCoMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_avxlCantorFitzgeraldAndCoMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_LincolnParkCapitalFundLLCMember" xlink:label="loc_avxlLincolnParkCapitalFundLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_avxlLincolnParkCapitalFundLLCMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ValueOfSharesObligatedToPurchase" xlink:label="loc_avxlValueOfSharesObligatedToPurchase_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlValueOfSharesObligatedToPurchase_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_AgreementTerm" xlink:label="loc_avxlAgreementTerm_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlAgreementTerm_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDescription" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDescription_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDescription_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NumberOfSharesObligatedToPurchaseProrataBasic" xlink:label="loc_avxlNumberOfSharesObligatedToPurchaseProrataBasic_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlNumberOfSharesObligatedToPurchaseProrataBasic_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodSharesNewIssues4" xlink:label="loc_avxlStockIssuedDuringPeriodSharesNewIssues4_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodSharesNewIssues4_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodValueNewIssues3" xlink:label="loc_avxlStockIssuedDuringPeriodValueNewIssues3_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodValueNewIssues3_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodSharesNewIssues3" xlink:label="loc_avxlStockIssuedDuringPeriodSharesNewIssues3_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodSharesNewIssues3_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodValueNewIssues4" xlink:label="loc_avxlStockIssuedDuringPeriodValueNewIssues4_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodValueNewIssues4_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PercentageOfGrossProceedsFromSales" xlink:label="loc_avxlPercentageOfGrossProceedsFromSales_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlPercentageOfGrossProceedsFromSales_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees_80" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails" xlink:title="00000018 - Disclosure - Commitments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PurchaseWarrantsMember" xlink:label="loc_avxlPurchaseWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_avxlPurchaseWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_30" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:label="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:label="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_30" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails1" xlink:title="00000019 - Disclosure - Commitments (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockOptionPlan2015Member" xlink:label="loc_avxlStockOptionPlan2015Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_avxlStockOptionPlan2015Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:label="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_30" xlink:to="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract_30" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract_30" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_30" xlink:type="arc" order="19" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails2" xlink:title="00000020 - Disclosure - Commitments (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails3" xlink:title="00000021 - Disclosure - Commitments (Details 3)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetailsNarrative" xlink:title="00000022 - Disclosure - Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockOptionPlan2015Member" xlink:label="loc_avxlStockOptionPlan2015Member_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_avxlStockOptionPlan2015Member_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_RemainingAllocatedShareBasedCompensationExpense" xlink:label="loc_avxlRemainingAllocatedShareBasedCompensationExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlRemainingAllocatedShareBasedCompensationExpense_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:label="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_40" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://anavex.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000023 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_OmnibusIncentive2019PlanMember" xlink:label="loc_avxlOmnibusIncentive2019PlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_avxlOmnibusIncentive2019PlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EmploymentAgreementMember" xlink:label="loc_avxlEmploymentAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_avxlEmploymentAgreementMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLaborAndRelatedExpense_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_50" xlink:type="arc" order="5" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>avxl-20190331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Products and Services [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ClinicalStudyGrantMember" xlink:label="avxl_ClinicalStudyGrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ClinicalStudyGrantMember" xlink:to="avxl_ClinicalStudyGrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ClinicalStudyGrantMember_lbl" xml:lang="en-US">Clinical Study Grant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PurchaseAgreementMember" xlink:label="avxl_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_PurchaseAgreementMember" xlink:to="avxl_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_PurchaseAgreementMember_lbl" xml:lang="en-US">2015 Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_LincolnParkCapitalFundLLCMember" xlink:label="avxl_LincolnParkCapitalFundLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_LincolnParkCapitalFundLLCMember" xlink:to="avxl_LincolnParkCapitalFundLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_LincolnParkCapitalFundLLCMember_lbl" xml:lang="en-US">Lincoln Park Capital Fund, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingSalesAgreementMember" xlink:label="avxl_EquityOfferingSalesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EquityOfferingSalesAgreementMember" xlink:to="avxl_EquityOfferingSalesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_EquityOfferingSalesAgreementMember_lbl" xml:lang="en-US">Equity Offering Sales Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CantorFitzgeraldAndCoMember" xlink:label="avxl_CantorFitzgeraldAndCoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CantorFitzgeraldAndCoMember" xlink:to="avxl_CantorFitzgeraldAndCoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_CantorFitzgeraldAndCoMember_lbl" xml:lang="en-US">Cantor Fitzgerald &amp; Co [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PurchaseWarrantsMember" xlink:label="avxl_PurchaseWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_PurchaseWarrantsMember" xlink:to="avxl_PurchaseWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_PurchaseWarrantsMember_lbl" xml:lang="en-US">Purchase Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockOptionPlan2015Member" xlink:label="avxl_StockOptionPlan2015Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockOptionPlan2015Member" xlink:to="avxl_StockOptionPlan2015Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_StockOptionPlan2015Member_lbl" xml:lang="en-US">2015 Omnibus Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US">General and administrative [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US">Research and development [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_OmnibusIncentive2019PlanMember" xlink:label="avxl_OmnibusIncentive2019PlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_OmnibusIncentive2019PlanMember" xlink:to="avxl_OmnibusIncentive2019PlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_OmnibusIncentive2019PlanMember_lbl" xml:lang="en-US">Omnibus Incentive 2019 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommonSharesToBeIssuedMember" xlink:label="avxl_CommonSharesToBeIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CommonSharesToBeIssuedMember" xlink:to="avxl_CommonSharesToBeIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_CommonSharesToBeIssuedMember_lbl" xml:lang="en-US">Common Shares to be Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EmploymentAgreementMember" xlink:label="avxl_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EmploymentAgreementMember" xlink:to="avxl_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">CEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_DocumentAndEntityInformationAbstract" xlink:label="avxl_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_DocumentAndEntityInformationAbstract" xlink:to="avxl_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Reporting Status Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_GeneralSalesTaxRecoverable" xlink:label="avxl_GeneralSalesTaxRecoverable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_GeneralSalesTaxRecoverable" xlink:to="avxl_GeneralSalesTaxRecoverable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_GeneralSalesTaxRecoverable_lbl" xml:lang="en-US">Sales tax recoverable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Deferred costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherShortTermInvestments" xlink:label="us-gaap_OtherShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherShortTermInvestments" xlink:to="us-gaap_OtherShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherShortTermInvestments_lbl" xml:lang="en-US">Deposits - short term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments - Note 5</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Capital stock Authorized: 100,000,000 common shares, par value $0.001 per share Issued and outstanding: 48,173,241 common shares (September 30, 2018 - 45,933,472)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="us-gaap_CommonStockSharesSubscriptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesSubscriptions" xlink:to="us-gaap_CommonStockSharesSubscriptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesSubscriptions_lbl" xml:lang="en-US">Subscriptions receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Capital shares, authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Capital shares, par value (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Capital shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Capital shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NonOperatingIncomeFromGrant" xlink:label="avxl_NonOperatingIncomeFromGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_NonOperatingIncomeFromGrant" xlink:to="avxl_NonOperatingIncomeFromGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_NonOperatingIncomeFromGrant_lbl" xml:lang="en-US">Grant income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xml:lang="en-US">Interest income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign exchange gain (loss), net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss and comprehensive loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US">Weighted average number of shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash Flows used in Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in non-cash working capital balances related to operations:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Sales tax recoverable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US">Cash Flows provided by Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuance of common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Deferred financing charges</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="us-gaap_CashPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashPeriodIncreaseDecrease_lbl" xml:lang="en-US">Decrease in cash and cash equivalents during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Cash_2_lbl" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Balance Beginning (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Shares issued under purchase agreement - purchase shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Shares issued under purchase agreement - purchase shares (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" xlink:label="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" xlink:to="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement_lbl" xml:lang="en-US">Shares issued under purchase agreement - commitment shares</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" xlink:label="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" xlink:to="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement_lbl" xml:lang="en-US">Shares issued under purchase agreement - commitment shares (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" xlink:to="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants_lbl" xml:lang="en-US">Shares issued pursuant to cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:to="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_lbl" xml:lang="en-US">Shares issued pursuant to cashless exercise of warrants (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedUponExerciseOfWarrantsCashless" xlink:label="avxl_SharesIssuedUponExerciseOfWarrantsCashless" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedUponExerciseOfWarrantsCashless" xlink:to="avxl_SharesIssuedUponExerciseOfWarrantsCashless_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_SharesIssuedUponExerciseOfWarrantsCashless_lbl" xml:lang="en-US">Shares issued pursuant to cashless exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" xlink:label="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" xlink:to="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares_lbl" xml:lang="en-US">Shares issued pursuant to cashless exercise of options (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Share based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Balance Ending (in shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xml:lang="en-US">Business Description and Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_lbl" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="us-gaap_OtherIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAbstract_lbl" xml:lang="en-US">Component of Operating Income [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_OtherIncomeDisclosureTextBlock" xlink:label="avxl_OtherIncomeDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_OtherIncomeDisclosureTextBlock" xlink:to="avxl_OtherIncomeDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_OtherIncomeDisclosureTextBlock_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingAgreementsAbstract" xlink:label="avxl_EquityOfferingAgreementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EquityOfferingAgreementsAbstract" xlink:to="avxl_EquityOfferingAgreementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_EquityOfferingAgreementsAbstract_lbl" xml:lang="en-US">Number of shares issued for commitment</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingAgreementsTextBlock" xlink:label="avxl_EquityOfferingAgreementsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EquityOfferingAgreementsTextBlock" xlink:to="avxl_EquityOfferingAgreementsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_EquityOfferingAgreementsTextBlock_lbl" xml:lang="en-US">Equity Offering Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="us-gaap_CommitmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsDisclosureTextBlock" xlink:to="us-gaap_CommitmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsDisclosureTextBlock_lbl" xml:lang="en-US">Commitments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of exercisable share purchase warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of outstanding stock purchase options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US">Schedule of general and administrative expenses and research and development expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of weighted average assumptions for fair value of each option award</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Loss per share for potentially dilutive common shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_ProductOrServiceAxis_2_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TypeOfArrangementAxis_2_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ValueOfSharesObligatedToPurchase" xlink:label="avxl_ValueOfSharesObligatedToPurchase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ValueOfSharesObligatedToPurchase" xlink:to="avxl_ValueOfSharesObligatedToPurchase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ValueOfSharesObligatedToPurchase_lbl" xml:lang="en-US">Total number of shares obligated to purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_AgreementTerm" xlink:label="avxl_AgreementTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_AgreementTerm" xlink:to="avxl_AgreementTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_AgreementTerm_lbl" xml:lang="en-US">Agreement term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDescription" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecordedUnconditionalPurchaseObligationDescription" xlink:to="us-gaap_UnrecordedUnconditionalPurchaseObligationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecordedUnconditionalPurchaseObligationDescription_lbl" xml:lang="en-US">Description of purchases price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NumberOfSharesObligatedToPurchaseProrataBasic" xlink:label="avxl_NumberOfSharesObligatedToPurchaseProrataBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_NumberOfSharesObligatedToPurchaseProrataBasic" xlink:to="avxl_NumberOfSharesObligatedToPurchaseProrataBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_NumberOfSharesObligatedToPurchaseProrataBasic_lbl" xml:lang="en-US">Pro rata basic number of shares obligated to purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodSharesNewIssues4" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues4" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodSharesNewIssues4" xlink:to="avxl_StockIssuedDuringPeriodSharesNewIssues4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues4_lbl" xml:lang="en-US">Number of shares issued for aggregate purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodValueNewIssues3" xlink:label="avxl_StockIssuedDuringPeriodValueNewIssues3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodValueNewIssues3" xlink:to="avxl_StockIssuedDuringPeriodValueNewIssues3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_StockIssuedDuringPeriodValueNewIssues3_lbl" xml:lang="en-US">Number of shares issued for aggregate purchase price, value</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodSharesNewIssues3" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodSharesNewIssues3" xlink:to="avxl_StockIssuedDuringPeriodSharesNewIssues3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues3_lbl" xml:lang="en-US">Number of shares issued for commitment</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodValueNewIssues4" xlink:label="avxl_StockIssuedDuringPeriodValueNewIssues4" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodValueNewIssues4" xlink:to="avxl_StockIssuedDuringPeriodValueNewIssues4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_StockIssuedDuringPeriodValueNewIssues4_lbl" xml:lang="en-US">Amount of shares remain available</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Gross sale proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PercentageOfGrossProceedsFromSales" xlink:label="avxl_PercentageOfGrossProceedsFromSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_PercentageOfGrossProceedsFromSales" xlink:to="avxl_PercentageOfGrossProceedsFromSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_PercentageOfGrossProceedsFromSales_lbl" xml:lang="en-US">Percentage of gross proceeds from sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="us-gaap_LegalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LegalFees" xlink:to="us-gaap_LegalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LegalFees_lbl" xml:lang="en-US">Legal and accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Balance, at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod_lbl" xml:lang="en-US">Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Balance, at end</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Share based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price [Roll Forward]</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Balance, at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_lbl" xml:lang="en-US">Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Balance, at end</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Outstanding at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Outstanding at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercisable at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:label="avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:to="avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate intrinsic value [Roll Forward]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Outstanding at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Outstanding at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Exercisable at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Total share based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life of options (years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Annualized volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend rate</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_lbl" xml:lang="en-US">Number of warrant exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Maximum number of common shares reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_RemainingAllocatedShareBasedCompensationExpense" xlink:label="avxl_RemainingAllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_RemainingAllocatedShareBasedCompensationExpense" xlink:to="avxl_RemainingAllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_RemainingAllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Remaining stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Description of grant option</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Expiration period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:to="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_2_lbl" xml:lang="en-US">Shares issued pursuant to cashless exercise of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_2_lbl" xml:lang="en-US">Shares issued pursuant to cashless exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Issuance of preferred stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock par value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of common shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Annual base salary</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Number of options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xml:lang="en-US">Vesting period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ClinicalStudyGrantMember" xlink:to="avxl_ClinicalStudyGrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ClinicalStudyGrantMember_doc" xml:lang="en-US">Information by clinical study grant.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_NonOperatingIncomeFromGrant" xlink:to="avxl_NonOperatingIncomeFromGrant_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_NonOperatingIncomeFromGrant_doc" xml:lang="en-US">Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_PurchaseAgreementMember" xlink:to="avxl_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_PurchaseAgreementMember_doc" xml:lang="en-US">Terms of the purchase agreement under purchase agreements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_LincolnParkCapitalFundLLCMember" xlink:to="avxl_LincolnParkCapitalFundLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_LincolnParkCapitalFundLLCMember_doc" xml:lang="en-US">Information related to type of legal entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EquityOfferingSalesAgreementMember" xlink:to="avxl_EquityOfferingSalesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_EquityOfferingSalesAgreementMember_doc" xml:lang="en-US">Represents information related to equity offering sales agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CantorFitzgeraldAndCoMember" xlink:to="avxl_CantorFitzgeraldAndCoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_CantorFitzgeraldAndCoMember_doc" xml:lang="en-US">Represents information related to cantor fitzgerald and co.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ValueOfSharesObligatedToPurchase" xlink:to="avxl_ValueOfSharesObligatedToPurchase_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ValueOfSharesObligatedToPurchase_doc" xml:lang="en-US">Information related to value of shares obligated to purchase initially.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_AgreementTerm" xlink:to="avxl_AgreementTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_AgreementTerm_doc" xml:lang="en-US">Terms of the agreement under agreements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_NumberOfSharesObligatedToPurchaseProrataBasic" xlink:to="avxl_NumberOfSharesObligatedToPurchaseProrataBasic_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_NumberOfSharesObligatedToPurchaseProrataBasic_doc" xml:lang="en-US">Information related to number of shares obligated to purchase prorata basic.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodSharesNewIssues4" xlink:to="avxl_StockIssuedDuringPeriodSharesNewIssues4_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues4_doc" xml:lang="en-US">Number of new stock issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodValueNewIssues3" xlink:to="avxl_StockIssuedDuringPeriodValueNewIssues3_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_StockIssuedDuringPeriodValueNewIssues3_doc" xml:lang="en-US">Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodSharesNewIssues3" xlink:to="avxl_StockIssuedDuringPeriodSharesNewIssues3_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues3_doc" xml:lang="en-US">Number of new stock issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodValueNewIssues4" xlink:to="avxl_StockIssuedDuringPeriodValueNewIssues4_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_StockIssuedDuringPeriodValueNewIssues4_doc" xml:lang="en-US">Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_PercentageOfGrossProceedsFromSales" xlink:to="avxl_PercentageOfGrossProceedsFromSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_PercentageOfGrossProceedsFromSales_doc" xml:lang="en-US">Represents information related to percentage of gross proceeds from sales.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_PurchaseWarrantsMember" xlink:to="avxl_PurchaseWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_PurchaseWarrantsMember_doc" xml:lang="en-US">Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod_doc" xml:lang="en-US">Represents information related to share based compensation arrangement by share based payment award equity instruments other than options expired in period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod_doc" xml:lang="en-US">The number of exercised in period made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod_doc" xml:lang="en-US">Represents information related to share based compensation arrangement by share based payment award equity instruments other than options expired in period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward_doc" xml:lang="en-US">Information related to share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Information related to share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_doc" xml:lang="en-US">Represents information related to share based compensation arrangements by share based payment award equity instruments other than options exercised in period weighted average issued price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Information related to share based compensation arrangements by share based payment award equity instruments other than options exercised in period weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_doc" xml:lang="en-US">Represents information related to share based compensation arrangements by share based payment award equity instruments other than options exercised in period weighted average expired price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockOptionPlan2015Member" xlink:to="avxl_StockOptionPlan2015Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_StockOptionPlan2015Member_doc" xml:lang="en-US">Information related to type of plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber_doc" xml:lang="en-US">Information related to share based compensation arrangement by share based payment award equity instruments other than options exercisable number.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice_doc" xml:lang="en-US">Refers to the weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_RemainingAllocatedShareBasedCompensationExpense" xlink:to="avxl_RemainingAllocatedShareBasedCompensationExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_RemainingAllocatedShareBasedCompensationExpense_doc" xml:lang="en-US">It represents as a remaining stock based compensation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:to="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares_doc" xml:lang="en-US">The number of shares issued during the period upon the pursuant to cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_OmnibusIncentive2019PlanMember" xlink:to="avxl_OmnibusIncentive2019PlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_OmnibusIncentive2019PlanMember_doc" xml:lang="en-US">Represents member of Omnibus incentive 2019 plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_GeneralSalesTaxRecoverable" xlink:to="avxl_GeneralSalesTaxRecoverable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_GeneralSalesTaxRecoverable_doc" xml:lang="en-US">Information related to general sales tax recoverable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CommonSharesToBeIssuedMember" xlink:to="avxl_CommonSharesToBeIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_CommonSharesToBeIssuedMember_doc" xml:lang="en-US">Its present the common shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" xlink:to="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement_doc" xml:lang="en-US">Value of stock issued pursuant to commitment under terms of purchase agreement during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" xlink:to="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement_doc" xml:lang="en-US">Number of stock issued pursuant to commitment under terms of purchase agreement during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" xlink:to="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants_doc" xml:lang="en-US">Value of stock issued during the period upon the pursuant to cashless exercise of warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedUponExerciseOfWarrantsCashless" xlink:to="avxl_SharesIssuedUponExerciseOfWarrantsCashless_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_SharesIssuedUponExerciseOfWarrantsCashless_doc" xml:lang="en-US">It represents amount of shares issued upon exercise of cashless warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" xlink:to="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares_doc" xml:lang="en-US">It represents number of shares issued upon exercise of cashless warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_OtherIncomeDisclosureTextBlock" xlink:to="avxl_OtherIncomeDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_OtherIncomeDisclosureTextBlock_doc" xml:lang="en-US">Disclosure of other income disclosure.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EquityOfferingAgreementsTextBlock" xlink:to="avxl_EquityOfferingAgreementsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_EquityOfferingAgreementsTextBlock_doc" xml:lang="en-US">Represents information related to equity offering agreements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_EmploymentAgreementMember" xlink:to="avxl_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="avxl_EmploymentAgreementMember_doc" xml:lang="en-US">The information of Employment agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Deposit Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashPeriodIncreaseDecrease" xlink:to="us-gaap_CashPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2_lbl" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_StockIssuedDuringPeriodSharesNewIssues3" xlink:to="avxl_StockIssuedDuringPeriodSharesNewIssues3_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_StockIssuedDuringPeriodSharesNewIssues3_3_lbl" xml:lang="en-US">StockIssuedDuringPeriodSharesNewIssues3</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:to="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>avxl-20190331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Created by S2 Filings, LLC- http://www.s2filings.com -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://anavex.com/role/DocumentAndEntityInformation" xlink:href="avxl-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:href="avxl-20190331.xsd#InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" xlink:href="avxl-20190331.xsd#BusinessDescriptionAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/RecentAccountingPronouncements" xlink:href="avxl-20190331.xsd#RecentAccountingPronouncements" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/OtherIncome" xlink:href="avxl-20190331.xsd#OtherIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/EquityOfferingAgreements" xlink:href="avxl-20190331.xsd#EquityOfferingAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/Commitments" xlink:href="avxl-20190331.xsd#Commitments" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/SubsequentEvents" xlink:href="avxl-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/RecentAccountingPronouncementsPolicies" xlink:href="avxl-20190331.xsd#RecentAccountingPronouncementsPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsTables" xlink:href="avxl-20190331.xsd#CommitmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:href="avxl-20190331.xsd#BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/OtherIncomeDetailsNarrative" xlink:href="avxl-20190331.xsd#OtherIncomeDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" xlink:href="avxl-20190331.xsd#EquityOfferingAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails" xlink:href="avxl-20190331.xsd#CommitmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails1" xlink:href="avxl-20190331.xsd#CommitmentsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails2" xlink:href="avxl-20190331.xsd#CommitmentsDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetails3" xlink:href="avxl-20190331.xsd#CommitmentsDetails3" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/CommitmentsDetailsNarrative" xlink:href="avxl-20190331.xsd#CommitmentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://anavex.com/role/SubsequentEventsDetailsNarrative" xlink:href="avxl-20190331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_DocumentAndEntityInformationAbstract" xlink:label="loc_avxlDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_GeneralSalesTaxRecoverable" xlink:label="loc_avxlGeneralSalesTaxRecoverable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_avxlGeneralSalesTaxRecoverable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherShortTermInvestments" xlink:label="loc_us-gaapOtherShortTermInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesSubscriptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NonOperatingIncomeFromGrant" xlink:label="loc_avxlNonOperatingIncomeFromGrant" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_avxlNonOperatingIncomeFromGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentIncomeTaxExpenseBenefit" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCurrentIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashPeriodIncreaseDecrease" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="loc_us-gaapCashPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity" xlink:title="00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommonSharesToBeIssuedMember" xlink:label="loc_avxlCommonSharesToBeIssuedMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_avxlCommonSharesToBeIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" xlink:label="loc_avxlCommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_avxlCommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" xlink:label="loc_avxlCommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_avxlCommitmentSharesIssuedValueUndertermsOfPurchaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants" xlink:label="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrants" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:label="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedUponExerciseOfWarrantsCashless" xlink:label="loc_avxlSharesIssuedUponExerciseOfWarrantsCashless" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_avxlSharesIssuedUponExerciseOfWarrantsCashless" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares" xlink:label="loc_avxlSharesIssuedUponExerciseOfWarrantsCashlessInShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_avxlSharesIssuedUponExerciseOfWarrantsCashlessInShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInStockholdersEquityRollForward" xlink:to="loc_us-gaapCommonStockSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation" xlink:title="00000007 - Disclosure - Business Description and Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/RecentAccountingPronouncements" xlink:title="00000008 - Disclosure - Recent Accounting Pronouncements">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/OtherIncome" xlink:title="00000009 - Disclosure - Other Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_OtherIncomeDisclosureTextBlock" xlink:label="loc_avxlOtherIncomeDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_avxlOtherIncomeDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/EquityOfferingAgreements" xlink:title="00000010 - Disclosure - Equity Offering Agreements">
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingAgreementsAbstract" xlink:label="loc_avxlEquityOfferingAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingAgreementsTextBlock" xlink:label="loc_avxlEquityOfferingAgreementsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlEquityOfferingAgreementsAbstract" xlink:to="loc_avxlEquityOfferingAgreementsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/Commitments" xlink:title="00000011 - Disclosure - Commitments">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/SubsequentEvents" xlink:title="00000012 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/RecentAccountingPronouncementsPolicies" xlink:title="00000013 - Disclosure - Recent Accounting Pronouncements (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:label="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsTables" xlink:title="00000014 - Disclosure - Commitments (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:label="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative" xlink:title="00000015 - Disclosure - Business Description and Basis of Presentation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/OtherIncomeDetailsNarrative" xlink:title="00000016 - Disclosure - Other Income (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ClinicalStudyGrantMember" xlink:label="loc_avxlClinicalStudyGrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_avxlClinicalStudyGrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NonOperatingIncomeFromGrant" xlink:label="loc_avxlNonOperatingIncomeFromGrant" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlNonOperatingIncomeFromGrant" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative" xlink:title="00000017 - Disclosure - Equity Offering Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingAgreementsAbstract" xlink:label="loc_avxlEquityOfferingAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlEquityOfferingAgreementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EquityOfferingSalesAgreementMember" xlink:label="loc_avxlEquityOfferingSalesAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_avxlEquityOfferingSalesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PurchaseAgreementMember" xlink:label="loc_avxlPurchaseAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_avxlPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_CantorFitzgeraldAndCoMember" xlink:label="loc_avxlCantorFitzgeraldAndCoMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_avxlCantorFitzgeraldAndCoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_LincolnParkCapitalFundLLCMember" xlink:label="loc_avxlLincolnParkCapitalFundLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_avxlLincolnParkCapitalFundLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ValueOfSharesObligatedToPurchase" xlink:label="loc_avxlValueOfSharesObligatedToPurchase" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlValueOfSharesObligatedToPurchase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_AgreementTerm" xlink:label="loc_avxlAgreementTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlAgreementTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDescription" xlink:label="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapUnrecordedUnconditionalPurchaseObligationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_NumberOfSharesObligatedToPurchaseProrataBasic" xlink:label="loc_avxlNumberOfSharesObligatedToPurchaseProrataBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlNumberOfSharesObligatedToPurchaseProrataBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodSharesNewIssues4" xlink:label="loc_avxlStockIssuedDuringPeriodSharesNewIssues4" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodSharesNewIssues4" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodValueNewIssues3" xlink:label="loc_avxlStockIssuedDuringPeriodValueNewIssues3" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodValueNewIssues3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodSharesNewIssues3" xlink:label="loc_avxlStockIssuedDuringPeriodSharesNewIssues3" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodSharesNewIssues3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockIssuedDuringPeriodValueNewIssues4" xlink:label="loc_avxlStockIssuedDuringPeriodValueNewIssues4" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlStockIssuedDuringPeriodValueNewIssues4" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PercentageOfGrossProceedsFromSales" xlink:label="loc_avxlPercentageOfGrossProceedsFromSales" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlPercentageOfGrossProceedsFromSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails" xlink:title="00000018 - Disclosure - Commitments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_PurchaseWarrantsMember" xlink:label="loc_avxlPurchaseWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_avxlPurchaseWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:label="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:label="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_avxlShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails1" xlink:title="00000019 - Disclosure - Commitments (Details 1)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockOptionPlan2015Member" xlink:label="loc_avxlStockOptionPlan2015Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_avxlStockOptionPlan2015Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:label="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avxlSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails2" xlink:title="00000020 - Disclosure - Commitments (Details 2)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaapGeneralAndAdministrativeExpenseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapGeneralAndAdministrativeExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaapResearchAndDevelopmentExpenseMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapResearchAndDevelopmentExpenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetails3" xlink:title="00000021 - Disclosure - Commitments (Details 3)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/CommitmentsDetailsNarrative" xlink:title="00000022 - Disclosure - Commitments (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_StockOptionPlan2015Member" xlink:label="loc_avxlStockOptionPlan2015Member" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_avxlStockOptionPlan2015Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_RemainingAllocatedShareBasedCompensationExpense" xlink:label="loc_avxlRemainingAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlRemainingAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:label="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlSharesIssuedPursuantToCashlessExerciseOfWarrantsInShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:label="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_avxlShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://anavex.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000023 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_OmnibusIncentive2019PlanMember" xlink:label="loc_avxlOmnibusIncentive2019PlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_avxlOmnibusIncentive2019PlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="avxl-20190331.xsd#avxl_EmploymentAgreementMember" xlink:label="loc_avxlEmploymentAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_avxlEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img001_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img001_v1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (1 PP# 2(  A$! Q$!_\0
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M_P"_ _QH^SW_ /S_ *?]^!_C67_:.O\ _0/C_P"^3_C1_:.O_P#0/C_[Y/\
MC1_:E+^27_@+#ZI/NOO1J?9[_P#Y_P!/^_ _QH^SW_\ S_I_WX'^-9?]HZ__
M - ^/_OD_P"-']HZ_P#] ^/_ +Y/^-']J4OY)?\ @+#ZI/NOO1J?9[__ )_T
M_P"_ _QH^SW_ /S_ *?]^!_C67_:.O\ _0/C_P"^3_C1_:.O_P#0/C_[Y/\
MC1_:E+^27_@+#ZI/NOO1J?9[_P#Y_P!/^_ _QH^SW_\ S_I_WX'^-9?]HZ__
M - ^/_OD_P"-']HZ_P#] ^/_ +Y/^-']J4OY)?\ @+#ZI/NOO1J?9[__ )_T
M_P"_ _QH^SW_ /S_ *?]^!_C67_:.O\ _0/C_P"^3_C1_:.O_P#0/C_[Y/\
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M9O\ OD?XT?VG@_\ GXOO#ZI7_E9>^SW_ /S_ *?]^!_C1]GO_P#G_3_OP/\
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M9O\ OD?XT?VG@_\ GXOO#ZI7_E9>^SW_ /S_ *?]^!_C1]GO_P#G_3_OP/\
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M9O\ OD?XT?VG@_\ GXOO#ZI7_E9>^SW_ /S_ *?]^!_C1]GO_P#G_3_OP/\
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MG_/6#_OH_P"%2L/C4HQ]B]&GT[MC]KA[M\^_^5BG81QRV-N)6 C2Y:23_="
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MJ.'_ )3I?^$OF_Y]H_S-'_"7S?\ /M'^9KFJ*/[7QW_/Q_A_D'U'#_RG2_\
M"7S?\^T?YFC_ (2^;_GVC_,US5%']KX[_GX_P_R#ZCA_Y3I?^$OF_P"?:/\
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M$$0[A@_QANH-$DWFVZ1O9*7C3RUDW'(&2>G3O7<_VKI__/[!_P!]BC^U=/\
M^?V#_OL4O[)A;E^L*WHO+S\D/Z[*]_9/[W_D<#,99HH4,>!$FP$=^2?ZTMPT
MMS.96BP2 ,#IP /Z5WO]JZ?_ ,_L'_?8H_M73_\ G]@_[[%0\FI-6>(73HNF
MBZC6/FMJ7]?<<--.SV[0Q6BPJ[!WVDG<1TZ]!S0]S-)-=2&$ W"[6']WIT_*
MNY_M73_^?V#_ +[%']JZ?_S^P?\ ?8JWE,'_ ,Q"^Y>?GYL2QLO^?3^]_P"7
MD<8-0N3Y'FP+)Y431')(W!N.?>HQ=S*R".V5(D5U6,9Q\PP23U)KM_[5T_\
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M_>SGAXBD"E19X'H%%(OB&1'=DLR"^,\#L,?TKHO[5T__ )_8/^^Q1_:NG_\
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M %]QYYY,G]PT>3)_<->FQR)+&'C971N0RG(-.K9<-)JZJ_A_P2/[5:^Q^/\
MP#S#R9/[AH\F3^X:]/HH_P!65_S]_#_@A_:S_D_'_@'F'DR?W#1Y,G]PUZ?1
M1_JRO^?OX?\ !#^UG_)^/_ /,/)D_N&CR9/[AKT^BC_5E?\ /W\/^"']K/\
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M:'_T$S^8_P */[(T/_H)M^8_PKFZ*GZ[1_Y\1_'_ #']7G_S\?X'2?V1H?\
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ME_PH_P"$7T[_ )[R_P#?2_X4?V#B_+[P_M&AY_<<;179?\(OIW_/>7_OI?\
M"C_A%]._Y[R_]]+_ (4?V#B_+[P_M&AY_<<K964U]<+#"N6/4]@/4UWVFZ=%
MIMJ(8SECR['N:-/TZVTZ$I;C.[DN>2:N5]#E651PB]I/6;_#T/,QF,=9\L?A
M"BBBO:. **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFO-.E)7@NO;R_K8\7,Z5.-IIVD^G<T****^H/("BBB@ HHHH **** "BBB@
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M\_%^ G_"'O\ \_B_]^__ *]'_"'O_P _B_\ ?O\ ^O2_VYX/_P"@E!_W^?\
MQH_MSP?_ -!*#_O\_P#C1_J]A?\ GT_OE_F']KS_ .?B_ 3_ (0]_P#G\7_O
MW_\ 7H_X0]_^?Q?^_?\ ]>E_MSP?_P!!*#_O\_\ C1_;G@__ *"4'_?Y_P#&
MC_5["_\ /I_?+_,/[7G_ ,_%^ G_  A[_P#/XO\ W[_^O1_PA[_\_B_]^_\
MZ]+_ &YX/_Z"4'_?Y_\ &C^W/!__ $$H/^_S_P"-'^KV%_Y]/[Y?YA_:\_\
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MW\;_ !H NT52_LFR_P">3?\ ?QO\:5-+LT=76-@RG(_>-_C0!<HHHH ****
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M6STRPT_/V*S@M\JJ'RHPN57) X[#<?S- ''0>']'N/B&/[.T^WM8]'A,MQ-
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M%% !1110!YWI_P#R6C4?^N'_ +(E>B5YWI__ "6C4?\ KA_[(E>B5TXG>/\
MA1QX/:?^)A1117,=@4AZ&EI#T- 'SSH.G_VCXA"F SQ0!YY(@,[U49V_B<#\
M:T=2TF*SNM=9K01(]DEU;HR\P[W3('I@EE_"N?\ ML]NE[;Q,%2YPLO') ;(
M /;G^56;7Q!?6END"^1)$D;1!9H0X*,P8@YZ_,,CTKZ.49N5T?)0G34>62U[
M_A_P2]IMU%;>'[BZO+"PDA13!;;X!YDTI[[NN%!R3]!6BNC6']KAO.LL?V9Y
MGV/:V_=]GSNQC&<_-UK%D\37LT*0R6NG-&@8(ILTPF3DX]*JC6+P7WVS>GG>
M1]GSL&-FS9T]=O>E[.;N]BE5II);VL;>I);6^E:=%&-*4RVENSQF FX8MC+;
ML8_7I5^]T>PFLM;MX;6-+Q=0F^R,BX.(U#&,>Q7=@>HKF)=<NYK.*VDBM&$4
M:Q)(;=?,55Z#=UIW_"1:E]J6Y$J"5;LWH(0#]Z0 3],#I2]E/HRO;4NJ.FL]
M'T^&+0[66UBDN1?*EXSC.XM'OV'V *\>N:IV0M[G59]QT.00V,LBO';E84;<
M,%P1R1].]8<6OZC#,)EE0R"Z-YED!S*1@GZ8[4DNM7,A<K#:0^9"T#^3;JFY
M6()SCOP.:/93ZL/;T[*RV-;6I=/TO4;FQ%C'MF%L;AXN$V@!G\K/(#'&#GI5
M?Q)'&\<5W91:>=.>1U@FM(RC#H=DBGD,!Z]?4UER:E<RR6DCLI>T18XFV#[J
MG(!]<>_:GW^K76HPQPRB".&-BXB@A6-=QZL0.IJXTVFG]YG.K&2DON.D\FQN
M-5L]%?3K58I["-Q/&FV5)#%OW[NXR.0>U-B33()88C'817D^GVSP-=Q[H2Q!
MW[O1FX^8_I6))XCU&2U\C= G[D0&6.%5D:,#&TOC.,<4D7B"]CV92TE"1QQJ
M)K=7"A!A2,CKS^-1[*=O^":>WIW_ . ;30)8:*S3P:3:W?VJX22.ZA+GY0N%
M0X/ R<9/<4'P\?\ A"2XL6%V(OM_VK;_  ;MOEY_W?GK&'B&^,+QS+:W(>1Y
M2UQ;K(VY\;B">G05%_;5]_:O]I>8OVC;L^X-FW;MV[>F-O&*/9U._F)U:7;I
M;_@G20VUCJ-WI;V%II\NEBZMXY0(R)XB>"LG/S!CGGD?2L+7Y(VN42-],95+
M?\>,)CQST;(&3Q0?$NHYB,9MXC'*DQ,5NJ>8Z_=+X'S8JI?ZE+J+*98+6,J2
M<P0+'G/KCK50IR4KLFI5A*#2W]"G1116YRA1110 4444 6;"_N=,O8KNTE:*
M>,Y5EKWWPIKK^(=#CO9;9X),[&R,*Q'=?4?_ %Q7E_@?P/)KLRW]^K)IR'@=
M#,1V'MZG_(]HBBC@B2*)%2- %55&  .PKR,PJTY-16Z/=RJC5BG-NT7T_4?1
M117F'LA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 V0$Q.!U*FO'O"GB#4O"EI<VCZ!=3M)+O)^9=O&,?
M=/I7L=%;TJRA%QE&Z9S5Z$JDHSC*S5^E]SSS_A9.H?\ 0KW7_?;?_$4?\+)U
M#_H5[K_OMO\ XBO0Z*KVM'_GW^+(]A7_ .?OX(\\_P"%DZA_T*]U_P!]M_\
M$4?\+)U#_H5[K_OMO_B*]#HH]K1_Y]_BP]A7_P"?OX(\\_X63J'_ $*]U_WV
MW_Q%'_"R=0_Z%>Z_[[;_ .(KT.BCVM'_ )]_BP]A7_Y^_@CSS_A9.H?]"O=?
M]]M_\11_PLG4/^A7NO\ OMO_ (BO0Z*/:T?^??XL/85_^?OX(\\_X63J'_0K
MW7_?;?\ Q%'_  LG4/\ H5[K_OMO_B*]#HH]K1_Y]_BP]A7_ .?OX(\\_P"%
MDZA_T*]U_P!]M_\ $4?\+)U#_H5[K_OMO_B*]#HH]K1_Y]_BP]A7_P"?OX(\
M\_X63J'_ $*]U_WVW_Q%'_"R=0_Z%>Z_[[;_ .(KT.BCVM'_ )]_BP]A7_Y^
M_@CS'PI->ZM\1[K5Y=.GM8I8#D.IPN J]2!Z5Z=116=:K[22:5K*QKAZ/LHM
M-W;=PHHHK(W"BBD/0T <<VE> -QW?V7G//\ I/\ ]E2?V5\/_72__ G_ .RK
MR&TTZ34]1GACFBA$:/*\DK$*JKU/ -6H_"^HS7<MO$T,FRU^U+(DF4D3MM/<
MGD >QKV7AK:.HSY]8MR5U11ZI_97P_\ 72__  )_^RH_LKX?^NE_^!/_ -E7
MD^FZ#<ZI:QS0W-K&TLIAABED*M*X .%XQW'4TD6@7DMO%<%HHX'BDE>1V($2
MHQ4[O<D8 '6CZO\ ]/&"Q;:NJ*/6?[*^'_KI?_@3_P#94?V5\/\ UTO_ ,"?
M_LJ\I3PWJ$D5R\9C?[/:QW3JK')1QD8]2!U^E-@T"YFC29[BW@MS;BY::5R%
M12Q0 X&<DCH*/JZ_Y^L/K3_Y\H]8_LKX?^NE_P#@3_\ 94?V5\/_ %TO_P "
M?_LJ\FAT.219I9;ZR@MHY?)%Q)*=DC8SA, D\8.<<9I[>&M22+47*QG^SU1Y
M0KYW*PR&3'WACGZ4?5U_S]8?6G_SY1ZM_97P_P#72_\ P)_^RH_LKX?^NE_^
M!/\ ]E7D_P#8%RMHT[RQ@&&&2)1D^896PJ#T; )_"H=3TMM+;8][:3R!S')'
M!(6:-AU!R!^8XH6&N[*HP>+LKNBCU[^ROA_ZZ7_X$_\ V5']E?#_ -=+_P#
MG_[*O*O^$;NS!&T=S:23O +@6JR'S2A&<@$8)QS@'--A\/W,D8EDNK:"W^SQ
MW#32N0JAR0H. 3DD&CZNO^?K']:?_/E'J_\ 97P_]=+_ / G_P"RH_LKX?\
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M14LOB.WMHYWL9=[0-:10"12//2-'5R1V!ST/8U4_X0+Q/_T"9?\ OM?\:/\
MA O$_P#T"9?^^U_QI_N;6<]/5!?$7NH-/T9#XBNM.O-5LO[/G9+-+:*/<5),
M6"<@CN5SV]*?K]U;7-A!YEY;7^IB4[KJ"-DW18X$A(&YL]\9]33_ /A O$__
M $"9?^^U_P :/^$"\3_] F7_ +[7_&FI4E;WUIYHAQKOF]QZ^3+,=]IL%_IN
ML'4$=K2SC06J(WF-(J$8)Q@#)Y.>E-M]0B\RT:#5[6VV6$,$\5S$SQ2@%BRL
M #G''Y\&H/\ A O$_P#T"9?^^U_QH_X0+Q/_ - F7_OM?\:7[G^=?>B_W_\
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M!,O_ 'VO^-:>VI_S+[S#ZO6_D?W,YRBNC_X0+Q/_ - F7_OM?\:/^$"\3_\
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M9XVN+.%W:-(C@MU.0I[?6NWH I?V=_T^7G_?W_ZU']G?]/EY_P!_?_K5=HH
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MEY_W]_\ K4?V=_T^7G_?W_ZU7:* *7]G?]/EY_W]_P#K4?V=_P!/EY_W]_\
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MV_NF@!M%.\MO[IH\MO[IH ;13O+;^Z:/+;^Z: &T4[RV_NFE6*1V"JA+$X
MZT (BL[A4!+$X '4FO5?#EI?6>D1Q7\FY^JH>J+Z$_YQ6=X8\,+IRK>7B@W9
M&54](_\ Z]=10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF7$[Z8OFPRK%AIG[ALYYZ\5;NM(MQ996!8B1 L4HE+%W<#(9>PZGMTH M_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ K.;0=)9BQT^#)Y/R5HT4 9O_  C^D?\ 0/@_[YH_X1_2/^@?!_WS6E10
M!F_\(_I'_0/@_P"^:/\ A'](_P"@?!_WS6E10!F_\(_I'_0/@_[YH_X1_2/^
M@?!_WS6E10!F_P#"/Z1_T#X/^^:/^$?TC_H'P?\ ?-:5% &;_P (_I'_ $#X
M/^^:/^$?TC_H'P?]\UI44 9O_"/Z1_T#X/\ OFC_ (1_2/\ H'P?]\UI44 9
MO_"/Z1_T#X/^^:/^$?TC_H'P?]\UI44 5+72[&RD,EM:Q1.1@LJ\XJW110 4
M444 %%%% 'BUS_Q\R?[QJ]:Z2MU;V[?:U2>X+B*(QD@E?5NV?I5&Y_X^9/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV]Z[B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **AGN4M@I=9#NZ;(V;^0J'^T
MX/[ES_X#O_A0!<HJG_:<']RY_P# =_\ "C^TX/[ES_X#O_A0!<HJG_:<']RY
M_P# =_\ "C^TX/[ES_X#O_A0!<HJG_:<']RY_P# =_\ "C^TX/[ES_X#O_A0
M!<HJG_:<']RY_P# =_\ "C^TX/[ES_X#O_A0!<HJG_:<']RY_P# =_\ "C^T
MX/[ES_X#O_A0!<HJG_:<']RY_P# =_\ "C^TX/[ES_X#O_A0!<HJG_:<']RY
M_P# =_\ "C^TX/[ES_X#O_A0!<HJG_:<']RY_P# =_\ "C^TX/[ES_X#O_A0
M!<HJG_:<']RY_P# =_\ "C^TX/[ES_X#O_A0!<HJG_:<']RY_P# =_\ "C^T
MX/[ES_X#O_A0!Y'=_P#'Y-_OFK-I?I9V,\:PI)/,ZAO-7*A!S^><?E7;/H?A
M^1V=K2[+,<G]W+_A3?[ \._\^=Y_W[E_PH Y>?4K"]CN!/Y\37#QRN8HP1O5
M2&QD]#G-17-SIKVUO%#+=*MN,JAB7#OG)8G/?^0KK?[ \._\^=Y_W[E_PH_L
M#P[_ ,^=Y_W[E_PH Y.YUEKE]4#S7#PW(/DHS9"_.".,\<"K$VKVLFJP7OVF
M]=$G63R'4;5 '..>M=)_8'AW_GSO/^_<O^%']@>'?^?.\_[]R_X4 <O:ZO;1
M);Q3PO) L;K*GJ=^]"/QQ^9I8-:CWPO.\ZR"*=9)(QR&D.05Y[5T_P#8'AW_
M )\[S_OW+_A1_8'AW_GSO/\ OW+_ (4 <FNK&T6Z:UN[IYY#$RS2##?*3D'D
M\=*JSRV<VJO,!-';2-O(3&Y"1GCV!_2NV_L#P[_SYWG_ '[E_P */[ \._\
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M4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\
MM.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =
M_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X
M4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\
MM.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =
M_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X
M4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\
MM.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =
M_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X
M4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\
MM.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =
M_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X
M4?VG!_<N?_ =_P#"@"Y15/\ M.#^Y<_^ [_X4?VG!_<N?_ =_P#"@"Y15/\
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M&>%YF%O%@%^,AC@ '\3S]#59[;R[221\B5)_*([=#35*B_LDNKB%O+^D:?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF2AF:0!@F47;_>/;-,BN[91;M+'*9+<_)M(PPSD9].?2EBU+RTA1@YCW/YR
M\.&HE[3I_6__   C[+K_ %M_P1J6EN/(2>=UEF4,-J@J@/3/_P!:I(],1E1'
MDD6=VD4 +E05]33!=6C&&2:*4R0J% 4@*X'3/I[TDFHR26Z1%Y%!=VF"G ?<
M<T/VCV!>R6_]; UE%#:0W$TCX;_6*@&4R,KU]0*DDT^#[1+;PR3O)'&9.5'/
M ( Q]:;-J?VA;F-XE$4JX0*H#*1]W)[XI#?K]LGG57'F0^6N#R#@#/Z4+VG4
M'[+I_7]:"+I_[J)I3)&SI*Q4KC&T9'YTV2VMX$"332"<H'PJ95<C(![TY+\"
M*)9 [LB2J23G.X8'Y4V6XM;A1)+'+YX0(=K *Q P#ZT_?OJ)^SMH+:6D,\(>
M5Y5+2B)0B[N2.II9-.,5E),9 9$<C8.A0';N_.HXKV2"Q>")W1VDW%E..,8Q
M5@:HH81^2/LWE>41M&_&/7Z\T/VE[H(^RY;/<$TL2><J2G>D2.@(^\6&<?X5
M3GA$*P$,3YD0<Y'3DC'Z58>_!238'5RL05O0IWIE_=K>2QR+'Y>V,*P[9R22
M/;FB//?7;_@"G[/ETW_X)+I6JRZ;/D?-$WWT]:[BVN8KN!9H6W(WZ>U>>6UO
M+=3K%$I9F/05W.E::NFVVP,6D;ESV_"N3'1AO]H[LNG4=X_9+]%%%>:>J%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !61J&BM>W@N8[DQ-C'"_\ UZT;B SA0)Y8L=XR!G\P:I3116Y
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M /?:_P#Q-'UZ7\R_ /JU#^F_\RN?#4CLOFW[.H/0J?\ &N@K(\RT_P"@Q/\
M]]K_ /$U:%@Q&1?W9'^\O_Q-1*NZN[O8VI4J=._(7:*I?V>__/\ W?\ WTO_
M ,31_9[_ //_ '?_ 'TO_P 34FI=HJE_9[_\_P#=_P#?2_\ Q-']GO\ \_\
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M^E_^)H NT52_L]_^?^[_ .^E_P#B:/[/?_G_ +O_ +Z7_P")H NT52_L]_\
MG_N_^^E_^)H_L]_^?^[_ .^E_P#B: +M%4O[/?\ Y_[O_OI?_B:/[/?_ )_[
MO_OI?_B: +M%4O[/?_G_ +O_ +Z7_P")H_L]_P#G_N_^^E_^)H NT52_L]_^
M?^[_ .^E_P#B:/[/?_G_ +O_ +Z7_P")H NT52_L]_\ G_N_^^E_^)H_L]_^
M?^[_ .^E_P#B: +M%4O[/?\ Y_[O_OI?_B:/[/?_ )_[O_OI?_B: +M%4O[/
M?_G_ +O_ +Z7_P")H_L]_P#G_N_^^E_^)H NT52_L]_^?^[_ .^E_P#B:/[/
M?_G_ +O_ +Z7_P")H NT52_L]_\ G_N_^^E_^)H_L]_^?^[_ .^E_P#B: +M
M%4O[/?\ Y_[O_OI?_B:/[/?_ )_[O_OI?_B: +M%4O[/?_G_ +O_ +Z7_P")
MH_L]_P#G_N_^^E_^)H NT52_L]_^?^[_ .^E_P#B:/[/?_G_ +O_ +Z7_P")
MH NT52_L]_\ G_N_^^E_^)H_L]_^?^[_ .^E_P#B: +M%4O[/?\ Y_[O_OI?
M_B:/[/?_ )_[O_OI?_B: +M%4O[/?_G_ +O_ +Z7_P")H_L]_P#G_N_^^E_^
M)H NT5%!"8$*F:67)SF0@D?D!4M !1110 4444 %8.JQ)/KEK'(,HR@$9QW-
M;U8E_P#\C#9_[J_S-<^)5X)>:_,SJ;%K^P]/_P">)_[[/^-']AZ?_P \3_WV
M?\:T:*OV-/\ E7W%<D>QG?V'I_\ SQ/_ 'V?\:/[#T__ )XG_OL_XUHT4>QI
M_P J^X.2/8SO[#T__GB?^^S_ (T?V'I__/$_]]G_ !K1HH]C3_E7W!R1[&=_
M8>G_ //$_P#?9_QH_L/3_P#GB?\ OL_XUHT4>QI_RK[@Y(]C._L/3_\ GB?^
M^S_C1_8>G_\ /$_]]G_&M&BCV-/^5?<')'L9W]AZ?_SQ/_?9_P :/[#T_P#Y
MXG_OL_XUHT4>QI_RK[@Y(]C._L/3_P#GB?\ OL_XT?V'I_\ SQ/_ 'V?\:T:
M*/8T_P"5?<')'L<]J^F6MI:))#&5;S ,[B>QK<MO^/6'_<7^59_B#_D'I_UU
M'\C6A;?\>L/^XO\ *LZ<5&M))6T1$4E-V):***Z34**** .*UO\ Y"T_U_I4
M)M8XXU\VX"2LF\)L) ';)[9J;6_^0M/]?Z5')+:W.R29I5D"!&55!!P, @]J
M\.:7/+U.%VYF1R6C)91W)8'><%>ZCL?QP:FFTUH9WC,@*B(R!@.N!R/K3I+^
M*7SXC"JPL@5& ^;Y?NYY_P YIQU&)FO RL4E4^4<<JQ&#^!_I3Y:?<+1*TEK
M'"F)+@+-MW>7L) XR 3ZU*UA&+I+9;AC(SA#F,@#\<\TVXEM;@F9C*LQ4 H%
M&-P&,Y]*L27\37T5Q]HG9$D#^6R\*/;FA* 6B4[BV6&..1)/,CDR 2NT@CKQ
M4BV2<;Y2FV'SG.W.,G@#\"*9<W7VJ&,R,S3H2NX]UZC\:LM="%S.IYEM@B\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ?Y5G3DI5I.+OHB8M.;:):***Z34**** *4^E6=Q*TLL67;J=Q%1_P!AZ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%5)M5TZVNTM)[ZVCN7QMA>50[9.!@9SS1#JNG7%V]I!?VLMRA(>%)E+KCKD
MYXH MT5&)X3<-;B6,SJH<Q[AN"DD XZXR#S[4YW6-&=V"HHRS,< #U- #J*K
MV5];:C;+<VDOF0L2 X!&?SI\]S!;>5YTJIYKB--Q^\QZ >_!H EHID,T5Q$L
ML,B21L,JZ,"#]"*?0 4444 %%%% !1110 4444 %%%% !1129 (&1D]!0 M%
M%% !113)98X(GEFD6.- 69W. H'4D]J 'T4 Y&1THH **** "BBHK:Y@O(%G
MMY5EB8D!U.0<'!_4&@"6BBB@ HHJ)+F&2YEMTE5IH@K2(#RH;.,_7!H EHI"
M0.IQ2T %%137,-N8A-(J&5Q'&"?O,03@>^ ?RIT,T5Q"LT,B21.,JZ,"&'L1
M0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$7PKIJ^*&\1%9&OS
M&(PS.2 .>,>G(^F*@U3^W9-5VV0OH[7Y5WQ&V*^YPX+?_JXKHJ* .8\27-K%
MK>C1:K(L>F?O96:4?NWF4+Y:L>G0NPSW4=Q661/?:W)<:;)+8PZK<PPK-%'M
M9X8$=WD&1QN)" D=,$=J[NB@#SU;^6ZO[JVL=:O6O+?4(K6VM=^<1H4$LDF1
MEE/[S)/'  YI]K/-92V^L_:;XK>W-U?30*,K]F1& &S'+$"+'?)]*[>RLH-/
MM5M[=2L:EFP22<LQ8G)]22:L4 >;P:MJ-[-?"POYT2XCMX8W$_V@)+-(<LIV
MA05C!) R.E=7X?\ /2[UA'N[BXM8KD1PFX;<P(C4O@XZ;B?R-;M% 'G5K)9:
M]X?2WM@LVH7U]]LE=%R;5?-W[F;^$JBA0,YS@5=BO+N"STO5+S4[F(:G>[V$
MK8B@@^>1$ Q@$A57)Y.<5W%% 'FFH>)[F8)_I=Q':W3W%P&$AMS%$I$<67(R
MJDJSGOSWY%;VN@:=X*L]/O[XRFY>"UGNY'SN#,/,8GT*AOS%;%YX=L+Z\EN9
MA.&G01SHD[*DRC. Z@X(Y/USS6H %4   #@ =J . UB]9=1DUK2%2WMGCBT\
MWK+Y:-NDW,^<'A0-H8@C=)[&DNKZ\L](7.L+<++<&:*V@O6:>:$*%*12E06;
MS/FQCGID#FO0>M&!QQTH \\U;7;FUN6B,]R+>2[DC)601N((8PI._'RYE))/
MH#@TX_VA%I4L<FMWDT>GZ5Y\DUO+DW$\A)3#XR0 HQC&=PS777V@V6H7GVJ4
MW"2F+R7,,[QB2/).U@#R,D_F:T(HHX(4AB14CC4*B*,!0. !0!PESK%Y<:SI
M]A#<SB^@NH+6XQ/M#$*'E?R@N"I7(RQ ].E5;!V58=0L;O4)Y[F^N[J>W\XL
M-L0;$;*>AXB7UKTBB@#SM=7O/LJ:AI^JW%[*U@[W8'S1).X41*JX^5@Y/'7
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M)^4YXP!CO2ZQ=Z@)M=U.WGN3%I<2I;VT9(CDF";V9\#+ ;U!'3Y378X&<T4
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M=7,T"*2T<,6_;$>."2(QCJ<FNZP** /,FOY+AX-1@U2ZOKB#3GNI%'S0K<R
M1Q!1CY2"[C Z#KSS5^.[U.ZUJ6S75(K:2RN8XHXGN"CO&@5G=H@F'WC=@YP
M1C!%=]1@9SCF@#F/#-Z]]JFI2-=O=HIW1W$,^^W9'8E5"X^5U4 $<]0<\X'3
MT8QTHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img002_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img002_v1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (D PP# 2(  A$! Q$!_\0
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MHH **** "BBB@ HHHH **** "BBB@ HK'\0:GJNG0P+H^BOJ=U.Y0*9A%'$
M,[G8YP/H#FLG0O&=Q?\ ]MV>J:4;'5M'023VZS"1'1E+(R/@<'![<4 ==17F
MUE\1_$+Z!!XBO/!K?V)+$)FGL[Y998X^[&,J"0!UP:]!L+ZVU/3[>^LY5FMK
MB-98I%Z,I&0: +%%<WI&KZSK,&L2PQV$7V>ZGM+0.7.6C<KND]CC.!7/2^(]
M<M/A[=:A/?I)=V^I26TUTD"!A$LY0F.,\%@O13DGW- 'HM%>9VWCW4+#P9<:
MKM&L%M6%A9><5MI65B%'F@#Y&#9XP#C!(&:Z&RO_ !M?Q7<5QHFG:3*(@;>=
M[LW*%]PR&50IQC/.: .KHKSJW^(6HQ_#+2_$<VG076HWMRMJ((Y#%&7:5HP<
MG.!P*TTUOQX89F?P=8B10OEH-6!#<\Y.SC YH [*BO.=*\;^,=7U&_LH/!]F
M'T^X6WNB=4'RD@-Q\G/!J]+XVUG4]1O8/"GAP:I:V,I@GNY[L6Z/*OWDCR#N
MQTSP,T =Q16?HFHSZKI,-W<Z=<Z=.^0]K<@;T()!Y'!'&0>X(KF?&OQ!_P"$
M5+0VND76H31>4UQ( 8X8$=PJEG(Y8D\*,^^* .VHIDTT=O!)/,ZQQ1J7=V.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;J!&CVD</EG/)RG7-9OACP5'9>!M+T'7HX+N2TE^T'RF;8)!(SJ0>#QFNOH
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M&5_,=0[-EL8S\Q/8"K&E:18:'9?8]-MUM[?>TFQ23\S$ECR3U)- '+>.0/\
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MI6K?V1*L:0VLRJC/A,9PK\,2!S]<UHW&CZ?=:M9ZK/;+)>V:NEO*Q.8PX ;
MSCD#K4&N^&]'\36J6VLV$5W'&V^/?D,C>JL""/P- '$>#;6Z\/?$[6]%OKX:
MQ<WEE'?OJ3C$R -L$3@' '4@#'!KTRL?0?"VB>&8Y4T?3X[;SB#*X)9W(Z99
MB2?SK8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKYMUC]H/Q19:U?VD.GZ7
MY4%Q)$FZ-R<*Q R=W7BJ7_#1GBW_ *!^D_\ ?J3_ .+H ^GZ*^8/^&C/%O\
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M#Z?HKY@_X:,\6_\ 0/TG_OU)_P#%T?\ #1GBW_H'Z3_WZD_^+H ^GZ*^8/\
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M^&C/%O\ T#])_P"_4G_Q='_#1GBW_H'Z3_WZD_\ BZ /I^BOF#_AHSQ;_P!
M_2?^_4G_ ,71_P -&>+?^@?I/_?J3_XN@#Z?HKY@_P"&C/%O_0/TG_OU)_\
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M3#YC4->%BF_:,^[AL)3D_P!8OU%-IR?ZQ?J*Y&6??-O_ ,>T7^X/Y5)4=O\
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MFZ&QTH W/31[T^+[^:^*Q=1J@['S5"*E428Z5-H!JC+/(D^T'BM&8DITJC+
MKRABV!6O#E52IR]L=>*C"%;3:Q))@V[D]UKPWQO$JZD2H[U[BZ+Y3#.!CK7B
MOCD*+\X.>:^JRU0="HH[7/2X>=J[L<.>M-I[=33:\R<=3[U"4445DQA1112
M**** "E6DI5[U=/XM 9*AYKU'X=2<[0:\K!P:]!^'ET4O=GO7M8&?,I1/(SB
MGS865CV4C(Q35C"G:HP3WI5/R@^HI\:F208KY7&8AT*,DW8_.J,'.:@B:.$
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M!_*I*CM_^/:+_<'\JDI %%%% 'PGXC_Y&?5O^OV;_P!#-9E:?B/_ )&?5O\
MK]F_]#-9E !1110 4444 =]\)%<^(=7:&6VAG31KIX9[D#RX7 &';(( !YSB
MM[Q%;7NI?#^YN-8O](UV[COH$AO-*$9-DC9#>:RJORL=H (/(ZUPG@_Q%;>&
M]1O9KRP>]MKRQELI8HYO*;;( "0V#@X'I6C/XOT>ST6\TSP]H$MBM^T8NYKF
M\,[NB,'"+\JA>0,G!H O:QX,\,:;XN/AZ/6]1EGMGD%TZV08N0,K'"JDEG/3
MG SSTK7T_P  ?8/$/A:]T^?5--&H7<D 35+)!-"R)G=L.592#W%8-K\08XO'
MFM^(7TZ00ZM'-$\<-QLF@63'S1R8X88ZXZ$U<M?B38Z>^BK9Z+<&+2[^2\#3
MWOF23[TVG>VW&>!R!C QCO0!6L?"/AT:5X?O-8U:_BFUMY(XX[:V5A$5E,>]
MB6'R].!SUKDM9TM]#U^^TJ=UD>RN7@=EX#%6()'UQ6I/XH$UCX:MOLA']BM(
M2WF?Z[=,9/3Y>N.]4=;UIM6\57^N11?9WN;M[I8]V[RRS%@,XYQ]* /7(]0N
MM7O(F\)7N@ZCH1C51X7G2.";9M :/#+EFZ_.&))YKEK;P[INJ?#W3[6UM)X-
M=O/$#V:[XUPK80;&;.[8JMGIG=GBH/\ A.?#,NKQ^(I_"<G]O)(LY\J^*6KS
M Y$ACVY'(!VAL51L_'TL.F.LUJSZK'K']L6MVDFU4F.W<'3'S*=OJ.M &IK?
MPS2STG5KBR36UETE=\TFH:>8(+E P5FB;/;.0#U'/M4]U\._#<&K:OHXU^^%
M[I=I]NGD:T4Q>4 K,@PV2^&X[9X]ZP]9\6Z+?6=^;+0KB*^OSF1[B],T5OEM
MS>2FT8R>[$X'%+=^.UN?$WB+6/[.*C6-/>R$7G9\K<J+NSCG[G3CK0!1\3Z!
MIVG:;H^K:1=74UAJ<<I1;N-4EC>-]K [201T(KFJV=2UX:AX9T/1Q;[#IGGY
MEWY\SS'#=,<8QCO6-0 4444 %%% H0%V'2M0N(EEAL+J2-NCI"S _B!4PT;5
MA_S"[W_P'?\ PIMOK6JVL"PV^IWL,2_=2.X95'T -3?\)#KG_09U#_P*?_&N
MNFI+5$LFM-+U=)D/]FWHY_Y]W_PKW+P#HE_>6[)Y+QR)'OQ,A3/; R.M>%Q^
M(M;!&=8U#_P*?_&O1? GQ$U/2YI ]U).\D?E@W$C/LY!R 3UXKU::J5:$J:W
M9Y&9X:G5BO:7Y>MMSTVXM;BVF,4\3Q..S#_.:D@BP,U6BU235-MS-,TK$=6/
M3_"KJR*%ZU^9Y_[>C-T;'RF!HT%4D^W?<25?EJDRAAM:K$DW-5W=<Y8@#W-7
MD5/$TW[JW,<RJ4YR]S=%:^Q%9NX/ %>$^*;O[1J+C/0UZKXKUN.VLW19 ..F
M:\1OKCS[EWSU-?I%%3H87]YNSVN'<-)7J2*AZTVEI*\F;/KT)24M)6#&%%%%
M2 4444 %.3G--IR=ZTH_&A,=MYKJO"%VMIJ"LQP,URXYJ>"1HW#*2"#7KX-J
MG.YS8FG[6FX/J?2=G<+<VJ.I[5IV)57!->9>"-:>15BD;\Z]&@D"L#GCUKY?
MBK+I1IN4-4SX*G3^I8VTCJ$"O$,"LS48PHI8]22.+;WJE=WGF\>M?F^$P==U
MTK/<^KS',,-+#6NKV*A;' KS3XE:OMA%JK=>#79:YJJ:=9.=PW8KQ#Q!JCZE
M=L['(!-?L639=]5I.O+XFM#P,EPTZ]959;(P6&6IQ&$/TI#UI">*K179]P1T
M445P%A1110 4444 %%%% #A2]::*<*Z*>JL)EFS)$R8/<5[AX,E7[ @9@3BO
M#(3M.1UKT'PAK(C=(Y),?C7MX:"J473;W/!SO#NM1TZ'J\H5F!QD5*C1C  Q
M5:UO(IHAM8'(IQW%N!7ESI2_ASTL?".#^%EDYSQ5*\ )X'-3NS*O)Q59Y%QD
MFE@<.Z=3G6HZ46G<JLWEPL6/%>6^,)HY)FVXZUWFO:B(;5@IP:\AU2Z:XN6+
M$FOH9/DIN_4^HR;#R<_:,RI.M1FI6&:C(KYZO&[N?71&TE*:2N-]BPHHHJ0"
MBBB@ HHHH *6DIP%7%78 HYKJ?"4Z17ZASU(KF5ZU?L9C#<(X.,&O7P"5.5S
MEQ4/:4W$]XBVR6ZLO(Q5NTVJ?FKD=!UI&MU5V[>M;[W:E0485ZE:C*HG%/1G
MP%>A.,G!FW( %S6=<HDP(.:K)?,PP2337O #R*PP^"J47O<PA1E%BHHM8V/0
M5YKXTU-9Y3&IKL]9U416[8/:O*=7N?M%RS9KJK2<(-O=GT&489RJ>TD8[G)I
MM.;K25\M55Y,^O0E*G^L7ZBDI4_UB_45BQGWS;_\>T7^X/Y5)4=O_P >T7^X
M/Y5)4@%%%% 'PGXC_P"1GU;_ *_9O_0S696GXC_Y&?5O^OV;_P!#-9E !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !110.M-;@.%/4XIH
MI^*[:<>I+'"KMC,8IU;.,52'%2 GM7H47RZF,XJ2LSUCPWXG2&-4=LC%=C%K
MMI* =^/QKY]AN9H3\CD5H1:W<Q@98G\:UKX;"XK6K'4^<Q.1QJ2YH,]QGUFW
M5#L<$XZUQ>N>)WB+;)*XL>(9B,$FLR\OGN6RQK6C2P^%A:DK$X3)53G>9)JF
MJS7\A+N2M9#8_&I&ZTQAQ7'7FZFK/I:4(TURQ(C24XTRO)J;FZ"BBBLAA111
M2 **** "G+WIM.3O6E+XT)DJ(:G12*CC!/2IBK 5[=""4;V,9/H=%X?U,6DJ
M[FQBO4-(\203(JEP?J:\+#E3P<&M?2]4DMY1ESBNJ].M'V=1'BYAED:Z<NI]
M )+'*@=6&*S-7U>*QMF*N-V/6N.L_%I6UVD\X]:Y;Q!XAEN795<\^]<E+*</
M1JNJ]?(^?PV3SE5M+8EU[7)K]V7?QZ9KE)8'.25-3VK/-<J#ELGFNGDLHA99
M*<XKT'%5D?4)QPB4$CAF4BF,.#5VZ0+*P P*J./E->1B*/+<]2$KHAHHHKR#
M4**** "BBB@ HHHH <M.IJU*M=M&-T2Q%S5VSN&AE5E8BJP6GJN*]&BG!W1C
M.TE9GHNBZ_+$B@O^M=5!XD&!N;]:\<@NF@P0QJ^NKRL,9->E>G-6FKG@8G*H
MSE=(]7F\4VQ&"WZUD:AXHB2,E&_6O.)=1FSU-5Y;V212&-3%TZ7P*Q-+)81:
M9KZIXDDNMR@G'UKFY'+L3ZTCMDTRN*M7<W8]VC0A2C:*"HV-/-1FN"KM8Z$-
MI*<:;7!-6+"BBBH&%%%% !1110 4X&FTX5I3;3$QU2H<&HU-2J,UZ5%.]T9R
M-BPU*:$@ FNDMM:EVC)_6N,A;8P-7_M)"_*:]BG-V/,Q&&C-[':P>(F3[P'Y
MU4O/$TI?Y ,5RIN7*X!J(2N#\QXK7VK.6.7TT[M&SJ6LR7-N=W!KDY6)8FM.
MYD1XOEZUFR#FN+%2;B>EA:<::LD5S29I6%-KP:ETSO04J?ZQ?J*2E3_6+]16
M#&??-O\ \>T7^X/Y5)4=O_Q[1?[@_E4E( HHHH ^$O$)SXFU4^MY-_Z&:S:T
M?$'_ ",FJ?\ 7Y+_ .AFLZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH 7<:4.13:*I3DMF%A_F-[4>:P[TRBJ]M4[BLB7SW'<?E
M1]HD]ORJ*BJ^L5?YF+E78E^T2>WY4AF<^GY5'11]8J_S,?*A_FM[4>8Q]*91
M4^VJ=PLA=Q-)114-M[C"BBBD 4444 %%%% !2@XI**:;3N@)H[EHSD*I^M2O
MJ$CCF-/P%5**W6*K)64B'3BW>Q*9V/84JW+J> *AHI+$U4[\P^5&@NKW"KM"
MI^1JL]W)(V6 S4%%4\77>\B52@M4B[:ZE+:R!T2-B/[P-:<OBZ^EB\LPVX'L
MI_QKGZ*:QN(2LI$3PU*;O*-RS+>R3.695S[5"920>!S3**SEB*LMY&J@EL%%
M%%8E!1110 4444 %%%% "@XI1(1Z4VBK522V8K$HG8=A3C<M_=6H**T6*K+3
MF%RHF^T-GH*D%\ZC 1:JT4UBZRVD#A%]"P;QVZ@4TW#'L*AHH>*K/>0<D>Q)
MYQ]!1YQ]!4=%3]8J=Q\J'F0GL*;NI**AU)/=A87-)114MM[C"BBBD 4444 %
M%%% !1FBBA.P"[C3A*PZ8IE%6JLULQ61+]HD]1^5+]JE]1^50T5:Q-9?:8N6
M/8L"\F'0C\J#>S$8)7\JKT4_K5;^9BY(]B8W,A[C\J:9G/7'Y5'12>(JO>3'
MRKL.+$TW-%%9N3>[*"E0X=3[TE*OWA]:D#[XM&W6<#>L:G]*FJ"R_P"/"W_Z
MY+_(5/0 4444 ?"/B#_D9-4_Z_)?_0S6=6CX@_Y&35/^OR7_ -#-9U !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2K]X
M?6DI5^\/K0!][V7_ !X6_P#UR7^0J>H++_CPM_\ KDO\A4] !1110!\(^(/^
M1DU3_K\E_P#0S6=6CX@_Y&35/^OR7_T,UJ:'X,N-:T275VU72M.LH[D6N^_F
M:/=(5W8&%/;/Y4 <U16YK_A6_P##R6T\\EK=65T#]GO;.82PRD?> 8=".X(!
MK#H **** "BBK%A93ZEJ-M86J;[BYE6&)<XRS$ #\S0!7HK3U_1O[!U:33VO
M[.]DBXDDM&9D5LD%<D#)!';BKEYX/U6Q\)67B698OL-W)L15;,B?>"LRXX5M
MC8/?% &!16]?>$-6L/">F^)I(T?3+]W2-XV)*,I(PXQQG:<=>E4]3T2ZTJQT
MR[N&B,>I6YN(0C$D*'9/FXX.5/K0!FT5U=[\/=9T[4]#L;R2TA?60H@=I3LC
M=L?)(<?*PW+D<XR*Q[?0-0N?$R>'DAQJ+77V3RV. )-VTY/H#WH S**[&'X>
MW#V'VZXU_0K.W:YFMHGN;EU$K1$!BN$.1R.?>JL7@FXN]=71]/UC2+^ZD@::
M+[-<,5E89_=*2H^<@< \'UH YBBM>V\.7UQHE_J[^7;VEE(L+&<E3)*?^6:#
M'+8R2.P'-:]Q\.M7MX)PUSIS:C;V_P!IGTM;C-U''C<25QC(4Y*@D@=J .1H
MJSI]G_:&H0VGVFWMO-;;YUR^R-/=F["NEOOA]>VFA7.L0ZQHE];6\B1,+.[,
MC%W.%4#:,GJ<>@- '(T5U6J> =5TJRNYGN=/GGL55KZSM[C?-:@D#+KC'!(!
MVDX)YQ7*T %%%% !1110 45LZ%X;N]>2[GCGM;2SLU5KB[NY-D4>XX4$@$DD
MYP #T-5]<T2\\/ZD;*]$98HLL<D3AXY8V&5=&'52.] &=1110 445?T72;C7
M-9M-,M2BS7,@16<X5?4GV R3]* *%%:>L:'<Z)]A-R\3B^M$NX3&Q/[MB0,Y
M P?E/%9E !1110 4444 %%%% !1110 445K^&_#.K>*]7CTW2+5IIG(W-@[(
ME_O.>PH R**EN8&M;J:W<@O$[(Q7ID''%14 %%%% !170W/@W4;;1I]3>6W\
MJ"UMKJ5-YWJL[$1C&.N "?8BN>H **** "BBB@ HHHH **** "BBB@ HHK<U
M3PEK&BZ#I^L:C;&VM[]W6W23(D8* =Q7'"G/'K]* ,.BNJN?A_J]KI\T[SV+
M7=O;"[N-.2?-S#"0#O9,8X!!(!R >0*Y6@ HHHH **OZ)I$^NZQ;:;;,B2SL
M1OD.%0 $EC[  G\*?K&B76B/9+<M$WVRTCO(C&Q/[MQE<\<'VH S:*** "BB
MB@ HHHH **** "BBB@ HHHH **T]"T*]\0ZB;.R\I66-II99G"1PQJ,L[L>@
M K0N?!.K1W^F6MH;;45U1BEE/9R;XY6!PPR0"".,Y P.>E '.45T&M^$;S1;
M!;\7EAJ%D9C;O/83^8L<N,[&R 02,D'H<'!KGZ "BBB@ HK8T+PW>>(!<&U>
M)! T*$RD@%I9%C11@'G+9^@-4-1L9=,U.[L)RIFM9GA<H<@LI(./;(H K444
M4 %%%% !2K]X?6DI5^\/K0!][V7_ !X6_P#UR7^0J>H++_CPM_\ KDO\A4]
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M-(+>1U=X@WRLP! )'<C)_.@#VFZB@D\):>-(7=XL7PU!)'YL88?9 7\P0_\
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MBQ;SL5B "P'3. .?:NDT#Q5;6+7CZK%J4]W<,'&HV5^T%TO8J7(8,IXR".U
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M_P#0S6=6CX@_Y&35/^OR7_T,UG4 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %*OWA]:2E7[P^M 'WO9?\>%O_P!<E_D*
MGJ"R_P"/"W_ZY+_(5/0 4444 ?"/B#_D9-4_Z_)?_0S6=6CX@_Y&35/^ON7_
M -#-9U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !2K]X?6DI5^\/K0!][V7_ !X6_P#UR7^0J>H++_CPM_\ KDO\A4]
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M '$?\*@\ _\ 0MV__?R3_P"*H_X5!X!_Z%NW_P"_DG_Q5=O10!Q'_"H/ /\
MT+=O_P!_)/\ XJC_ (5!X!_Z%NW_ ._DG_Q5=O10!Q'_  J#P#_T+=O_ -_)
M/_BJ/^%0> ?^A;M_^_DG_P 57;T4 <1_PJ#P#_T+=O\ ]_)/_BJ/^%0> ?\
MH6[?_OY)_P#%5V]% '$?\*@\ _\ 0MV__?R3_P"*H_X5!X!_Z%NW_P"_DG_Q
M5=O10!Q'_"H/ /\ T+=O_P!_)/\ XJC_ (5!X!_Z%NW_ ._DG_Q5=O10!Q'_
M  J#P#_T+=O_ -_)/_BJ/^%0> ?^A;M_^_DG_P 57;T4 <1_PJ#P#_T+=O\
M]_)/_BJ/^%0> ?\ H6[?_OY)_P#%5V]% '$?\*@\ _\ 0MV__?R3_P"*H_X5
M!X!_Z%NW_P"_DG_Q5=O10!Q'_"H/ /\ T+=O_P!_)/\ XJC_ (5!X!_Z%NW_
M ._DG_Q5=O10!Q'_  J#P#_T+=O_ -_)/_BJ/^%0> ?^A;M_^_DG_P 57;T4
M <1_PJ#P#_T+=O\ ]_)/_BJ/^%0> ?\ H6[?_OY)_P#%5V]% '$?\*@\ _\
M0MV__?R3_P"*I5^$7@)6##PW;9!SS)(?_9J[:B@!  H    X %+110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%0PW5O<2S10S1R20/LE56!*-@'!
M]#@@_C4U !1110!R8\:A-0UY+K3+FVL]*LQ="648><9<$JO8?)P3U^E59O'%
M]IL,B:KI,27DEK'<V<,%QN$F^18Q&Q*C:P9TR>1ALCI6CJ7A=]4U/6I)9D2U
MU+2UL1MR71@9,MCICYQCZ5C7/A#7-9#7.I3V$%[;6D5O9^07=#(DJ2F1\@$
MM&@VC.!GDT ='H>LW5[?:AIFHVT4%_8F,OY$A>.1'!*LI(![,"".H]ZVR<#)
MK T'2M0@U75-7U3[.EU?>5&L-NY=(HXP0/F(!))9CT':MN?_ (]Y?]P_RH 7
MS8_[Z_G1YL?]]?SHB \I./X13\#TH 9YL?\ ?7\Z/-C_ +Z_G3\#THP/2@!G
MFQ_WU_.CS8_[Z_G3\#THP/2@!GFQ_P!]?SH\V/\ OK^=/P/2HY0-HX_B'\Z
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M_P#CWE_W#_*N5\,2VUUXO\2W6FO')I[BU7S82#&\P1M^"."0IC!Q[>E=5/\
M\>\O^X?Y4 .B_P!4G^Z*=4,:/Y28D/W1V%.V2?\ /4_]\B@"2BH]DG_/4_\
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M]T?[P_G3Z9+]T?[P_G0 ^BBB@ HHHH **** "L2_M9O[5LE34+Q$N)'W*KC
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M8<J[HM455V7O_/>#_OT?_BJ-E]_SV@_[]'_XJCVC_E?X?YARKNBU157;??\
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MYF6+RF#GC(!7&1[\<51L/%UG=>'[35);>]C-P$ A%I*SL[+NPHVY8=?FZ<4
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MK16^I'YMW+_JX%B']Z5LG\A_C7(ZKI%[_:VT_O6N')1AQGN1[8KM?-']Q_\
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M78<(S*ZO&VUXW4AE=6'1@0"#533/#L5AJ#:A/?7FH7IB\E9[ME)CCSDJH55
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MBBB@ HHHH *CCZR?[W]!4E1Q]9/][^@H DHHHH **** "BBB@ /2F1?ZE/\
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M/+'W_P"]CIN]^M;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JVHV,.IZ9=6
M%QN\FYA>&38<':P(.#ZX-6:* .)7X;0+<6]POB?Q()K>(PPO]L3*(<94?)T.
MU?R%=?96QL[*&V,\UP8D"^;.P9WQW8@#)J>B@ HHHH *R_$.L?V%HLU^(#/(
M&2**$-M\R1W"(N>P+,.:U*R?$ND2:WH<MG!*D5P'CF@=QE5DC=77(],J,^U
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M5_NC\J (_M,'_/:/_OH4Q[B$R1GSH^I_B'I4^U?[H_*C:O\ ='Y4 1_:8/\
MGM'_ -]"C[3!_P ]H_\ OH5)M7^Z/RHVK_='Y4 1_:8/^>T?_?0H^TP?\]H_
M^^A4FU?[H_*C:O\ ='Y4 1_:8/\ GM'_ -]"C[3!_P ]H_\ OH5)M7^Z/RHV
MK_='Y4 1_:8/^>T?_?0I@N(/.8^='C _B'O4^U?[H_*C:O\ ='Y4 1_:8/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>s118023_ex3-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 s118023_ex3-1img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$)0,T P$1  (1 0,1 ?_$ +8  0 !!0 # 0$
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M-YPF5"(:LFJPM]<4&^K!@9Q<PR8OIHD)G)*B &Z[2EC#<#J(<.HG(?J<ADM
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M HV[@7$U6NDX, =7B/ 34H% H% H% H% H% H% H% H% H% H% H% H% H%
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MK/P/'  %OW3[FV]B%W![S1:\ ;JP[#3/><.:K,W'8";'#\39F?$DSO:E&0I
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M'G][N:-G_$<E-5Y2-)$P!)*SKXS7$D8\5MIC7,$]L6\8+BV8 _6%X$-][_\
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M%L1:]>XFOSI:28F-YC13"JB*FL.MPO&0TAXO LX+3G45ZYY)<+ZJT7S+HL8
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M=>))W+A:/-Q9XC=U*L<R'%6O:KY^JW7.A2?C&NDC&V+Q1D?$45DY1$MN[T>
M&$M!R10>Z!$>HL1;1(&EF]DZ["67%L"_R0!)>UT8+>P.OK94HRB12F&1H&C#
M8R1I[B15?9U1N^4^KS7 ZN;?I3</,ZQ$P9:[N[9W8ER('?/T?9>@,?XN*W="
M4!BPM)*=(WO&ZI-V[UU9D\K-H\I.YZ14STDY4M;,"<A<&$?G 91YP!\R"D3N
M_9M@KP1$#^>Q()U%51B?=&65=X;1QBN'8FR3DU5DJXR477B% :$TG5T9\*H)
MY@<:U]+@11'I1D[/ O2 2]BSNU;K2=)$;.E;@&/8=@PNTVE>KLDQV[4EUJ,P
M*;DW+B)F.515$!S"ZT='1B0A([C\N.&6C"573!Y+TG\0#7O<>G6',W?#8V'-
MW=P9BU(84::=,)V:5_ N5IS@Y8D&2I)-(8/YS?P7D-M1U,TJL)W,A&Q6JVU(
MH%N"H"'(B F (<,K?+<-R[61MFQELW:C>,Y WHBN&\O)V58$PBG.3 DKMGLF
M5$9URHPUW8-LLZ+[BPY+1;@,]O"CA[TJ13"/)1+GAU [<7=NF+8R5I386X#-
MBG6Y-UR<31U"DAR9WO6W!ECN#N61Y!;I6;#XNH"%.TE)@L&VK8.!^Z@F<UOJ
M,(%YH.5_=BW,W%UJVX[K\F13C2?*&I[$@O4J )Y:;5V3DADOF!'-.3*4G$W=
M@('\CLK21#]LIKGDRJ8ELAQ4S@H''@1"@E%"W?$W<F.3_@'%^L<%83H=][:-
M!UQPYDDYW-]]*^#KXD9Z_'BY):)ZF\Y5@9F2F>JI_7[$V^A8( F$" -!KB6_
MO">QSBAUHS]K@C:V);.=A)[7V(RI08DOC),K)VH<:QZISRV2V\EZM%H,PSKE
M)\ AMT SE!P_LB?T(ZB)CT%AW?[L$GK&W>N3:<TE1!##-@'N.0LQ77'#2GV8
M(SG([;5(B9DG.=T; Q<+>*VY$UN'WN,G"8H&#UA?1R)AH.AG;3[PLL;NSQ,T
M./UHPXA-M@ZEQ]LHWI&AM765//,1\J8X-Q(6&XXEQTDMBW+93'Z<HMI0-<
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M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@P=\IF6LLEXHZ<?,PU%4;;A3L/)PA
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M[34?Z)Z!_>XE_P"R!W*_VFH_T3T#^]Q+_P!D#N5_M-1_HGH'][B7_L@=RO\
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MS,[V7$)BCEYYPN9V<)"](W,@_0037!XYYX#T_P"^%UH% H% H% H% H% H%
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M2]])?Z'_ ,S#,,C0>#V0UV',:)%<-2%$GPZ:LM8B/):JL*CYE3_UB/"5&?\
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M$5I,\;-2)%:#K>^XT56>^?HQ,5WD\)W;CQXD1'2'&\4:-T;#\R7DU'\A3?\
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M5+3KBQ6=:1%BBIF:S9=3'43164<2'VTQ9E<8K+O8C<**PNN7W5X60\0\O!4
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M1VP C V];!B)WLI%S)(66+\*5@R0[VVVVR\,-M+HH3K !\KX5%#D?* C%DR
ML,#'1YM6YLTA^(R2XG^PV&_-I?.$QLJJFIK"CAK#P67Y\.V>\-;W(\/<_#S/
M]G_2G^M -]/1L9GMM#EJ2-=X&RICAAU.UAYF#[H?$R5&RY9(4<R8(39Z/%?\
M,'(S_BHCN3Z2\X\A6$?_ ,GT$G/>B/XW4&W)# <D=M.!W$XVJ@L_6]AZV?$Q
M32Y?8TD)SD1WY[9&^LJ-)'DZ._'(L?22]A_YG^ZE!>6."NR7/LWCZ<YKR:3H
M9#T:P2KM,[6J\7S)J2^ D@%@-95AMN0/B-";:CF+&YAH(>9)#5CY[<#[!]'\
M<A O>7:D[*7]<<:%GW*<8LZ/6_%TLRDPF^UDAM[,,![*2RXROF(((2)4@=]_
M#A)UF*C>7H7[2!'#E<#S@>/8,T.ETH6)8?\ LPCN3&UC3O@CEP3"R[B+#\E2
M(/-)IB&,YA^*GOXV_<-N/QB,^8$=X^Q^3H/O)YPY''YA]'^7_N>&[$:9W.XF
M-EO4K:4([R560TE=P7=N$Z49BR\_F*V%=YR.K@KMIQZ[@XP5P<:,I)OEN'F>
M0IG[L?N'_E@8AL! ZPMQO";28#PUW;R\]W%Y"PWA+3_@=LOEU^XT;_$CW;<C
M#>$5,]'?BPSW(C_P;]V_)_H%U><?1=!H9WXZN[HGW6U69#DD55EJ0I4:V [X
M>8D_-%R/EU.5T+ ([P8;R)''O<VT>./<-]@L/S#0@Y45C_"-!GD[LAKIZ:KL
M*6=?)EG"(TM1Y?:3G-5G-EL2 Y5,%&%)3DIWK+.>8N]9FN27>/MGEP)OQ"2/
MH_\ \Z4%9+6QV1#VL^W\?XZ1'K'?D>Q9LB[O-\U,6GN^AB%[I,R+3N<C/DDL
MBJXOV1VA'()O(/SR%QJ:OX" A01(^YCW["@\^[+D8[MRY'P\]_:\J.)(JMAJ
MF#GOLE]4V8,1VJJ6HW;A[5YR=899B'-ZXAQ$#\' :#[M*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*#^0;K,G/59[IFQ;/C=;!!;)=R9G>.;*KJ:0.A+:RI'"'MHM-HF=
M&0@X6HY7BX$3S@J$12 26U,OS1'J$0#[1;F<])K?\P+D#RO$\0(F(]F-):L+
MXU^:4M)$ VFYKHY#+SZ<TT-U74D>+5UP6<)0*9I<^^K7, FRBE0AZ #0"@U]
MZ$S7?;22)95Y5>SR5E%_X$D/R%E6!Y,@QTL9S1O.\/\ QL8;;;;,]^WA[A^^
M"PI+S5]U?]7_ .K_ #"@U7&^N[XU=>$;SK%TD//81Y,CS6-'Y)"\E(_O,J>6
M3Q';;9^&VI(FQF,]^22+#8@*2#Y.L+'TEY;A_P"IZ#I.X96VU(TF[%;3GAH-
M]Z)D42<]VWE(,@1*W9N:DOL."SOUL1RBP C-Y:94B1:L)5[$S#'5U!=$05PZ
ME'@A?;PU;C3S("@@:_,J4G[IMKZIQ0J.B,WU*>O,]^[4EH\01J%M51FT5'<+
M(5V@W"2I)4;]0Q\+E-YZA"/EX\!P 9A/FRNV$:N=:D=:;BCK[*"L@,.-_A8[
M9\50U[56T=)F=(9[NCCHCDH18\%5^-Q!400N.> ^D5 4CD5$)&O'&W+SFJ#C
M1EMO.EK*[W4_>^83-II);Y54]NM5P.,CX<<19T?,-'*VH[NK(-\I/+O>\?)_
M,@5^/+PH(/I$_P!YV.$+FJLDSS)D7Y$@G?69%?Y-ZTY%!_*,1"5(6G,DR+"4
M>J]MRF<;ED1 1UT15Q$H((\#A* CR&B9@R-L%*:$?)36VXIN^+#,=32<F9$K
M_1FR^0]^9(<3;_@&V_>)X,]QR1"?[I><>\GTQ^Y_[E_2E!NN"'P\D1PX**#$
M;;K:T8QZ_P 5IQS4Z139-%R1HS=>'(L0.^O>."@6)%'7MC<"FI X3+0> ]OS
M ^C$]=4PC'*;53F]G03N9'$;R+$Z5&DJ.M]#/,".R"5!MM1L&A[A9E4NH1!+
MJ=(J0X_<3V,%- >("#<^E P_,*"<FMX.A.?,UO::UF&W6EY7E;]PY?B15=\F
M;,->,N%)79[P%GQ H.1RJ["DA^C[K(Z"' _0W[GT%XB>>5\9(BQ;>L<[4PDV
M)A3DIHMUR>ZR-)D0JC[3)>D-HR1EC^[+EBIN.1LI/G/T"R6JCH/F?[J?N?08
M"KSQ"$3NB7<ID1Q%NQJ!#DJI!F&ST)35U%\,-L-IW,X%B15EW1TW'B\]C?B.
MD/ !3O)\QQH3.^C@= I?F@IZ>&-,C8!044K8Z1HNU:V5559\1V[5)'A&"52"
M%37TST2V<FR.WOBBD,1GMIN0\\)>3&D5K".9EO%=74QU* )ZOX@-!I52W7F)
MMFMZ[SDXB:NWU?6I*]WVXQFN.WC'1R*1%0TC/-#VF"0&\KW(O6(D J8O%3E,
MCO0 $3)X\@&6(8$R-[7)&#*@6W*3MD',<:\X(%A.16^PY\+\-B/9E3S*,63(
M[46+DAY(YD5$DN2K6 G""P*" B57_=#@/, M4+]Q#6!@>R,#3K-V9%XQDG-6
M-5;,FG9*.'*^54&S([,1W(V\-N3P]'+\.$CE8Q,/^"O[L O?^3TN@P#8[93:
MUU1 VW<ZU?9C+3<MDH[X&(L)U1NR&X['';F"/5A\PZ\XO;L=Q8_VDL.*+'^A
M*?O4*<*#R(BCH_EXBH4$?=&T]HMIJ:LILOQ5'4/SBJS&.R[ZRXH:\DN*2G6K
M,:7GG[M%,;!>288DO-QNO!8!-;J\#K%7!'YX^2@SV/\ 8#9A[>QNUI,-YRPO
M9;S^);D<GNK&[&E\=9_-V9YP\&>Y?=UGR1_TJ/!X)J:O?P/_ '>_TAY?Y@N4
M&2RRX)W@N7MY)A9.QVP\A2S,<>1;GM!RM*%FA\(8M"-9(@<&WE)+#E65O>Z-
MRE]B\G]]O)O+D?D5!(\U\*"=J_/PK3 UCBZ2,R9)BV= KI=BM(S":<;O@TSN
M=2]Y,-BK//4L,V+'T+C88 SLO@/>/A1\G3%'S$. C)%Z!-"TZ7&X\>2&XX)9
M=LJNE^.[,C75AH2^,+Q%)LD&%RR/#\ISRS&&[_.%>4@4D+S)T\M5-\G'ROZ/
MR_$,]G"2%ADO^4TQ_P ;O2;EV5V9%6?)$P(,5QNFIBK[S?#OVQ':##%NOS7!
M8<ONW[M^<+SP]STWS)!3_P#T?H-5Q?D.!@.!MMMR?%637EB0RU0C=^9[_P#B
M8IQ6^5.!W$L:WQ7\-F?'<5QOK?&_O&L8;V_=[R%R>0_ZOH-[:ZI&"_W>L.W4
MV1Y#VO%O2*PGX_-@Y)2];VVV%5[O@PMM666>+0;CN>$5-QNJWO(UA9&&F-7A
M9\ORT_S%/\1"\ZO3*U9&R!@MQX,ZY2%KHWH!>#G8FPLT*\9OIAOMBQJ\G XX
MYU:9[C<3;?LP1RCE1 3,QMKZESP"GYXL<<)=!J&5I/!3EB-VVRXY<.US7R\]
M@L1R/ =DDGW%59-?"*S%EX2D[YK+%31:$\.2.4>1_8E=21TU'=_GP^3B/'T?
M0;HS=5M9"R>Q(NPM6MI\Y_2$J0U@Y4W.E1CEPL5TYS:N8#]4F9FHLQ.=DBDQ
M>X&LD*Y3(?EP*YS (HQ2@/2IAM.<LA!<K\=RU&%MZSK+>$FI<)K.4_HO>&O[
M:^)B2DRJ[8>;J,WY(BPT*Q$6(VT58, F;8&%,$% SK >0 -0--]0"@I:X>8D
M-41'4T'A*S&+9RTN,Y+B1M"I*[C60E!464&"[<YLZ(VDLK'F(>7IY2^<CYH(
M@'D^;06J1Y7U^9.0Y&D_UA.DV;H13FM"WQ4VE=2PF29*D0)BQ':P.PCPF!8E
M7^$K#<B1)/MC;9.&L><)OGWG'E?[CT&MU"8&1BQO ZE$JQ!#A@>0D[_HX>&?
M_ 7WJ]QO<Q8FUGYCD8;SC=B>^ ?NDCYG\&_)UCZ'3\/R]0H(W-]T->=6>L3&
MP(W;L3JK(46!L/$&'YK)$01!-*G](OQ^ Y)4\M6(K<@(Z.C^3_3'_E#SQ8S*
M#5KP7WQ"C&@B#& D!J(NR#'FR6<CO!>E57U4574IILP#*F'#["<:PGH[EDEM
M/#XIH_D0OQ2X#^$&&@>D*"<:O-[=UG=4D.:'I>9B5&&'L,F-!6Q5WX[OA5!2
M9$P!)+DBI&>0Y\*Q!LXK,1O%*G,I737(\'(Q./+_ /2 #02/=^>#1EEN(DCO
MMY."1VKKPE,0S]FAU+"DF.MD,:1W ^I3%H>;J+D]Q!D@I035Y><CP6%[S$$/
MR]/\T^BZ#2FIZ/-#2<'G>-,#S<+HEB1/;\Q^/R:6>V5-JMF7]D'%&[;9[/UC
M>,=L]^,^2/X'^\C;1UA'6$?Z2\P^B_\ 1X2^P6;%KOD?#FN'I>D/5%SO:/%.
M)\)&B9J!,$F1_,+$>4RYSN%^83<^,#/V027<YBJXJZ<I>@?'SB@L\D2.C-&.
M=3<?8?W>>[.Q94?V=AMN:6LLR:]XK?#8\O>,;?#<L6-WWN18X\X,T%(15\+S
MAN)GT>/EZ> <!$YCQ?-[L@>28OB::W%#J5B2I*N<V\N-6JL^\J2^51WN)QN]
MXR0XVU%8(\V1P[]?!YPV>FMMR+'T/Y@*Q[?YAGIX;W?"Q*&P\3S!Y:PW%'S-
MC+X L/,8<EJJQ$#Y:K&4UB1/CPL/Q71WFL([/=[D6%C#]PU+S)-6/)T']W$]
M04/VF$0)/U_>&/"&V>*Y4AN26EQ1KQ*DE+"3@M6(6,Q73+\:-"=T?XK+,)@X
M8X61FM&9[D1U+R<$Q3'Z'\\4UOZ83_; \_N4%S-76_W)W[F\W%-T/V 2*@82
M<F)B &?:3)H5>,2RF7BVR&,*P(B4F$4A ,''(\T'W<4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4'\DC2=LWE/N+[=.QHC=S9E2-I9E0HM8RFPG<^DN5C.=E;D%>$/.#"
M9Q\<2ED-&P0('TI_B_K<T>2@'T/ ^-=V2X%B)8XU]AJ,Y0RH'^-#E:#NC^7X
MSC.+-9XSC=.A-^-R58W9P/!^(ZS*ONUYEY/F>_:C]#X:HL+'T?AT'337%P1'
ME1BKO/889$G5">[T2F*PF+G1ZDNI\:W9Y%=XL\6SKZW$AY2/.LH&<QV*F+OO
M'Y<(N4@"X"\#]$%"*&.S];W(V&)%WG#-F-^.M2=49RH\&DU5ALR8P-F&R\'"
MC^XC:]SWI\!]5W)R\/=OS[^$GG'^D/+Z#:4.Q:^DMK,^-Y)B*/6#([>9ZP:-
ML7#8$BN6-(J<KHCIOK6P1)3FPB^B*S;V:5"M#+2U&3FVX^I-*HY_L"((\YM!
M)W7C ;$D&?<CLEQ*3MDX6V9B>XS\%&8R4Z$U*9[*]^Y&8CD\SPCN47.KMP5(
M/>]165'P%8$0\.0YH*NG<CH^RTU.[)D>"D9L8VP[74,%]10#/8;)2Y<4FCYN
MVVE*J(\6\VY)E)]R2KB ^>M#@P(X@!L\$SS0 "<\[8$8+D_ZW#).'(<\3>WY
M#GU0U[5V&K1PV5-J-J,XVY1Y(D=H18X2B\=2WW[9])<@ _N>G^3J'ME!QS=,
M/Q@[HR;6M\%S:S8;9DPYTTS0CMJ2FI.B62 Q;3PD( 2/I>0V&=7A::7VJOQ2
M]Y&VSP74+RE+Y2Q3/$ NZ_WI=2XWVM28,16^N$R,./DEH0@ZS.]G,6%(;46R
ML2*KQU$KA@]MIW_1!:?"4**BOQ.2%\!6Q' \Q!)R[=T;8=B-8-@UYV3)B/*:
M]IGF@O"/H,BQ_MR!\2&YEC6(51M*VKK>=+G?V"WS//'2I&;EI965-35$P/-U
MTO %*)03@X#DVZ)+8NH6'E;A3JXV?ERE'Z^FM5QOU^1ZM)CV?X2Y!"^!@U]@
MQGRFP[:(='%+PN%U3;@"8 P!#D '@,2QMU\B.)O8C 8&FC+RE[=M.8"#&[O:
M;56=>F,UU.7WC'66_ V#VH;2:L2GYRPG>//[400\ 3U#ROZ0^D E-)TU6&5'
MLIM/5[;)FRK-ZNRDEW8CZ<$+%<S;2(T;4[N%(>*O!,68+U6F;R$J_0V9Y,W%
M]Z^\G_HWYY^W*"/VS^P>M?;]<V*GS!-4IXKGVM47X^VBW=/X%9DMI7EIUD6#
M;*Y%ISN*!WV,E+3^]C7\P,-2%(=10-@N!O\ !4B@LL;SQYE!\;RR[9@G>,F'
M&7T#&^9GZV3Q\('5&?G#B1W@Y$=WMM.>#;A.>)48;;6/>1237(O+#/1_W+_;
ME!3;ISA&+V;3M;;\?<[0G #'BMJ+[Z;+OU5D554FNJ26CI[$9RNLJKR;<JS5
M%RPW(W#,4D>0.!=2H/AF9X\\4&<Y"/'[ U7UCC=26&8DKTA//6Q!P]2Y:UL9
M\F,9U*:FL.)X/QWL/,\N;<J+/P3%X>_GGR\ZOW-^@_\ 2%!K=/P)81/R6'LF
MXGQYA%V.%4]CV00=+=0&-&?TI)#,<F&L,\(?<3#6/X'N186,-2\M_P!/+'D_
ML:Q](4&E9GB"3U%7QM;HOD5MQHV)$D'VUQXB' 2W#\1;'R_[I%<V'!2))&$]
M7U-3$;HN/!$ONJ8&NU.##X>P>78&$$=V'N/DJM^=M:(-U;D?;:0%1YM5U[YR
MWC1<M-^ '1-3)>F!="=I$9Z*VG J0.VHV>"8)A611K93F2#""=RH#P%-+#V:
M&O,3K(['P].[L7M@]NDI"A2;(6=4;@INH(@1V7A>X;C1V'(H.05EAB*:@^ZJ
M/AMM-_\ RA036?,(+^T*?LA":F+SD+WLBM_+N7#^K6MC/UZ4G]&D0/#69MQ7
M\'\W^$GQKC?XJL_#]Y/+?IADBCK'[L?N?08A#&N[&C? U\C?8_811<#[;T$C
M\-947X"F!T0<DR6F+$B?&"*A'"<*,Y%EN(S;>'D_GR\VV?[JJ7[G^:>84$P)
M C^8$2!\-I0YEO.''0K*+J?OP2P(!F#W&FE,E]'D2-W@C_$=R>3H\D><([D]
ML36V@^3IOT]^Y=!E^T#%>T):H["RG$LO/)NL7,*D/J(&ZTH_>#%;36<KDCA3
M8CB<3#;J.XG(LZWN,KQ.*" +RQY:".(I_FF']'T'/B)WAD>7RIKP]G>I*R[&
M4$)4TR0CZ\.KWF^*C&;*.I,1R.22&VSY$]\)@<B/[R)JDO?ZX;::CI_TA_EF
M&%8S\>08!<"P[7:Y)WC+*V$48KGA^;"9\5^6IBK)GF\=_"O,F!'>$J^_DD16
MPY(<GL:.V_=5MH[J_=105/H^@V2\,>:)^DA8EM[,*.VGI&TY$BO99'^)?D_P
MS5G-\-W$\'+[GMMA-WWD1W@Y%AMKV8I)KD<CJ\G^E/-///\ 1X5B?CO]I,]A
ML!2?D=Y;GEC55U><>0ZV1NF,9@QFYV>HRIK>_'(PV>H^3K'P?;D;_P#H2@_2
M7F7T>L?Y&ET&7M]\;4-MT>^S C=Q.R4,37> <!R9FZ35DB#9,=3YC+WBPWXL
M>3K$RMO_ *-UB'_>K^$G^C4?]T/VY0&NWT_X\9BVB(_QN='OG-+2>#\P$MX,
M9SL!,C.-W%)".Y7)/$;.*>$=X,]X+#D\A8:\L(__ .)T&!NB<(W;<+RK,>1%
M<[PB@LB9F PWX$TQ7&^WR8DQG&:.FN2*VW-B.L2)[^([#]Y,)8S$=8\G_P!#
M^1J%!%";=RV OOG;/?"'WEGS;&4FYY8H2&U$;#MLER/Y*D]3B9ONUG;.-ZW%
MS>!AW6T#&][VD[<3#5S+3@#I'YP" !N=7>$SLE_QPMMMG_E-8VPC-F=^(T:S
M3 $;L9RP%L)&BQ%CP>,VI#<DA2>#<\HE/S@/VWPY?*$?]R^/,Z#?#OC?(6WP
M\%+'8FP^V"]+#<?[$U[PT((XC-\I28#O>C<E.-E?XP +P<C;C@7'Y:O)J:I?
MPD__ #@&GX_>$\2BH2IC1OHXW=A(Y5H[5=:5AMNWXD/I,8'P@DAZ+#;9_N>Y
M%&'_ ';9[/!A^[::L?N:P_=M/\O6/I#V.@G)?3\!;\GB69)@<,QH3(CP7Y\'
MD_5AH:]@E,5LK+-5V=['&[<>4UH_O*W)??GBCMM!\X>R1^Z'GF'01[3Y_1WM
MD/!M[#MN=]N\68]>'5[X0^TVK&[83(6B!C([S>"P\)@]Y&9KVL21,$6+$5_Z
MA\M_=3ROZ4\PH,OQV.Z7J\&+.SU6%%\-?X5>WL[;/4V+.-A'^YWSL?';#84U
MOR-W>46X"NV_>1235AJIN8/NHC_Z0\PH).K$#Q?&Z^Y-5'^L::2;L;'R@U4&
M'UA?]\)?G*:6,V4=Q.3B2&>VXJ;GNVY?=MGIOO4F_P //)VJC^V?NA](4%FS
MT!11%*."K>#%D@PAL<53=SO<[#BR1G-)3637.T%-X.67D:*IK4UAI?"%6D=W
M!RL"  S_ ")3\N$?,!X"M=$/K'N_\47:VXK;RI(3T\A?F&[?)V-+Z5$#96'$
MVVW)'O)&ZBVWY*G\#WA] M7W;]ZO_$_W47/+Z# ;\$L9E>\DVS6W-AU>3Y"B
MMA+N)"C[A?F,U1.:ZU(DCMR'9(?8>_K;C=H D,YK!B*7T"I *[A@X/\ R<&#
M=Q]0=&-JAMFTY0S)%^"23%<IR6[Q]ZIY^)JI.4FM"5%B-HW]\ 9N9K@KZWMO
MVORU!]C\X_<U0_<N@P/[C\CV<9C]Q-=]JZ<G->.MB'[(;PY*F)$T9G63IRP
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M?<0.X#CZH]X@J)@X'GDH!'":8?PM=]?^W5-4+/O;-6V1>N*P,Z27=(#Z05*
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MJT3JR(^95D53=$7BI(ST?D;."15A<UI(V%>8GDL1LNAEXAA*5!$?+TP<Q/\
M\L#JS&[4RE&30D;)7&<H(:M%\5HL5QRXFP&=)J0XU1.4%$7"_'F]<U6"259T
MRX/M6"XD@/HHI0 XCR8U!S\V?<*AE9Z,B>[8LE!Q'"DH+PBW!?S/4A2H-;*Q
M%3;6('?K:68("*Y&A1M^V>V>\B:NNE8;?TQY6J8=!X[+:Z.>6+,+Y3:FV"\5
MTQL]E0^LK;46&=^:\.ECI;,2LCW.ME.]1?6T<C>YJ(#D35=PO8J6*UR/&&(B
M(AS,VMU-S][9AF#7MRP[.24@NUYJCY11UOA5G0?)4SMR(UI,C7 BP"3<+"C\
MT=-QS+*:[@?9L):4131XX]@4 \O"<4&30ZX&:#FUP8+'P%77:"=:56)]<3[9
M*J*F*LJ*K&:,B-%RO%MK$6Y[=*\(K;HN1'9^:L((?3 #A_\ I!0<^'#VO->(
M@T_BN"UMY;VXL7,C<EI[0+3$*E:W?P!<LCQQ[EL.4HM8<I1V$C[(QPX7);3$
M84W]TN0S.4OGVSD-S=SJ.HTVCA]O,G-0IWV U#G:2(#V49DJZT,.'5:<(%<2
M8D2'%CXAAV)'OD[TI].1S%6O,3%0T!M)R*<!PL_J "G,'M2^TGJHTYHUR3V5
M(V[+RVFU59LJ+L)LOXJ1 EN)TOC F-Y2.6<T9^+K.<[&?KN2'BY5<%<$_-,(
M^YX<IXC00?G;1S5AUJ,Q)[<E+873UGR?,4@);[;L52E&ROK,_$H9V<+76(L5
MLHRB,C>_R*A+'OWE-P<)932(/B5+ P%$ SEVZ,ZA2.[8X64:(-A]<F+H>F*C
M[8[13X_:"5#Z8R 64US-!HSO(Z/@2ML-*<C3"M!AKRDZ1$R/Y"Y/+T_R]1 $
MB@\]N-5-4=F;LI[+-S8/8?&GG9=/:;MVDU^T@E0PQ%,D8**0Y3+,T6WY)!\Q
ML20V&]<4,,RF@II1%'0@\$ .3* A1.[1S2'/8*/E/96E+1R8]4H[8&?KG(^H
M"2\&0"LV)@6%$6(Q,*2)A>0OZ4GD_7Z_,P/>57Q&^91Y'R8?(Z"\PG#<0P*O
MNQ^P]A2B&3)#):ZUM+*F_;00]IQ?[7&9-:E%AO&6%HC;<;3O)3O<RXO^YQFD
M)C@[FH!78/2FE  N^SFI.N#]UYBH9(UO?[MTUV: 9IUFG:#(G2(CEV!)=<JO
M%;=67;.S]5A".E1C/."48%'V562 'RQ!'Z,!8Q.0"*\!1FP=3D_"W8QY(+)D
MV-%-]T<+?G;*9Y>4&NE.;WO!%A]RPHP<%E@XS029@LT&>*TZP\T,L./Z(2!Q
M$/,H*W6S6*/70XMOY_8Z'(-^-Y V%4$V2-F4W91ZMLJ5)I)<2W:DM-AMN/(_
M@N2E<]\[BS3F5P:RP4#&'I I>"Y84#HTX261GBH[G25*P1=%,[3[M'!.7G"T
M'*^%=R,5:BG.!WSRY(?CR5&V,;/R.<%,'R=MX?OARF*"IY?Y?_D8;K=[ZBB%
M-Y@[H,2ZR.269/V7D1U+B*#^GZ(18T?R8QP9;Q]Y'>T,^*L.8=??.7@/DZ<W
M''[N.04CGY>:"U1QK3JQES]O=J7L0SG?'F)L7GI.PC[=^PI8T<C:8*D^FBJ/
M]MOTTP1LS&<M0NY4=S/T?=9#-R*N' * @ +Z%05NM/;ET[U5BO6+;B6)@G(N
MR*0S3.[7UA;2OFVVHCAB2VTL>4@\ :CPBEMO3REF'1FUY884@R""@LXI0\W\
MI&@JL[M?::SRSY8W-DZ<Y>;=IQ(+68T_S-V^)J@IR1IMR]WQ(KA"1Y=>42NQ
M-8A]?6[)KF1D[*.W<\+;;\V$! O40ILP,'4M;= YXB+'UR7EEN(+/T]MI,CM
MQN:?%C;WY="2EHN>B.UQ2AF3NXGVSY;D94?+MPBN("J0(P$#I1\]0+RG)X1
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M&OL\RQ'J9YOB-]T1PH/A**VEK A0DUL]A#@+<<1P9Q$DAM G#SP8?HCA3 >
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MV,&^_=0IUEQDMUR8*#-JH5?6(N37\SHAC9^IBDD<L^+2L)',5'E0Q7(ST%R
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M;6C!,GMY8CHPEAWMJ/D1M@>.G KB"N.9B#[]"/*6&: *"V(;X*WF$M2"WLF
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MTE2NY9)=^(FRH[DT95<K<2G!@_DS_P#21/#N;*0[2 YD<RFL_0ZEYX&!P ^
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MO[F0#,28'/YLSU++79&]^8XS5^+%9-2H>>@VU"+7>LL*$D5 B'W/*^F^E9@
MLM=ZJQE%45C*&7\TR@)@@M/\CY$^N_N#MI-S%+SUNJ*I$FL;PUY$6U)J4F1E
M(_\ TD/R+!612(4<TD^</Q2:JEY"L>??P;^E$^@R*0%ISXL<-K/=T6)V7'>J
M#@BQ#D=M.V/Y@5',K/B74=MHSRBR2&?%:C\-O=IQB\P4G5F?P\9*;[MJF&J)
MZ?YI01OVFE#6%.FABQ?C)&NSB>+X9K4P9%?>?'L<[4OMT2XF$A?#1X=28K-'
MFU*PW(A]TD<<1-]VT901P!' $]7\TS^1#:D[,Z?PR1Q$-GZ].QFNR*DL\DZ^
M*+_.R',J^7ZXN2.95C9G,6%I$: -SW"%X*?_ $@ UFJL%!-!&7  $M.S*#,,
MZ 9>TKE:-Y 3&>WHT!J12U,";=LW=*20#:?ZD*N\F(VV<M%?P \G$\@BH4'E
MQLI=!94OI#GZ4H(:/& )O0Y E.4%)&'3F1GPWE5 DA'0)\@A5UZ2DQ3!NK+P
M<HN5QIS;8;[E.8'VK_\ )9.\F5W5^Z"I0;4;$;J+M4,.2'_J XX00I8@F%9+
M<GGK 5YR3)^3%)H/*'_<_P"">O;A@AMZQN\??M-#RU'_ '>#]V&O09CD->8&
MW!&9C(D5A(4VR$XFJO1!\-%:'U.,P;+&9X-O+C=R(^'L.\')*OY*_L?^GD%2
M:O\ H_\ =C^$E!L=1P-KW_'[[4GOK'##L8>*HL!H@_%!U0/.2F,9^<-U(<D;
M-K#1GFVEAB?"MX*_F3)3?8U+_1_F'\(*#6\02OMACWW+(TM,^&@77Q(<6 L+
M"<P324^H5@U]3 XG'AR0[XX18\1GZ^G*Y&TY,SQ75-,_TYYHE_ZP"LD!1VOQ
MLEG8J+"C+291U;4%:%VU+^!K:$9P=*L0-A9>4CQR,5OM^2LY&>W(3?8M#"^C
M?/OI[GR>@U:WW CPG ^H&2Y(W3G"\I8>;J?B/%;#\XG*3'5[LS W<QGH[;;<
M5QVCQNL,^5'YYPL>[?\  EMH*"@_^<*#;[HV(]VY06'^THK478J/=PI32>$J
M8'QXC/\ ]GKSCV-'BN-_</\ Z-__ &>UCRWRUMO!-_<U>_\ RHJ!M-H2PQY(
ME"1\F?E=QLEAQ[^7XPF>\%YU2/.28'FCPCM81UEMN2%$YM>^ ?!_R?RWVQ2\
MS\G\P1_,%3#\O\K#(]J$A1F.+08,.34II,=2%.JKK4\<F2TIFN9MND?)I41V
MVXO?QMM]XR@PVY\8$A-!X)JP/F[D_P#(_P!(>8 AF&-V)]*T7=(\/17)Z\ZV
M4+$E]W;*0M#R9&B8V5*=VZ\)'9[OBL4]FS4Y&@\6VV_?5 3<WA,^GD__ %?0
M4D[S?+&382)DU=689<6-KXHM3 S-8Y*:QM9V*U02_>.+%=MLZ4GA'D*/L&?*
MGG/D+*%21U)''R'Z/\T]L"@I'0GN]HXS/?\ "?;W4<3*A'RIVQOAM)JZWL9C
M)3F8SP9B/)$)^V+'_38C_P (_I)-6,-J^<.3_G!05%]Z1XX[)'>X_P GG#E&
M7\V YT17=.[8N)CB57NG[4KV((M%?S&_)#+2DDHNL/)FZ.6+@*'( F !C<AB
M<@.!84H0DAI,F*WGB0WEP0JX"PV_<!GL93?[YDQ8>;#DB5/<^-_?!G_PD;;#
MS/X'J3)9[D_=3_3B/0>II)NJN.ALI\,Y V7*P) P-+T!-FAJ1//#)4EIK*KL
M<C;C58(:4U,C%EJ )UO.]63O+U)'2EQ")U*>:7D4$Q ]#7GC/E%01Y'8$D-U
MO3:R9W2F'F/QI-583$QU*<9P.HMM88;D@A^)S/&*A<CDS/+</CS+]TO]*(_[
MGA&.-YH=$<)\#SID_E=S&_'9'<J,.2/(H6>$0)K_ 'RIK#=6(WP\QAN3SC9"
M-_<]X>V8:"L>QIJ:@^]7T/Y>W\R@R.'W@GNR2 1':VY5=JJD[5),EXC00-TG
M@^'S%B9+\/QW)$;L]7<;D9C$6&?":P.&O?3W_*3S)G_1_E_TA038CZ?WQ'VQ
MTUXDCYD,LB)'6G-1A,.2#.M)C76E_N5+C=06$=AQ +^F>28M%N-MM/!-S$UN
M"D(0KWEK@6*"J<">_&"Q7)*,%19,<ZN&,F>E8*Q$$M*;1U&?#K:JE'4,YKDD
M9N;3OR+)">(1TQT)]^Q>7*3E$"&3N5#/,&%[>(;*<#.^.K?9\D20S]9LOX9,
MMTY^8CJ#!UPG*,VK+\XL^*_<..$=866ZQ/'^&";Y..8I(_O)]%J'[GT$?)H<
M['V/9^L:VVV(HXD2I+=]P\.'QBM84QA:7TW7"5FXL,)AN1QR)&[P;:Q%7^EU
M)GX:Q^YJ@G_NA0:'SV-C_#]MQ*P->X9:DH-]QM7PDM@3 +9FAS/GX59CD=[D
MPT=NS L-OGXD/ ?/L-R?\I$?Z8_Y04$'M[?=V8X*VQR3X9F\^5?4:9YXDMX)
MS5!RLE*<B9!$4OUHP0BS 9N_$=GF?@>\JP#/<JEPO?2"AYHJ>7X:?07?[CSB
M60;/<:4#9>#Z_)7M6<$$SDH9Q2IR7/-P,OYQ@.!3FOCP  (<@/(A0?>]0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0?R9M.MGM78&VZW?2MGY<4F6@_EL.J66^SEQB22Z
MXX=A6G:VOB]9N6U^(,\)*CB6<?$G 1;ZR1'N%LB ]8DZBE .TK+[O7;K*GY2
M8BRHFY4<PJHL)=RL_-3=['0V'\QTLR>V,3#E1I-J"6,1LMMG.58]D0<,WT.*
M@I@/ZT03!#)G/]X T\3V>_\ 'C;8_77$>-LB9AQ:Y1@7=1*<J0EJ9%)+<I9)
MDA)CX'@_+@E<:GP3#\A3Q$,  #D!  MV-]Y[US3'TLIZ8,&H$%)+,3GYB,]@
MP[L>WE!^R0EIF?'AXBS7 4Z5:+9!(2DQ<2[@M]'0>GPSC>V / 6F7OO53$S4
MUGO!BQQK7)>7(6:HM:1\.2H%F!NWF$D)1I!5X?R9(7#N)ZMYQF0G$X_,?+F[
MYZ<_4J"44LQBB(1(DC[R+:V,B!\:X3KB1=/#6FMW&RG(V5'7*>$]*%,4P3#8
M4;LDT=;>Q:_?)"..V/L?5F]8]0@/(B%!M!S_ 'B^-%*V\6++2.[G!ANLCJQ)
M38;38\LL56;!6RML>VSVY;M.62'>WT!RQNE1* +RB5,$5CS8_P#D?0?I#7^!
M]X@C/&2)5STY(@9YH;2379AQNT9KU&EI[O=V->1R.)!-&SN?]S9IR6SL-+MN
M/]M>;YO)^H.CD1!/H,)CCO\ <?I>):9N676-N)-DQI7;#E4M29P<C&8$H*$>
M*5C/ML=AXNQ@++4DVT?A",H'\V;JL0Q3B $-G&$/<W_O)[B:*?GX;1E F&FJ
MR4T<#&2EZ&)T# 85M*C=OQT[2QND1OMY&[>8R.[O+!-TX6&(HJB85), ,_D:
M#)8Y^\A6\-_OERY;B9F2Z)04%0S8_P#9ND93;4?O=]K+=\W>&,V_RB7@\%44
M@/;,U,!/4@4Q5A WZT0P!#&6[]Y =<!I]S#CVU'GE;=;9<UC1([(4V/]QQ4<
M]**K(SB2+CCW+<CD;RNX;F2"EYOR/ GY^6@SM%^]0.)<;C;%_-N!\9P8XI3I
MRF\.N$[.9(*^ '@<M]K:SN:"_+A6XD!Y>GCFB'(<"(\ ' 8[#/WG!3AQ&8F(
MT_A0C^[S;MH;DQ7;KA+<F.9^^N*7&4SN-XYVUB2K<@&, ^(#T_XWMGC094ZO
MO0&(NWU]OMQNP^V(S45)J^[T>X^N$YX."VDQGJRGD-TR7=8>Y3"(1>N>;^SK
MP6\.W:52E "@4@ 6@UA*OWB9N2NCL,%++@QE)J"9(:3D8D3ZM3Q&B;(,;,9%
M4,!GQM*96WN=TNV($;WM4O+T4N64"CSR "(T&VUC[T:X;R6WTAQ+FO,A9B!<
M57"F.W TVG9F9Z8J/8H+:P2U::>\#3+:54@1*G^UV>GJ$.OQ 3"(1V=_WB)V
M/]C8;)<DU)V*7#\T$7*T=659CN0J6J)#(;66T6\='V)X8# $627+\H;@I@<C
MQZ:#7#I[W#-=C 9\;*;M3_(H]P *W5;X+R^J.@%8S14XT5U0SB<6WCE,6\L,
M56%-Z! $GPYXXH-C-;OXM.*)?CB4&2XH:57C"3+/$C/?JCJ)([B4U:-"!SG(
MI%MS;-D>"0F._P#TB4!ZA'T!S04B-]X1;F,]E>6D1H:ZQ4\G WE=OK+=C/4:
M0FVVA,H*[=615S(Z)M9A-IX&.#"3>GWD35?V >>GF@PRUW]W\Y' X;TU;!W)
MA;&86WB8+;6( D5DMI7S@>3@DD7<L?!/;F+W%[P-YWN_H3^%'DONJB9?)3!X
M!:']WB81F)WNYQ.,D$-MS2:FJ2?*3O4-0I?<17\HF^E[;Q<@FV[<2L5V"K_+
MA\)?'^CZ#)G!WRHD7%!9=B:S=>&3)ZZG,'!&8&'J)+[9DI)3HS=Z9)#016V.
M'N9Y*CM]'DA(!7X#YW/AQS08SC=^)1;JTJ6$5VQ:L8:K%AH88;N=.HJPY575
MEKVT4R1=<D#X;OV'<RP+N=]L1%2%35Q* AS\G@'N<?W@^8D#(="&D'C:2X]G
M9?9JB^W:^8O=BO[K*;/*2XXP288?$\R395&ZIE6@4;A#&1KELX]*#G)0E/TA
M'S+[\<LVW!'.2QH;@J,Q:3+=+4]X<)JR1)0I#D5)";K@1YN66W-DJ/M'D66F
M%C-@UU(/G\$ BL;!$W 4&T4_O?VWM8R4N5RQ8M)R#,JF_$A6?.JP.A]/TYTI
M-1 D/WD8$\1:,#O1R)"24,TK0 #=0\>9^@1#:;6[]Z-'#%]A:2'!,F.9DMB5
M6Q&GQ-@*=FNIMJ+I*2S)JUK^R9';VU3B<S)8-MIV\9&3A)U+!?*\'E4^:(@&
MME?OY/Q;SGWEJ3/UW9++=D>/[-8D<L.%UA1;#4=#Y=RD:1\))ZI4*[XUDJ;O
M)3*ZN\/.%Y83Q<0@'/%!NUP?>*'))]]R9$HN"//9G:+6&1L1 @.=DTLKE24A
M"\KN/D6UN8VPN(;92;1FJ. 41*Z$<!\UH-4M'OEX:@R&Y\4LF+7!(Q2-1$<K
ME7M:Y(<[E58P8\DIKZ9VOZN\D;:EH LQFDG20 #>7)JB//I&@SO(^\ERG'$J
MSK*4<(K)?*[+\?M?"#&?C9G((B259JK/2DM5&A]P;%/KR<C323BH-M5!7"VB
M"82@F#R(4'E)OWB!R#'Q5&'7.VF1*"2\U1UHZ4QH&D-BCRYE@59QXIY@5MFI
M'?9$4YW&L!Y>( 0$<03^0 :"[M#[R)(:&I/%QHC9BMOB#+2W<L8;08$D,A25
M9*!WO4RSC(XEV:$$A6<A9%4Q\_Y6 3@7>?(^$^@U;9^\X;7.F64"0'\W&4.4
M<S # S$QU;17&U#9V,KNX,-93(JM;')+#E%7]2M I<KV(?YP='R")0BSF=^:
M;LLS<1\>%HJ;C#:CSLRNCL9HNB76RVQE\7@X7.Y)1.9*>]M61G&^2K9TU0\C
M,C<I_@'I$0#? _>#WFYE=HN95A*'&8Y"MU0@?.6D0NQKB58]@VX0#>W,9VN/
M8RXY"+X"L"'6D"@N@01\(17 YXH-O-G[S-L8XFA@YKL5V?&:]#N8IN]I8"&D
M3H^'+L:^'-$2A"87)5<BQ._D!+359=ZV(&/AE*92$%0H>8<B(;HROO(3J<F"
M1S/<L%*V.X4M*0VT5=TP>*FIQ6XV2K*#G1S1#(9=K,-72/AN5\>R)@B'S2CR
M'@;Q#''!]Y E-226"VT/:)R1\SV F>3X+;8,)R0FF5RIA< N'=<;O5]F%EY+
M =)!^CO,O+>/U*#(I,^\I9<L KX3U6(MS&PX'DUGZK,_%U9E\&V+W:YQRD9W
M]6?N;E+)Q+Y,FE\N\4,>.1P!'D:"X'^\JK;FR,:Y)DMN%[XF,JF4+N*G17+K
M$\U;BA9<6*LM%T^X>S2-YND!87OH 3<>4+EO$SPYZ1X#0[C[W+,D17C47A*8
M8:FU5!JX.9*N=%VQII+=+:2P;@BB3%*K9V\&4W<U"@W0\Z(D<&7>?$/&@N\F
M]\=%EC7Z;8?REE"3&K*\<.B&'E()(8VB<KF2$J648R9?QK9W=OTML@+HH;'#
MRI-,CF1B 3GI+P?D.FGW'3]S^Y5ZKCCV_5/C_N-A^GG_ /4H/OLH% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M+2NDZ0ZD)2HX4U51E[/3]?(C3\]837,<AEY*5+F.TK8WK*Z;@+I1,/K.>!X
M>!#83\U&U1E!OE:\C:S0/(#8Q,U/S\=N.^'([<:03.3A*;$N@CK+<O8XW+0@
M' F*/AR "!>0H,,)V^-$"&1S!I5JP86T@ U6X!X!B<Y$AL K6W #>2 ,V^G$
M217;09GJBE(0;HB;CJ$PT&6.?3?4IY9^0JO76/7UV*F5<;&5EYB_#T=K&>H9
MC(N*66S3'-GMPX7CM0RCE>7B;J/9"X;@0 !Y#*2ZZZ^C@)*8,%0\*8@"F9*1
MA_#)H^7I(IO(I(I!2H926C)@%#H$H )0'PZ>>*"O4("@=3#!.HPM%67Y9G@H
MX/M; :)P3\\I38X9ELHIH%*<2B/B'I#_ '. U.;1+2:VC*K<#4/6BVA+[;(Q
M5A*) T:D2E-E887+I&TK8ONV-B^@%,(\$. DZA*/'/%!DBQJ3JNX@-:<>M4#
MK/M;-4HWOE48;CK/MF8:@ &S6+U>[WSV@<$X.4[QM_K? !YH,CAG6_7G79.5
MD;7J"HGA%)<*EYBO)D1QZT8WP%91PP]E+G*^.T4Q'(I72%#@ICE./'/HY$!#
M>] H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M\X'4F],;EMH\=-91:-[S@RB>RH60N%XMF >0"2&%WGM=<[6^6=H$V/9URV=
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MSD2?K>D)(Z_]TS[MUJJW4=DZ^;91W$\=(*HKN)"CAO(NQY60F.1RI"DD.%P
MVU!GWR'O.!)5N#&_6B/B' ^ !H)O[._=+D3&P\'*E."WJD)!6S:;"-):1L7)
M:6U&ZV <7NVR6LF/MMK@-QB-[WM41(@D*":4+WS[8\!P'K8.U/W8*)W/)2E&
M6Y6 QV;*\&#KP^X71%'8U1@];CD&@1H)ILR,'%'ZVWA<"0C<!AJQOG%$1'@>
M1Y#H?&/?N[&T1QVP8O:N^T>E;,;,ILL-N>WM68E!0,VV8D6&VC$S5(8Z,%ZX
M7'PB\&'P'GP .KB@S?\ O&?90_K]1U_%*8?Z.Z"IM_>+.RI>N!9+OQ%YC7O
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M);\F-. UI]+30=\FI;%CE+?*>S;JHI-M>E+)(J(S<;6.X^;0K(@</4E"X(@
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MC',F*=]O7+IK9CD$0.)1-P B %#9E H% H% H% H% H% H% H% H% H% H%
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MM.E-WO[GKK4"J@M-RR'JRFMNQFC@CA%4VOJRR!</E'0M'. 7"N).ZQ/C6^!
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MY-G*]-S=\M8>,QE!?:9$I[I:BE-8EN1U!VN''SC6W'[VOD3*2=QBD!%LG'!
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MF[DJ'6LZX_3V"=5!B@^TQ)C-.'!(X6K:9!EUM!D):NSL Z3TAFVQ+;N#X"(
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M3- 5)9$P@)3$ 0 >>0#E1OUJ)K6YMC\K2W9C</:B7,R%&?$#!?9M7.V1'*7
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MT[?K(8S3=';AVH<D*PQO?,$:MO5J57JK-SX5NM34FGLG#D>*74? (<4<[B]
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MVH'=6_.3C+]'V@?5=./[4#NK?G)QE^C[0/JNG']J!W5OSDXR_1]H'U73C^U
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M@XM),);MY )FTF[#2#-.BB H.RCN,? \L5SJUT+?O*+AZ#+A.,'+'@PG)R
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MUAC'H-KQIWE-WQV^EAH3V_XABN &A$,O9[><:?IOL0#,2W*V6I<3&<ZI;QW
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M52S&HW)(=?O([7&[FZY#!@YH*1O4@'4;V\!\ [T1NI1TQX_PV6C/EMJ:9"Z
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M$!( "%!)#6-3^[U;7;/AJ7%/;WU35I'RT^45)(R\/7S7!PIOJH56O=20SN_
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M;:;:XS/<3GRNV'L0583O)S-MA8,VZA*+F=(J7'M?K+I9K*VV\5O_ .,%Q2.
MT'FB[=;2*> LGR>VML2@.#$P&QFI#<6Y8U9 %8RF8P.4IG&C32LMQ*,V!'P
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M5+O6;H' 0']8;J\.0 0S#UUG_.0_WPH.*VWW>*B]@:8;+;0Z16V=NHI:QO[
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M/YS:^3"V(LC!'?EUMR#@/D&U)VN@KKK=Y>>1603_ $J)1$ S+4?LJ[1:QO\
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MFNMZWSZFV/4(<\CQP "/'(;+5^ZKVZT;('&4=P(-M9/E[74."NG'4>4]Z7#
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MX'&$V%KJ!B\EY .#$, ^//AQ052A"'WK^_ZCU.YG; 3?9A'UGEC#>USS(XJ
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M?OM%CU/M/M >S<?KOD_!QSQS_N4'C[?@_P"=XO\ W9/^%0/;\'_.\7_NR?\
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M.!V=B&2-BFVL@[F$CH^9YPZ4'R=QR$C*7"AX?N@'TQZKMYOM/7>($)IQTE1
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M^C5S8S>PU3:;N-%QVB@6VFD @[][*-@;J8GE "7'%<:+_1P=BQR)@%051O*
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M/"%VCY.W)&>67*7E'EG"HG%3..0\! ,HE[:K:B$XETN@W6!P[#.U<6OCTO;
MRK\+G@Z18+Y<MLSAB)%?KUFN-7S;)&[:?;]^F#)J><QD9#$, 0*   1:8N^W
M>(;D6[,ON=E.877>PS7$**XV@K6E'3IO!5Q&A+"Q?>L=%>$+N9H&8MZ5%QL(
M1S*0+YC(Z2902^>H>0F5V_-X=WL:<-@%/<R1) <4)QZSRHD4I"_JL[&.Y)F<
M[E1H[=S/=+3RFW%3;%N&;*(1717?YB'E7O2I@ "4J8(@$U.SRU5G';^S;F>N
M&\O?0LPMQAHBN[FN#9\TC1M1HRW*.>S^N.XZ42L)7G=]OQ0P\8ULX@!^/ !$
M#!VLH.&?8]:2^AH'=#<2V(^S2#WEM_7$W **B'"0DO%ML,1,%X0$"><,_,\0
MH/-_]F; F>X_DK8?;*:)D:.?&C_C.(U-<;$>H4Z,-.DHI+"N22YS:" CJNQ#
M<;@$+[O(SC3BV;0]=Q2,JY?L-Q-#))?[*6M$T)J+COY4S'IDI,Y;+3QDVY+9
M3-DIL*#EVZ64I:ES".T'$E^SV;1%M,"XWS%,(HH>!0/P'(:V9O8<UUBYSSJI
M1>Z[;+2YDN9*_C+!(:A]R3#'LCD6H_<B"XF=(JNV[R.D-1F.6-DM41VYC(=J
MV2YU?.\  0E'LSVF=6=TY>D"2]N$UQ3NA.**TB+&%&+I4Q3V1!%G"]X\ES/V
M)?*3)JPB2@]\]?(;+6QNC<+:3K9"\%* "$)&O]WIAQ'8K/B9Q;7;,/V,HF09
MH"($9QFC87K'TDSC(T;S,YI5-)B*S$9W/%WI$NQ:FN!.,J^L*2[X?. !$0WQ
M]3%%+OD">Y2FF=9DEA][+Q]/D9S!G +2C9,5FS.:7K&VNENHT;I:'[M&:+8U
M80D_P$WG #E"H^L P!0:J)V"X*QXV5HN1I;7VDV''*;\F@49H1A$+;^%4I/E
M%9K;O/O6%8Q&L1_0$Y[;48UNV%VVNJG)C^)2]/B$D--.TC%>FFQ3WV5;\VS0
M_GJ[F<HL)1L.?X<M9+=#>4%PCC*XI3".68T#R_*"=DAQ[TK0&536^0$>!H.N
M= H% H% H% H% H% H% H% H% H% H% H% H% H% H.;.T?;ZP=CWHKOAN;,
M[%:VYK_9V#%4Z(L$.AGH"?,,?I:HK*J4G*&:Y&:YE5@OM'\Y.5/=[<O)CBLI
MYAM!<$O2!0CN\^T'$K=P7D\HNQ5^3GY;2]S\%)BN8I0R;$9R#@[O-1FI$K1Y
M*+SN,Y^/RX@WE9B)2GB*A>M7M" E,<X&\ F[V_\ 5' T9T\@#4W =N:]+<'L
MPS5R'?G)WEIW.HJ:PI.%64/8^H_0%Q763](]7/2'B/(F  FC0*!0*!0*!015
MFC6G%F![1S(N+,D[12YXRP':FI/PJ=*1:;3H2'R"7:5TF0X[?K4?<9/LE@4@
M#8!L](,=+,81*( )> Y[X_8UTW152-%!HN6<6IB1JSVHT/=K#=K1>3'?I6TO
M3.[$E9D=GRO'3^;[QOVG)L,YE ;8D*C]=T@>P_M4*#",+[OCI&V,%OD83EG1
MH*3,P(_R&I?RG8T7PVDYZQI$BS"R+(N?'<D,!WQFLN%3CI8+@J('1@P+H$ 0
MME$*#JKJIK1&FG, Q?K1#F*MXL9Q2B7$!JE7E0Z^X?4J*PJN-54%99N )\J\
MJ+BK<.<> #DP\!TAR 24H%!J"8HQMS-&CVC,[X>T?XSZ;JLU\MXQJJI24]DC
M!5;(X.;<;RJK(+ALIEX0-QU>K,)?$ XH.1DB]G2XJ:FM#6IE[92K;P8&:5M)
MUBQ7ZU8A]QHJ?B>S)#C;"?*XCQ9',:NU^708$DYMGI5%JY^R\9V8*@;DH!(=
M"[5T-7=<=E8"F)_RI."]N&] DO8F>%ZY';'EET2,F)K-P6J[FW=C1DM!K,,8
MZ"/DDS9M)R<()%PO(<^(@&K5CM'*;]6,-[RQW!MZY+E>-1:@ZZ/K/?,<LO"A
MDS$63.%H*ZK%[!CEMQ!/[Q(L  J:O(2 Y3*A? 0+Q08!A]B^%D4ZHB-W8&?[
M$:3%(;7E7=&/%\L<N;\M^2VU).;)-UVS4]5=@^_2$9775D_K,)H9C?2 ( <V
M^H"GH-U=NGM$ZU]M1>=KAA7,5E%2=C(;,6XN3FHK92\\C*;"RX'$C^\F:VDS
M%,^G@:ZX.,Q;4"@>Z0H> !R%!URH% H%!$W4'_U>R3_[U6W_ /\ %-*U!+*@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%B7E,$=&55CV8<H4M.4% ,8
M/3<\OMFN"!? >GDI1&@^4&,>Z!NRRXY:T\*$E:_[$1ZO081X*3>6FZN1F85%
M)U9?^U N!#E)*-<MH%M<=SW;D5MOSID$,\S-D]P@DNG,<0]ZMWKMY,;5%=V2
MRFAI.PE6Q@Q0=AL)Q2$LJRD_$J;':NHR+(JL'O$SUEGVVRDV4<_D*<FN527C
M.9-'Z+ZAH) ;A]W*7H.@>+9):CVTE3I3PM7#/R7S/!^2PJ1,F[ O)Y18ALR+
MFVE,QO7WV*HO6/>L"IRD(7$93.E@J].%RH $FG)OK*RJQ-?E2.)MU);2ZZ(?
MBUPS9EO$+#H4423I->46-?-04J+$B96Q=::1%+=57 LN$<URG$A+=L"@'!S"
M$)']W;]XV[C,]+;HZAN%]O69F'$Y$G#:LDJ;8:D&/@S<LDW>?3[3IC1T=&!(
M.X2@L1)Q[QH7 =:J/B-!FL*=S';XKLWVL33)6H[J;4/1;*JU"GPV4DU!>HRZ
MG+CRR8+C=+:&4]7>W'N+[B>TDN/-.GN!=MVSJJ=A^WF$<\N('/\ AONA]P)O
M-#)?[0VN9&U6+DM!U0T;#E:%$=LL9M23KRS8*9LA;$7%=IO2.Y?&R\MAYA<A
M[:.#; ZNQ8]5/8$T5?@*#JKH_O-L@\K$0JVU.S&J[4/G(,?H;];8-A-3E)U.
M@230O.)Q>]H2NW0C6PK,*PRQZ5%M>K*YC&1N.H1,(;F@&<%J<NY_(-R)W=(R
MOK8P=?GRF2099D%:46PYMB568VZE-G':3%5GFI,T\?-J+FR"BBN-F)!"W@61
M*IJ1C'"T8.TM H%!R*[1"'G(L8[FBHI> E7EGNG]QY= WEV>FYJDG7=EWJ%A
M04@SOV0<F\< "V(\D'  @!X\\!UUH% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M!"[2I0OYK*FDN1G-K,(G[C;?X.,1"-\]/MEV0D/IPU\O/'O"7UOSQX_QBT$T
M:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!08#(5]%P&,[E!R-VXZVYAM
M)S9C@;N$D>\9W$E@E7S*J"5MB2Z#@\YQQ/;#%,'%X>"CX&H/DY9,LZXRU.^=
MDL[M.:*.K758P818C066K D'.IL%V"DJ-BNQILV:9V"+R([-6DE3E1BL]10D
M=(7P0+@YYQSS<>7"&X%S8&*7B#^Q7)V_^VI%\C0E*;3B2'Y(E=,9DE1#%+I2
M7E.QWVHRDY6U&[;>,/I7N[K:'N@4V&D*AE=23 ,40$0H(9-[>& %(=@Y)<?:
MHT'D#7]O[-2DIM$R!KBSS[*S_&RBIS(U4EW,^$;D==(/J"U:-\Q3DY775P">
M[JOU<)QA$1"2)]H)#C=X-2"U31;MJ,J;7"99%9=VOC#49<'6O<UT1[BN15?,
MNQO:B=EBPP9D5.#+!0%07O6O8EO-%)<(B!T@0VK"?<!F=.2X 7YZB31I48,B
MX2NU+[KB=N.\TER=+9]/&7M(T$6-XX+:*BI8J[C?::T00C*RPL+!_$O2 B%!
MI]T=RITQPY5F-&#K5ISB->$C&FM7CJ%F$[DM6=$:,?7.=9DV @=&1WS$S:1F
MY-2[-;" J, @DJYTL/-#I1Q$1$,Z8W<OVA=F!KCE!I#IW(6),<Z*3?3WVPY$
MCE.8TR0:D*L>LQQ.77I'6WHM2,Z5F'UAS+)E]9.C'0S)[<^C1,&>0"A(72K=
M4VV,B0LW'&W]2$I6<4[2D@+3%A=L([X3'[#S7U8;TD'<Q'$XK6>X@/#TZO%-
M;:PH@1'ZE, PU!/2U'Z,H._*,RV>V\@^2W&@WT#*RB^RY66A)"2E&Z>..!##
MMD\.?DX$?PT&9T"@4'(WM'Y65D19N4&6L9ZKG6.Z'W(2YB7F'2@OM/IVI?0I
M:0!2\&Z3))K6<4<D1-U71\ \.0P'638W=1;[@2QKG*SO84N,Q'@!RR=L$GQO
M%ZRVV7J7+JO(S?N09!;;F@Z\<\ON%P1:N'.XK68FENE%**KE!/PU($\ [84"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4$-],4-'0V-+V8G). EY+CVUV[6EB_@I
MPX JJB78V24DRNHB(]5R_=!)X$PF'D"A^KR$R*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!08<Z6XE/1JN)I..P>^C.M$5$)9QL)34TL]Y+4TXR:JXQ%
M9,]C44OUEFX8@F(8IP_4'D "&+5[9NC3)4G'EMW7QNX=MR7,#)R$<[B>:BV$
MKR]-#"Q[K29BHY+S38@6RATCY)B6 $1Y'CD. RZQV^=+,;)RE#'URC<,M6!-
M]ORP1S"=5\M* X(J7)A*<"B/RE\?P?)08T;MF:&7VQE,M2U9B=PM54,J>=(K
MK13.C 6155?SE6!P>\=U6%PBI*WSC>UA<$0YXXXH*M0[;>B2G;3C*6K,/*@I
M'DIDDV>U;*B*8#9/[4W"I@'(/1[N_P#B(% !('HH/5D=M/0S+O*-_)U2AJ^*
MNXD1UJA#-*ST*CI:XX(MUT*?5\^\XD $D@8.<(@<GR#R(#04_P!6'V]1N<!I
M_ P\V+F$! 8*.(#A9A\'(ND$1M]708Z67@0'_%H,3/V@^UQ>1\1"'0750$+"
MSO,L5(^"S.*F$4 Y ;OE9DOU?(<<\"'R?@H-APQVX=!]<9 PI7@33G7B&Y'3
M4Y73L!\QQ%+/:CF3TY3*6RKX9%9&P+5X2J9/ Q>?$ $!^6@G#0*!0*#ESVJ5
MB^XHJVH4\KGVCZRWN()P_NET #:VJD1M@'.;Q< ?H?T?K?\ =H(LZX:-=N^&
MTQW(^N>_&PV,B;<.2=(_3++/[@:^JX#LG-75_/IG<L3@C..X<FQC;NLXPYJJ
MF]:W9(!^L0Y,8H2X<:]W2FJYG,U8AA/29Z1<VL$V%%SPE?:J?DJ278GI]HI$
MDTB).'K,[P17"8"@*B>VL*X&-\X!Y,/(7M$<_=3RVUY@XX>T707/ZMP\-M$G
MR<W*F<IR2;R$I7=<UY;QQ]Y%?D+G*. I-O@0#/,(@ ;&3LON!Y*=AW5-NZ=8
M*K[#^VL/$=<Q*.!@J8 !A"WE&9N)=/;+U<>@!\/]V@K\C*WZ]GN>SHVHHY/'
M[  N68ND?U3<MG@WA08&CY_<VRX_1LA;;NBR3) MQ-%QXF ZYY<;((Y#EX5\
M5)R!9B(L"CD$H%*)BF-R'^$:"Z8V3W&K#?\ :%!#TL5G**=GY9</"<\X)*5Y
M@8.M)30RKK=5KA2#^L/GB4#>'@3CQ$+LG#W#?9Q\XQ=.,B_[=GB'EZI.& 4,
M#J-[%:*)TNZ8;X 'SC#R'' AR/(T%U]KWU_U+J-_&:8_Q:H,6]7W)!=63EAE
MZ3>XWL/3BMP$Z=O>DJCR(^T7'D-P4@;7/CT@@CXT%&^K'<N5&_E8L;Y>C#3<
MHYB>.,LOE+GF1VWY:'1[9U-E%4XSRO7"4!Z.E6X]//\ BT&J%! [S]]*0L9(
ME/MC82WAX2E[P*"C >TBHDJR@"B44D4)(L;%I&0V;)4H!ZO6Y:N/K.>/F\#0
M>TR%WGO-<S*"5.V@"$ YPXJ06 ]I/-./*B^Q]2V.Q06A %7D3\)PB)/1X\4%
M!GMSO5W%#+O)TO=K_&2O;?VKC9^OVTZFHX">(<'$ZC8V712'O& O(_L?''H_
M!05J"W>\_85L#(=<J=L1=0R%Z59(;\";4-=34.HG2 XCCS]BGC83A)QR'4F7
M YH+9[L]\'^6;M6?FV;>?I6T#W9[X/\ +-VK/S;-O/TK:![L]\'^6;M6?FV;
M>?I6T#W9[X/\LW:L_-LV\_2MH'NSWP?Y9NU9^;9MY^E;0/=GO@_RS=JS\VS;
MS]*V@>[/?!_EF[5GYMFWGZ5M ]V>^#_+-VK/S;-O/TK:![L]\'^6;M6?FV;>
M?I6T#W9[X/\ +-VK/S;-O/TK:![L]\'^6;M6?FV;>?I6T#W9[X/\LW:L_-LV
M\_2MH'NSWP?Y9NU9^;9MY^E;0/=GO@_RS=JS\VS;S]*V@>[/?!_EF[5GYMFW
MGZ5M ]V>^#_+-VK/S;-O/TK:![L]\'^6;M6?FV;>?I6T#W9[X/\ +-VK/S;-
MO/TK:![L]\'^6;M6?FV;>?I6T'MOMWO5C9P!Q)>[86/D6\0!50S-?]J,ZUG*
M7MO >Q%)LS9!-L='AP/K.#FX] ?-#U>[/?!_EF[5GYMFWGZ5M!6IK9[TXJ6,
M"W-/; !,#_+00]:]J?,C<?*0<S:L2"'-!1>[/?!_EF[5GYMFWGZ5M ]V>^#_
M "S=JS\VS;S]*V@>[/?!_EF[5GYMFWGZ5M ]V>^#_+-VK/S;-O/TK:"N]W>\
M]Y#ZKXK=L?WG]X?;?-?@%M)[N>[?EOK/*_=K\HGVGSGS7YWMWG'1ZOPZ.?"@
MQ]-9_? PK)K-R=>UXK&'.4<KVG,UJVH+\W.4[ERUA 3#VJ(!02""( /^ /D\
M N7NSWP?Y9NU9^;9MY^E;0/=GO@_RS=JS\VS;S]*V@>[/?!_EF[5GYMFWGZ5
MM!8;S$[Y06LJR78[MA8I\E0')P\H-6]E1!,2RCA$!*L$-L\%NYU"4>#GY$1^
M6@OWNSWP?Y9NU9^;9MY^E;08WBL;OCVEA54[NQG;'R<%3PDW'QVUE:N[+6TE
ML'P_V.YDI=TFSI%O),N&$W47,N7 )T@!0#I#D+ID-COAY.+G8]F=.U?B9&1A
MB7#R\+6G:L_EQN #UG1D[5&&X4>? 1#PX^3B@U\@0KWUL3&P\9<W8T'5?++>
M!F@KCJ+*=M55%%.3R ?%6"X<\HB41,<%XH>VFPP ]OQ]6)0YH+[CQIWW"XN#
M9';#MJ9&18X#,RAU4GP14  ..#%+L0(6Q /E  H*MO,+OE(>![!G;&=L1[7_
M &Y0R_.'!JWLE@J7J\]2&X":6VV]FT='*5+,)@ 0)ZP1X*;G@!H,I]V>^#_+
M-VK/S;-O/TK:![L]\'^6;M6?FV;>?I6T#W9[X/\ +-VK/S;-O/TK:"J3V]WK
M+:ABBIR]VO\ ,2^.,S#PM?MJDQ1\>1Y)E7-F%@@"'X>*#W @=YOU^:<95[:)
M<,^"G&2L<T"[1FSTS/Z<$N8.:<-BK@*=D0]J$O2)3"(%Y_Q@H-T-^UW%\6SG
ME=!]+5R_Y\HY*6"-\;VW;PVV8/HM-RPRB.(YEHI0$#YI>+?'/3;'GQ"U-;&[
MF6'D* NY6T7<-@^:Z 3+: ASRU[N$G9@88-#%S?,%YVF/>1@*)E'I* *?(>K
M\O\ D"D>#B[G:7TE8<5:+O,OF:4'+AFR=F*4$_-NY1%[),.#!;^XN)YA*)"A
MXG 1Y#GPH-UPHI[9YRM(>+L6S()0$!,4D[#BU7AJ0Y$<JFYTWU1C*2D]T9Y1
MVS[32O\ KA(4A,//6BB4#&Z^0X,&ANV8X'8Z=8%5??RLVUAX*&TV\!596:2F
MDJ[<SS)^XL[X6/<2\U'$4LUL4RP4/#QY*(CSQX!T3H% H% H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H.4/:(_P#4WM7_ /*A=S3_
M .,65Z#C47LJ;R,Y,8CQBY_QZK.E*SMX-DY.AV4Y.DA0;1=WY?C:3H383OA>
M7&$#4D5N,EW,U^$N'*848Z1[N)IS?2)LP1"*L4=DCN$.YA.]!?;&3F9%Z0F[
M(27K% #WGN\GYT#S@_-6$]BQHI6SP_(+O!N6TC8QNE6!'#>"ET@)54W"H;+Y
M"T;4=D_NPJ3^;@0$LJ>!KLO*T6K1H):^U*S;)%VS"G#$+WY>VF4GY*Y'"Y'G
MT3^VW 8RH4QG=X#GI_ J)J#[J\?_ "</\!J"IH% H% H% H% H% H% H% H%
M H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
M H%!RS[/J$N-/2-+0W&WEYMJUO97>;-,E+R:HIJF">J[L;#K*-E7,+/_ &0G
MF*/>MG#Q /GA^$.0ZF4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4'*SM,8 )T/;3V0RT_+]9W+NY(H>TIZD*A@\*6X$JYG'(
MF*)>GUGH'T>-!U3H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MVLK*+242([L2D_1N9%//;*GG)I%BTDN/%L[X""4)DO*(8H&\3E'T#\[@,O\
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M]/GPTV@M/]J8N[G:RUPUM;>=&Q7=<8J0\@<+R," Z;9'-EI!% MM123D,I%
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MNBSXYX-D=MZOO!@QY.:^@BD1L_)&25M?9355LX]LIE]02$/G(R!34T#'P?\
MZ6;/*4# )1'J#YHY[[7G<.;V@"GKEEQQH3-[%C071(K;8D=,2=W1+$R;!2&1
MQ-M4E)[J<U/=RHJJKW'))2JZUDW3UB)1)A& "6R $WV=VEY82]%MRM?5)^P4
MP)LV@V31]I&?BP0P78VM789?<;K,$N.+FVU8P6LU3N6F@+B@3".X>GQN^87.
M"?-+U!C^R&AW=AVWL)+IG'8/2-6LPVY&-(L4ZBH442$&HLT/=M+3@!;5=I5A
M\E=\O*J+:;:H2VD(R3E@D^96BYY^1+0<ME?[L_M.J'6HN^)NI*)'4_2"UIFE
MZ;6+'SO;$W:G.5F.YWK988T9PS73E;,%JR4Z/5!@Y^9:,4Q!'IX$#F#HYV0N
MS7,G;1EZ>WQ*;MC[-;;KA^%8/8S>C9T/-R8;G/&@*BLY)>7\=Q-]ID:=QR+"
MQPGHH>>G2B'N%\S,' "'TI4"@4"@Y6]G1.44;1C 3%O"4$M3QMFM^PR\11M^
MPJ)1#>[8T0,8H"7CGT<_AH.J5 H% H% H% H% H% H% H% H% H% H% H% H
M% H% H% H% H% H% H% H%!R6[29+1HMVYR,"YGA@9'<][D(8Z7E^5YI<&ZG
M;62(E+ 6\G$PDT"E6'#9NJ7283B 7. -Z1$.M- H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MD!A?VAL#_B10/RM^Z=]D!A?VAL#_ (D4#\K?NG?9 87]H; _XD4#\K?NG?9
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ME6Q+8<R1=$R9FB'J;A/G@)BFY$-IM.:^^.[5(R'B0_VH\)=2%,R+)#=+L1L
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M4&.+;=0')A>6N1(3E],]KPLT,-:P4Y2P S<(Y#8UX,?+MW"#>*<H<"("("/
M#P(A09'0*!0*!0*!0*!0*!0*!0*!06)51T=;P,A+64S 54[*+SDX6<GD4,"[
MX!R V[A!(;_=#PH+[0*!0*!0*!0*#G]VR7*INS32.552QL/&R,1YSZU"$P@S
MPM>6,?8V56:CW;9LTH7@ZDI$ PB(CXB' \> !T!H% H% H% H% H% H% H%
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MORB%!T>H% H% H% H% H% H% H% H% H% H% H% H%! +837S=R1Y$%R0)W
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MR6A97=$WJ=&,^\1L8#><2Z758SVC/#2S!YO?:2S;UC.C^:.,  #W#I9>G@/
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MQ7(@]R'9-45DG@HF]IPK3O>;E;YS\_YSA'YX&@_%GM"1TH#@^P;P]U5OA8,
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M+.;KY%&NC@8C!;*9@M]1D!AD:#E=LDL>.#.$&NAG<(X>"F+1@32FZRE,!Z#
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MAU]I-LN^L%CDO5-SUI'SK2NMG;R7A8!/7]#P<AF_;1V(L' 3"7!5CV;HB3@
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MQJB;HM%GZ:-R)V38<ZF@;(X#4B-E,QIX2>J76(OJ@R("4DXZ'8%7QSIHW!O
M'6 %#]<%!O-/UDU$=R:9RIFO6N[A2I P$Q<R%?#BJ.U!/=J?GFQ%=*5;F;[N
M>K7[1P*7+MG,)@, ]7B(AR%\S=5=8<_'3+"CK?!6=CH.#[$D8BC#L>J94I/
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ME&?XLT#\CC3_ /JLZW_S)1G^+- _(XT__JLZW_S)1G^+- _(XT__ *K.M_\
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M\T4/#_R=(:B2EMM)( %''#IPD@MLA>"#Z>GG\/C055_!;J6"NMY&&AI?M&$
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MXEANP+E Z;73,CA;;N%G+*3'A@(4SE.EN_A/,! XZ_#GI\:"<- H% H% H%
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MF4&7CEUUC_ .;_&]N32W$E5,(\>CUUL0X_\ GH.L% H% H% H% H% H% H%
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M&"/=-:J^SG<DO1)3W SU-OK&"[T!13@4\!5;F<E'*L)"JDY AZPJBEF$HD.
M //!OU0^.*/MK=5$YE(<D(783@5UH'O$X6.V'LUD76Z(W2T7(F-.*7Q=3Y#;
MBHS"MN!V%'SYG5N-!Q+]QU#T. #*/L!@Z2 &?2U+VAL,H]M:DOL2:)([JRYF
M:VOB4T"N+5AU.25YNEJ'RRI'Q85]T8960>\6.XCE:Z<#P4_(3%,X^13A*4Q1
M#!&UM=VPE&6&?#&1V8NV^CN5_P BRC&F,ZT]RZWW(CBUQP\\)(:2T.RSP5M=
M&V,)&?R1&RNHLOE-6A<H< 0 $1, :M4=W=* A@'^G=A;1.,T%6459W84;S0J
MP,V9,E1L1J\6W%KO5HX80:[="P 2G(WD#;Y41,'/FGE@8%!A[9VOU)3HP9KB
M=O:E[1CV??OG\&'A%S!BI#39+=4ORZ9>>.JY(681HI<JRY(@N,]XL1&=2PH!
MYN#H7A_: #P-!WTU![?.G4G*NTR9.?;M[=^,:,ME51A1OC1QK5&ZFVDIC_!^
M*7&"!<=;BAF/O?QPMI^.19Q3*7E!>.. \1H)QY_:R[9ZED8F2H]OS3+-R<-.
M34W%RLS6N'C"3!3?VNDX?4+-XZ;8#P <<A^K07YB]MKM[QHY,5[1QH[J4R'/
MAVU##Q7&TM?HG15<F I" Y8%4\%L6LCHN&+\X.KQ#PXXYH-JQ#J?K!K]GY*K
M!.OT,0ZIY."HHN1F1A&;08>;=2E15.X\Q).9LIB3ZRQ<6+GM728!#D 'Y &@
MD;0*!0< NR<R$Y3:'=R2W7B)CC;,@=YGN'GRT7.3SYZ>J-SSIF-%22%DRH4R
M6K6CBG&*;PZ3%Y 0$.0H.N[OUEUX?;59S&>T&Q2^&=&*<9$830=; :;C;[';
M^8TSL:\C--'54\R6W[ LJYY3T6P*4$WYGB4>!#4=SMQZ 9"%'[:S-*M6<IMQ
M3GJRC&#</ <;^4L!2<:N#A<64ST<6Z-AN'6%K'#+/ZGIY/\ J>%!L!9TWU4<
M62P\UQ:UP6X;L9/)]OV. 7HN9ZQ[A/>3%NXY'X[F@7+;UT6XXWRX3AG*N99
MMV[=#YPCZ0#561VN^VQDV5FQEZ#::Y.,XE,%QP$-K7#@%5E00SQ,I*?#/*%Z
MY](G$!](=0_)0371D1,0$A+143"PDM$2\).P$E*P;88*>FIZ>4A</%P\4A1*
M0A2% H!P'@4 &@R"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@LZ@GIRV
MG92<HXN(I):EB#B9>)E@&;@J&#FAT&MW"GZBW+=PIA^00$!_P" 8Q>C6/[]C
M&Q<ED-'+QTU!.U4O&RFVD7036UE%M6S-_&YQA"TAB%L &P7@G@/I\:#5>O6L
MT4:PMEV-:*D5;QK#VD1VRJ[U9V.QTOUSN9]O/("XLK2^[WGFK#C53B%HF#C=
M5P0MX%H@  CR80DG0*!0*!0*!0*!0*!04.1CV<JR?'R"!DV,D.C(QS\&*)3
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M./ !^I04:5]XT?.796_-^RUW7TC(PD;V]#Q,;7M=5S+:Z51PK/DUPQ$VR*.
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M<IRBI<$X_ '/Z@!DJ=]XCNY%X 5.T5W=4S$*@)B@&7;U#=F:7WCRTX+BHVA
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MMBHP-K2K9J%?]8!@N+5E6SQ-F" B3J,-!UHH%!\N'WA=0EDCATMBW5K<C9:
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MG;37F;'@[59X1M+,U[ V]0E/:=L[!/J2'[*9VNT4:2Y%,CL<ZDIH_'2!>.!
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M[J6VUN5OY(2XT\-JR0=O!L=W4#/=6MN14,WV^\(KC<5:RY'<?UA@ !:B;=$
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M/V8-EI>V68;+\O(W<^3^M)MF#/'A',( &Z>T[VX-<D':3<K46,3)^R&CNO\
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M;0]0<_+T@'%J:V[#>\FWVPC?1<) CW174523'7W,WBB1<@6R;VS<PTBT]FU
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M#2GOTMQ"26ZE]WW7;&2F^GI2(DX_U>3*,!4Y+2B81 .8'J4>K@A>/#CDOR>
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M]ZZ"I2NUSW'4A72ENWWV-HU7(3,]-S3X"]K;KFJHZD&"8#>K4TJ\EE"\0X>
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M7)?;?8.KIZ^CKZ^GK_W.?]^@NE H% H% H% H% H% H% H% H% H% H% H%
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MW=BLZIL-[8^5W+\>05Z0G_GSS&J&U=;U2<4C95/C=-+'#1A96PN6PV^WRL[
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MJJVM7FGJ@1[1;K:=G.:7G \EC:-8]_RJY$5 9O3:Y]OYZA$)$*NA_?0GQ64
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M1_34VT1Z)5TS20)7(LYMY6)DJ7K#'LI?2 @!@H.QU H% H% H% H% H% H%
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MB^^8505%UW,Y9CEP8)Q3&@"\:&F>9W7<*Z2T8!4N@MOI Q1$>>D/IVH% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M.HW%D4=CN_-E8[ACPMW,NC<$4(^*81 .1$.KK#?>N.I\$:G-)59<",8[10W
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ME$0,41 >/ 1*<0_P"/X:#RH% H/$2%$1$2E$1\!$0#D>/1SX>-!Y4"@4"@_
M*4"](% "\=/2 !T](!P!>/1P ?)0?M H/'I+R!NDO44!*4W <E*;I$Q0'T@!
MND.0^7@* !" )C 4H&.("<P% !,(!T@)AXY,(%\/'Y*#RH% H% H% H% H%
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, H% H% H% H%!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>s118023_ex3-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 s118023_ex3-1img02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#" )8 P$1  (1 0,1 ?_$ *L  0 ! P4! 0
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M0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
MZ!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H
M'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
M Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#
MH'0.@T]Q?VA_:'[?;_M^G]?0:@(#Z@/?^K^CT'_9Z!T&G</VA]>WU_']G]?0
M:] Z!T&G</VA_;^SZ]!KT'$DN@N"@H+)+ DJH@J*2A% 372-[545!((^Q5(W
MH8H]A*/UZ#EZ!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H
M'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
M Z!T#H'0==TFLLU<HMG'VCA5NLF@Z^(B_P!LL=,Q4G'P*=DUOA.(&]AORF[=
MA].@^6C A\LW&GE'S,Y+\U-XT:Q\/:%E^O[%6&3_ #_&ZG3=&)QG@[)F=88:
M/&1,E8G.&2&KQ2K*W1*=/!8DZT8IN)0&;HAFYPLS>#SXJ'BVA_/ZCSOY$VCE
M+(U^H<C;?QL<V2-/PSDN.\IH#&)4Q!IB;.)81\;^AT26&04F4EROQ?E5[CW[
M*]!=K]G(^6'R)\T\WW/FCR:XE8MPWS?C/)8IA_'C9/\ +W+6F#VS+(K4K-O5
M]N16SI[;6L+..OTA'V I'M0*4/E ?^4"RVB^1WECR$XB<).#\#RIL(:KR5\G
MF]\%+7S:J#IJ;3+OQ?X_6!M-2&BTB?8MFB4/>+Y3;)%QJ,R1 5P2*9R!B'6[
ME#()2J]R9\;_ ).TN%F#[EL7(G$.7O!7<]BP//.4FI3>DRF><KL&9HHMT@UB
MW)R,]#4&[INV/WQ"IN$T'#KWBV$J9#]!CEYQ\=;[XX^'>3\HKUSXY(O//'H]
MLS&8AZ-#\FIVXQ>Y7:Y:;&-K9B%?X[LA&IS6$U.$F73=,S6(19).VQ?\?VK)
MMC!?A5,>M/F<Y^<^8G>^0'(O*L/X'*Y)QSRW&>/^LW+(X6)Y)2V=-K5K.RS,
MW4Y**>VN?HV@$<Q\*FL!VBK1LW6,(IF$A@][@IY7M=RGQ.3]WY&L[+R-YDXS
MRLU?Q\Y50"-$V.F\J-THME;U_+JR5G$(RCIQ.K0LD@>PR94%%2-8QT]<>\1^
M50*3\(RG+BVR7G&P#>-;M%IY"U#E*5PMI5.M3NO2$)HEYS9Z=Q7,PE;S%7^(
MIU3K$A7FS2$<'BW;<C0?F,U.42D*%[/A5X*<ZN',7NZG-O;[%J$Y?K>6^5"*
MC-$AY[.FDEK)D-+UQ9U3VE*@73;1*YJ$I(QJL^:17:S4=[#-6+%$I4Q#/$4.
MP  _@';T^G^C]G0:] Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@
M= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T
M#H'0.@= Z!T&@AW 0_:';^WH(4Y#8[ ;W@FS89:%@3KNQ9?>LQF'"B0J@T97
MBMR=<6D!204;'4,Q_42K>TIT^_Q?7H/D&2FN=MI\7+#P(M_'YR4KG)-JUA>'
M-DY.R%",?A;&X?$7IJ20Y"M]@*\(C)M7N=-P5+&(('<"[7_*H90!1 +G?(7@
MF90.ZM6/-7P]Z#Y"<HJ^,Y7F'$G>>'E;N$MJ\^_JL U96G)N6<9 :93#UR!-
M96(/XB3<HO80C1P<A@$_N(4("C/$CR[XR<%^#?(O&./U9L',/BOSYT;GM8>'
M%6F(5I"QN=[W(G;6KCO0)M1ZVC6LSG]$AX%J@1)5RF#MJO\  *WL3*8+VJI%
M\YN87-6V^34O#O6.-[+B#P7UO'.'G'_D!)5"#T[=>2^J,'\U9)69BV%B?0E8
MH43(QK2&0</'*19,/A=$]A .1(++N!]1YE<,9:?Y/<MO";RDY9\^M&F'CW0>
M6[;>>.VR6YPX?23ARU@LQI+^8B$L&SN%:*I-6K*)*HH"1!!5<4BD(F%W#V+Y
MM^,?G9S1W[C[X^-)YAX9Y'8C.=T3KN3W"G1]]PKDU5ZP$-<:;IHSKY)DG2[;
M*3BC[[YF=T5)4JWP^\I3)D#L<:_ 5&Z;Q1PPW.'2MXS/EE#<@N2O,:U3_%;:
M7&>+T_8>5LS%N;5$I3:$78&3V5K%3A646#^,3:>P?NP2.*2X^X*F\3?ATNW"
M3G[SQW6Z:3R<LU$E[Y6"<<;#H?( UVCMKIMESTR-VLNU5YBM]Q=+]2K$O^FQ
M<G,HMW*""('1((&$>@^E4 [=_KZCW]1$?[/V=!KT#H'0.@= Z!T#H'0.@= Z
M!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'
M0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@#Z@(>H=_Q#Z_Z/Z>@L1\C/.B
MG^.OBCHG*&\T#0='B*6S51:UN@UV:F3.)U:+?O(0EMFHF,ED:%3)"29ILG4^
M]1,QCUG*7R=Q.4HA:=:_-+@D;PRQWECGN9:_J<OR3OL)C_%["8>IR=:OW(?7
M)UFV52B<T&WL(C[_ #UD^%RFM:E&A(_XV:BR93 ) ,'0XX>8FOVBP\F,JYL<
M>;GP'Y#<5\2D.36CY5=[I7-1BYSCQ&M%W3W3\[T&H(1\7;&<>HW^U?-4FY%6
M[OLF F,!Q(%M5%\X>\,H[CUR%Y/>.JU\</'[RCOM4I&4\GYC;:A8[?44=.?.
MVF07+9<99P325I5/T)--NM]X5\HDQ0>)KB<Y3D P3/R$\M&]L^16_<?^!G!V
M9YI*<+(:O6/F'=WFO5S(*]5'EA@WEF;9+DQIJ(EE])U4:NV.\.D0$VZ*J1FP
MD.L8!*'DW#SG4ZW\7>$6L\.L)MG(W>_(?.6BE\=>/;RS5ZD!!73,$DE=HC]C
MOB[F0BJ>QR@H*_>*().#NNQ%"%(B?Y"A+?!SR8Z_L/+35/'_ ,T.,43Q4Y<Y
MKDE7W2&BZGKK39,YUK,K%,.H=_8Z38F4%#N(DU<?*-4'#5V918ZJBP%]I4#=
MPS)$3)[2B)2B8 '\P 'XB'?MV_W(]OI^SH-X$*';L4 [?3L'T^OT_9_>'H-W
M0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0:"/8._;O\ V?\ ?$ Z#9\I.X!W
M[=_[HB'H;Z  E'Z#W$>P?MZ#052E^H& /3U'L']X0*7\HF _83#V^G0:@H @
M ^TX=S>WL)![]_Z0_P![_3].@W%.4_J4>X?M]/VB'[>_U*/0;N@= Z!T#H'0
M.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z
M!T#H'01CKN,Y5O=+6SK9L_JFG45Q-UBQN:E=(AO.0#F:IMAC;569%Q&NRG;K
MN86P1+=VA[RF*59$HB AW 0^?OR,9;B''[R'> !HE3JIE7'>I\H>4D/&-(AN
MA6L^KNO:3E,C.9G'(,6 H-(J2M.I.#.FA/85L9U\A1[%$W06_P#DHSS(>1?F
M&U^GZAH;JM\?<K\%V]Q/,&P51F^G9'/:K=],LLO6PF8^$%:2"?C4OM[,P8D1
M7<NB1Y2@E[%P'H,6'-RF^1VW^,O@KQ8O/)'Q_P"P\8+MMO"[+N*ECQ=/1AY(
M\IJ8^EH5AD$S(T^P-8^&H:- I8-'<ZDU*LY'L*:RJ0D$%@S.^'G6:AQWV'ST
M5KD/H%(KVHYIS_TS:[BVLDO&59=7"Y>@PILNMH'E6S!=2IR$/$';H*@FJDB=
M0 ]3KE%4,>O!+FW"<#_&=P1<(<?\ST?FIS?Y"\P=$X.U/3[-5*'6,BS;4=%E
M)&>U:ZZ/:/A>9OEXUA%HJY3BTT'4XV4123+W,<P!F>\;/%6NM.3VB\W^3O-W
M#^97D7TW+T\UE6V!6NF,<=Q7"X>=0D6M#RW/H-ZI:7D,#_[<[Z;F@574<&[]
MB'.JJX#+>WY4<:U,=L/(!/>LE5PRH/)N/M.P%O\ 6C9O7GU<G1K4\SF+B,F,
M''N(:P_\Q<$57*9)UV2$/=Z=!5-CW;&:A(Y5$VC4*-7Y+<Y5*"QIG,66*CE=
M1FUXD9Y&(HGW3E(EFE%H,!=D;M!55.W 5"E$OKT$K%,!N_M]>QA*(_TAZ"'K
M^P>@W= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@PL>5;SH\-?%9774+H,X.K<
MCI&+*]IW&[/9%DO<G7W8*!'2M\E# YC\VJJXE WW3TJCQP0>[1HY'T /@7Y@
M_P TKY8.3$S.56E:16^'E!DYI!NTK>,0J\1<8)HDN<A$)S5; G(7A9X4BG9X
M=K^EHK 0!*V(7ZA@PN',3EQ=YEQ,7+E-R$MLN)19FEIG9]%E'*K5%0_QI$<.
M["<_V@&[F(3L!2AV[ ';H*\H7D8Y]9A)U^7S_F?R;JSRJMS-:_\ 8;7H2C&,
M:>]58[1*+=3KJ-.T.HJ<3)'1.F;W" AV'H/IB\??\XARRQ,L)1^=- C^5E)&
M6 )#4Z\2*S_:X>(<F22%'[&.C&-!N8Q!@44235;Q[ER'^&=V C\A0^_'A7S\
MXL>0?*V>O\4]7@=(K9D(_P#>&&3,,?=J#*R*"RJ5>T*I.3!+529(=JL4"K$,
MBX^,3MU5DNR@A>?T#H(?WS;Z5QNQ'8.0.DFDT\_Q#-;QJUT-",?U6:&K9_77
MMFG?TF-^9L#Z3/'L3@@B*B8**B4HF+W[@&+RC^=3B#;^/_)W>IJE\B<L7XDU
MG.K7K6+:IE["M;4,5LAE"8Z%1@FMOE:G:7NH*$ D4BA- <5%"E6^(>X 'D['
MYX>*N3P&;W6)RKDSLN=:#Q1KG-&3T;&Z#2+#6,JP.Q6T:2:T:@E/Z;6)Z,>P
M-@(HC(,HYE)N$3I'(4%#AV$/=SSSE<3-(YC1W#*(H^^,K5/[+<\#JNI2%/IB
MF4V;3J346UYD(AF2*T62U6)CW=9=%61D).K,H\IP,199(0[B%+3'G[X3LL;Y
M'[9 P>XWBO\ &7DK3>+5R@*K1JX6S6.]:#89"JTJRT,+'>J_79_/[--Q;I-M
M(*2#93VMC&%'VF*(AY,S_,(<)JIQS4Y'WNK[_0XF,Y42/$"U9S8,^K*NDU'4
MZ_$DLMQE9-"$T&8I,GG]#JBJ<C,RT7-ORLD52$,3[@Y4.@ODYI>2/B[P#@\P
MM7)&WNZS3M:/>VM3M\4P1FX9W+47/WFBIP296SXCZ0G+S&,195]LR2='D9-=
M% /:"GO )F)R5K,%Q??\K-=JUXP6D0&5RNP7:K:G%1*&A9W58>#=6%\TN$#4
MIVTL$+*VBFP**1[5ZZ635." C\O<H!BHM7G*:T3C[(\A;_P8Y-9C5I>8PA7&
MW&KR.:9[4=@SSD5./H3/KTCJ<O9CYQG4BA]B5U+5VQ2#"9BF3MNNNF"2@G*'
M=F_.#"-:_69.G<3M&U62;82CR6W!+-]IXWS]*PS(9B_2&?4IRZUT^EM<OTB]
M:')04BM"UZ#DU7[LC04ORKG*F(3C=/+Y@U4YUY=P$:U6XS.I[+QH7Y"9_/ :
M)B:Y*3#J#LMJJ>+J!*NV[@FC76L5-T[9)D%1$#&(D/<X]!:S+?S#&#H9LVU&
MN<?]EM59;8#B>MWB01=56%A\FT+>=CL&+5'"=3L<P_1@J99X:>ITP^G)5ZLC
M&1<8Q%901]Y2]!Z-D_F \0JU,Q:1DL/O;K3^1[*TQ6 XW :#E=GF]FTZ"WRJ
M8-$T3.[I7+%+9W-Q-F=6@+ C8E9)K%(P+550X_<>Q P5Y1_,RROGDXD_&HRQ
M"!K]NITBPKU^M=KWFK1T\G95LCB]@EF6;YPQK$I(:+%5Z(FT6CEY]]&_X[9T
M<$P(1/Y0SA] Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z"W3
ME+Q-X^\TLBFL+Y+YO$:AF<XNV?JP4JL_9.(R;CRK!$V6O340Z835<LL,=P<S
M1\R<(.$3&'L;L(AT$7\//'=Q*X)T>WT3COF)(5KHTDXE].LUPG9S1K[IK]P@
MJT^2_7>\/IRQ65LW8K&01;+KBU22,8"I@)SB8(FP#PW^,WB[M1N1&%<1LUH>
MPD=3;V+N#8UBF%*R\L2RRTJZIT/89R6@*<X5!PHDF>,:M3-T#BDD)$Q$O057
MRB\4GCQYI:1 :_R?XJYIK>E5V.;0[6WS3>6C9:2AV)SJ1T/:%:Y*0R=PBHQ0
MXBV;RI7B3?O[4RE+Z=!7&_>.G@MRG&@?YB.*N+:^GE5;6I^;-[I2XV29T>JK
MBP]U>K+(")-(F((6+;E302(4B14BE(!0[@(>9Q[\:' 3B?=I#2.-G$S%L4O<
MK7)*H2-IS^H-(*7>5B7<,'<G!KN$!'WQSUS&-SG3[=A,D';MZ]PKACP:XB1G
M'BQ<2X_CYFK3C7;74P]LN+(P*9:)-/9^PDM<R[?Q/O$%G$C9$RO5#>[N*X ;
MZAT$@6KCCAEW=8N]MN85*?=\=; PM>&N)&,374R^R1<$K68^9J0]P_3GK2 6
M,T(;\P%1] #N #T$U%(4OT_TB(B(CZB/<?VCW'_3T&[H'0.@= Z!T#H'0.@=
M Z!T#H'0.@=!H8P%#N(]@[]O](_0/3H/G3_F'/-"AXK,"@*=DAX.;Y;[^SEV
M&9Q4H59VUSJFMDUH^>V&98MG;=152*?N"-X-!3ND\DRF,<JB+9<@A^3U?;[=
M-8M=MTK3;[8K[H5KEPEK'9;E+RUBM5MDGIEP=RLE.R"KE9==NFF0O^,KZ$$I
M2?E  Z#VJYG&AZ97KM=(>MS<U%Y_"I2]CG6[!@A!1T1'?"W=A(2(J,TE9,@/
M6WL01(X=./F$YP  ]PAD"X_^)KDSR>D-*A<KAX1__"1G!-'D\F=9K#6*=FQ8
MO'(R<G+R)&56BH5D_%%24??8,#J(D*7N85# &29;^5:Y\-<3;:6>Y80A>91X
MTB Q>UV]W7;5#?J<@=.%L)[%#HV.DJ1,LU9F*U5>OVK=R+I$B9U%CIIB'SQ[
MG@NO<;;W)Y9NE N&7:7!JNT9^DW>N3%:FF!47:K5!\1.59-4):)E!1.HU>,S
MKM5T@ Q#CWZ"XCQU^0+<O&WR:HG)#%)MZ P4LP3O^?J2D@UJ>KT7YC)3=)M\
M>R=-TWC5VP<*"T6.4ZC)U[%TA 2B A^R9P>YG8IS_P"-N><H\!GEIB@: Q7]
M[%\B#:<JEEBU"M+)3+(T 3 TGZW)^]%<"B*:I?8JF)DCD,(7<=!;5S!Q:O\
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MH3EXT*&U76<^>;)4QR/9;[%4J$SP\YIE,9Y@Q<SRTI7ZZU,]^%^V!59,IB@
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M=R[18'2<@T;N%&!0^Y"/63<,VZZ(N#)KHI+D,[;JM'1RKID6*9PT70:KM%S
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M/']*MKBD7SF$^X\H4[!Y&,FGNJ:+QTJ1IG4H30K(LDLXB,XR%*>5B5XZ!=.
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M M7ON\ZW<H!T@PB6U&-<)QO3@8M6K".CH>-HD.X95=HS0;,4$DFS=BFF4$2
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M;,>S2Y<NA4&\<NP75>.3*$%HH9R9/H+[.'W(WC1R2Q:$MO%K1Z_H.953_P"
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M.@= Z!T#H'0;3]O8?O\ 3VF[^G?T[#W]/Q_JZ#YU/YB"55BJ?XL%4WS#Y?\
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M*J"#%= JDHY,FT!1TBF!A,?L 7=^X/=[>P]_7U[#V]  ?K]/]UT&[H'0.@=
MZ#';Y7__ (P'?_\ YWS;_P"K'GG09$N@= Z!T#H'0.@T'Z#_ %#_ +70?-9_
M,Y__ !M?C][")3?ZVGAY[3!V[D-]KJ'8P (" B']/IT'TI%#M[OZ3"(B/U]0
M#_:#T#^@.@W= Z!T#H/-E';6.9NI-^L#=A',W3UXX]JAQ;MFJ)EW*_L3(H<0
M2;)G'\I1./;L'J/;H/D2N_E?YXW/4<.1RB_66'C-LX77/F/E.<Y#P0L/*=2]
MRMRY%:7G.$Y!IZM>G&5CS*IML_@(,DA9C2$6BK-/E_>L4GQIB%[$!Y(N6CSC
M!SPN^L-LMR#;>+_(+ACC\?6V4?[V]=D-HS;AO<=8ITJG,3LRC8+%^].S6:(A
MEDP() (W(4BBJ)CG"U/$/(QY%)'EIEE%M>K/)*(T/6.<L%.4S8.+>=8[Q0:Y
M1Q8F=FA7-NR7EM#7(+QH4O7GM7KX+1QH@[C[8)5=X1)% JO0=2E>37GK05<&
MHVV:/*DUG3M,X/6.Y1MXP;$VF6R&'Z;R6I&7;]HW&C?,:N=CS30>/BM>TR,:
M,Y2<!C:F#APQ=%%4BSH4@G[R$>5SD+QOL_.3-,_EZ=7[G4=OXL8UQ1FI')[A
MH[:*=77!'&][Q,W&LTEI.3MT8PT/%IMS'1;IA$C-M#J" #W$(7L_G6V=U;KO
MKM48THG"E'QSX3J4Y=485=W9N-/+#D&TY 0U(D=":.D574KF<3LV,GI%A;N4
MDPAI-RU66$$#+& +]<*TKEQL?*SCC%M>:$D7%-?X6TCFJ^H+' \4 RR;JWYO
M7GV8M+4M6QM+*H2[.UN3B\%091JH(%37*!0#H)DWQQRX@.<.5T.E\P+'7<BT
MS+=VVPV5M<*Q*?<12''N3X^1O\.HBXS=?<6QY&Z$CI$F9V\55/(-%?B^V4(!
M>@L<X^<KN7$ CXS.3]WY;1/)*I^2_8X#,+]QCA<^H<)3\%+?LKU+1F3_ !RP
M5^!C=*(&!R^?E@+4%B5>A('%8ZWVC@"AT$$\I_*ORRXW:[Y+7EOGHY+C+1=[
MRGC[@=VJ583>3.!;!$5'"]$?5*_JE8S1G=4Y&4NYSR+&450<*1MBC@9E(D#Y
ML)0A3)O(#Y IKE93Y>;WO88&@Z1SPY]8K74]FH''> X$.,IXYNMHAZQ3*W=*
MG$CR.?;+'C3&)FD2X004E%8F150.[+V)T&1;Q4<I>2EKY!I8YRTVV[WBX:EQ
M6B]_HL1(,\.T+#=3&NW*,KUVW?B1N^!QU3^'#Y<MVC6Y:5=H)O8XOY&BQ7*Y
MA=$(%G6Y[[S[P1[S:N%"YO;MOM)H')'CCP/QZD2>9<>8BX6;D1M.BYW;-G+E
M]D2H<74X.1S7*+DA5ZVZLQG<>2;.\5>^Y1%L!@OHX_<H-;VCQ:4"5T'DQ/Y5
MRE>:SH&$6B9<O\'AMQMF@43>]%SB%PR%M,FP5P*L;#?VU7:UP+:VC'T A*&7
M<-6ZIA)[0Q-T3RI\U'-HXE/+EN-M5KF,4?C,TYG-Z]$XW$1"5QO'/.Z<<= :
MWF/M4 \M/)0]CSZNDAFDIE3ABS0GF+B9( M5P2*&4KQ.<J=]T#8=*H_+G;VN
ME7ZS8Y8.3%)?9=M&+Z=Q=A,/D-VN%*CDX]K4LKH=\S._TE./:QRA)*=LL1*1
MZ*[E!TDX0<(IACLE?*=S$O6><W7MDMNRX+5^6-'L^C^.35[)E$958+(*A0-P
MKN6/BY[<B#\&N.+;C%X@M!1<BH82"H^;I&(F0BAPKF_<S>3M[V2Q<9^1.X:I
MQ.MF;:!XW.//("Q97=F&?Q=?F;=H7+%S>=QHVE3E;4@X*G<G\]I57DVJ[@JO
MVR2P0ZA@=MU.@R0<2]'GM2X4<]:E>N5NYW/$N.^Q;KF.4<[Z#<*?_F'NV*Y/
M4*O<+/:XB\Q51-5++>\VMAYVK!9$8D[2;_2_D(F)O<<0P \H-[\B''3B=P\G
MHKG'OY+1I/''DMSSO,GL^Y4^G3U?S]&_8^[P^J5VQJTN/?<A]!K6-3_VJN7I
M$9H2L_(N7IG!$C-VY S5>6'E:,=E=/T;CMS&L^=Z54:8]TN&RRJ:%5LZ1LK2
MIWJCLM+EI*N358EE=SUVB-'P5Y'%EY:,6?R<T +D(NFD?H,95EYI\S(74K^B
MSW7434V_2^RH\J=9K>ST&T5+ L;:<N\"S>DZ?D&"1,:[U3B7;\SQ6SOZ_/)V
MAI'F;282$FLB^-& \ ,A?!_E#MI.1V TZ1U*^;/D-XY6>2?B5FUMM-K:WY78
M<"PUC7=AQWD(I:TGC5G<W](L+2:I:ME:D7(_CE$2*>]8A%3A])G0.@= Z!T&
MTWT#_P!V)_\ -EZ#YY]8L$=#?S._%B,>,G#EY;O$YJ\'#.D%3$2C7K#>;'9G
M*[U(%2%5;+QL(JD7T,8JIR=@#U$ ^A=/O["]P[?E#T[]Q /P 1_$0#Z]!OZ!
MT&.["?\ _H_Y!/\ _$G![_\ A?('H,B/0.@= Z!T#H'0.@= Z"&^1>5#NG'_
M '#%"S+JNGUW(M&S,D^S</FCF$4O-0EZRG*I.(U5!^F9@>3!4?A.500*( /K
MT&';@ZY\H518<,^&FC</LSR#$^*>:1^4<E>0EEOU4T>J;I5LXS F>YJIQ9J=
M2F6-K@)*^.F+>3F5;)'H$A&ORL014.?W=!3U\\?E[./FIH&<<<J8?)N2V.\6
MJ=Q[RUK:T\8SC5&V;8[8(>\YTPELY=1TMF\<_E'1HM5U\3-,5G?N,8R!CF +
M.*%XN.;VI8=K]/SY-7@]@D]O^,:]G_"/EG>K5S7AW]>R3)'T58J-<31.R-_T
M&@W;;DHZ;;P9+.[8/$81N+YJ+=4S10/!6XI^5BM^)3CYP,OW%FJ<@&%QP6S9
MO+HXOL"'''5N->BMEX=QB++39J;OEAI.DY9#/$W2MS49IO&4JB0C12(5;B(+
MAEJUJ \GO'W#9_5:!?(#E[J<+QGSK/J/PZA<6RZA5%]R=;PM3AK#L3[65[%7
M9<:)'SK:0E#0:8,FQ&YB(('2]I!(&*'$>-//VOY9QRY5O^"NF.>7W'[G98N1
MO*&C:UO6-3VK<RPU;CK.8]>-6S>RU]U#YGG:5#)/MHVKU!==!LP@HDC?Y%%@
M]ZH4'*>,SR(XSB%9J5*P*C[)9.2_CLY8<'M>@(77*M7"<:K]R0Y,:)R"J%XG
M['92H1]XSNG1FBKQDX>%;.'2C]@7[5%5%1(PA,^T>)SR)PO*[BUO5'U_ =:A
MZWRIX=K.&\KB]E_?3CU@O''&KS2&D+'723UV)CIS+&\S89:1?1L?#-I63M%B
M1DE#_"V%N0/JV2 0^H@(^H]_7N'N[#V # )BE$W<0 1'L';H.;H'0.@= Z#'
M;Y7_ /XP'?\ _P"=\V_^K'GG09$N@= Z!T#H'0.@T'U ?P]!]?V>G0?.=_,L
MQ4>^XM<)GSU^#9Q#>5#A6]BFPJ))C(OEYFZ13AN4A_SK"G&2*ZXE)^8 1]P_
ME >@^C O?N?_ -V]/K]/:7]H_MZ#=T#H'0.@XE0$0[  "'M-]>X@(_@4P?3V
MF_'^CH+4^.'$+*.,$8$508P'98=YI$=0I*:8Q1YK/LSTW1'>IR.,5Z;8L&LD
MMGD'=GRKF-0>*.%6R8D1^3XT4BE#O77A=Q3T?6XW=;Y@6:VW6XF2K4VUO$U7
M6[R26FZ8W=-*;+RK<X_IDY,4YN\4")=/4'"\:(@9N9,P%$ K20XVX),0-,K,
MKD-"?0.=:0YU^A1;FNL%&U/T][8YNVOKU7 ,E\D38Y"QV61=.'*)B'<'?+@I
M[B*G*(11#^/WA)"-M,CH[BUC2<?L5?6J6C,'5)BI&/L-2&2<RG[I QD4G;6&
MJI)=T=XE&L"-623KVK$2*J0ABA7F8<1^,V+R<7-Y=B.>TN=A'MRDHN?B8%O^
MOLY+0VE8CKM($G'7W,L9]9HZEQ39VJ98RBC9@BEW!,@%Z#E;\2N,+5MIS)O@
M.2)LMIB9:"UMD%$KQF6D0L[/V2U2\7=&AV)F]A8O[)<)1Z=-R50OW#]8X  G
M'H)!@<DS&K35=L5;H=7@IRHY\VR>KR<5$-&3JOYHR=,'K2C1!VZ9 85EL[BV
MRA&B8%2*9 G8/RAT'M/:-3Y*X5_07]<B'=WJD)9*W6K2NS24FH.!N#F!>6F)
MC'Q@%5HQGW57CE'1"" +&9(B;O["]@B.I\2>,%#V2R\A:5@.2U3<+A'!%6;4
MH"BU^*NDPP$# JBZFF;%)U[G@'$'"A1*HY ?\4Q^@DV2S#-9EE8XR8SVCRT=
M<99G/6YA*5.!D&=IG(XC!./F;&V=L%D9R68)Q;4J+AT559(K9("F $R=@Y1S
M?/!CD(?]PZ9^DM;*I<VL6%8A CVUP6?.)-:UMV0,?MD;*K).U7!GQ2@Z,NJ=
M03^XQA$*>HN%XIF$E*3.:Y'FF?2TV4I):2I5'K56>R"1",B%0=.82-8JJMNT
M<@84Q'XQ.D4XA[@[]!ZTIE.7S<#9:K+YS19.LW.5=3UOKSZIP+J%M$Z^6;N'
MDY88Q9@=E,S+EPS14.Z<$47,HD0PG]Q2B >(UP/#&4 A56F-98A66T,QKJ%?
M)0*K^C)P$9,C8XZ%+&FBA9_I;&Q",@D@)/B(_$7  "PB?H-I./\ @Z;BJNT\
M3R,CJBI-4*0Y)F]-*XIJ#&77GV*-56"&!2O),YYRH]2*S%$J;M0RQ0!0PF$/
M2K6,8]2S6(].RG-JD>WMS-+:>L4:L0!K0T.H\6.UL9HF+:#.-CJR+@QDW7RD
M,+A01#_$/W#TG^99O*QE<A93/J1)PU/311J,3(52">QE61;M2,&Z-<8N6"K6
M#2;L4BH)E:E2*1$H$  * !T'4MF191?23*=ZS#/+HG8F\,TL!+92JW8R3K6N
M.73RO-IDLQ&O"RC>!=OEU61%_>5JHL<R0%,<PB'JPE HE:J2- KE*J5?HC>.
M>1#>E0=<AXFI(1,@9<S^+1KC!FWATXY\9TJ*R (@DK\A_<4?</</.L^49;=V
M]<9W3-:#;VE.?-).HM;13J]8&U5DF!$$V,A6T):.=I03YDFV3*DJU!)1,J90
M*( 4.P:2F397-KQ#J:S2@2[FOVIW>H%Q*4ZNOUX.[OW NWUQAU7<<J>,M3UT
M855I% 2/%%!]QE!'UZ#>WRO,6DI=9MIG-$:S6E-4F.C3#:HP"$I?V*+1=@BS
MNT@E'E=VMHDQ<J(E3?G<$!)0Q #VF$!"C(_C[CT-?:!H4+G=9B9_*J/8\VS
M(:,:Q$1GE-MTE"/[5%TVOL"MX2!&>7KK,CM9LBBJ=JU31+^3W@8)PZ!T#H'0
M.@VF^@?^[$_^;+T'S;[X C_-*<$A["(%\8VVF,( (@4/X@Z8'N,(>@![A .X
M^G<0Z#Z2">A"A^PH!_5V#MV_T=!NZ!T%A6J\#Z]I6V7+=JWR*Y681=;_ %JC
MU"[M,*TJM56MV6-S@MC_ '2>2438\_MHEE&*-J>)BN@JF*A#E 0_+WZ"FO\
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M#_O1_P!G_P '0/</^]'_ &?_  = ]P_[T?\ 9_\ !T'5=R#-@E\\@Z:L&_N
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M$PO!)2D:I,-62<BYB"/6II9!@Y5%)L^6C"+'>H,55$S$*LH0A#G#L7OT'M=
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MT]!O*B0H^@"'T'OW >P@4" /<>X^[VAV[A]0Z#4$2 '8/=_=]@C[A$QB]A
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M\$.LVN@2IMVDH&6?V>PO!>,[FL#.1$P^YLL!&YS !4R 'U3] Z!T#H'0.@=
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MT#N'T[^O_<'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
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MC;F',##VFNS-*M])T'C38MMK&0WC0I-#.+<$S6"5Q[. DV;NA(Y66626,D5
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MU.Q/R&[![W[S5DLNM _O#!%GD&WW:\*,LP"619E2%?[I:-%Q]XFV*@/O]YB
M7V>O?MT'E#H^>%13<&OE,!NL_/%I+C:(,$59--))=2.35%][#OTT%R',B BH
M!#E$0["'06^1'-##['LLIAE/F+#=[Y5];/AV@MZI77LG#YGH0Y6ILS:/O$FH
M9L6-8/:20!3>HE=-2O1^U.<BW<H!-[+8LCD8Z<EX_4\X?Q-8LBU-LLHRN]9=
M1U>M[94J#BJSCU"3.VB;(W7.!#L7!DW1#" "0!'H.2KZ[E%XCJK+TK3L\M\3
M>U)=&D2E7NE;L$=<E:^FX6GDJJ]B9)VVL*D(BT5.\*T,L+8J1Q4]H%'L$A]
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MZE$!]/V_3Z]!O!0P_5(Y>Y1$._M^H=OR#V,( /\ 7Z#^WH-PG]>P$./J ?0
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M=MB+H(_.3W&*(@ F /Q#H.)31:$D+,JMSJB9Y$YDH\A['#%,]5*@=T*;7N]
M%S?:IF5'VB/9,HF^@=!SM+[27Y .RMM;=%%PHS 6\W&+!]VDX,U5; *3HX"N
MFY(*9B@/<IP$!]0Z"H74@R8E2,]=(-"KK$;HF<*IHE5<*=_8@0RAB@*QA >Q
M?J/X=!Y+>VUQVHBDSF8UZHNY2:%*Q>MGWM<K_-\*2@M%%@3%0&ZG83=@'V#Z
M]!YLUH5/KHJ?K<TC' B=XFJ*Z#P?8I'QK68>$,"3=00^"+>HK"/T$J@ '<W<
M #T*_;ZY:CR2=?E$I(T0JT0D@23<)_:K/F*$DT3/]PBB)C+,7)% ]O<  W8>
MP]PZ#FL-F@ZHP_5+#()QD?\ <M&?W2Q%E$_NGRQ6[1#VH)JJ^]98P 'Y>P?B
M(=!I'6B!EG2[*.D$W3EL]E(]=(I%B"F[A7"3.41$54R%$6;M<B9A#N G,';O
MT'O] Z!T#H'0.@= Z!T#H'0.@Z4@];1[8SIVJ"*)5$4_D$BB@ HNJ1!$/:D0
MY_S*J '?MV+]1] Z#RY11A&B>>E)3],8QS4Y7)GKY)E"-RJ+(JB^>'<G3:D7
M0^,"D4.H4H%.8/43>@>6P@&:[$AFUCGY!JY)+KMWXS0.3F1L1B+$48OD2_']
MO&E*'V I"/VX '83=![:<(FF]*]+(2XF*Y*X^W._4.T$"QI(W[<6YBB7[8WM
M^X,4.WN="*@B(CVZ#S5ZDFN#0!L%J3!HHF</BFU2"X!-\N^%-X84C&<I*_/\
M)RF'L9N0A/P[B'=-7R&!4 EIU,54WR8&))' 4BOGB;SNB D$I#LQ3^- W812
M2,)?7Z]!T!J*0II$&?M/=)U,.OD_63@HH672<(@T6,"/95E% Y$S),0[-U"%
M, B8O?H/#_AH@!BF"[:0'M747 O[XO1(/OAPB 1,4R8@=%/M]T4![C]Z(K"(
MB/;H-T)FZ<*LX6_??1I;[@R!A2G+8XDD$0;DCB%(W24;D*B53].[G[?F.*ZP
MB/Y_0/'N.914RA(NY70=)KD?]E/&<+P>A2M4:Q+.1]CEZZ1<1IV9&!8EJW$K
M98Y_^9I"<2B _F *3IE'S.X?HNKT#3K/=85_'/R15JJVL2%JK=HC5'SQ+X_U
M6.DY".L47"2)7!628+*(,5S+?&!3";H%-5RJO+7:&:[8ZM<AE[.'/HJ-HV4E
MGDLY1C8]2?9.+RDXE!<53[N+!5VNO(D0.[; )E3G2(44PJ/.G>7Z542VG*-0
M;WZH2]DDY5&WT/3RWR#>2K4"P\A&L["QF;!&@RC5V0$4CVZH-V[E,P_&4_N[
MA5UOH,?<*PK6'T[<XA(Z#9$LY4[;-5.THG;_ &X"Z;V*!<L9%)XX(A[55 -W
M.0YRC^4PAT%KNK1O&WC3G8V[>.2UOR>@1X3#)Q=]@Y2VJL,CKS:!U7B8V*V6
M]F+R0311,+5%-0RC4H&,W(0>X]!6''35N-/(&DN[CQLWNL[Q4"RK1O(VVA;.
MMI[1M,PJ*;9-B[EFEAE0BES$:]U4!! KKL)U"*"83"$YES^&20^$K^U'(4H%
M*4]OLQS 0&Y&HE]_ZG[SB*1/J83"!A$0$![" 1W QN/:%8[XA5-%=VBP5!ZW
MH^@1E5UV;D3TV<;1[14D#/0L-954*W9"L 36.5=%%YV4]_?\W?H.ZRX]T1@H
MBJC,ZJH=!H=D0SK:=8>=T5'1G9A4!S<5066!4P@"A^YRE[% 0    ]V/QZJ1
MKM%ZWD]!560$PIE?:CHLDW 3$$@F,T?V9RV4,!3#V$Q!$H^H=AZ!6,>J=2>.
M7T7)7YPLZ-)&5+.Z=H5E;@:62*BZ,BUL%EDF[?V$* H@0I0;F_,G[1]>@[QL
MNK8_:]GUQ+]HV@6B?LO=Q*)T:V4"QXN!_6N[A9;MW=JG]RKXPB9P94PB(AUW
M.0TUY(M)9Q^\ZD@R%B+=Q^^UP 2C'G,HV]R99L$5.QC#[O<4??\ [KOT'G_P
M-SL5P<&9V$YP7%R8JMWNBR2BHJBL85$5I\Z1BF,/82]O;V].W0>W/5>A1-=G
M'5@39QU<;(.9F>?RTTYCHU@S9QSIN^DY"3<OVZ<>P91:RQEE3JIIII@)S"'M
M P!C%S_R6^'W5=5#C;0.86!6C3K+8DZPTIL;HTX9.P62%*U9DAJ[:'CA"LRC
MY0[$J3=-A(+"^.4P)?*<QNX9,#Y)GKYJFBX@#G2"/-%@496?2.##NW#[<Q_U
M(CCWA]FGW.(_)W*/YNPCW#>ED&=H_%\=?$H(%B")?^5YTWM+!+J.(H.YI,1,
M+9941$1[BH'H?W%  Z#OL\UID>S(P:1!D6A!5,5+]0DS]C+*'55-[U'AU!$Q
MU!'Z^@>@=@#MT'*KG=.7(=-6' Y%  IBF>R E$@) @)! 7?82&2[@(#W[]Q[
M]!Y<?C^;1*#EM%U1C'(/$RI.DF:SY BY"%4( *%(Z !'VJF#O]?S#Z]!4<53
M*Q!_>C$P[5@:26<KOE4?D^9RH[.11R)UU#G6*"JB13"!3%["4!#MT%$Q6"X]
M"2*DM&Y_7D)%8(XJKL[47*JGZ0B\;1AC&='6[J,F\@N0AO[PE5-[A'H.97#,
MB67C'"E KIE8;](_2O\ F@@FP&!D2RT.=LB"@(IG82)"JD-[>_N ._< [=!4
MO\/:3[0)^[,0!0*4OM!HF "!!*8ON[!ZC[B (C]1$ []!PGS6A*N57BM2@E7
M:[>2:+.%8YL=55M,^S]60.8R8]TY'XR_*'^[[?L].@ZALFS0YE3&H];,9?\
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M0=7:N3Z,BLA&0T58V3V.2?/4TI!U,GA#,U',<D<C!R+ L>J8BJA3JI_*8"B
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MB)B>P0"F<.\Y^_T/)/);2+Q<L"\BFT\%L%I&_8YN/%%DJSS;D)2+I*L:L_\
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M:IQFUBFM(-*$O^DX9?JNUK+^78NF\5;K?1I6&:0;NPLA5CG3=E-216YWI/\
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MJ(^O0 3*';ZC_6(CW[@("(@/H(F[^H_CT&@I)_F[E*/N[>X1 .X@ @)2]_\
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M^G0<$?(<CU61SRU-QQO("[.0J$;?+@Z; T^)$$U5%W%(9'*M\PG!0I2#[2
ME$QA[=!6;%SJ9TC#)0E'07^50"$96&:<(? 'Q_"<QUH!!7YS&[]_R]@*'XCZ
M=!JT6TTS9F+V'IB+LS<IGJ;6<F3-TG'L#WIM3&B0.J0%!'U, =B=@#N/0:/'
M6F%;.#,8:G*O 12.W2=3DN@W,?\ -\H+'1B5E2& W?U !*8.WK]>P4\[D=U*
M]<I1]6RURR34,#19Q<;.W<'3#U3.X03JC@@"8H?@8>QOZN_05)[M),S(92(I
M8/E&?^.D2:F56Q'JA %0@*'AT%5VQ%?0IA]@^ST]H#T'D.U=F(O"%CHS-5F0
M1S@+&V?3-D0<DE/U!))H2OJ-HA=,8[]**HJI]T'R X]J91]G=3H.PFEL!VI/
ME)G+=Z>'>E6$B]H=M4ITB[<(P$RBFR67B%415.X$QDURF*4A $!$P!5[$ME3
M@4PDR1#FR%8J@N$:=XWA%GP(JBD"(/#JO6[8ZOM 1$3'#OW[]!Y\N2Z@V7-"
MA6 5^9A\*<T>5!NFV]P!+_(JR,H<50]QCMC 4H  %*< ]1 *8'^-'P/#-4<M
M%T5T8(P%G%M30%CW5*11\";90Y'7Q@G_ (:?=,>YA]W]WH-WP[.>)5]Y,P2G
M_P!%:_;J%&U.(@MB$I_O"J%]S-Z,&4P%^,0$' @)NX=^@\MLUY!G-%%D7F-F
M0]Z?ZZ#1A>"J&(#%;WA%BO)G+[AE/C,'S=^R'N#^]V'H._--=K]QE:VIE95!
ME4E$_P!=;6T?9$&>NP=$4"->@0TF,69 "&#LG]P!S& 2B4 #H2K/?_A9E@W.
M.%6*D;[P\LSNZI07+)IG1,T^UD2'%,L200,!Q_,Z_-_<[@(=)5KR6!@H#9]A
MWZD*LF*)EX^_F8%1%9$88%"$E?N%52(G6^Y[F]AC_'\8% ![A[+5IM_PF^]7
MRH7!59LR7VJ-Q^#XP33&KB;YWIU0516 _P"H=A]JY#![.P]^X>Y&IZ0+UR67
M5I!V)55OMR1[6?\ O"I*1Y2( HN\740,J$B4XF,!0 4!*'8!'N(>C)HW04 &
M.=5QLNFXC5#'=LI)TDNW3:*_JR!2)/&ZB"CAW[ ;J=S?$F!O<4XB =!1LG![
M<[,92*NN;Q*1G-:,5HYSZ?FA;,VX+_O>V!T6^P(/7#\XI#'*F32(V]AOE35]
MP>T.U2X396+#X;_=J#8Y0  WZC5J!,U-H)RS2BP)!&2-]M:@H#7!!N(BX 0>
M"*P![.Q.@]F>C+^J5R>"ME>AA$P&: _ICZ>^W3*8HG(N*%OA_OE3E$"@/9(?
M: ]B@(]P"G?T/9B"01TZC 4O<>Q<HEC]@(D8J@+'_BE[3?XO8WU+]!#^H.]&
MP^MDBVZ$U>:9)S!7/O7D8_.I&)8+LPC720()1+F_RITUOU<Z+CY!=B44$S)>
MWW&!7H.)W7=@54 S;0Z0DG]L@44ULPDG "]!% KMQ[D]+:=D57*9E$R"4QB
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M 2N41$@@4![]!WTZT8JCPXR]@'[N7-*B49E4"-@5:IM3QK'LF)VT,F!?E*V
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M_K-LDJQ/5R-MTC'PLPV;E5<&5E51$J7V F6#/ F @7U#L(CW-Z 'J)0$1'L
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M6KY--GK<[%_^HA(C]Z=5=%J=$)/>\%.!MBXW!@=)<<D<RSB[SN,LD9G/+5R
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MVF&,DEXF13*Y3]QQ[F$@F, =^@D$\)"F'\T(P/ZHI"3]/9*%3!(AB(B4/@,
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M-(HE1M$5S<O.ZPERM%DF)>.?T>LXIG$;H+U_5VT8BNSDIB2;.U"IIN_\(13
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MO$[=&O&GC73/%9%VV-IF8K5>+8FM&AZ)-U68B(JZZ58K4Z:/&\3+H.B-XWT
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MBK \O4U3D%G,K/0!VYX:Q3,,DK^[4]/1QF:/QO7S)=T;XB=S]RAV#(*4A2@
M%*4H%#VE H  %       /0   #_1T&[H'0.@=!XZ\M'-Y2.B5EP)(RHOU6*
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M'8!Z#BB<XH$$^@'\)0Z=#OJO )U6LR,95H./?UNKIE$$ZU /&C-)>'KZ)0[
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M$:R"8,V H$!N:3!'[TR $* >P3^WL';MT'K=@]?0/7Z^GU_#U_;Z= [ (=A
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MTHSHE2<&9O0CU@F*L N1>G8 "(VB'*Y1^Y( F 73<3) 7T]_O]H^@]!72?J
MCW$>YS_4HE$/S" !V'L/8H!VZ#?T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!
MT#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0
M.@= Z!T#H'0.@= Z"BY>52;7.FQ1HY%RM*-;4=.1.4HKQ98YM%JJ$0,(>XI7
MP."E/V^H%#H*TZ!T#H'0.@= Z!T#H'0.@=!&VM" 4AWW 1_\NTP/0IC?_CG
M>O8H"( '[?PZ"10.7\W;N/8W80#U'T_*/I]?02]!J!RF$0#OW#^@?]']7?\
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M8Z9%4S'32-[?8HH4#>XA%/>'M$0[#T'9 >X /80[@ ]A]!#O^ A^WH-IS@0
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M61M.Y\$-%Y!X=R8L2C$Y+=9GN!&=V$EPD:\J9FY;3EAHKEN;XE"(_.Z2/V[
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MEN4MJ*XL+^XJ0K^+-+3UR:S<3(E+!LCJG/&-#+F53/W3Z"W)[YV>5D;E\7Y
M97Q_QL=XH).VH03;9EMI9AR5-F\S>B4*N<DE,87@6Q&.7R$JJF<\6<YY<K8_
MW'O!  .8)=WWR\\J9_E?N_&+QV<6\3Y(.N*-4SJWZZ[UCD.PRNWZ<KH]';Z5
M$T[CK14V#^7MTG^Y<DU<A++^Z.,NI\!2BH=,#AFEPK5KGL&!YOK5AR.U8]>[
MUG</;9?$]%.6-N%#M,G$?>+T:SJ_"4K5_'R ? HJ*)1]A@.*11[E /G7V_\
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M5.FL3U_;V#!=S3Y@93D',W?L-\R?$V+UWAA:D,^N7 O:H[B:_P!ZKT0S3K!
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M .F<1#/KR7PG:YGS"^%WD/1,ZL,_DM,P[E3GVM3\?59)C'Y6A.YC7GE;>6]
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MOD$ [@(E]0 /QZ#E^7L4H 0_<H=S%(4![" =Q+V$IA P_L'L(] .H B'?Y2
M!?>(_&(%#N/M[")DQ ! 1_ 0$/Q[!T&TQ0]H"'T#U$?C.';Z% Q0$#%$2F#N
M =A#\?Z>@U,B(@'R=C%_NG[B/<Y1]GX!V#\P]_=W[_M[]^@% 1[J"3W&#N)#
M 3V>AC&]Q0^I@[AV_-Z_7N'IWZ!W$P]^WJ @(!V.)D_=W]Q.Q/>4#=@'\W?M
MZ_3MT&]18OM /S^XQP3+[/4P'$WM]0*;OV( ^XP#]"^OX=!TTVZ#%)-JU00:
MMT0-\+=%,C9LF4#%-[442>Q/U5. ]RAZ&$?Q'L(<I4B$*(%2*'YO:4@]@*H
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MT'KH.&SDJ;INZ(X25*FHV7;N2.4E2' H>Y(Z9S("0X' 1$/3L(#WZ#T0*("
MB(#V 0$1#\WKV^@AV  _:';H-W8>_?U^@?CZ#ZCW].P]N@UZ#9[/41 1 1#L
M(^G?^CMZ#T&OYNP>O;M]0[>[O_I_+_M!T'BP<_!V-H$C7IF*GH[[ATT%_#2+
M*49?=,E3MWC873%==#[AHX(*:I/=[TS@)3  ]![G0;1. #V]>@U !#\>X?\
M=_1_W^@T,<"]N_?U'MW_  #T'MW$>WU[=!&%KVS)Z)<L\SRZ:!5JM=]9=SC#
M-JO.S+&-F;F\K<2I.3B$&Q<K$6=GC8I/YE.P '8Q0 1,8"B%<RD_#0;!U*SD
MDRA(MD F=R<N[;1L<U3[@'R.7SU5%JW)W,']\Q>P^GU >@YHN8BIQ@TEH609
M3$4_0(Z82D6[;/HU\U5*!TG3)\V54;.VRI1[E43,8@_MZ#KS-C@*Y&N9FPS4
M5 0[,4P=2TW(LXF,;"J<J:8+OI!=NU1%10X%+[C![A$ #OW#H.TG*,5D$W*+
ME!5NJW*\37370.W49F*)_NR."*F0.V!,HF]X&$O;\?4.@\FNW2HW!JX>U&T5
MZU,F;H63QY6YN+G&K-X5,BIFKIQ&.W*+=P5)0IOC,8#^TP#V[#T'><V"$92$
M7$OI:-8RLVH[2A8QX_:-9&748H?<O"1;%=8CJ0,T;?XBOPD/\:?YC=@]>@]C
MH(VTS9,CQ:(86#8M0SW*("4F65<C)W2;G7*-#2-@D_=^G0;&4L\E%L74N_$@
M@BW(H9500[% 1Z#;JFR99AV?3NK[!?:OF^:UE*.6L%WMTPRAZ[$$F))C#Q/W
MDBY5*DF:4E9)NW;E]3+++$(4!,8 Z"06[Q!TBDX0."B*R*+A-0HE,F=%<@*)
M*D.41(<ARCZ>T1^H?@(=!S?*4._?N %$ $1#T]?[H]^_;L/^Q^/;H-/F*';W
M 8O?Z /M$?[H&-_<,;O[>_8?Z>@CF];)EF836<5W0[Y6*;.Z_<TLZRZ)L$LT
MCI"^WI:*D9Q*JU=FLJ#F6F30T0Y="DD41*BB8P]NW02.*I0 3=C"4"^[N'8
M^G< #W"7N(^G;^D>@I6[52!T*HVNAVEFK(U:YUBPU&SQQ'#MBH_@+)%KPTPT
M3=LE47K=1U&/52%41,14@F[D.0P /01OQLX[XUQ)Q'/N.G'^GDH61Y?$+0U+
MJ:<K-3IHM@]D7\TY^>:LLA)SLJ[?2<@NNJLZ<++'44-[C=!.AS 0HF'Z!_2
M=Q'T  $P@'<1_IZ#:*A0$O8!,!OH)>PA_1]![C[O7MV ?0!'H+;L>YB\7^0>
M@ZYE6(;?0-3T+!I5A";!5Z5-HS3RA2LDY?,VS"9<-@&/,Y^\C'*)RH++"FN@
M=,_90HEZ"Y#Y0]?RG_H]  1'U$0 !$!#V@'X]OZ.@A>Y\CL0SS7,DP6[:17:
MUL6\H7%QCN>R:ZJ-AT)'/XLDU<C5Y$$3-UQ@(E0KA<#J)F^,>Y0-Z@ 30*Q
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MN5>/B7S&3H#;+LI1SUW'SD@Z56:33F1>) X14;E(0B?H;N;UZ#S_ ":\ _\
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MZ3:+_32B]$GO8BY.)P]H" + 3L/?VAT%:] Z!T#H'0.@= Z!T#H'0.@C76S
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M51^O;TZ#9'5*0CR,DEKM;Y3[5XB\67DEX0R[U--5VJ+!X#2%:%^S6*Z*F<"
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M6S/G&/7'6.05MKT(YPV(VJD1\M3:O@T9/S5KLS>058K-&""B#$R K&<'*;V
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MVV[-'FK?OTRT:T?H$=+:>TC6.-.L@_A)GEKM;*/ET'=U9SQD2+NFS54!;HN
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M5<5 2.%AP\BN;=WO%17M&Z<MJ9Y)K!;N%@X3Q$KE0NU/XQZ1Q@NF=8[)\CM
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MLU?([+\XWNA\B;75-2U"?KM2@6$YQPU>LYI8:#86B[Q95"QV=I8R3L>5%10
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M=:#Q2RO,,0TW2\B0NMNBM&>T'/;WR%CJ 1MGR=<R4EIX[T[8L;D=2;2EA?\
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M1-V5B*I454C&]Y0Q(<:?')BVUR_G'R^^ZQRIF<X\:5]T:H\),^+R<VEO!X$
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M/:4>_< 'O]?0/7T[>O[?3H- *4![@4H#V[=P ._;T]/ZO3H %*'J!2@/KZ@
M!]>W?^WVA_9T&OM#T] ]/IZ!Z=NW;M_9T&GL*/U*4?02_0/H/U#Z?0>@W" #
M]0[_ -?0:=@[]^P=_P!O8._]O0.P?L#ZB/T#ZC]1_K'H'8/V!_9_1V_VN@"
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MJH?W=C 4 ](\2!Y5M+??R13MFJ[7]/3>*IQ"X+J$4%RYC@$4E7B7M[)J#ZD
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M(LC*3=Z+-.+2Q=OBP3- %%V,6I[A$RJ9#!%#'S,/JQRDXZ<2K1E].M4KL_\
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MNY>_?H/5A8O0VZ2Y)R]5Z:<F65,@LPH:D*1!J(.3)IF35M$L5=4J:R'=3W%
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M?(20%P53W#[@'OT%4S%'I]BK+JE6*L5ZP4U^P1BGU1FX.*E:P]C&X)%0C7<
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M?2;ADT I'4M(N7*HF,<H$"=N@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
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M!5_<:[#2[YJL<@O&BB36Q?G,U.DX.E[DP,)#G*8,\29@.7WE$IB''W$,4P&
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M\3YB*N%+6MF3R-]Y2S%QEM%I,0@\2<6VHRMDUZ6E[Y'(EC'"0O69WIE#('3
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MN<HYC0+W>LYY0UO4]*2Q^IP$K;+_ ,G>0V=[_-:)%1(3DLQKP5A;/R0K6/\
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MB=^P 8PCV'L =_0?Q[]_:/IZ_7T .@T*NF<PE*/<0,!1[=O3W% Q1$._N #
M/IW#\/V=!S= Z!T#H'0.@= Z!T#H'0.@V*&$I1$OU !'Z=_H C].Y>X^G[0Z
M#!SK7F'O>(45*[:?P7W.D2CY'?\ ]WLQMBC=E>K0;,M@X[99FLZQ&N,KA'Q=
M#TT-_3=*R[H +%FC%"'1.55-00R%;WS5QOC%-4: V8ULA9*\MX]R@]@*I8+)
M6(9"1NE.SQ->7GT&;9L@B%PO4>W]I4S.RMU#NSMTVR:BA0@6G>7;A3<Y$D>2
MZ7&G$<&8.8V5TO-[;G5>G*[*HZT6+NT)8[<QB8.1HDI,XE88EK,$7%DZEVB;
M1(YU'"/O"5=G\@F&891,(O\ :8;9K&RY'Q3J;R^M9KB]]T6^/X:,SP^JSLO-
M4VK1;^:KL?7:(BH]?F=ID%M[!3,'R@!!#"]Y<.?L5O=%IW%K IS<8G"=+OSQ
MMS3Y"XCFUXGKG#\1:5F%;VC4Y;!D(>)5<W&KS5<N,%%6JSQBBB5?9S!6YTG)
MW*B:07?9#Y5O&1A>24G*,(@-(JN452(=9WQUJ=.X_P"@Q4!L<S4-#B<?>9QQ
M[>.(9K':9H0Z#86:#I%%<'"ZC_[UPL8AE%>@JMWYV.#D%<8>HV='=*C'.,DN
M6MV6^6W&Y^LTC/VF?MM 4N%*MCN77;S1[O79/,I:*=(Q;&39(3"23)1T5PLF
M0P>)?/.CQ84RN7MW'Z-NNYWZ%4I[NPY['UM_"'SJH6O7:5DS;0-3FG KQM6J
M,A(7$B\2JW4?N9=-$YVR)TDUE$@OBY4\_>./#2QYC5]UL$_ R>NRS*%I9HRK
M2DRQ=OI"W5:D-D%GZ!4VYW1IZXLBF:MA<O$FPJ.CH@W2.H4+9$?-?PE^-[(R
M9]WKU4BRUIU)W^Q\?-1B*,QA+MH%YRVDVQ6;6@CJJTVWWW.):.CY1%!9HNJ@
M0WN*1=$R@1.R_F">!LY6&L]4V^V7"6$V@S,O1ZSG+27M-;S'+J+7M4NVRSKA
MI9U*BRSR&R^U,YQ0WZH:3(D"[-1FG(MUF9 ]&P>;_#H?131L7E.Q7#))2 C8
M_,]#J]52=26]ZQ9>2<9QDJ51Q2NOY2.+8*O*7]=RT5F9)Q$D0<(D'XC-U"KB
M'7LWG_X)TFNRD_=6.ZU%RW9U6P5ZI6',D(RX7VA6V"T>98Z/28YY9D&,O46C
MC(K&Q6]SE)^=Y'%*@V6(Z:G5#JZ+YY.,450KE=,:SS9]Q1@ONF5.>0%/+!5S
M4K=4GV4N]6S.F/YZ0:3Q= SJE:Y&RBJ$A%LF+XPG;-'2RR:A2A>#RH\FO%_A
M7*4J,Y)RUKS8;]14[W7WDC6E7,<JW3T?.\TFZ^I(-71V1[74I'36$E*L45%C
MM8-!Z_ 3MVBAN@A@GF;XJ.(I[=XNM[;8L8C%;K%R6]5_/D'F6,[;3,]LNO'H
MX/G$^TL3VQSF4U=6?9F;1RT>+1TT35<I.ERH '=WKRLT'&.041@41FD[J=HF
MX^WUB#K]0ME5C="MF]0UHQ&)K>0U"HW!Y7H=^TGZ[LZ4P[L3Z681T,W8'(N!
MCJ%  ]^A^2**8^/#&><VYT"2KRVDUZ!?3]!HSJ&=N*W/3TS*Q80OWEPLD!'
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MQL/'O/8W!)#*J^QA7LU9U^6$LSN+/*K<\V&ITV3KTG1K#F;AM;)""41*V$R
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MQ%" 80L@Y=^-;QM5:6K6C;SJ.F4>6T[3\YP^*1K,A%V.<T>Q6C-,@QQACK.
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M#QZUXGO)K0K3QH<0'*&6='A\6HD1MM])OM\>2\)L9R:(?DS8*B6\0%L>.?\
M,:G.0;=N_:(-BPSJ/!T+,!02*<(91\3?EF)2^.]7#:YBKP=%U:YRQ6M!Y/6)
MA<,[DK7/YK+Q^[W6R/X%*L7Z:K;2MV&-+%0D:4RR4P"OVY%GCTR(3F^\37+^
MGQ>)3JMKN>_2E8V:OZUL==<\HKW#.-!NT#RYT*<J6H0JUKL"=<KS^K\:] *F
MYCVJS=H8D:G'MTCJIH*]!T-/\9'-N@8C/ZY%;+9W6[,Z<]KNEEI.L;-9'6GX
M_#XKQCK$9A+&OPT=,-H6/L^E9I9G<A,0<2C-1T9,*N455555$N@N2QG".5.F
M^*#2<VSS/GV:Z#I')#4KIG^:;%J&M(K1W'F8Y(*V>#I[+0;0$-IRL?+Y2D+>
M#3L3!D@HU.DV>,4V?9(0K2O<!.6EO\?/#'B_M^@/YR_9-<=(D=L?);;=6KZP
MU$F9\C(;#H%[HE/:UF<MB5-N%RI"SA(H-VH!#B8I#D0(3H+.+SXI.?T3QFA,
M?RRU4.7LB[K-KHYF;5R#UQ65SS=$.*F/YAI.JU^>G(>U@Z"2VZNVF=7.@@,L
M8)- 8X&@.7I1"K83A;S6Y#NZ?L=6DWN>PERM,M9*'9M-T/8,BUKBO4H_9MTL
MNA5=CB\3'GCM%)RVA;A#)JN)PS-2*BS*F7;'429"(4A)^&[8<FB<IEXQTV>U
M_$L,TQH\F,FN^LV#6XW;+IPF@:3=]FS^!E%72]RLECY/4="2:QWM1=/T9APN
MY,/M*TZ"^=/AUR[O'COQ>KZ);TKIRCG->J'*+EWGL]HUFS:E[I*V%]+6'3^,
M"-YIC.0?YQ1&B4PSC(A)LU<QK<T&V1724057-T%)\0/%1J.+9?SSA],L=&EK
M]S2XX4G,'TU'W33[TUA+)$T38ZHG!RTW>E'M@EZCGD/?X6 BY#V)O7\5!E<.
M$$UCB!@L\N7@WY+J8Z]B\FNF68SJ]\F"-=B84/6=D:9G>,BA<<XY4]GD$@A)
MUY^S>EM-UQ>1<.IIU7G3DK25%-<CI!9PW.%_.>\ .15)\7N:\7*CL[3->7&7
MVM76LAN$Y>IO6J3F5\8:3.W2NT$\LC6,^DKCF,)29X\"HR+#H-FJ"X_;H$01
M;>T+/I?PA[.K_$>HJ6;%]3ITC5KVRA[OMETVNXW_ &QE(UJE)Y%BV_04DUF:
M^AEF%W2IJ246^9O9-P90X+I1[9ZN]76">5O%7K*E1M-JG[97V&YUM)>2Q6S9
M3/V]Q/99$OKYR-NMQI&5.KP\B8R/">B-:@HA$K\[9A)*0R1'ID6R* HA$?&#
MBKREKOCL\F=##C4AQ_TO:<X/5,7SFFO&]6>WJZ0W%:JYO,WD6S.RO%JU-:#H
M;%PJ\7%R@HLY%95-1</:[<!3\5X3ME7MK2]3<G@=4"WVK/S067TFU;"XH/ F
M*JUBH]PN]RX<OG<3'.;!I&^2M7>_O>,HC7T5#2!2I.E4"N6[T*;G?!1RUG6.
MIQ9N<2K>'L^?6^-HM<5=6MQ 5Z\T6:9Y9Q4D%&ZS!5W'5.J<05I&JV=H0Z_W
M\\]4??$Y3563.%Y7C5\5VH<4]%L6T<@[UFM]OBN32N5Y0E2&+M^;!(>;V;:K
M^]K.<S;^IT&#C*PG5= AXPJ$57H-F*L88I6B3<J8"%NF.>#C::AMG%W4;SON
M8R#+C!J.,W.84@:?<7MOY/2.226]KDV[;I:<F0;H;S8HK6F;$SEN5XDV08+@
MHZ<I*-D6P5OR'\1/(72>9_+OE!G^ST=,.0^6)U7/)#39R\S#C)5FF(S&42.5
MR&90T UK]WQVV2LVI++I.IU%HS5$BIHMT\10<E"D>.WA.W;%Y(]E=ZUQ]L;F
MS6*Z3;K/KOG]PU"BX$VLVDU#4V\AQP!W(TAA6M&<2,/(1\C-_I,:U437:KM(
MYJFT-'KA=[QZ\6#G!\'Y+875+[7LQ:\A^)G'["UK/C<*^K3ROZ_G&)VK,-,W
M-5FDK%)NK#H4Q86;P[A$Z$D[28@#EP58"'(%IFG>%_>M(H\;5TM*XD9?#DJ+
M6A6#(<.PRXY[F-DK*^F4F[SB9Y>PV_0['!V"T_N<@X=2T>W;/DWOY4C%.H9W
MT$&TC^7KW:C(*L$>3F1RK*1P:G9?<TI?/],E76C6*K+XTYCYF4FY2_R-QHG[
MN+Y(V6C'%?EFI3+)-?NV"Z972;H,DT[XX=@>\/\ BGA;[6<FT;2.-,I="OF&
MJY4>0XV:A6;Q6=%HB$!<,CISBO'E7^7T^ZH'KK\QB",Q%?>.D!.Z-\85AP^\
M84)QAX[<F\;LNAQ^M7OD\\L3.Y[%.4T["QOJ2XRR!S*ET6Q@A/JS4W5L\BF+
ME./9I235-LS>G1;F;&-\H!CYB/ GI*T]B3VY<E*Q-0E#D8Z%L$)$UZZPSNE9
MS7]CI.NPD'BMD9VP)Y*SR*U6=L'TM/G=/Q;R) .NY(Q2(H$Y;YX*LQTOC[D^
M%4*P4^C06;*5%],5)U7KB?/M1E8FM[!79^5TLU-OM.OMGD9Q_KBDJF\6E3.T
MWS(2G5,1<XE"4N#OB;?\+N4UPWZ#UBJO:Y:\AD,\EX.&H4LPL%KGI'^'CI.Y
M626L]QN;6/?U]>AK$+^C_9I3*#Q(TDBJZ:E<+!95&_R\#BWS-CMV[<C:'=;1
M/6V@R[]Y!8%%-X2RM<WJ/*&G04S.5:6M#ZLQ5DG6O(U%RY:0[!A$-#UYLDDB
ML)SN #U)G^7/I[K3YZYP.[!6(=9Y6[S43LZ?:G%B@M+J]6QNKL*W+P[/3V.5
M3_'9V.2'5>512OD<OF4F+!9[\;=)3H)(VGP<638';JUK\@\QA;J]=52QK1M=
MXZO,]S<EMKCS>XX@I5_)];S^TIU<:AOTA\3+]7%VI86XR2[A8KMPWZ"?.)_B
M-;\6=TR70H34ZK.T?&)R_P!FKC9SEZY->GGVC816<6?56SZS)7:==+YK34*P
M+^N18-C+1[=R1@98R+1(QPA;D7X@;_9V_*>^TZ^U*U:!?I/<[OQ=8Q5 B<MN
MN.;EONTY5K<?K%XV=Q99IU>QPBUYC'2%?13C&AT6J+EK[7)G!"=!?!;_ !U0
M$UQYX@\>J_=TXB*XLJ*"O89ZHL[>_P!'1G>/6M8/?E9))X_8FB9JY_Q;>SJ[
MPBAP"0 /\(0]H%"SKE;X)\_Y)WD)J)UXV3488U]00S2D45S7:_7LJM&?X=4[
MO&5%#/[Q0V"-ZFIS$64FWE9EK-,6WSD2.P5^V1. 3WS(\7SWE9R*PO9&.^2N
M>5C)X;'(2RYT-=D)\UQ88MK+G5X5PC+L;M6HP)"4=21FC@TY&3B+4J)%V*39
M91=54*+G?"=@]AI,'27]]L;>-CL?R;')=Q!UBI0KV5K^6<6^07&!:0C7C=L=
M2#F+?&;\\G'Y@.LB,C'I$,0Z2J_04IBG@XRG*LSG:)*ZJ[G9RUTSDC2IBV5C
M,Z5GZ2S+?JAD- 9V).!9+S!37#/*EBD8DS?"Z.===PL<PIHIMTB!V*OX/<M@
M-'H=QE-VO5CK6+L*Q!8G175'SJ+0H]?@M%MFFKLIVSPT4VF="FIR;N;HCN4E
MBF7%(0. ?**JAPCK>?Y?_)==J-,A(C:YZ$E*56<#I+1.V46)M5%F87$,"MW'
M5*3M%%@9JD(6FT2M0MQWZ!GSM:.;R+9%%9J\8>]J(7*M?$5F]?H<)5*#LM[H
M\A5C[X\J5JC*[27CZLS&YZ)Q_P!-5DV<;*1KN+<&ILYQZC",$E0^ S=TL"G_
M ":'L"3.9OC,RWF=*WRQ7VTRL/9K51\"K->?M:_#S32DV/CCKEPV>D7-LP=B
MW6F"2$_<W#24C5G*:#AD0GL.FJ0BI0QP(>&;<:=JV0YMF6IUB)XD,);-]%W.
M39L:M7+?>=$SYALL8_?0-$8Y_)KTN:D%=;1<Q)V%@-'%3CA/+)NG)U!?!/.'
M^"G%\HA-)@+;M&BZDWU.B;5G-D=OJW4JV\:PVS9)CF/O9""<M&TJK'V&N5W%
MV+ENY#Y2KOWBXJ)_;B5$H5I8/#73]&SVUP6N<D-6TG2+=I*VT.M;>U7.:M-$
MU%G)8Q(UR7_=ZKP4;#*5B'3PZ)04ARB@1VBX<&.NFX.54@1PIX%,2_4J:\B-
MRTJJ1<#B$SD5FB:E3LH@&E^>3=7ME>E)^UM4*I^CRM:E9*VJS#FKR3&4BC2C
M<BJ1D 47!4+Y,7\?E4QGB37.)4+KFFDAZU>D]":7N#+4X*8AI8V@)Z*I6*77
MW4)/UVJYZ5\)X]K% B[^RC53HI+@<"+$#O<.^!E:XCV6PV)OK>E:[)K9GE^!
M9[_$(E49)Y3QXQ4LXIFF6PK:FP->;SBL<^LKY=].2)7$C)JG3]PD*00.&0+H
M'0.@= Z!T#H'0.@= Z!T'6=^X43@FH"2@E4!-02"I[%/B4]IP3 0^44Q_-[?
MQ .@^7C!=>\K5"S*1KD3 6-G>&6%V_0RVK>\ATS4AO>@Y]GW&E6&K+EHC>X)
M6OK6>6T:Q-01C52'4/$@8$%%$71^@DAIJ_D;:;A'CIZVKL6^6:/ P\Y?LOX^
MV)W \CZG4=VY*TR/JJ=#?6J7IE!/?*9^ZCE[+LBID0*^0>*N2(%*4@683/+S
MS!Z53W[:X5K4XU"M6_1*@UAZ/Q[O5?>[,]N/'J'U'.*Q*6BF$HMAICZA[=69
M.NH34<G'1J:0';/7LHJ<5U0O-SKE=Y5;G-(U%^PEJM/:1>\OIU_E[+Q#L$?!
M<,;?;=<M4!9:=2)!Y-Q$1OT#'9"P9SPV-VZDHUH<Z*JSH >@T2"6^)/+OR'W
M[F9EM#Y!YM,1.7:'@=8L5OK54P2WUB!Q6Z)9XO*2,[>='O+6*9?97J\QCE..
M2B)NP+L_NFD8\B6RR:LD8(6JW)'RU6W14J+(RL[3G%LU7,J#J2R_$HO[L\5K
M#/;Y98>>JV;W9PX"#WFK/N/S%G,%L:ZLFQCS+MG*[E$[@6*83YSZW;R39?>=
MNEN/(NH[(\[;</:G&'9X(II#U:"V"ZVY'D7O4/(1L7;+'8Y[&*] L&K6&8PL
MJQ;?J!W#M@Z ""F%DNE\E_+IHC/9<J<Q%]CY70.$%PL69QV"<;+W4Y:M73^%
MDO/P5[_?35*U771+O8;;!IQPPC*6,YBW\TU8## =,7Q0F&>USRCT9)':+8KI
MMBIC6Q[K4F!H?C)))V7*<%B=MXKTJ$UJ?RZM3[UWJ6FV;'9.XVZ.:NXE;[56
M'41;M?8"Z;H(OJND>5!EM>V7BMN]ZU%!^T=Z5E,%J7'B5R2MP.>NN-P4V(NS
M:GQ]QD:^I8I&YUR1>%I#Q873B<;(+F8,%91-ND$N0VW>89S)S]J:2=I?9'F5
MER.*S]Y9>(E;AKERIH6G<AI3/[/HUVI2<S%6?+)'+\_*>4)$QB,6M)1:+)\J
MW:?>'3Z"=>-W(;R76#A9RIF[S1;'<.3.5V2 KV435IP]7%R:!"R=5H4]<;W4
MLHET*](R"E'C;!**LX!PFNLYFXL\85[))G27,$2Y7NOEHNM\D;*T3NTE@E&U
M#%X'/W-OXO5^B6[D_E%ZY,A1=,T&\P\@YB)[+'V;8^W>R2:4>SC#.H\K*44:
MIF5.U,$V\C<HYRW7EE?H_%^2W(O(ZJSME O],G6.*9M>,DK$"OQ:W6K2-0K;
MRPQ+E&QD=:K Q;B;1?E6=M7$PT^W]HKIK(A1W$/D'Y/K5Y#K?E7(ZCR\#@"$
M'99)",/C3^/J;"H)T+.I++;Y ;+&P*57<6>V7Q:QL): 7L$A(-E"F2&,9I-4
MW*P1[-:GYC8>Y2T3>(VQ5O%<\WJ:Q":U_,,1KFG:KHU'B(G9]/IW)"F901"0
MB_W/N2SR@T:;;"0X-'K6050(V*H+A +9\G=>8IY?26^WP?(BE;!H]I24M(SU
M!J=^RKC[5MFEN!<7*.\@:.FYZ^^;0581T>0=Q#Y[-%KKN*434#YBJ&?!4Z'-
MKG;4N:O%OC[M6MWRLV^9Y#9)G*.>5C*LL1J>Q8-*7KDQ7;?IN_G5@Y&Y4+0+
MM7<S@9B#"NN(^'(S4%4$S%=."L@][8N2GEDE.1W-.$X@#IVI0>8;G:,JG:K:
M<CH3;)<APHF6X7966@\<KB2!B9O7N4L#.VJ>,C59>2D63M-5$5V@)((BX"-+
MILO\P5105G<@I=KW/+CN+E?*"^U[+*EG6URV78W<)"L0--T>G5BF-"P>I\CH
M'3(^8^($(]X5M0C*$91RC]RW*'#I%K_F$H_4-2RZI3.@RC-C)4:M-M'@LLR]
M.$'+6^A\=:LWUC.9":SHM*'5;16WUWEYYFO,SP-&Q%2GA(O[5H=0+K?)AQ6Y
MP:=RFX<Q6%:KRO<92W_RVP&D6RBSF;1E?K[C..4F;VK1-9O:"E2901[H?-6+
MF6*3]-/&2#IB+5%B*!U&*H6DT>^?S#\MI%(K]^/>JU%/,:O$&P:0^&9E*-;"
M_AJ_O[!#1=*T/V1=(SG71LT)2W<<P1]S%\$@E\,.NW.Z!N'KWMKY_:'L^D0E
M4N6VZ?6F6$,W&>2J^?X2^@9:*G<4J+^_23JQ,W^=4^,Y04O<%9Q"M1JD([;N
MDF[-(R:L<JLL 7+<)LBY62'+6B<KMYK',6ZY[G..;%@W'I'D IFK3765*ON]
M92RK.@[#2H5U%MV>BR%3<S;F6DE ;22U8@69EFI')CH+!]%Z11^(H'+V$!,'
MM-^;L &'L'<>_< #Z?7TZ#E[?C^(]!H)2B(")2B(=NPB "(=A[AV'^@>@T]A
M/3\A?00$/RAZ" B("'I]0$>@U[  ]P  ']O8._T /]HH?V= ]I>W;VAV] [=
M@[>GT]/IZ=!I["?[TOU[_P!T/KW$W?Z?7N/?^OH-?:'[ _'\ _$>X_VCZ] $
MH&]#  A_2 #_ +?0.P?L#Z=OH'T_9_5T#VE_8'U[_0/KZ>O]?IT#VE'L @'H
M("'H'H(=A 0_I 0Z![0]?0/7U'T#U^GU_LZ![2AV[% .WJ'H'IV#L';_ $=!
MKT#M^/X]!H  'T  _J /V]_]OH'8/7T#U^OI]?Z_V]!I["?7VE[B/<1]H?7U
M]?I]?7H-0*4.W8H!V[@'8 #MW]1[?L[CT&GM+_O2^G?MZ!^/<!_M >@U[ 'T
M  _[N_\ M]!I[2B'82E[=P'MV#MW >X#V_: ]!K[2_[TOX_@'XAV'^T.@T I
M0^A2AZ 7T /H'< #^H $>@U]H?L#Z@/T#ZA]!_K#H'M#]@?V!^'?_P (]!H)
M2C]2E'ZAZ@ _WO[W]OX]!K[0'OW /7T'T#U_#U_;Z=!I[2]P'VE[AW[#V#N'
M<.P]A_#N'0:^TO[ _L#]G;_:'H'8/V!].WT_#]G]70/:7_>E_L#]GM_VO3^K
MH->P#]0[]!H!0#Z  >G;T  ]/V?U=!KV[?3TZ#;[2]RC[2]R]_:/8.Y>_H/M
M'\.X=!NZ!T#H'0.@= Z!T#H'0.@=!L4("A?:( /J ^O?\!_H[=_3_1^WH.$6
M_N W?V]S@(&'\Y@^O?O_ 'R_3U[=NPAW'L(=!N!'MW["(>H^WM^ &$/<'8/;
MV] [!V^@!Z= *D<![G.!O[P=^P@80$0$.X]^P=NWT[=N@V_!Z]NX%)V$!]H?
MF$# '< $>X$]YNXF[>HCZ_MZ#?\ $(B'N,/8IA$ *)B )1^@' !$#B'[1^O0
M!2$2^T3=R^T2^WM[2B';L4! /3M^T.W8?V=!L^#L7L4XE]/3V@4@@)A[J& 2
M%*'O/^WMT&X$C%$1 XE]QA,80'O^(]NQ3^XA1$!]1  [CT&\2&'_ '7H'T]/
M41[=O<(AV$H@ C_=[#_3T'&9 3"/YA]H]NX&_/W$ +V-[3?D P&+W] ]>@W?
M$'80[]O>)??V$P^X [ (=_< ]S%#MWZ#:" AV#N'8.Q0#\2E]/0#" F'VB'<
M ^G]'TZ#4$?41,;OW/[P] $0$2@ ]A$/VE 0^O[.@W_'V*!0$>P!V].Q1[=P
M'_< 4 ] '\/QZ#:*8F#L8P"'<3>WMZ (^WT >X&[=N_]?NZ#3X [D[>T (!"
ME  .'M*4>XE*(*!V 0  _$ [=!J*8B AW 0, ^[N >HCW$WT /0_IWZ"FG5-
MKKRPQUM<P4$ZM40P>1D59G4-&.+%%1L@=-1_%QDXJT/)L(Q^=(HK(I*$(H)0
M$P"/80#W6\>V:BL9N@W0.Y<'=N5$4$TC.':A"IBZ7]H=EG(I)D(*ANYQ*0 [
M]@[=!V/C$!$P"4##V$3 4H>\Q0[![^P?0>X_CW#H'QG 2=C !2]_P#N'[/:'
MM[=S?0>_X?3L/KT&X2=P[   '?U#Z /U[=Q#U].@VBF(]_4/4"]_0!]W8/7W
M^[N!N_I^'H = %(1[]Q#\!+Z"8.X=C>\2B/M]X']0$.@WD*)1-Z@/N$!_'OW
M]H /?N(_B'0;^@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
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M<K]X?/Z=/CI%PL,'(;G6YJHUJMS5P_=V,EXRW94U9IKNY-1E( X541.4ADC
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M=L=_Q-ZTIEB;U&Y/&>ITARRJ-K>)G59UJRNB3GQ0LZZ*F<$VK@4UCF*)0+W
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MU#HN@T^T:PWO!;FQW,(U)UDL,I!T6R<@0PN/O=UI<?9['<I*'MI:ECJ\&R?
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MP1/"CBBP[PB%<$[7CYE")@@6J[MRVBA$*D BS;N9!<Y$_H4RIQ#M[AZ#F1X
M\%F\#^["'#'BPE7PBSP81*?'W*"M/TI1N9J9D"9:F4I6IFQS$$@![?:(AT$,
M?ZGGQ2%#N3QN\)@, =@[\:,E,'80]I@$HU8@"4Q1$!#OV[?V=!D5BHR.AHUA
M$Q#%K%Q<8R:1T;&L6R;1FP8,$$VC)DU;(@5)NU:-DBIIIE "D(4"@   =!Z'
M0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
MZ!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H
M'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@= Z!T#H'0.@=
.. Z!T#H'0.@= Z!T'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>s118023_ex3-1img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 s118023_ex3-1img03.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$)0,T P$1  (1 0,1 ?_$ +@  0 !!0$! 0$!
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M&-)#2PGPPG>W7LRU0%#TQVM592G$W5.TFJ-U,RCX2RDW;Z5D$"_BF+R4Y@Y
M?'Y1H,(8<S0H]L+"&''S'\@IV4[51!RSQ8Z6HZ4U+<12KV<K>KG;ZF<MJX!T
M?+Z^K@YC%Y$!^-!\F2Z]?Y]R,MYL%:BV7<N,GB_(RRW8WKS2>N<Q'RE7+:/(
MK$!:L!DW6TX;(\6UA/ 2&,40"X ATT&YL7%QD[&P\# PRXN'BE)BXN+BDXQ+
M>('2!?E H$(4A \ ^//Z>:"Z4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@_)_U#!T]7(<"7P\0'P'P'P'@!^'XT'ZH% H% H%!Y9N_;WQ8ST/CQS:\P
M2[2R3N?*2&JM!(C9/349U->*\=8,X&KDN64$M:0\Z[=6E@BJ()R (EN9!K6#
M<$H)9A#/#P8.%ES,K[B,YR]RM6>LB/)5:$99F&@N-Q,I3]JN)S,Y0RH&CF7T
MF2)%B-M,R,!;+(#UE,%>0QM(8%$A_&@QB?7Y"2W"(0ZP&+(,JX&O> ZRNZ=8
MJ2D=C1NKIJF[V>&L\DRFCI)9(;97,V$A]NIAJ_\ BPRD84?I6%$P4'U?6W4U
M.!_,*28=8VO>I;$=1;+BAM$C\&GF!%=J)HVMPN^_3UR[;<\E-[\WT9N\.M)-
M;*5Z'$!+AW"B T$9K<1RPI,Q6=+(<,B.!M8T,MB5GECM2*Y:2&TDYS9D? :)
MFDK7$AI$9_+'*?U<7 ;]A")>DMSU(1)05T[7]@I 0FBC.61D&:69"&2VH/:.
M<RG/;4B*ZH]LE\2]A FMJ[Z:^G@HG77@NE%:.E")[@"3J,(@ A*Z\VH8VVOI
M& I2#$\%1C#:"BPPF+DN%2FQLJC)S'CC&>$D3?+B2WT3+4I@M9"HSU%L-5N@
MNEN%7W.C(]L2@ B8.E':P[L.\W9:E^/(?VWQ9#4]&7.:/,)Y-!TIBJ]%"%6L
M]V4$P-S\J;>.XP2V*]_;LN)[B7FD81N&3CEYQ NB41#_ $RH/G=C[!,])D*-
M'(U7:PG.@([M9SN:CH3'*EN=KN(%D$E4+=2P#TX#$2Q^)C<CU% >2B !O6@4
M"@_SR'_W'NZA%V^6S3R9.TD^W84:W>.5-,D&/WI#;/>NHB2R,^3,W'!H.*>E
MEPV+D7NBRV5>V!4ZTC );92&]3#I'@)@1MWN)BL]_P#D'7]Z[$M_)T\S7-*F
MDK&:-U51@LI<N1FU$Y7:,O.LJ>W ,9S/Z4PN-0Y\0Z:4XG$HEX3C=802[;'>
MR[JCVNZXX+@V4<,U+4Y2M,$<9\;31J&B-6-DICLED/.3G;)K$W';"@AG?\G,
M:TB@4&AZ,)"E,0@B/)>0G5VL^[MOC-FP_;/:6V4O*#NC?<I F;/45F2]0R:T
M)Y7/&L<N)'04#7V9F>]%AI[!>^7B4H*8BVD'H.)2X/!A* AD^F??2V!F@W=6
MQUUXLUZM3"TPVEW0[=V$*JS7%GL"(];%>48Y,UYI(VTQHR05W.ZY@HRX .DP
M+QDWDWX]-!7]I?NT[N//8.&8QV%V@9^R$3N+0=T[E[ $?&K0ZJ.F!$INI(%;
MS4B!X+QV0&RR*40)ZFX 1Q1OF,)54>##03)[%_=OG7?:5]@8BV3=\-Y;D5XN
MC_:#7#%B13:BBIMF$)$6':DYC E"XD?1#\YXW-<0@5K8X@=/U.3%#GY@YX33
MW7^Y>\=]I2[54*S4WX3EG$WF(Q(DVCE5L,AR,=$B1F03[A18D6E9#C[":3ZF
M:?W, *WIRBB%!'-=!. P\E-@!ZD95D64]>>WX_)9?!E&0I2B#6UV25(N AX]
MQ@JSH5&JS51U/'T#KD%R"PU2[<QSC;N"NJQ4L +TB8..0X(ZQ;3]Y60M?D/;
M'821>W0M17L'H[/&PK 8KZ2%B-7K#&>:.3.Z/;IF+AN5:+,,0JPM1/7E<<\Y
ME MI0,7SN !0  C- _?0W9:>GDP;C20JQY)R(V->D62VQ"K2T*V-U_8J/,<L
MR/'\4L=)0]D78X?RH?C"3'*]3*ZZ8@^I*><82IACAXT$RM=NXUNMK)M5).HW
M<BV)UIV!QHFU:?FV,S.6)VL[X-FZ&3PA'+/EYR-]):5MEMUGSJT7)C+H?3SV
M[U"I@51#DH)RAA%#26O/?VW"V%[<O<DF_#9T(,[;?5UN-C:6&&,I8RIG-13T
M[>JHDJYU=62\-T7+RTXFNR4A?( @I%Z\^Y@ <A>>!#=<O=\#93*96V>RVMS.
MCY>U0AQF]OI&9LHNYAO)UI;3DO:6Y'S]FAROPT=N7)<;VCR%H5?^%ZD5!30.
M1=\"=0!Q01+87W"SMBB*XZW'V7=T+S&QU'<:9->G<M:U.5YGPUB'[.K32=[0
M=["@]Y/%OOR+GBX90CS&,*:^$(!(5>.(F2Q,'(9%*'?AW<U+UBTKG"1VAJ1D
MX^]+P?N8Q6R"S)CX86K,01E',7'9[0?+XC92>,B2'(#E,OBLJARHZ@=*!1 #
M"/24 #T0]JO<1^[W:=L/9624J.4I<>#C?F!C6XG_ #&]BJ"4VW9E("6HI 2X
MV6@\0"Z%@WC<PRD$0\#<^%!TIH% H% H% H% H% H% H% H% H% H% H% H%
M H% H% H% H/)?,W:G<&@3Z[D7=L&=U&8,IO:S;HR5"<,.(LAI.% [Z,CYSO
MB12:CD6I$=1E7V:9R/4@E,2R!#.,?2R%$1$0@FIZ4ZU:CZ#=E_9B'6X@M[="
M_N7V\'%)&QN H&)([^3=N#C(CZ]]B1VJJ@OL]P%= )A"J_')$T>@ * T'/+9
M;.T[UZU"[B[#V48TIM[OD-3;659D8TM830F^[)2:EW);;2I'$KL/8!OY2JW&
MU%%N+"&Z ]?*/)N?F.)#@'7>+M,81[M>S_<]>&U48O"5'C&J%J7JHPLAU>Z$
MI/@A,5M<$!6DN:8\1'&O-P[>?*J_+GJ?HP\&1OB/J '-U!!W56$<[9'274??
M">\9P]VV3H!UG2X/B_M;9O0IN!.3WSL?,[ 59C=[D^H]<LURW#L>Y0(XJJ )
M1!"( F'IP.D-4Z?-Y2GO!TO[94Q61BB))X[Q>VS^V,T9STM^H^=K@R(?C= E
M1BZD9N8L*3?6S,%ZVP5! R>%L.;I3@83 <H!UTR^WXT7[NOW/.U!";[)JYK?
ML#KMH1LFX46,"JB6V6DYVW+XH\D-N(FA:>261OI$U,EM$Q50.HY#*(%Y Q0Z
M1"%,1,K6=&[T49:LQ1I!,G:N9\UZ7;8Z]>B/H) :U[9)X*:2Y$EON]'N1X\;
MITBVW6PC9V?Z\1;#/-U%*<]LWT[A@] O9'[3,D]K)F3LV98G<)Z<LGR#9=Z6
M]$U7EA,2P*K)*;F.ZVKQ\\'JY&B5PW'L4PBO89"JRY:_XZ/)0"@[ST"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'.CN8=P6->VUJ+*FT[
MVP?=5UD9Z.TVPQT]1 ,YT28\3VQ:+8RLL+O[ MW+5[U#.$Y?D2K9CAR EH/\
MNC 2)"ES<1(V7V\9S:W.SMV?SDDUX++"=4QQK^5[';,BN)%/L=A/QIQ2L?EH
MT&:DQ NJ:< (ZN5(92085!/P  @ &GVO+*U.<@-J%FDX7&HQEB-QT:@QVJX4
M>Q!(VW+[;LXK[T?D<Q\/N!RHXNBP>3T@$ 7(FJ-H6TWEK@. R@P#A-2(]:M2
M-8&'(Q=B)B_.!9>T7B;*C:*%21TK3!U*D1JR9DF6G')+.<K95MHG(T3HJX;T
M%"4T0".X..13_FH)PPS@20Y>F8M%G)IJTV)ALI)3VC"D;:LHYDQUICE:#S;2
MLCR*Y,QPN^82JSCC]AI@2RNIJD/M5>=Z6G_XT\ #NU!L!2<S(@;LUSDM.*>W
M1@P5I=)$79<LJDD>VD=.EZ-M=L62 :+::"B#<5O9\O1"C+X?RO\ 80-T!R_!
M="@MFR^O4!;'Q=IHZW_"J?M?DR&W@0QD8(82(?G&0!"-H;=R-*J0^VVH@[X@
MDEG,V.E0/;?G%)-\1]0^*70>3?>[M_/#5Y_YU_7!XX,DI.K[B1\YJRHPTUJ,
MK82&'I)$\-]8C3(WM<"P9M +A(JN\$!%>J4(H0+Z6"6!B^(T'/AN,G-V7E&7
M&O/LH*$>O5D,Z:7BL(8$><CJKKEV(X=<:T\'HM+"TX\YH)978X8N*9TJ@*Y1
MY.()& <H6\0H>I/[4+N5/J$9X7NU9L*XD1LQLOX+I=T X[M):;+E2YM655LJ
MEQ@H^0XU1*,*;(B1FWU)-1A3OKG5!$2@!CG*8/\ 1.H% H/#I$;D[,DJ]T1Q
MK:?KOL5E/F0]Z) /%<^R.>6W'HG/6\>"K.)Q"1(0;.&#<M22PUIW<%]1P *1
M/'J 0 X&$.IS![=O9A<T* UV LP]F1+J3L$BSM*C[Q-@(\4GS#4UQ>L.YQ%5
MILDIOJ#B$2.D%/I4"+2B7]DD /EX\ S)I=MOMN-N&=0V&SGSAQ#"T.SFHS)"
M><Q-H@4"/N7]D[CDCY5:.*\;QK5UTVU47\DHB:4IC I6U8$LH<F 3A&7)[:G
M9/U@:"2_1FB8&PUE3!NZAP[)*[LB\G)B:NR5.;6P$=-6()2G(*X6*9A<&*0A
MB+.-@B"6<3#TV0ZJ#=:_VM-(W6DQ WF'KD5@*VJFN\[:ZNAFQY/$>LMT*L;3
M%#ZG#SS09 6D/K5I2=3F;APX6'(HHX6U<!,8X@90 @;7GOMBZ+2.RHL3W"]I
M32FO >F;NT#(WF0_TA04&O"+C26TW'L22E]+MK@BOM)%;G&<8<H0Y*/RB AR
M&T\3MG:&ZS;0:Y;;,7!;FLUS7?7Y]0&TTEK.!DL1CNAOKQ1&V+M0KC;N+[\=
M2.E7U(_GO51.8>DQ@.:V E#F)/\ J-VT[\W3MII?S=BYJVOW5F)K=T/$9[>=
M*.$LM3\DNHR*[H*>?2PFA&JR_$0KG3$L'&LE5Q*I#R \)_ ;"8.Z?;1@/:C9
M#0E8F#9"9%C:[9US)DP%EQ-5W-":1+\G(N(W;FHK.E'U-H-1+ZRE @((%5B+
M7(IAC&$2DH(^:<]K+0IU,>85].WHGB28(QVOM+VS8 --<GI;A_)9CRBK%BJ9
M$>!&]F-=AV6H[[EM7%(-ZLB+R>4O0J](E, @&]8&[7&D&6G[2Z)N/N7;D;5P
M_ 4,(D)3SJ5.<HI1F+ ">Z#);MAQX-&V5E,9J,YX-T6,:XWE$H*-NV &_5(
M<!FS2^WC@R3&2LNR9MTM[9ND22]? UZPI4D&>VB]W$Q8.<:T@N);C9AJN,QQ
M;@MU5]/N8(_)<*>VKY_'/U X"1T,=E?6"*-JLO8J)XMN:_,5^:BOS4^:==8Z
M4VHV(F?B6L+> ;W"M(329EM9=JLY4F]E]:N963#AZ8G_ ,@ >KD-717V0F9"
M^C*1V\VI+<[-%M).XJAL5#&Q\;NU'2Y<C-524PKW9CI41.T :YS8BNC^WKF
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MZ(D;),7?G*W<=289(P+DX*2J?%PVDL18B*EA5:<86XU;A,,C>QC 0HD 3&$
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MH4//MO-KUMJWI.^X$V$@*(9B4\AQ3JJ:]3HV%-@NE18\J:J["H@+:/(468^
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MM'=Y,$!,(\?3\.>?$.QU H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M&D_?9Y6WUK2_YE&(G.7ZMR=TV/93<4 2]<;B0Y&'>(X6/Z8A.XI60"<WR>1
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MEQ$I)24S#"W:Q[1+9"E*!0Z>?AX^%!FE H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M$A?D]%FVT<Z)8Q($9K:5H%<^VEQS^N3!+*RCYJ7>G5\IEMR"!R*7RW#!X&*
ME H9U)G9'?R%I_VYH>U#V9&"]E.W(#H_+:>U%B6W*V'"IR['J^V)P<JK&ZM=
M7OVP^'$JCFX G4;@(13FZ>H0)TA %P_:EF\S!S<9>VS>;\4H[5U@0]@<!2@9
M!<DKNESP@[7>^GZ[H9FA27[KNAT)-=+LNB& F 3I/<*=0.H= %$/7VU<)R82
M1BXSG72.57MF4AS%C&3+;?"_;.HF,F%%(MG.2R:TGB!3"(B B01#GJ"@O"DI
MX**GYJNH&+BX"7@9V;F9(AX6<)/*-VX(_I +91, ?P?PT%?05% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MLN.&"MR2\$CMB8C<:;0=#Z=UHI7;GJ+=2V:U\]U98J%GW&%FX<]A)'@N'<N
M%P0\>!YH.DG8*[A,V=S70?%V3V#3F8ER7AS&_HUS#1TC*C:;2DFMFTW,Y+SR
M)"HJK5RW</;<G28?JF+\@#P B;D.W] H%!Q@UHDB/XX[AG>>6W\^&>RTG%D7
M4-?R<US+22D%*DMK2>*Q7EDYLP]LPD2"<<^!@Y_"@D9JG/+@E^4YG75>1+F?
M'2NSXL=L2M+/;)FQZ<UU5,75E8>#2RUC%3W$\FFJI3C;^-E*8D,4BR0]LH%
MP (2EFN;67 C4Q'H^R.'T#+<"4V#YZ&VU1RE2KR_=,%M55BIY#'MM_ \?JW.
M/E    $?@&[J"GH(=P#MDBSR9^KN.Q7&RF(P6^TUPLBNI1:EQO*_N=)77((8
MUU'4[UT")C'!,5KAC?*%I=*4> +R(;8A.1G%*J&IO+,:1VRQE?/2U*+E?/51
M.X'PR%%&3\['>*NAC:MW&L184C'\I@W3"<<$"&$"]0%H-Z4&(([O;"XNN=N)
M"JGYJZS<Y-3W6EXABFS4?.54C'7DJSF=!N"CD).2!R_'GD?AP(4&7T"@4"@4
M"@4'B$[G&@46,+8QA-+7J3]@]D^^#M%MBT9WC>6 ?CJ3PU?A-OOAO*ZF[I#C
MYM+'Y3-J 8T;:)Z<E@IIXJ-SZQ"VSB!#%H-([.Q<U=[YT^XUVNF!]2''\J=L
MW!8K5TK<9I>=C80(758G9;T5SJK/3V\NM--(KRL]XH V$:[X6[KE'@O6/4(2
M"[S:5NWM-V2XLW2<>T>$P(-3-*],)F?T,QLU59,>DR;)2<NQXDNZ_(CY%QA;
MMQ$WO?\ ZBG(9+8F,K62_4,(DMT$U>_GKGL1M<N]M&,8>TJ>.X<>M^0'_*TT
ML]!GBUK@G+#<;3 ;:+@Q\M2N=51[C(*\/<QQ(IDZC@9- @  &$2AQ@<#\@&3
M=8= >W_"NN$WZ-QSLCWLU76ON!0/^\?)$E.)'?L2!%+;D&-32FYL]6<*\W':
M5_(>6!RDP *I(/RE#I ]!T,UMW"8'9L<G>]@)'=(/W6W4*8M9[FED/YK]6E,
M4^7]N(\>J[^[CA/]].)V&1$:T\VN *0J @"<-M443<B)J# NSINI'NGSX[VT
MI[L[C0S+[\1WC#&P+Z>4=OE!54Q]*2C$2P\GRVH+;;=7')[E0&$\7@1HVQ1R
MW"==LA1$H !2A1=J;91Y2KWG=C98V%V?A9,D[<W01MO"*V(SI2CYSI\"*SGF
M#TN+-94#I<5QNO\ E^.V,W<516L,A#'.I'-U@8!&@J;.A$0P+W2-&89T+D38
M*<]^XHGO,V#[DFUSJDQW.9OI&OKC(Y,EZ-38%##)NQ>GOV9$AS>C(R>DVK"F
M %$UP#<E, 6ONCZ Q8S=@F:W("E#8#9/OA[2[1-&=X?DKW^ZD\-78C;[W;:L
MH.1[Q^W+_P"5[:UVBMMMKTY+!8P!43#>*%LXE*(4&^ON =!$&TV9LW[2<?:&
M7)YQ[D%IF#(<=S.IXC4[9K$C0$]2>4U-F(VNOI#G?+872%%=5$<B<H'MW N*
M)#IA0&Z(:CEZ.X:[OW=T<>O<ZRB\'QK#KYV@&!-4$/K!?;L93'=4ERV:/'%:
MVVS$=N.%IB8IVS)8=>"91 G",'5X!X!T+[2G=9A"/NU%H4]]_MK(^:$B2:G2
MS'3'=4AN=0*I2HGPA,;CBW#5_/73JMQ66RH ) 99C&\3W0$1^(@$-^YCVG-%
MIS[CVONK\416[T#9C<9Z2-M]ME.^%.\ZJ(,#7ADK9U)]^D1M=D:ZS4E:G=\K
M0-M,."85.1S!UE !$H &Y/N!.WLENV&)IW!CIK[)[ SM%L'-U#AYAMK8\8WC
M73-+8?UW(O[1H#42W VW2O.=(06^<;EH3."XJ&M?WOY2F('?30]U8#UTOU5=
M*7+:E/*8O:_Q9G8LSKB.I-A5E #LY,$S]S$=63D%42KCGN'&_P!)\,A^#@(@
M'XA,&@4"@4'*1V_]-O __L7VTO\ ZU&J=!U;H% H% H% H% H% H% H% H%
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MT*D#0##=UR(6&]&?&#$2W&A)":XC-5M1F[V8Z$8B<WKZ@CX]T3>QR810ZR%
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MY!FXNJ>R["))D![!15*[$$BERY&H^4E3MIGIG5?5P6N;@** =*+;'K+E%MB
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MD,EK+^5,CV4)GAI><WN=WJB=<B)BSW,CG%O663=,=,MW/67<8Q3IQ;=S@!*
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M&2+@IP^')1Y#?*%J-JPVD)4;B!KQ#".VERXT3.)$3XR9^.E*WY;K8NF/BK6
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MRXL=$</W7)<2TE)3VP)G<TW5&[QM.W"<&;BK,L109'S26%[T>V'\:)BVR 0
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M#;-[#I&KZ;(27J3$<[/!'<<<ZVV9,$/<1HXPTY 1S$,=)(7&((C\H% P^(
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M"@4"@4'*1V_]-O __L7VTO\ ZU&J=!U;H% H% H% H% H% H% H% H%!:,_
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M>3L142\O"4DQ2PK>:F*>%<)FX"A@9I"G)D8YR&,2Y;N$, ^ B' T%YH% H%
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MU5;VGL%(!V;$+68*TQ44 $5)P$!S%4S+[E5E?+.<RPXE=56#*%RY<\3W1'P
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MMC_7^8/]HM _H,>U/_-!;'^O\P?[1:!_08]J?^:"V/\ 7^8/]HM _H,>U/\
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MOR1V.YB8&'D+ZLA8>8^Y!EQL%,XDP+>4K(ML%O5>T8ZNECFAU$XZ@#Q$O@(
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MM=%!(-?ZE8$=4*7"',*<I3"'5T@40"@I ^[ZU_\ (#EAH9NKY@<7-S Q#-=
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M'PX:C2Y=_L?GH7^R T%7A?>$=KY5ODQDN+-Z,W)R3AAV,7!@J.LLWG3"/A;
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MI*"$FE2T@V9;O8)[=X4E,)].T(E$;91Z2< (]04^5"$,9&+CX&1$$7Y6'B
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M*5(U=+?5G6VY#9CA;""-X'$Y$%UHRD@I'DL'S62*FJ86=<QTL+5LW4;DP"4
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M.PS'MG^;D! !$!$!YH*O%SL#- ]S'R<7)^AEFPLHV/X]*CB?KVA$!$0-;X^
M\\!QX\4%VH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M(D^8!\>KXB4./C05U H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MO@ !S007AOLS[(:ZXSBQ-?-G]%X22G\FE0I01HW[3D>I2=*C7]+54_V9(?\
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MUH^N/;;I_P"\R5(D;;0[5,B28PV1DI%LI#A<<6N5)9QC-)FV@PB=*,4IBE$
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M&CZTGD&4L]":%WN$0\XVRZ&Q):6V\%4]X7\"/K:Q:Z,[$-_&)QKQPYZ1P.#
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M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'FG^[!S\$>S)L$F>:P/4QD'7[-##
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MWWV B. )FB=7;*7 9KL2P3Z-*<V16KYP-MAMR8)(8^65 0K@W/50 !' $@%
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M:EO'N 3C-&S#19S25-E):<V($RO#TI,B2(I<E:PE![%9JB#<*;\MV@438"<
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M(BGGJ"CLL;-QC82/C)"1BPVTL),2E3 PL^VL*U\3J=U95/7#Y("-L,PI+9@
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MJJXBH3U\# C$](2B%S.DWC<Z@*'B4:"PC+^R@X.'E#J*H>J'SL[ RTG\^8V
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M9)V\>Q$]YSM;BVIBRF0GZKZU;@/^1M@D_-?94UW&*TWDY,5#0"K@)AS'0@
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MB=I!]R2FUXM9;<D=QAF !3^M/1)0++GO <?UOJ7#"(A_5H*G]UW7+W1+SV&
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MY, !8E&?YGMN_!;R-IK,BJ@9+@3D#-?&8_M<D].34Y0 QO>&0B6IF57&=IE
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MF#KOB %Z1N#R'4;CX#^%!2>V6KZD*R#>0O5K_("J E)8J)AZ"B/.;T&N&\,
M/Q^(!^@:"QID;1\DW[F6FL=HIN5DG3S9&5@MQ+P3F%.1_;"24>GJX%+;H>GD
M+X@2V(%* %^6@^[;CE@L_ 14MI,5I--.;I%#$0,)";:4E8"1A*0@=5*C6DJU
M8M)%M4_M^CIZN.#%'\0OH(*".?C*((Z<*KBX%S"Q\WR*>&=:PLXUL<BV6YT
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M0RRQ%,6Q.M49=L5K[#RHU(Q<\/HQXS!LSE,P/J:%5&D=\,,SAN6F(URD,5&
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MKHGZ1*0 WJX.RTGY&H[E@QD[*/9F32?>17[@\1SUZ*U%=PP-.3I>Q79G^UL
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M]R3PWY<VU4$+,F!'>&="Z,EW(A;-IRW),6&0@+*ZU$C);1+^):4+06S_ %3
M!>>*".V1VAMYM4WA!D]:D/'6AX;0/)/W?1=LG)(S8EXD:)5O<J76;)*H\89;
M+7!3< #$=ZP8J4CJYS^ID PFY,8Q0"KTW[)6U^K[G1T_&EV.\14:W9>E31#"
MDC"]><28E;"2;LI($P-1R-QCOMMWFNLL1M-M8$JJ0_\ ?+GR^4^<34&H-<.P
MIO/$,/[5-?&>&HD*J[PP]5\R%80B5T[(N?6]U2UK3LC&VPP3W)Z'(JZH+T?.
MF3+D<VD ^(W1+;M6SB;D #Y@^ZQVCN[Q*#OV6GJ5WCJ4G/[8O;+5F9Y?UIAB
M8YVC.#Y]C&#8X6HM68M=$NX#)"88]MW"W[><8;5M9M*Q^0-P( %!)_MZ]GG9
MS3V;H3D=RK,'Y"!%6RO<;G15;4?N*1P1Q;6W<;:UMABM%KG=6,18ZFHKQBL?
M4,OYJGX"4W/4?JQ0O&J_:QWHU>W4U=V827;KVZ6BTT[>*%)U;.:K/ RBVM?M
M@=U) VQCQ7BKTQMHP.61[U]XE!4,L&(6T(B7G+'@0#(.Y/VMISW%VKV&E5@N
MIFLEGROH"PM7 =RRCO!ROAB27#NTR#M@T51!CNXF7F?+4;OE8PD])5P$Y3IX
MVS<<@4Y:"06C6I6^J;O7-F^>\^;K6D.M_:_L'5UF1QK<Y7RZ&XELED+UQ^'?
M"JKOYLMTXN!S.Y7.0,0H& EL>0^7B@@0L=F6>9IUG[GC6.[\2%-C9![GNX&X
MFETG-]TJJ0K-I*D]GI<<X:8[7$DIA\I%:DR,.VI(B\7"((>G7PY*82\ $F(H
M[0V<IWG6T-L8<@F8H\>>@NAVB]C.L*95%XL$\'1O-;8G*0V,IN:,Q.U+GJCZ
M3#-WR!R"8UCJ$;?@4 TLF]OGN^1WKI#T3(4CZB[5&@EP3O"ER+]UE61'Q"4_
MZJ.0S9<6O4C2BD),>6EA.V7A>\AB@VQ)UV_0AZ0.(^)@E_VKNW3,.B<1S KO
M1.U_:DK35L0K3DL0'KJVE3/@"*&Z1#!HECW72V\L]B*C057JV$4@9:LH#<M]
M1^DQ!*7D HX_[6\H+K%[S&).;\9^7+'<QD*4TYBOQJ6EDA6)!^!$ Q!K:EN!
M,NFMEN.&,4-2.)NGJY 0$/AP(:?U:U%[O<&2 K3C=Q>WRWWI(%W476UX0\WU
M&8E&)F/JEK8RGQC.&3T!83$QH+#HGYV++O\ *)>!EIUI,3$4 ()Q\24$2(+[
M=G>3S=VW%M3M R.VQ-2PI2)ALA%?#I=L\77SK!KXXUIQ+#^;NG2);CU!92$N
MF29%5A!64@.I7%$HE.82=74&<0SV7-Z6RT6'KV])2U;3H6TD@7>F%=%7W@M!
M7DA\OY5VY,IMQG2'LO';R;XL%,!B,ZZ7U%(3O5TY2N'$O'!1&@U!VW.Q\NP+
MN\E[&[(P!J1!S#BS7"3V0R(;UC6IRE"U(;R454C5DR7'868\2_(A?KMM8/;1
M,#%.K]5N\'0)#@43!K[<GL^[5[$; 2+)D:HT,Y49R5*>HZ] #[?TU;2*AH$9
M,'?ES'!HN0X28;8+%SCM.%3CJWE^[EDQP!#Y$!#J\^ 3?Q^V!LY=UTVFU83[
ML/*Z[,G>A4-[0>[O3W:GMM)U[4):@N=LFXT#^V%DR+,P?0%&)A=71T%4"AF^
M'4(8SJ[VCM\84EWMG1,Y<W5]1TP[8\I[)/5F2(5U2-F[#3&68!DPZ.LK4?6F
MAC,-BFLF?@@=.(OJY;8D 0./' !-*8.WG-3U[B.XNQ[6!F6(QV [1[IT[:YE
M!SJ(*OYYN62'DXRG648,,"D:)4M7*<<PHG'GP*4!'P#@U*/V_?<;<D/NC7BT
MDPS(YLS5G5F%V?+[@VWE^&X@8/Y.QM'K<>3=M:XQ9'2K^<#J*XTE>%(=3MY(
M!5+D4L.F@ZQ6.S7)SM[B;LDZ1GC@(^EF=#S<?C<8+,5;7J1=VB:O6-,U9^.U
ML*C>])<!V]#]Y15TM>$>L%BZ3J+SU@(1Q[9_9SV)UOVDU/79HUZ@MK,/1J/Y
M4:J9L':V0G><'K/;D<]H[59KKC2'':OXS#U=1A1C"JK279M7.;A@* <=72&W
M=\M'^XCDSMW"6CK4B0A)$$]WN+8_B1Z/"99C66VX]6W.S8C<,:.MSH[-M,U>
M5Y#;-UC?QB4D(9A/:5# :X4H<\AI>?>UCNZ\S39K.U<J'5CM_;8*';X?4B;7
M2*_G<D[+Q<R-'H@UY:;M,MQNLLVX16?LI_DX IQC&*">)LP%3H$X<!'=[]K#
MN )\K)[70L6&Y,BB$]Z-OI*C^-\+:*0]9'-,C*WR7$-Q(CJD:8XU0UMWM6VP
M2\"LM).4BKSC0S&\D \=1PQUQ=CON!VM',W5WTK7I5D5$TI&!PS(X=3RP6/<
M?#C[I$<[9"Y%UPR*@MWUT@1$V,L%)1X!1&YR' F. B$HMMNRWL-.DM;O3\R\
M!H2JW) VV[=^WVO$<J.Q<CLT9Z;6MVNKFC*2&*[)2;ELJ]'+E5 >!_:Z_P!9
MAMB!3]12B!@#&83[9'<)U%?[;W=A;6N('ELJ6=9F5'EIOE;(2,ILLL)3=&C<
MC%%5+FV4\.1X*LBRTR+D3AGJ@FXYMKX\%$?E$)\03I%N+KCV!U_2Y&5HMC/<
M3*C^?D!N9*"Z!"-&RYIPG20W2D(& YW'@+%LMLC=?H)@&&V< N" ?'QH.-RQ
MV5.Z7+4CY\EOR.(R2LQX(FA[0SSOO;%<V8DMKAK/L.V72[5DDDOADMH6^PG(
MT4?-7#-=LW+EL+GD"!S<*<HAL_N2:^2!J!$_<#E%PN?!8.R4Z=V*+MKNU3[&
M*L/=\2I+Z8T6:V_8Z.V6C;!82EM9;N6O)"@"@)+9B'$WB D$0]-';*U*+HWH
MIKIK4HEP<AY,"/4[*E-4P3FSR..7W'<.[91<),SJ/>4PRGXM9HDN<B8Q0+X\
M\4$^Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#RC[<=YS=#
M7>=^Y^HHS3UL7M8^WXLPY%J:VU),DC$FU]R_M-$C0RH,MVUI.O+#+%J-63LI
M0%QB);>09*,)+9>HI3"&M8A[V'<3?[-G>*,*.->75L*E;3Z9Z]03,SBA?9*
M(2=&)N$,BI!%QU1-,!T^4[7Y5J\=7"FZ<\!4P.'' $X,$S->^X?W"\[;J/\
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MH30>;5@MT]W&*]>=4&V:9O8@[F-DT1S,VG+E36(M[-%AQJ\9?10Y3C)A0].
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MI2"O%-:%RC;'HZ1$"4'I'H% H% H% H% H% H% H% H% H% H% H% H% H%
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M!'8W8O"8]O4+9#92>G>[(D8VP_[V<>ZN*28T9)%KS>H)6!ZZEXVQ[P;OYNC
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M,' !XCB"/'PH+[0*!0*!06-26<%&#"%1R0Q_5%)/1,,/#YU-0$P6B /PY/\
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MU_B%5UG[2,P,!Q-%^1O<DYJN+8"=>I92[0)*!AK;O+*!;KK;-P5< +;MM8.
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M!9S<?\J,Q3AMB3BVH[::8(OE72GU)#-A\K0(81,A%?:2^GD5/N)XW.KZEL>
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M]J(75]CY*>D9O=4=&'J!$1M7W.W8TCR3HYQX =^L H5I!58J<%E_&65K.-D
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M#33'6I%V!&9<[0 8L>>?VU+"7@L[.:=MJ,ZVX%%4V/B)W9"MEW%<SC9BPA'
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MR]ITE*2%Y79+11DMWJZ@F(R8)R%M":X80* F\!.4H:AT0UF[BVC&@>AZQ%+
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MSFBU2UG LC(YMD)+515V[Z4XO? 8:B*,FCX ' @)0Y"S,GOV[_9K VA;SO\
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M)3=+5!;"ZU&JDESA*IIYS L%LE G W"F .,G<WVT[A;?T?V>TUGS)UX:&QV
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M_IQ?LC[TM!YN9*C;9>-H^>& TLX6G%MNV^MBQ5[O%Q:./0/(B8OS=(A.&?\
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M7>!X$N+YG1<A.&XLB7W&=.MIHN0L:LQ!:!5\Z42YE%3!5@1A.8G48"";Y1$
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M:RTUP7K3;*4F/<(9,*%P"$LX %,'2;@-*]V_M7[C[+;!QW.>EDLL!OED%YP
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M1_[8</\ L 8U!^RY%C)#^(R@Y_27Q_[/%!64"@IZ"HH% H% H% H% H% H%
MH% H% H% H% H% H% H% H%!:,!23EY.Q%%.R\%42U3$#+Q,S$,3.P,_!N
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MQH^2+&-8L%S'>(6#I9@'/?;OSS#Z:I%4B=8W' <#G$Q>.1#]4 #C@.!"Q_E
MV_0O;WK$B^E^M^N_5_..6_<?J77U]'N_WK[E]+^G\OD/K?1Y\>*#$LO6^/\
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M #D1$1Z0*0H%_P#:!0,?(Q\S'Q\G&R RL;*#S.-DXW D.00Y 0$.H#$,!O\
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M[$" 0A?$"&)@@Z'G_L E([T;\]2/ ["G:0G[(C21K@H:01RF,8 4EPW@/[/
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MW&;J($DQ@DM153+:$OJZ:VKCC(!LNVF@'Q#F=W>(=:^PFZ>]D0NQ+>F.A.+
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MPH+_ $& KK 8SDSQ5%]I-Y>51QDC!',4DI/4,X<)(6RN5*L<W?E B8X>,\H
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MH+?0<!/1D-(2, B<EI*4G%+BIJ8GXF.!26L>Q;*!0*7Y0#CPH,DH% H% H%
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M-B2(ZYFU<BI&5F+:3\UQI*9+NRD41L^%E"M9Z$X+9KZ6QG*I7"B:T/' CX"
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MDY];"_OO1;D["/F]FHZ84@716"()O4DSXIA@']( $EMC-.F$W&3N/ODVFVX
MW,)]PNKI\#OQ"SG>+I;#;;NX+-8>0W&TWTDX) &<"NL9V8;J*8ZEU%$#!T\"
M&GV<L:AANEVMSYN?(YN[RZN[ 1U]P&S)+5EYN.4$MQO)Z'QF_E%<C90HD5F2
MU#)C<*UBH)KA4U,(42@41-0=A/N-'(QRSAVZH]F' A?\L'(H[$O3-<>XK[E]
MMZ1ICT83.;ID7'E-C1 WO<4@2"J(RVHX;6M>K63$.8_!3 <1$- ]LU[.B<_M
MJ=F(M3GLGNM;PHDWCCAM6T)9D#!<#5=6"20Y&P6N&:^4/ZK-C]ML-<0O30Z.
M" 8Q!'JY"@Y(,%WZA,5MPLZ.W'BS&\\QM]F+<Q>[I2TRU564G6IN6:H:;K0C
MVR]%5?,J-4).:<UN0^:;R &,G(A<#CDI!+01Y3'3!&%JMW)8UAARLW$498[<
MVF)([B[7S!G,T.RI(S2VCC*W)KJ1LN:;?NB0)T:@"D KYJ?Z?;.K*2N0A,X;
M9LP0]E&R_:RC9P=F"6-&M1L'-B9K9+"SI>BI(S%6\_EA\S0S9!;.Q+:<%QV.
MYWK?JR/(KG:!<,WJ!B@2PI@<1*! "@\ZLM3-E[<Z\/#N@3]'CAQTC=K8?2'1
M!G(TVOQUQ#&<?ZJQ(CBL35+TZ+$/@ONLNMLH;2@L$7$Y-*D8/ %'D3!R(8GI
M0OLIUR[KY#\%.-DNMBQ_]P0U7[',=0R>1U5CL"-''J\]?<CQC0)$ 'A9A16=
MC;6?3<JX(^".8P?K%H,OA?=')?>K_9\@74_%]3WRU'UG[F2<NQ!%3:=:FYXJ
M?J=JQ/,9QNZ\DN#8MMT)%>+F;I%@$XQS&/<5# !2@ =8?/LF!' [<:$KL4RO
M"<<*(P=.1M[LV&GQM'<D]^*Z]'96]:3]W%K8U0:3)9DCVIZNB+=*V_40.JE
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MGK?@8 !TATJRC.[**D&Y-G)_!B7!#X]8?P#^(2@H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M:R88U,FU<@R1B-?:[5C;O:+#P4562%108"3J.TTAY.!ON$3 E<BZ\=7$+*@
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MP2W(?D^ ]7DM^;1;+[2,I1E2/KKN<4;R$%J(WP]$Q8]0:ELMQ0019*!<%94
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MRZ]I)EU0LZMM.*X[<VP+6F&'X]PY0ST?)QL>6$9MAC!'7.?Y$EQ94QSQ,3P
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M6 !$2@&I<#[B/30'BY8QR&YLSG)L?SNDZV2-L8A0P=QP['RD]1!'BJ7Y$>6
M'MMM-F7W&4WI*<)3*9N?%/ H=(!6;.=_#5;7.7'TS52_.SKB+7]Z)<,SE.D:
M0$M/B,TG8'.#+,2%QEC%SK;2M/ZT-D!44XV"(D, @4W@( &SXY[Z6AJS,"+K
MYE/B4_.*LZ*.KS&G%<AF2TR#Y"G9,5C)'Y484LW6Z1%NR:!+J<;.*8I"]:B
M\E ? .XE H% H% H% H% H% H% H% H% H% H% H% H% H,'>K3PWRT72S%+
M-7$Q)=B I-K,ST!84FZXTY.74TZ;<RV\OI9K:HD*U@3]=NX4>JW< ##\.#!Y
M^8%[-.XK,4<!W3QW+G).[]UT96P37T3=ZW#+0.H10^IRCF[')=@9Q5UE1S7A
M.LHM)$,4I0554P")!-]3Q M!W=AIHR*R8:CIE2M*&7,$H-QAMMOO>7,QL)#8
M,_7@EI-JRL/0S102E2$85E5ZKHX=O@H!P7DP_,(</$;L<N9%[6-WMQ)>TQ<9
MPNS9+'V#EN: BRWZ:^5$)RP9?5VRFQQ;?%L[<2;MQN)ELA"J]P.JSU"(@<0
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M3B,14388=D<ON=90?\;*TU)TD.Y CYQI<<+)6R,<$68L7#Y=U>%16"]*<4#
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MPA[((Q1-<+A 8WD.D$<,<VN[%]B8%:Z9B:^[=,E+<3+@F&W\Q8T[@T2-:()
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MA&3)!C%^HB])\<S&_G_&F&N/]QN!S,Y8;,BCZ)(,P+!,121,L2B5(7E<#"D
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M" % 39Q \ H->+.\FP6)?RK"-VP-V7!C>I>G!G83GT_3 !-.L9N"5P$\YLZ
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MV04/G*!1ZNGGY>*"L<.R,EWQMH@:<;1A>.EIKBOYR(J0VG>G)PFSLD$PJO\
MFN"89P6Q1 )EII3?"X!>?$*#+V1L5(KM <E5U%V(CQ-QC8&-?*[?R:%0$QT7
MU<X8:,V9B<9C6PR3A@FX'GZ@_'C@*#+7M,+S0&4I.MIZ_2A(2QA-U47,1AI"
MK&K?=:BH)[715Y/;IC/!_(S=(KK%Y2%/'G+$"72&#D0+S068LVRR?,P0RM4Y
M6Q+-]OE5 O ZH:NB"F9'<BL5NGM?F >X"D6^@6\$1\"E,J$-R  /(5>+,4P9
M"[GXAM79$PT7"<-S#]9RGQ$0%5&X14>"?[D2TPKT!2-<*1O)N47#,!;A[:V7
MXC;,80HEZ9I$;N;*F7^[3*RTB1V(^C+#?5H[4U.5#BDQ[EG_ "^;%M[@N\"9
MU*1?VB2WXMNX'/\ &80"'YBV;Y1?8/@KMU2F:*A:;_;C0;MA^N6&U0S\;RBK
MXV IR4V_84FO*U;:K?L\99@4#VE4P!\MKQ$2!41G.$FO]9>*6OZO3+$V*UE-
M/2\%5D13B J<[>O/\L94:?LN1WG<.F@0!.!LGH-QQP'Z0QC,V)F+&CE@/,=,
M)TR70\7H5KN"*L-UP.+UC)('!6^7V[\[\V2M([<$R<4A01E12S^;@?(8. H,
M"1MO)V/DH^.[NWCM*T/6TU-S\7+]VZXO4J<J*2H5-.@.,&?-BN#>O 4GU!NC
MU8(!_;>%!LW$V&D+-475C%U0G--QFY(Z2S4O*6AC/A]-Y2%O'N2(T01Y$6QM
MMY,"_F=7K/HY^,#X^(4'SS=A9.!9Q+#=U%GEQHF6@.Y1Q'.57B-JIMQ1;92Y
M+=1\A%=LDH[K3;CZZ>,(PX(!;#PS2D  H+*J[+2BB9&-B96E&RJM:!OE<>9D
MH"S!2L5,4A=V"W,5IF \T8GJ;@%N9PN " (E"R0"<^=^0H9]E3D][&4U,2QK
M7,V1?<B<E9JGD@>,S)K2SU)0'"N);ARS2"'%Y)/9$3#C?5#IX'P$? ,/-LY(
M?OC!:5O3;: $SS[E)D/<200#6(5'3\O,3#@ 309Q7#.CC^*#R!>@_ "/C07L
M-AGV?RYBZH[!GQC/-*;?@:'1*5.4$[%4SN_PE<1! 2;AQMG$!YZB_I#B@N"]
M.CY1)-RV/@:RSNXVOAM\7!ERJAFB 60)@3?J6V\D8JM*B<\%AQ"(!R0$L #X
M<B'Q#7^1M7)]@V8(:0;491,-[*K4Q_3_ ,@CF5$U-4<,A'OA#^>A#"VE0+@F
M*(AU" >/Q&@M\M;13FS'TGMJ-]%]A)I;I52U@+KU;SG@=DIR:924$0J6J(Q'
M[+#7O.)N\7,DV><H$.4+0?$!$*#9C8FZ3G#@.[/4-6ID:&,W?K%0L)TN.(1<
M#Y MOQ!!24615D+/2 \_M$]KJ^ 4%Z195DE7R,G&R-?Y$;UW#4RI^7E++DCC
MTPW6S_<!<I)R\!Z9P*UKW<<$,>DI0 P=8B!>2T%FD"9Y39N.[[K>U=E&3,MN
MMU174/":;IA]+,^U/!51LD;;>%WR,VPMJ]Y*(.64<\+0"/RAX_$,8?NQ,QLF
M]F$3=-IUD#%,@.M21LID.B"@!44FXT,-PIC>50<DIMOV^K.Y8,9#3^0,7U#X
M\%$# %A1]HYUR<>*+ZUH1L4@?F48/<6,+LUQ51A@WJ!B :43)DSF'Q(/5^P
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MT/NLU]M]HX7=VV;V:5UM:N#$>J\<,"0WVLYD?(V=:>"H^U6TMF$#%.A)I2W
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M;R4X5PSMM/=JG^HEMFS<)=$]FV)A* F)06O7SO2]S7:IDZ7-6%8\UX2I/EF
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M(@PI'"1F8IZ_/"^]X7?4'RB[X2?4?K*DTU)EYEQHNR.%5$5TJP=MJQ\02 8
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MW8'6Y]&8DGL 7RCE;+[3;"I:MW"WD)\-JV6UFVA #&  X,' @<-8PUV<=1H
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MB!&V13Y#GX?H :"2M H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M3&_L ("/]F@J?K_P?[G_ ':"HH*0;V.)BV>?^,=0@ ?CR' _U/ *#^963CV
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MLN! PKGX&'H^(\\4&(XW:S[=N,X,MU8^FT"XK@R15P,L P44;QO<=XN:JB(
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MV",+QZ5H"N/EPD;XHMOT]/<,F(RHTGXJI5OJ-Z9==+=6,S$N?3Z Z;O >/'
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M\:>GFOC>>BRHJZDL+6#'J#;O*><Y4I>1W'F99#63D,9527*H6S!TAX7!'P$
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M;W/BK*@!C!P  8W!N<TQ@ E=L'0!$,B"C:FPQ@9+2Y]I996K:\\U?V7FI?\
MHAFW &XT1+84CEZDT;8<&'PYXZ0K$WMJZ%HBBBJJ'J=#28H-UDFC9)R4YK6<
M"XG,0".+%*T2!;*!A;XE=RH;IX /XX?CX<!CV3VJ^WAEJ">M9&H4,WEU)NNE
M02E4[3(*@GYSVX]Y7<13 X72&=X"(*OS#Y_JY. _"@RRYV[-*<EO9;2'7"-S
MMC*P$9"44;TC]G*J4UU9S++=1E2T!P,I)*&K/E5.0MPQA(-P0$1X *#]Y_;L
MTS4<G.R<J"VX?$5<)4P<YNE579@M?/(HJ)54]L[/MN&VTQ$;Y3#SY+GQ_  X
M *\- M.\8Z,%F"67ABEIXH201/,KIO0E L.!WBD$\JN6C')[D<:@H_B(&N#^
M!0H,Z;6JFO32'".VHL0$BVE.*P[< ;8J)@P71A-5PLWW$ #GF,"J#9=J@G";
MG]2X;CQ !*&(.'0O3MWXR7CNF"6:X<=*;MQHX(*15;/ &YEI)D8Z3R*B(FLW
M$K@H_B!1Y ?QH-I-K7B%6<5G%;<=-Q(QXZ9]IA,?"QTP 3VNR@2"-P&XCX?U
M#!:L W,4N"(")A&WX" @(@(?,-<8+/E2'EGC%GY?YKWTW-D7S243/!U>E(K<
M0TL<H#B;K*1-9J44 *'3_("#P)@ P!8I U*UJEKV/;DJ"XY>^/&,B)TMQSBN
MAJ(ZEA,Z24X1^B\FU:.2Z"6LE ?UA  Y#]4?&@R/!UWA)/'$],C%FXGDC)/E
M/II1 Z!;2FS%9& 0Y/SZ6K1TA'*!OQ32>''/(?FUKO!&/(BE*F-$T?$DY73U
M;!5'X1L(X/16P%120U95P\QQ%M L7K1U-OIYS 8_!36R<!\1H, 5M*-2W J8
M*TM:[0\L*6,]7+)&"938*&I)UM\.EKX3-<+B*D'M74RY?<#;2R6SC<YY H#X
M'$W(9WDZ\P3EN%X.O(B&/<AUR*@W&F^749D(QG.YVSF-7!:0H"LYB8 +9VZ=
MI)9$TUHUSH"V % "^("&(_N9ZO%?*Q)YX59OOMPJ"THK+G&VHE4U!2<X)N*O
MY5P0R1*)E,$C%ZA .#=/X?$0Q12T+U,ST9-;61";,N-;&.JV;C?N)=M33%)-
M<BI@+2N@WL-4-D$](.N(B;GB4@?K8 <   -!AP=KGMY^1QDLFHL+8J9A8"*G
MXN!B-0B?@6TYLJX+;?M"2R:WP*6I !R\B(@(B/PX  V.@:):>MJ'L[7Y&UPB
MO#A%335=$S(M(TDDS(.D.(?VND>@FM!C FW>/$G'@ CQ^F@_C"T3TXB_)?.3
M'VL\+M/*DQQ-EW/X^ QD4HNIQM,V:+365@AK V[BFW15\LF"8 YM=8](A091
MA:E:Q)Z=EI&/K_#V0A*)$JSF(V6PFFJ)JB+>,O7$+ZF(J)U_&NG2?=*E](Q@
M$Y"W3](@ B A]L;4[6NP[\=_GA",,N1,5.3<$[\SFBC9SW4K2:02XGKSHR;/
MK+A-;'Q <PYQYY\?AP&GY![;FA\KV\6P^]48+71QD]LIG)6&B)V4"2S'B:0V
M^D?42+9#@EV'KGG41M@/3U71 P&Y 0#^G[<FD7MXC0+KE'6(S03DA$,QT]/4
M4QCF2DAXK[_24D[1Q,XS:"VEOMRY:OC\6^05+G442B 4&9$T<U5L+[=<6+";
M,PU=D-L&DPS8-@R=;9[<]#!M#A-/&Q+ED$0 0!\IS;Z0Z?T?&@SJ-M:H+B B
MP6-XZ06EC+PI.2H86!ZB&'=,VE/UA'/Z7D736R>EJIRW"\ 4>0#\!XH*]6@"
M)EU74EU2:9/-*C<]IJ.$555D](N-P%050; (6&H$2  +X]74%L/AQP'PH-0;
M$Z :C;7I+91-AH70))2F.=/]I8>:J.I.!*MIBLAN*T7$!O.!($I_6$"V?^'I
MX^ B AG>1JE!F5'Z_%^6TLZ^SG%<4P5\ '6[A4L@%3/0,XY!<@K_ +F)Q<;:
M>;PS.?XL/P$0H-4*7;ITX7/:7N*%$MU9<>I\@(<?Y[L<SP<ZDPTV3EPSA=1&
M0J.1QJ"NTB>O@!DX<*X0R3P'D/I!07YT: ZE/;,PU!W18=?R<3@<0,]]R0)"
M@/N$>"XXO  'P=F;SSR/\9_  4&TU[7.&79&^-$2VSL+-CS"7[;@Q&V915P*
M153G<5WCE!G%4"J9N'(7J,'U!$.K@!XXH/F[=:8,?J\Y7&ZXY;ZRX'O@IN"[
MU@3*F HJR:G8 X:7;RC86?9$2XY<;H+\!X#QY$.:##W?I)J9(#>1&V]H(CMV
MIC;3@3D$5Q'+GJ2;@ DBBB2TKW3&5N12L@2<=8\=7Z>!H,$2.VWHLA>K>B:Q
MQ2EY#A54YP+>:G(US 5%5PIAG+DX*IE*]K/]6^K;.\E7GQ$1!0,-!M6_J_#.
M4\T1YY3&2LS-:?I0M$F:93$6NJ)B"9H^N(X&O]1;XM(F*GAP EZ"#R/XT%9G
MZT0DHY2NJ7VC=Q%%=?Z9)*LII[H=:6HWWTFCF^D.0V6DK]LY,BUZD<"@4Q+?
M!Q$P#P'2%OR]2-?LK*P<^VR1P\I)%.'%N8+G=N%T@G*[/<%D@D(O$#Y<ACI@
M\\A\MK@1\1&@P)VZ!ZK/EI8C)=L7G5$'%2$A (!GS(_KXMQNJ1<_";^<[1>!
M72I();OA](U[]4?'Q$! -68O:<T$Q\H%#&@G#]3_ "N?T,75$7W(F:IYT8R.
M&?[P9N3D7G@<38N492/XB8QR]8\&#P$H;>9NBFL<?L[!CYF1^H-]G)& W$1+
M1\%^R'Y!-26HG?3;=NU;OO2YP1(N\91!^8_JO\N, W!ZP#9$#ZT0WK.EO% A
M=HF:*%(+_69)<>![G=CC*H/9Q)^!B+*W;N.A<6+B3=RK:3; Q<4P$X* @4!Y
MY"0M H% H% H% H% H% H% H% H% H% H% H% H%!&;;[8UNZA:PSMLZ\$K/
M<#:@R+W7(R@AIPVRJ*J1MI-W+*D63W!&W]52N 4G4;P+SR// 4$&>WYW,I(W
M)E618;EK3]X:U.]D1;'\LVE5/E!+G1AW$Q^!TGCIV/AGLYN)#$FQIW!#U-K7
MC&4+9>3"( 4:#97<CVRVUT]C5%E'6C2[][] 2,!\KDV'_.5H0_GQ.Q&0U?<0
MNX3N^U=,[[9RVLX#VL O64"!^)@Y#F6Q._\ 2#D0O ^U>Q^D)=2-3ISFB&8S
M:L^/?:..)(2KS7EQFR&^<Y]76FT6O@KS;M-5 8-LXE5PM&'U0H"7@I@$.N*I
MW..WXWH>8FP:]N-KRBPM)"DH(3%D92E-HX38=#C2\"ZJ+#>P,L5$I+CE2K5L
M39>$ A<M@8!, "8 H)'8\\Q!>C:W,N._V[E0[F1VI3$66DY3*I1D6-T]*]:R
MW>#WM@=O@D6T3^6"(7!*%L!-X@'-!!MC=Z+M>2EFSJG1QN+%;TR=<8O=$S2I
M<;!76K)Z9&K/3P5W<\FRJ)S=-CR.BMVP'7GBVS*Y[8&+R7JY"@_:KWH.UB@Q
MJR994=W(+QV#(RPY41FK?NL+V4JJ#:N%M./]CA;%Q62)%ZZ0EPYK) $;A0+R
M/  $@[.]^HE]@R)*.-/\>7(]B69TF!Y(=(*EGTMJ2^Y59G(Z0Q5<3F*>VL&5
MI%2""!0'@;OAX 80#E-KQ]P3J+GQ#"DF;O2I'FH#QFE+?IV[$*T62'*H],=2
M[*,=7)$]QXK+M6[,>/'"9I3)YU "@-T/ P@/(A()B]WR$6JW-OI%W"D. (#B
MF!]R'EK'%#N2Y32'Z,IM9$930=J"N&;;.%RN.R]%3'<!S746W:$Q+9>? "\T
M$B97[K?;J@S#C=9D[;V$FRB2VVF0[8X60=N,J(+L:4AJ+@3VF[D9921RDD6I
ME76RH]2@8Q;($L")SEX #!LMP[_Z5M.:6-KLXMH832)NDO 1UEB1SG/Q&]R.
MA.<YQ]M'2;07P&Z#A"^(X  /-XI1Z.H!#D)5*]]0QD94OIN+AY:I8P<\<3$S
M##@)ZCG 03D+<-_*CEMG.3@1'GGD?'QY //1JOWKUG:/<#4#6%AQA'JFZY^U
MM1-E]F"A/J:JX&M[:5H[-G)#$8J05*/;E-Y*:T&$I'%/'^+1UDI\D Z.NV'5
MR7.X;I/ T[L36*7=F(?C^=)']+]IQLZ'CCX#GS_5+Q+" 59_7MML7!>^1,]2
M/;]4$!);$PCXA\\3N+:/*4Y8^M*9M1!^=.N6L.MMXT7IS^0LQR^YH^,!G:U/
M)DNA]-VHY"F$4TPA?_BS"!!&@V*D;;:TKJ?!BT@S7';A1MGU!1P( <* Z$A4
M;\JJ2>E7U@Z8QU?'N&3%M1(E)9CE(!NH1(8H"(^%!@F^FZD4]OW5V5-I)>R\
M Z''B I9R(VC*Z4WU9_O8Z=<N-J.&WD*_P HN1W7B?3LAXF+QSP(!Q0:%TX[
MD#1G&/(6<FS&1$&I4Q[*D2EV#-95S9"-I(D9;8ZPD L,YQXZHW?1!6QD!#_:
M6'BAA\@3@O)S\@4)9,/;C6*3I)S(=8TZQ<OS%A8#GS5:(<%X(8R4E8+,6 ;K
MO%P,6YD$<2&+;7\TEG,"Y:*8I_'@0&@Y#N+OZ:ZXVQ: P,#*;:7%;?WID'1&
M:)(>#K:B*FMESLF(W"_[<O(J[:>!TBS%XN5(*DC=4"E$>C/-\2E"@ZFN/?;3
M9I1OB30Y-E8<1X<S,/S>),66_D$L9W>5,,'TTKZ)D'0 7S'_ /?<)_K<^'''
MC08]LCNFW8?U?G39>*&ZG[ H<+Q2Z)5-BH3Y1F6UW2FI;/%Z(]Q DA7M7VVJ
M(R\D 82*2:*D0##QP(B "%KA_N+:JR7>@Q@.:98IBO9*:HR8<C)NLK@F..%6
M74GWPBD6;+7.F(+C4A5E6P8#D_BA,-T  Y>.> #/\#?'2I8<\N,I.VD@+,>$
M IZPHS2W0E%H>K1:FMLUSW'E/+#]5$R)9;_EC>>Z^DMH2\'$!X"@V@I[ 0:B
M.C%9"I*T=I[R4XL5YUQF]GNQ%P5*]#C>4<+"6I1);/<(!6*DWU.V%Q4'BR &
MYZAX,)0U<U][]*'DTG,^FCM?KTXF>SG"V6<\'@ES$S5!LM=SO4;(-)%6UXJ^
M;%1\MRGS2AA!<.7Z@"(EY AND&%O;IZHQ<L34F;+PWF0JWU-S-];F(C]0"QJ
MEN%F#PY4&X^KE[VI[G2"_,*<%SZIA+X /P$+ZX=SM2FFS6))#LV:@MOQW)KA
M(U8W?2I*;.3VD^G*;J $IM.85\$=9O@)! 2D./'@(\ ("(;:59.CE#1O<:P^
M6FE-8C:.] <ZFL)J>VQ;)38@'<8N2_>(A>DB"B3BX)^#]8& >/&@YE[R=WK7
MC5'1M<W:B1886V+6PI$;$4-M C.44/!P'<]7"K6TT6_AO'"3'C9M*B-;&YDG
M+]+GH*)A$/ 1"Q[/=UXVK.M^LDKOC7E1R9WW"N,%HP1JS^<T3)CB4I<=:0J+
M*JW7%,68I&B!&CAM$%+^HZQ4KMHWJI3!:+R 4$M,+N$:B);*?#JD78^#&#G1
M WV N;!MU2F2/E<L!J4B&+BH[=?:PC*(XV->]P\II#G I;EP X\!"@S-U;P:
M>LF&VOL,Z=F8,;\$O<.IH2^I2BSL!@.@!3,U3ZFZYSJ@)"Q<^@F''@A_@4?X
M $("[%=X*$X=E^>(@CYGO:;9GUR86N;Y]C-1[M!%;<J-[:%[MYEXBJAJUS*5
MAN%CFPM82JI']/X&TH$,3D#@:@Z5)^T&N2G,"SKRGSG#V7.C>3TS/5X@Q9":
M)I)3K:H&=Y+ZC+]4%;*-STPW #;\.GQX#CD/P@;0:U.C,54YJ["0B[%) 0%!
MSN/$;DIL!9449LIAB@J.-9(C+UXR6CI8&_C;QP*0@?$P" C006VC[ONG,.ZM
M;4[!P[-<7;&*NJN$E9$B1_#+^93V>B,IJ\B-^.BDO)EIP>7QR6EAP 43G.6T
M ^'5R( (3ZE#8Z"8-8)I.FR56#$3#(BVUO*<<D.I%:J=:336RGZQ.KY]GK#I
MN? O5\>/$>> @M)O=;U@B[;>&=>75)\1-9A2OJLL;7XL^.V4F@DLE8;EQYMU
MBQRVFF?(N$*MJ[W,L7%BUEDN!9!+23"7J\! )@R?N/JG"ST:4;2UL=!L9OQ\
M8@9K/:#\E!GM5Q.)/*I)R4;.1DI:5,:]EX_U5,@ 8H#SU 'P PE"_K.R6O3?
M>V7&2U.,0I4C)[>57*KL3-?S5P7:G-ENI=I<<2PK-HRB9:3$A(0E$F::[=*2
MV6T;K$P$ QJ"R!MWJT,9.*:2['0=^4;47E-JN.4?S/9Q6$DN1O& JNW,YY&7
MB(@+-C@>;87.L"_VH^%!M:.Y&8$M-%OR+%[Q;D@L1TIY5%MO!GJB:X6TJIQP
M$ ,DK"3<.2\4P!\>H>! 0^/P#6LT[4ZU:Y*3'19\G>((:6)(700F)B28_FHR
M,ITJQ@_412N)4L!DF#]/P_#D!\*#^+&V&M3>F%GZ]KNP$.)4[O\ ,I@S8>S)
M":EN2W0*6D&<5WTAG&4R+-\I6^7S@"-L $@@)>>:"!>5W>H+R.X/*6DB4=IE
M:^ML/JDE[1[&NR:H\9#!AEP$, (T<XC<5;QUA[N(2VC"N'(>R1O&$ N 8W@(
M31P]X=.U"(T:>,7:&";L).'.*FH4K#*3/(QU-1,8Y/2,-R'7RX]Q7+TCU$ZN
ML 'X>-!IK:+N7ZG:BY6J(2U(Z$"?N+*R1%45N!ON5'54T+"^AJZS:D?(O@I$
M"Y%Q%0J8GW%C"-=*0ZY@CQTB4:#".W5W3H0[@,<MQ93\MDQ;,BTH3,.7KEER
MFU'A)J2V(CE=4B_-=V:D88(*UZ.KWL ,L#"FE*4MS@!,)0ZPEK"^W6KFQ+GD
M!EP+L!#\O/"+\LF!(K?C5]H3TS6IGYER[;ME5BH^?<*!#7,0Y>HO)>H@EY >
M H/[C;>ZMY,S8FN>)L%#^7/V5[B#%A?$?[3-)1S-KJ%P%]G IBLV3)0$'KZB
M!X<CX@ B 654W<T_19&=T.J.S$%X<JQ^@G<#QC:[*+.(^VTEX@"<Y\YL&4R+
M! YLCU%,4#@(? *#("[8:Q&2F&X3S]#N(A2M'9I;C=8SI :">F/V-,0C?,+\
M;=_-5" JM8@.Q/ <NV/27ZA>!X\:# [W<"T:LM/!?%[;G78K,5)/P853W=^<
M+.,V<R6LX!OX<=65HB\;&]UGM% WTA$# 3Q'P 0 -A?O8:S?G?\ NT?O!0_^
M\3Z;ZU^27O\ :?YG>F_^[/9OJOK/'X?J=7X_"@P+*WUTP!6D5M)6S$,NUXQ5
M%+LFE]LMAR TGL]$:-F/:N'<COO-IMJ*LL?021Q!+^ISR(<@/X!0:;[KQ%N7
MJ%&.Y315T)NQZ^F:+M5K:BZD52_+$<$HF<C<?#A+?(CH[A9XE/;52W!()#$$
M?U>DU!H?97NI:J0UI]L'NI'<PLW8&-]6UX$"44:%'6TWUGJ3U4%A.9J+&AES
M$6?2&GDWG<\DL!SS&, $+X=7S=0;BURVN6W=K,S9[V]9C<TP678H*8Y;0DJ6
M(V56VEIZHKJN8QA3)1;Z[[%=5M?8MJUFVS6[G48YAY*'3R(;=2-K-:',^F;&
M#<GZ'5V19'9RA(T>,U%DUH*3D?#&P%($HSM9Z7@J9RN9&*J'Z!N637"%-SR/
M!3=(76QLGKUG'D J9.<0*IHK0E=>D^PCR$TEC.8* W _;ZL][2<J7[K6QT<!
M'Z@YH6P+P(_U NS0G>%9%M/N\P99CM\8\;*=Q$D7+:+Z0G#;8JIAI@JMW$=X
MHZE<*W<@F,'6)3](G+S^@W2&#LC;?5R1\%GJ$>[ 0\]TV0'(=B,3.:TA-)43
M74],-J8CR]FMN[@J)K:LX_:*D10!.*-RX2V/B4H\4&PV1,D4R59?MYA2*T'7
MAQ2\7-&\D9*"XDU0!B/MEG"T[6H[@MF_T?7FV<W\=:NB!B!XFX+QR&CFCOWI
M$_&M*+V9FUFO[M:$&J*:BRZ[4*46>J-J,%-353)*5;>:W94QPT,515)](IKM
MP"F.7@#?B(:AV;[ING^M&DRMOX,B)<N0)9SL!&:*Q#:LC.@9)<*B[;C2!!8]
MPBI;2%94(KV<HUP37"$"W9.83_+S08CK?W,8-V-V%FV+[,BL5AID9RLQXJB'
M"7).CHKDV15'3$*%*2NKM!E>HW7@*"DV) 2 P3$_O@B(\!ST@$RTC:S6=QS8
MM:YH4\0ZK3^V$\%!PP[@R ULV34E/-T\^=:!%$5JT7YPZOD^7XCX4&B7MO"C
MQCN*JZV24T<!@Q.W-9DG817VF>3Y0&O'B:ON*8/R@1(ORTM7MV M9MZ]D$O"
MH&4 M!_>Q(4?G -^9FT^L^,UL%]WMBH,LL557A;Z6\CRI'Y6JI.+&Y^HWL-R
M77'Z1>6"FM<C:"YUE#CX<A09%C3G#"A84[Z=+D99F.AM!.?R_E8K_:8$2&0I
MD/E)CU61*I'*DM!4(4PD43]-H_("4WAR 6%Y;0:X1_(#0BA^3I$++D^00P2L
M1A.N06FCO9UFS^0PO;C8SU.VLJ_U3!X#;MF 1\0'CQH*W/V-@!(<?M%2FV*\
M1X^:5$\S/.^FH1S&46_U^L8GMPR@5<&XDFM\G+T=1>0Y\!#D+I@3E#"H^56+
MTN78OS9,2 SO5HYPGXU%%\IPX/ADG56=94_<MCZ(?K]=HO'XT%<TI:C&15!R
M);"D5@/=3:1T_"<F"TG4AN92;6>HE,;%MKY$11O"EF.'B!#=)AX$0XXXH*Y8
MDR.VXZVRPG"^6>A/=XAG@T6>MN9&37.Y_(!_*[C<0<W)(J+)"\\F^F4WA^F@
MY\,+N?QU)O<0G;M[1W%$I/%R:W1TDO.6Y?0K+2S(W;;A<UUI';T>7#"O65@S
MDN)[D.-P!(4"W$XY>!$##0=2Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M0%[G$"OC:7M\;=Z\QF3"R9"EB"7ZT61B*%SR";GN6^CGN)*5=./5TVE2Y;^F
M ^)0ZN1X *#@7I0R-L-57%/^XFL':1D37YGX.J^N<(%T',_6@Q7)L=LQ;F$Z
MK*NP6)=4G [K)4F-6"Z1P"KBK^V7 0H\]7!S 'H6V7P7S+VF<TMY+2,K$D20
M];IX:UJ,"=!E%S/=9B-W-[':*.93\L(B#@NAT& .#%X$P@ B-!Q,8&J<FKVF
M78ABV0]<U!PJD?3GJS<V51'<URJ96);U\UOV69[BQY3:BN0Z.E-ML.44P$XQ
M0X!7. B7Q+R',#;?MQ;/H<^._9:,X&W::L8H_<+WX1$F/]3[C0-L$KIVR[+@
M\,?8Q&_-D'LQ!BV5G^BN-"4C#:(7VYZ=QP'4 !U>TVU*D;2+[=39"$-@6(J,
MQWXVL>^KJ<C!!^VW$Y$ANN1I2RK)2'G+08)6>AO$[0.4# AX8H93E X (F,(
MAQP9\ ;X;I]M;5W%AK0A3ADNLO:/GZ,VC(N>YXY4D[<HNT\.10Q+#;B]%:=T
M7)UNYB IO<?4Q(4'4)<+CJ$3&#H?NKJ[L*Q)DFBU!?;G;FPC"W7[8L8]NB"%
M<BE'C'4-;Y$92-,B4IH[G19*/A SXO,UUBTKW+F"!RG]L8!0 !XZ0SG([4\_
MI^_6H##S&V+MT656UJUM%M0K*"HM./ '<O0Z"W#!+-2%<F>OIMY=1)2,LLU7
MNAGD5O53L\3&#I+0<KYX[9.[S:@_7EE-K36:0DK)T$3(SS7W&CH@=[QBZ9+#
M8Z0)N58)WLB^5#.1(/"K<%93G(G*6$4 !2#T_D1Y!-#;L1:);UZG[;N'?9[=
MO4VU*(TMU]TKN9!,<J+02G&DMG8*(]:FFD3] ;1<J_<1EMFW%5@+J GIN6!3
M$0C^/0'!Z"1>C?:/E6+Y.R[&QNIK06V4Z>V'MTF8S,0T:.W&UXOD[8+;]Z2@
MWM96@KKUG%24I[-R*WZ*7UDX1> YZ@( C0<N7=VD^X9B*^M8DT8=ZI-ZC#/;
MO;V7GH+IUV>NO*Z77U$;GO\ #<5O/&V5\QU(C1QTOT).4VZL%3%DJ8(?$!+0
M>W'2#<U/W50MC'$BQZNLMO0=MS.^L#><*BJ6E%-E),A-:P44\JM)4QS<BT7,
MH=9+0<" &M" B;QH.)G9FTAGV%=K([E*:87SV4G,OM$ZP0%><#I3D<5=NRVE
MRV_E=Y,6V G,J$5"-/Z7J=P  .3E PCR4*#DCW/^WKOWM+LAW!BI&I<O9M[8
M&<( =T+/F&86UN;T8N6$VRC(#057E-,I2,*CL==D9H-VQB #01,Y&(*P!E 2
M<!Q02[#M'S&RX?=2RCZJ-S)GY ^X<9.R-I]IJ8B*KY6M2DB1V>M ]6R[5GH=
M_L4IE(^89-"YU%*!Q$AA+X!D>IS#QFYO7N._;,I1[/\ HKV1;6T\\ZRX2"_$
MO,4<";-S&K;F>0F2X'A;-BQ:4L$BV7LD$ P]2 9>#JX, \!V'W'._.X[V,Y4
M7VQ""G?E+:+21,DAG0=EDP'"XD]\OAFISO;3?2#W+=DMU6352X0Z=E"4INH
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M//L*[!Q4G.$S5W+WYCZ9MHI/6<!0O=:I,.S*V,FGCVXICRIDM^P3IK%,;J$
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M_;9CK:6:&DA,#<N3=3I2G7"CELQ;)#]9">EMEP2TQH#<\JE;>=ENR'H3DJ0
M;HI2NMWOI*1G ),$P\B<@3>S>]!JY J;%4;3L983IUS6E !IUQ(9C*077K_
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MS &DT'OM:CN'=1.UY2WXT<O7EP:-&W2;>T9E%TIK8-;;+P<5IXLM6M++3M%
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M=*7=^JW'(EJ5FUEI2\WU>USBKJ J6[@&Q<W$,>W<+XE$>>0#85 H% H% H%
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M21.ZDN=K+/;:C%LNZL(K*D-98[]LI+F4B62/6(7H#H2%C$-<2C6"= &,8P"
M;)T-[G"INRJL6UB:MSM'\;R5!KGG*.Y]=3"6$V('VEITQ.V-D1MX2P)<\6XY
MG&STM-==NVJ&*)DU2X HB)>0ZXT"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@QC.;B$JJZ.MJ"0GY2XWCJ!V\L9>!@9:FD!GX'
MD%$4;,-;.=-'((8"W?$ /^J/(#X!D] H% H%!:%%.3EE.RTY1Q,-23%+#/A9
M>)FD#,P5#!S &V?'R"7 ,6[:NE,(>(&#@WX\T&-L9@LB+FTD,J.6<W6"T$:V
M.*D-IIHZ4W6XG%X'@MA*2BV+)!,)0#@H>/X_IH,[H% H% H% H% H%!KC&BZ
M.4Y\9LC)S"9F%("FG^G*S[Q&NCVWLI)O1T%P,MU6K1'!>L"%CCI-<,4>/TAX
M!L>@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@YY]SW4%\
M;WZ.SIJI',HC"KKE1&;*9@O<UI1%/*G);P;KB6FLLD05%+6SMQ\HJ/=1<\I3
M@(X]XWR&\ H.*NI78,FN#')(+A77_JPQ&X[98[<4KH$-ZW1A(S;C1KFTQGG$
ME]V) 9KP=*NZG>X7"CV?3R.U5 ZXL'.(W?3RB!2!\-H.PE,TTK[YDEU2?!.Q
ML@YW<(FK;"'XDFZ,%U/UK".]@8Y:T<.^,YT,P%[$D*\9)9T4-DZ2O)1^JVN(
MH?R(_J!CD#ZQ;V3MI=)+$ 2?J&[]9'%LNTF?L=&\W-YXQ:M,?5I_0ALS(R>_
MQC5H(:2XW>\&S^1+Q, IN88.M>0R_M#C@4\P85-?V]FU$R#,*S(&UT#SN^YA
MBO3%=673-,.*OTW9LOJ$L7"XA7>D,X2)MN Y.9;N<24K$P0*K@!T_IZ^D]!5
MQ7]O/*L1ICKV&8<BZFZU[D($V0M/$,-F!8:D?,U'8?Y -!_-FY'CB2WH]32H
M_6],(OH^:MJ-PGUD"Z3]ED-QXAUL[9VF4[:ZN_:O8O9R>HMFN:]WG9&,IO$8
MABI3B9A,P[(8%QHI:$UR+3F7EIV)=I#N$(11S2V,WZ=L!.7J$PB$)= .S]L?
MI[(;"4W7/,8/B&M?F?OM&.OL=8!7<551F/MU-\?RKA93Z>5]%127G6@F;:@1
M8-:3;A!N&+T"!0,)0BV^?MTG>Y$>#%AK/C5=9D)(TTBO1*6UW:W6Q3G)*:.%
MK^TLAA-S8'5YLX,A-U-27VY2)&(()CI!0MD*(&$P !L(0VEE_;UV[6O7<>U3
M+-%BRQ-S79J5F0@\Q:X.9R0U9U7CU$M(ZO)Z6HJC>LK)7"J,\<#I23 ?Z=P.
M0#DQ2AI59[ ^Y^5#F0Z&*^^WI#FX&+OQKAM@S<*"H&5XTUIBULZ\H3_# ;2+
M9PV8N2.Y_>TBN\%U11U,OHA.@0*( ;F@U;O%VZ-DD2*H[AI9=LAR#W0>X+OR
MJS^Y=A-;(;>)M5X';KFC;]W&6$ES+*]@*GMR,VIK4[U$2]8I[E63EX$.D@"<
M/1[&3)EN%9NS$9ON5MIVAFO.KL40Q&,7(]PN"Z4J2D55/BNQV/-8<Q$VT#99
MT66D;I#U8 *4QKG'6)N0Z,T%10*!0*!0*!0*!0*#5+*;S[04E 3W7(IWZJ)N
M(Y@<2Y[:2&]FN<V>J?5;ET+"2>PE(PH2<<;0EM\C<'@P_$:#:U H% H% H%
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M9N48$M-3TQK*F TXH*L-M"<&&0PNTEE7$1S+QNKZ2J:XF" !@"(ATAH% H%
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M\'M.:K^([C>K8C8D)\1JGJ0NNX+'OVDB^XF*Y%:T5DW0]6*>Y:Y6 $2"-H
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M5%;UCPG@5XX0KQ,!M2IGME08WIB**L*&)G+@JZ8[15A5.@+I3V1(%L3 (]5
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M74W+1U;%+EIF:0,3)Q3 (E,0P (<B' @7CB@O- H% H% H% H% H% H% H%
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M5C:J=6%@IRHKP[K6KRQ'&&XDU8.Q[DE,=7N*)?==QO*+>6KEGBXGB5,!2 %
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M7F*(0WCEJ%9.CS8E?TTB-K.Y[1M%,FM$SC3,]ZJV3:M7!<X)SZ0L.T:W?Q!
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MK5%TFMI;P=.P'Y<OX!7$P4\C;45XF&!?E P4'4'=OMA30_\ MAP=H?JDHH*
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MR6A2GV]6K.L8:^1,QG?'#)472J]QN!H_%LK/_C9<R0]W:W$9.#I<(@ E*(<
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M"C?3G9)]MB698FZ>7D^(';>&_'$_G(M)AW0K0A'!XR!/17<HXI""CV_F-X
MALCO9-YI7=@M+W;-&/L7 ,-MW DYOX?<8U!6I'#8#6N2WN9O8F-&5])CAL/
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MK!86-!T[XD&93??R*NOS*S8H19:%^L9-$YEJ.R$<+@0BM,S@+; /5B#<NVP
M.D/F\0D-0:&V%AEN;&1%),!OS"+G1A-T>ON,)/QR*"HGJWM9\-11;MXS=N6
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MV565HN84E*;(]UX;1RWTUTESBVK;W:]QIO@$D56T8UHCL:5T4[. !XN6^2F
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MZ?GL 3%$2W+8Y &#K((_B CSX_H$ I6]B*R>D8F(LJWKJIC6^G,5/3BIOGC
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M8]T/93 R$[ ,40(4ESK$"EYXH-&Z!)><F=ZGOGIV=E9J!E.55[=<D(&"? (
MOEE6=7WFP\A4"Y=P;@"AXSOM'_5-R6Z3CX )@#T&T"@4"@4"@T7*VQD%P6JQ
MDWIAEI@QHNS6\4^.(F2G<YDM!4'X]U(]NU@M5IVLLQ3*ZM</DE I" /B<OP$
MP<AO2@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&.$<: .8I)Y%=.]32@3_
M %G$#-P//IA5 .,,5,GU!"R!PYZ>?B'PYY\0HL5UMC+4<Q#PUY%OJR4H>25T
MO%5$TV>F9^8G^J=&9AB<;A+MRUE < $ ZNKGQ^8*#(/4$_\ E/\ *\7^3?\
M&_F+_%^'/S_-^C^K062P[&KE9*KCXKC0LG*2C$Q5G%!53N4TXD\QQF@!^JUP
M3)#GJ\/']/-!</74?_*J9_G.W_VZ#]"KI%GXJB>'\!E.V/\ N=9J#\^X$/\
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MH):M#O7]S1_ZO:J2D)HPPI/W7S]JMDF*2%=7I+V#2XOU^U%5VC&H0SGQ V7
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M"1MFH.W(W03V=(Z%L<\F.GZ8-G7HSC]BD8+;5G);1&6VVNC<9F7B*?6(@/P
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M'::-\/0N<];9*RE#7+8DITU9"76%)L9)+<;YHI]TY"LX#75\N;>+:%-M CE
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M!-X^%!:LC[E'M"X^.E9&5/,H86.KVO/I0YFI.U!05<(%4R.)L$?R;X.7U4H
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M6>\GPF9DHJR*RF_(+A610X G=25#)T:=/N+T=O6XZ*XG$(^HV_3O3K9_5O\
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M<W&+^BE?47PB7W?C6KR25,76 L%;ZGA*R0XB8"\-PYR]0"4#B%OI$W@<!H,
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MGMN2XEMM08"JR(<4XWUEBA[VMCRQ1'<B1[<+*7O)%>)$Y=# $J29?%1$ $H
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M>!G%M9L;)LU,I6@K3N!'.V;K?589U$0G61T-URB4QOD<T\.$/<:O_%@ F/\
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M3<?UPVK9=;<SBM_RRRFG]UX(YS=QP4+09KA312_/?43"&O6[A@+:N 81 ?@
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MX-?W#MYO+,GHV ZU=,8\@8!>VYJ(TM9<EQHN"X2>L-X-C&<LF0O .'$C<\
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M(=K_ +,IH;D@EYPFE0],;JAB/ >IDH22C'+%3D C?E]H%P>1]FNBY=,"?U
MA],>?AX!)N@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4%IS\'!5<#
M)3E+$PLQ.S2FQ<G#SB$S</.M'X#HN6[G)3\B'P$!\0_@ 0#^8V!@85_,R,7$
MPL>^J'+E9F23I*.;G=!; &/\3'$"E .?CX_IYH/WFX":I!BAGXN+E^5S"9F(
M&2 ")%##$P6[UL.!^:V)1\0YX#\*#'L]DL]4P<U/46\FY:8I*1EO,P\M/*8A
MU;GD5,X& .+H=(>/'(?UQ"@O:DG)RSC^54<3"4\8>G*#%S2@8 \!Z3<"!P
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M#$Q</!MV\+$P;90'Y"6K0])?CQP !XC^D1&@NU H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MDLYU2;*R5G[31LF)K"8S)V^4=-<U/2EDJ1E%D9[/J4FTKE:Y$TH$4^@O'/\
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MMSR!#!PJ!],.A7:\[U2-W.9&D>.4G7%S0KEQ[#+0F@ZJZ'^DN>T=.?*VI(R
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MQ(IF)T+\Y--WMI;4E*:H4)/=^9X_C[W&=W X$5T(Z)T-_/5O-B>X0>HA0Z1
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MVD>P>F2$FYLCY$\)FN3EU^A:-)*16ZE &(_4D(J*+9.X^1 "F$5$'F/.6 >
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M;$ZHZXA:B_A:XHMI(47*PL^VEIII'9UO";=PJ4XD>*CN+#PLLR0G" B'4 =
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MI/W67(YDAYN7<?0E:=6*I=%]QY?;Q6,]52$+.9R\V7!D)HGV) RNLW\=6%'
M#F(44@0 Y@YZ#!'W<#M:]TC9R.93BW+W6TH54.2(_56+G+.)IB\8><:NF/@C
MR17W:4?:L[O$I3ME"=%PZ&&=ZT7U96S3B7"YY.'H*A:.<*&X@BR(TW,RU1,B
MF.F1&V KYPE'.4T]C-9-;>/GYG@ A=OD3 ,8/]]0;2H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H%!8K"NG9*OEHA!)ZEA8"=GY>/^
M),-4.HV\0>/ /$R4<!H+[0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
C0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>s118023_ex3-1img04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 s118023_ex3-1img04.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@#P0)8 P$1  (1 0,1 ?_$ (4  0 " P$! 0
M       %!@,$!P$"" $!                     !   00! P,# @0$! 0#
M!0@# @ ! P0%$1(&(1,',4$B411A,B,5<8%",Y%2%@BA8B07<H)#P5-C-":Q
MT9*R<X.C)>'"5!$!                     /_:  P# 0 "$0,1 #\ _5*
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M2(=\@ 1 'U)F=V;H@_-U_AF2+EO%.6<"Q5[C7*LK9 ^4X4XSCI#!_<GEF?\
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M1T?T0;& R- KXS23=J.)B,AUT<W%M6CU;_,_1T$D^.?+0_=68V:Y:=HZ(1:
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M43Q=HVC]8]K]6]].J#0R'B>6_4Y!7GST_P#]2SPS9*08(1)XX &,( T;00V
MP_7\4'WE_%396CFH[&;LC?ST,=*[?".%B"E$Q;:U>/;LC%][N[]7=T&]+P?+
M2USB?D,T3O6*M$4%>"/;N#M]PF9OU"&/5@W=!U]$&+%^-8\4_'):.4FBM<>H
MR8SOO'&[VJQL.@S#HS?$@8FV^Z#7Q?C/*8Z.6*/E%P@L9*3+V](8 *:Q(^[:
M9 S/VF)F?8WLVC]$'UA/&EW%T'H-R&Q-7DMS7;$CP0!8,[,KS3BTPBS@)N^U
M]K:[>B"3DX7/)SF#E9Y65_MJLE&#&]J+LC#*0F>A:;][D#?+7TZ(,G,>'ER:
MM2J'D)*=2K:AN2PQQ@;3'7D:6,3<^K"QBSNS>J#SG7#I>5X@,6^3EQU9YHI[
M'9",RE[$@RQ@[R,^@[P;73U]$$=G/'N3S..R5*SR*Q$V3KE5E*"""-ACE_ND
MPZ.SR&+,.\M79FZ(-D?'E)LF%PK1'!+B1PN4I/&':MP SL!'IU$AWDS;?9W0
M8(?&[EC:N%R&:MY#C]-A <;*,0]Z*-V[<5F418Y0%FTV]-W]6J#=#A(21<@@
MR%T[M3/Q-7*L\<<05X&B>%HXNVS/HPE[^Z",/Q;%%!QFKC\I+4I<4!OVZN\4
M4K%,T10]Z5R9G(MIE^&KZH/K+^,WRM+)#:S5DLKE("I3Y1XXG..D;ZG6KQZ;
M(A/^IV;<_N_H@M^.IC2H5J8NQ#6B"(29F'5@%A;HWIZ(-A 0$!!\F8 +F;L(
M"SN3OZ,S=7=!SDN:W<9D[AY"X<[B0RT:L+ =>U7NR]JF\1@V^-P=G:1B]?5M
M4$E6YWDIQ,'IP5YJ5?[O*=Z9Q&.(R/M,#,SD1$$3F[/^7T]4&.SY!RD,&/B;
M&">6R=8;E>FQEH,/P9^X>WXOO/1O;ZH-6WY*R=1LK(]:K.%220ZS-*X,\ R-
M6C$B=GUEFL;F%FZ:,@WJ_.LL4&-MST88Z61M3T1E:4MS21M)VB9G'J)E%I]4
M&;D'.K&))H&J =J"K%<R$9R.+"TTC11PPZ"[R2&>K#TTZ?B@UHKN=O6N09![
M\=1J=B3&<?B<W& I6C87*<7;0R>8M&^FB"/H<VRE<()I)WEJQ?='F(+>S[FN
MU &CDCB*+0)>Y8)MI>FB#R]Y1RE2Y,$]6K#6QIL>3(9BF/M]AI'BC9F9NX)R
MQ@7MJZ"Y<8R^0RM&2S=JM4-I3CBC8G)R =-"=G9G%]=6T=!,(" @(" @(" @
M(" @(" @_&7+\?V?)V:B<6F?]VL <+%L(@D=I&T?V_,R#'R7%018>5AKPTW%
MXS>1K'>D8F=V$=K>SOIJ@C,1+E99,,-J]!?^XJE!!6C=GDK10E^4OQ(O1!=<
M)-D\5FW*&2,8P(1CK.+=R2+HYG_X==6]>B#J5K-4:I1:S"Y2GH#1&+NSB+FY
M?R9D&AR/C^)YGV,Q4O15LN\3!/5D-HVL,#Z!(+Z]#TZ:/ZH*6V$_;HK<45V>
MK)3>*;):,8D 2/L!_B3.XMK_ (H/<CQ>2":S);L3]Z 1DNRO&W6.9V:.3I_2
M[/IK_B@DJ=FQ@N/94V<"H11/&)O&XO+-)J3@)L_RZEJ3M_!!%<'XY6R%26SD
MYBCA-W.K#&6U_EUWDW7XN_1!<+G",%#ASL 4XSMH\;.;.Q:_3H@HN0<JW=BF
M^(@)21&6C,VC>A.@YK:DN6*N)"SE8IZ4LDT[XZ)]3K$1:&+Z-ZEKJ@ME['A'
MCI'^P&*,8W>ODFE=V-]/CN;71]WT]D%[_P!KE-GY%G+@R=SM4*\)NWN4LIR.
M[?\ X4'Z/0$! 0$! 0$! 0$! 0$!!$<MRPXGC>2R#F\905S>(FTU[KMMC9M>
MFKF[,R"D3\ORO%\K0I7+LF::Q1 ;X.($\.0,P"%F*,6T:9W/X/U^.K(-^7R'
MG8GC8L7"\G8KRS0=]^YW;5IX(H8Q87=R*,>Y^'HZ#[O^0,E)I3Q=>NV1GF.*
ML\\CO%L:V-:,WVMJ^_YEI_RH)?!<JGR%&6U:CAJ15>]%;F[CD$=B&8HMKZLW
MQ=A8OKU05BESG*8QI:^2EEN9MI?LBQ^T2B>?MO8[\4L3:]DH=-!?JWN@DY_(
M&2:A=N148&'&",5R(Y]3*X0 79A81?<S%*([G]=>B#8L<XO0YN/##1$[D?:D
MR+L;M'##,[N);W'3<P Y.W\FU00T?E#+QXZ.:>K4.<IXXC<9B ?^I<I(A!G9
MW)PK#W)'_P $$O5YGFY)<;'+CHHRR]$K5$.Z3$\H=MWC)G'IJ$FK?PZH+DVO
MN@]0$! 0$! 0$'A@)BXDVHDVCL_H[.@CFXW@6AE@;'UVAG<7FC:(&$W!]0U;
M3^E_3Z(,AX/#R2]TZ4!2=KL;WC'7M/\ T:Z?EZ^B#[EQ..FF@GFK12S5M6KR
M&#.4;/IT%W]&Z,@Q2<>P<A;CH5R+1V=RB%]6<^X^O3_/\OXH/E\'7*S 1[7I
MU-IU*31BP13#K^JSMUUT+I]$'UDL+6N.TXC''D8A<:EXH@EDB?774=[(/FGQ
M[&U\6&-.(;$+.\DG>%BWRD3F<A-IIN(B=T'V.!PPPM -*!H1C*$8^V.UHS?4
MPTT]"?JZ#Y_T[@MIB^/KN,@N,C/$#L3$S"3/TZZL+(-RM5KUHAAKQC%$#:#&
M#,S-_)D&5 0$! 0$! 0$! 0$! 0']$'Y/\]8AL;Y.N6.TW:OQULA&[,^KNS=
MF3JW_-'[((#(A@XWF&&*0SFCUB-B 8X]S:MH+;G?;Z=4%3KQM]I+'2Q127J,
MSV[64B=]8ZQ-IM<6;06U?U0=8:<>3!7?"5XXJU> 6GO[&Z&S?,';1O5_7J@%
M#D*MUS>HXP2")-,+CVI!=F=B$WZ;M6ZC[(-Q\_\ IO/!BA*3OC/.9LS?*!OC
MLT]_BSZ>Z"=&YQ;D%V_E[;%5++QA6R&/$GVRG$[$T@GIJ(OTU9O=!,=O!2#+
M)VZYNT+1F#LY$<477:PD[[M/H@ALI2M<G^VJD4>.QLC,X12:--*/_P *)ORM
MH@QAPVO!=BG#.QQM7:*I+$VC.XQR.8Q&^O\ 4SZ:?@@QY7D&8>R].26NT<<A
M! SBV[07=F]7;5^B"G<UR&3EQ;UHB&>Y=)J]6K'$#%(9^NGYO9!0('A_?!DB
MQ@XTJ0C!8J,[DQS1_P!QSU;IN?U9!8,R>+DPSS0U!CED<8W<3)@WD[[V:%W?
MIIIH6J#MO^V+$/!QG+94F;6_=[,;[=OZ=4&#I^&\B0=F0$! 0$! 0$! 0$!
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M:-[H-[OQ[=S&.UFW.^K::?5 &Q$3LPF+N3:CH3/KIZZ:(,B @(" @(" @("
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M @(" @(" @\(!+U;5 8=-?Q0>H" @(" @(" @(" @(" @(" @(" @(" @("
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MQA[QQ$?8LU"V[HBUVDW^4F0;'%>+9OFG(X\7CW+OR?JW+9=8ZT+O\IC^I/\
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M)(7_ -C>C>R"QH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M_%5*CMZ%#!&#_P"(BSH)/1 T0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU\IYU>X[A\&-FA'+R7/68,=5QP2NT#6YA<C<IG'^U'M=]=NK_35! \A\JYS
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MV;:R TBJS,0_<G&_ZXD(%HX,+ZEZ=$$7R3P_FZT7C+#8G'?O&(X;-WLK-+)
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MD'K-H@\V#]$#:R!M9 VL@;60>L+,@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MY_U#K^;^:"FV.,29+_;2_+\AF<AD+_[')%)5DL&=8G^Z9P,X]7UDB9M-7?\
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M&*:,HY0&2,V<3 F9Q=G]6=GZ.@CJ'%>-8Z09*&+JU3!W>-XH@#9KZ[-&^/\
M)!]WN.<?OV0M7L=6M68V9@FFB R9A?<+:DS]&?JR#GN5\6YG(>:8><3-2L84
M,=^V28^9S>4@+<Y2:;'#74_35!9N1X+E7V^+H</L4,3C(2.+)4YH'<"K&.UN
MPT;,P$'5V;T=_5!9,;1KT*,%&L';KUHQBB!FTT$&T;T0;* @(" @(" @(" @
M:L@(" @(&K?5 0-60-6^J!JR!JWU0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:>7RD&,
MQMJ_8_LU8BE+JS:[6Z"SO[D_1D%0\?<GS,TO(</GY&MYO#6&L,U<&;?2NAWZ
MP@VK,3A\HG_$4'F'\N8_)5<)??$7ZN+STLE6E=F:)A:T#FP0F(R$0O*\;C&_
MHY=$$;)Y3QV8QF,O2X;,4\7;R4%6K>C**)ON1N/6[<NR7>P=P/DSMH3=$$OX
MQLWI9.5PV[<]QJ?(+=>N=@WD((ACB(8Q=_01<GT9!DY'DLO5\E<0I073#&9*
M+)#<HL(;#*O"!QFY:;]6<OKH@T>:\<Y&<Y7J_*LE1FN68:N/QU+L!7!C)AU+
M?%(9%MW$3[O\$%^B';$(;G+:VW<_5WTZ:O\ B@YQY'K\VH"7(L/G)H;,%RI7
MQG'P&(JEJ.24(Y F8@[CRGO)V=C9A9F0:/(.5YP(>5\KK9*6"CQ*_'3BQ0@+
MQ31P-&]SNL_4RE[S]LMS;=&_%!8YLKE0\MX_&#<D?$V\)9M/1<08&FBL0@,F
MYFWZ[9']705:7G>6&M#R(KO;N5^0M@\GQW>+QM!+:^UC;8[;QFV$$[%[MK[(
M.NCZ(/4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!!7.887-9C[&G6&E)B6L1RY:"XTCO-'$6
MYHP86<?S,Q/N^FB")M<.GQ/-Z?)\$..QF+"E)4SL!@4131=QI8S%P;8)1:%H
M[^NNB"I>*L'DL[P;C#3357Q6&MSWHJ[-(-@KD5B4JX2N_2,0W[WT9W+IT9!*
M0>-.6Q<(QO'_ +J@]G'YELL\_P"ML(1N%=:/3;KKN/9K].J"S\%XUG,)/G9,
ME)6D;+Y*7)1M6>1W!Y@ 'C+>PZZ=MM'9![R#C>:O\UXYG:LE8:6$&TTT4CR=
MV3[P!C+;M9Q;:P:MKZH)BWC);.8H7))&^VHC*0PZ=2FD9@$W]M!!RT_B@T^.
M7^0V[&6#)1P?:P67CQMBN$L>^+KJ,@S=7,'Z.8_$O9!"\BP?D6WRBOD<7/AQ
MQM,=M*.Z%HYHSD;;--^F01D;C\1U;1OYN@U\QXYRMRQE:%>[7CXWR"S!<R]8
MXOU]\; U@8M/@[6>T.YRZCUT02EKC.:E\C4>2QR5AQM3'S8\H"<^^_?D"5S;
M1MGQ>)F9D&4N(#D,_!E\O!3WTI7EJ!7BUD(Q9VBEFF-F,B!G^(MT9_KT06=F
M9D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M, 2 ;N/?:=C?</5Q]]$'7D! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MB9W)GTZ?B@L?$+O+9;62KYVMLK0E$6-MFT,<THF+]P9(89)1'MFV@EK\F?\
M!!'Y/.Y^/GUW P6@"D>!DR=8GA$CAL1SC#ZN_P Q=GUT=!6N,\WYUR"QQ>J-
MRG4'.<<DRUF9JI2&%D#C#4&>1AVOW?31!M<0YWR'EM;CM )*]*_=Q+Y?,3]E
MY0*-IGK#'#&1:#O,7(MS]&Z,@A?'&?S</ L#@,-$_P"XO5O73FA"&31@OS1"
M(PS21?!S?Y.S]&03M'DODB[RF'$S/1QLD>%KY>U0&-IR>?OE%+7[_<8&$]G0
MV_+^*"'R'E'D#\2Y-;8HZF?Q%..U/@,K2*.:'630W%Q/MV(';08Y0=^OYO5!
M)<DYYRZKDLO#CB@CNX^U2JXK!RP%*>0CLL#G.QB0DP_,]-O0=C[O5!IYWG//
MZ%;FUIK=#3B=FDT,053TGCGBBDD W*4G'5I>CMUU06'(\IYA:RMH>/4?N(,7
M?CI6(#>NT4H_!YR.8I1DB( DW S ^NGXH*MR_+Y/DF I9SO1#B!Y11JT*79_
M58*N1:N4I2N^K&<@.^C-HP]$%G\WA=?@I?:VGK;LACPFT%CW@=V(=KL_MUU?
MZ^B"H<\M7"P_D+$7HJ<C8Z;!V([5>N,$LIV9P<I)W9RW2: S,7T02G(.>\QQ
M\_*0J'0&;%YW$T*YG7-V*MD!A9]^DC.4@][\VOIZ(,^0YSR_&6^3XR26"R^*
MOXN"/*- X#5JY(&*6::$2)C:#VZMZ]4%DX#G.192YFPORP6\5C[7VV+R44)1
M/:%@$S/\SQNT9$\>H-H[L@VN4<@M5\_@^.491K7LW]S(ULP:1HX:8"<FP'Z$
M9/(+-K[:N@YWR_/\CR^#_;+<XU,AA>68W%V[<,;/%; YH989>V3_ !^,H[PU
M=MS?1!CS=+)8[E?D6U6EIS_:8*K>EJ6J49UYY&&Q(3R +CJ1'%N=_=]-?1!9
M*7,N4YM[M7"E3J6L%C\;<LC:;2*U+>@^X(')O[$0@+MN;5]?P9!LERSE^2R;
MRX&B,^/J9+]NMQ&5=X7C F">9Y^ZTHF#EN$&#Y,VGN@V/&^8Y9G!O9#+W:LE
M:O=OXX*E:N\7RJ67C"7N$9OU =''3^:"/Y/6R,OE_"MC;$5*W)@<BQ6CA[SL
MS3P;=!W!KH7U?T0:V(\A<GS^ Q 8VOMS5O&/D+$D(PR,YA*5=F:*:2+2,Y U
M)V=]&?1!]0\OYX?(K%:^=/&U\;A*F<OT(HON)-Q%*UFLUCN,'_I/MD9NGXH-
M+E.7Y;D^%\C/(41+CU_CMVV$TC5Q[,[0.<00]N24I@,"UW.S.+M^*#;#+<[H
M0X;!4K=:>SF\))/A[!5W9JURE#$?;F;?H<,K'MU_,SH)CAO*LIR0<)+!;%FC
MI%+R&/LBS_=L79>#U=XB&4).GT9!DS7)>0W.393C^!EKU+>'Q\.0*6T.\+$E
M@C:.)VU;MQZ0OO/U;5D&A9Y?S*_9FDP- )PQUJ&M;KL=<J\NHQG8=[!R!)'M
M"76-V#Y:?B@JO*\_S[(\'YM=/,5ZD&%R%K%C#5J[3DCCDA8"[IR$X_&4F+IU
M03F>S')QGYM@)KL+_8<;"[3R$,#16-TC6&-I/D[?^E\=NFGKZH(SCW(LAQL>
M.E:&K<JEPX\B=AJX0W-*@UW" I]VG:;O/ZMZ]703\W)O(U.OD++X@[]9ZL5B
MGVVK#8:8I6&6."$)C^X$8BWAN<7=VV^Z"?\ 'O)H^1862Z-X;IQV9(39ZYU)
MX7#3]&S7D^4<P_U>WNW1!6>0MEI?*>1IG?=\4W%Y;#X\H@('W6"C)M7]WVL^
M[^2"(X#R3D.%P/!J,T]6Q0RO'YY883'[<8)*,$<H$<[N;[" MIZMT]6^B#YS
M?/>1V^-\FQXV7CL!QM\U5RL431A\]X''78M'DB^/PF=F=_5!T;$P9*/@U=GO
M.5[[ 2CN]L6<7[3.+]O\K[4')N+QYNTWB"R]\),G<IY(_OIH6(@C.F)$.C.V
M\F=]6<G_ )(+7A.?<CRN&QM, W9NR>2CL6ZT<+ZMC;3UNY'7FDC'YOM<FW/M
M9!<<-E,^7#POYJK!3S4=>4[59YA[ R1;M'*47,0$F%B+J^W73KH@YMFN>\BN
M<<Y-CQM.%@.-%FZN6BB:,-3W@<==BT>2+X_"9V9W]4&S0L<FJ<TQG<S0S05>
M)G?:&>..&!W&6-G:21M=C/HVZ3U9D'V?EO*8N'+O<A&_]GBZ64JV7'[:(SOV
M7JL :MN.N!:$TCLSDVJ#SR>')@XS9JY6S2N%%D\)/BK(ALD$I+T8FTL+/T 3
M'XFSLY,[M[()-^=Y_'Y;D.$M=O(7*E_'U,;8C (-6R<#RL)1F;"3QN!,WS^7
M1!]!RGF\=BG@+L04LKELC)7Q>1G",G>C!!]S++)7AD,!E'1XQ;=H_P"9!E\2
M0RP6.;12D)R#R2RQ& =L2=ZU?KM9WT_%!FH<JY)F+UW(4)*D&)Q.9/$6Z-EV
M8I(H2&.6?O?TR[SUC#31VT9^KH(X>?<@+ 8OF==XK&#R60"F6):/26.O8LO4
MBE&75W>4#VD8.VFFK-IH@T8N<<\AP5[D-JS2FKX;D,^*N4(:Q"\]0+C5-8Y'
MD)QD%S8F]M/5!M8CGG(IRO8LXHCRDF>R6.KS4HHPT@H@$CFT4\HM)(XEUU+\
M4&/,\^YIA<12FS]1\4.VP-W,10#>K1''(X0%<A@,SKQ21Z&1"Y;7Z:L@O'(<
MU)C^*6,M5GJ;P@"2*U8DV578W%NYO9BU;0M19OS=&]T'/\GY(Y9!C,U!3[87
M<+EL91>W>K.!309)XOE]N)#VR'N]-?5O9G02V2Y#SZ*2_B\2 9;,8,8BL2#'
M7AAM'.W=$)6.9BKAVOCO'7KU_!!/>3+&1B\:<BM4K#T;L.+LS!*&AN#A"1.P
MN_3VTW?S053%9/G<F=PG&*V8JQ5Y\!%D_O)*?<F8@EBB(';N"#Z@;Z.@\P_/
M.4VL1PV]--"1Y;.6\1D@:%F:2*&2T(2!H^H'I5'7VZN@E^.<IY?F,IBLA!1U
MXYDFE[[F]<6@!A=X3BE"4I)2(AVF#ATU_!!M>0.593#2A'0EB$AI6;W8$>_:
MF*LS.P-$[,(0]?G*Y-IT9O5! ?ZVYEE<L$&/L5,?4M<6BY! Q5RGECGD+38Y
M.8B0Z_\ *W3\4&;#\QS_ "RKCJ,$E>C++Q^OF<N10]X9"NB0QPQB1,PANC(B
M=]7]&;ZH)#Q-:&GX;P%R0=1K8QI3$>FK1B1.S:_P08<7FO(>9DBDJQQU,;E:
M!V:]^<:Y#5G=A. 8QCE,K$<@$^YW9G;37W0:/&>>\GRN+OY&S-3HV>.TI8<S
MC+;A&$E\&=PM#8%R<*9BVX3V_+V]$&%_*N4Q\&;@L1-:GI?M+4;LT?VP&69F
M> 2*/U[41-N9WT(F_P 4#GDW-H8\=0GR\(-_J'%PPVZ\8M++!8+72Q [NP;)
M ?;H^AL@ZM$)C$ R'W#868STTW.S=7T;TU0?2 @PVZ[V()8=YQ-*+@\D9;3'
M5M-1?KHZ"KMXRXZW"AX8QVVP0Z,T7?+N;&+>T?<_-LW==$&6WXYX]=OW+MYI
M[DF0HQ8V['-,3QRP0NY1[A;30Q(G+>VCZ]4&YQCB.)XW'8:H=FQ/:(2GMW;$
MMJ<F!M !Y97(M@,_Q'V0?.9X5ALOF(<O8>Q%=BK242DKSR0]RM,[$<,C [;A
MW-JWNWU0:&#\8<:P=JA8QI6XGQM*3&T@*S)($=>5V(V9C<NKD+%K[.R#YQWB
MWC6.J8VO2*W >(&2+'VPLFTX03/ND@<V_/&Y==I,^C^B#!_VAX;%B:>,K#<I
MACRE*G;K7+$=H&LEOFC:83W[)']1]$&]4\><=JY,K]9IXS>A^U?;-*78:FVK
MM&P/_P Q.6NNNKZH-:_XNXQ=QMC'6RM30V:XT2E*<GF:F#L35@DTWM&Y"SNV
MNK_5!4YO'/()LUE[119&O9LV&:ADJ.8.* HHXACAGL0:B3RMM_49A=BTZ=$%
MNE\8X.SC\W4NS6K#\C> \S+WB%Y)(!$1*/3^VV@,V@^R#[L>,N-6,N&5F:T5
MC](K<;691@MR5V9H9+<(NT<QAM;1R9!\9#Q9Q6^4XS#9"K9N!DY:4-F6*#[P
M#:3O" NVTB)M7VNS._735!*\FXGCN28P,;D3G&H$L4^V"5XR<X28X]Q-J[[3
M%B_B@A+WB7CM\LB5NWD97RWV_P"XZVB;N_:/N@W:,VFQ_31 L^)..69+DEBU
MD)3OV:UVZY6B_5GI[>P9:-_1VQ]/H@CN>>.#NS6;^*KSVK&8N4Y,W&%XZL@Q
M4Q=HI*A=!"4-&;J[,XN_OH@F>!<;R&%>Z4TEX:<_;:"GD;CWY0,-V\QD=R81
M-G9MK/[:H)?/<:Q>=&J5L2&Q1E:>C<A)X[$$FFUWCD;JVX7VDWH[>J"/ROC_
M  N3QM;'V);0Q5K07^[',X2R6HR8@FE-FU,A(6=D&M>\8X2[:R5J>YD'ER]8
M*61<;+BTM>,2$0=F;ITD+T^J#R7Q5Q.6QC[$D4[V,=7:DTPV)(RL50T<(;?;
M<.^ .S;6-!L6?&_&I\\^;<+$=@Y!L3UHK$H5);$;,T<\M9B[12!M;0G;V9!O
M\7XICN-U;-:A)8DBM6)+<OW$KROWIR<Y29W;IO)]708[?#\?9Y-!R,YK(Y&M
M7DJ0L$KC$T,KLYCV]-/D0L6OU9D$*/B#B8XJCCHRO0-C&DCI6X+DT-H(9BW2
MP=Z-Q(HC+JXEJ@E,?P+!8[-%E:C3!(5,,;]J\CE6:I%KVXFB=M-!<G?Z]70:
MF+\6<1QHVXHH)YZENM)2:E:LS3P059FTE@K 9.T('[[4&S5XM7X_4ENXBM-E
M,K6J_;48[=I][P@^X*P2R,0QCJS==-?KJ@R\,P$^+I6;5RM7JY;,63R&4BJ=
M8VFD9AVL;LSFX@+,Y/ZOJZ#XY)P+C6>RE3*7X9!O5 *%K%::2N<D!_FKS%$X
MO)$3]=A=$&'(>->+7LRV6EAFCF=XGLU8;$L56R\#,T+V*X$T<G;9FTU9 @\;
M<=CQ6:Q4KV;-+/S'9R,<\Q'K/([.4@.VC@^HCZ?1D&&7QI@Y[.0LR6\@<^4I
M-C;LA6B=SK-N^'5NGYRZM]4"GXPX_6M4K#RW+'V%,\96AL3O)%]E*(B<! [:
M$#L ^O7H@\Q_BOB]"*2*![A"3Q- <UR>4ZP0&TD458C(GBC$F9]H_3J@G<)@
ML=APG&J)/+:E>>Y9D?=+/*XL/<D+1M7VBP_P9!JYGAF(RV3_ '.4K%>\]0J$
MD]:8HG.N9;^V6G1V8NK((R/Q;QD*^(K.]J2OA*\]*C&<Y.WV]H&CEBDZ?,7!
MF'KU9D&.EXGXC4W@_P!W9"3&OA3CL6I91>AUVPNSOZ!N?:_J@LV,Q$&/QD>.
M I)H(X^TQ3F\AN.FW0B?UZ=$%>Q_B_CU"SAK%66Z#X#N#BH7LD4<(2CM,&%V
M?47#XZ?1!B?Q-Q=\:%$9+L306I[M.W%;EBLUYK9.5CLSQN)B,CD^X?1!8JG'
M<54P38*&!OVSLG7* B(MP2,[2;B=]Q.>YW)W?5W05VEXEXI48ATMV0/&OA3C
MLVI91>AUVPNSOZ!N?:_J@W)/'/'97KO.UB8J]*3&&<D\CO-3ET<H9NK;AU;H
M@U:/B?B520W..Q>"7'CB)H;MB2Q&=('=PA,#Z/LW/M?U0?+^)^+#@PPW<O?:
M#-!/W2MRR3D54M]<7ED<BV0NS;!;H@V;7C;C5ZUF+%P;%@\X-=KXG,3,YU&9
MH)8]NUXY(]O0A=D"+QGQJ/&1TG^ZEFBM->CR<MJ62\UD1V#+]R3N;Z!\='^.
MG31!O\<X=B./2Y&;']YY\K8>W?DGFDF<YG%A<]"?:+NPM^5D&LWCWC3<GEY&
M%<XK\Y!)9CCFD"M+/%T"Q+7%VC.46Z,;MJ@R4>#X3'VCGIA+' ]@K@XP9':H
M-DGW%+'#^42<OE]-SZH*SP3Q_<A._9Y#6F@E?-W,O2IM::6L[V)7DAD*,'V]
MR)G]^F[J@E?^T_%WIVZQ'<=[=XLI]TUJ0+$-TVT.>"8-I1D3='TZ?@@V!\:\
M="J%:-[,<30'5L:6#=[,,IN<K67/<\KR$3[B?K^*"3S/%\+EN.2\=N5__P"I
MEB"#[>(GBV!%H\?;(79Q<' 7'3TT05Z?Q)Q>S]X\MC(%)D9JUF\;VY'*6:DP
MM!(6ON.P?3Z(-_.>-^.9O(!D+HV!L]L(+95[,L VX8W=QBMA&0C,#.[]";W^
MB"?R>*HY+%6<5;B:2C;A.M8@_*Q12"X$/333XOIT006-X!A\=F:F7@LW3NTJ
MOV$+S6"D#[9W8NV0OT=MPL_\D&G%XGXC')5(!M]NC?/*T:WW<[10697(C>,&
M)M!(I"?;^*#;Q7CCC.*S99BI'.,F^26&F5B4Z<$LVO=E@K$3QQF>Y]7%O=]$
M&?D?!L%R"[#=NM.%F&M/2>2O,<+R5K3,TL,FU_D);6?ZL_H@U,9XSX_C9^]6
MDN.;8S]F#NV3-AI^K .OH[/U9T'Q6\9<<J5\?%7.W#)C*KX^O9"R8S/2=]?M
MI";\\;/^7=U;V=!+\<XUB..X.M@\7&0XVL+QQ13&<S[7UU9RD<GT_!!!5_$?
M$H(;<%8KT$-F$ZT,879]M2&1V>2.FSD_8&330MGMT]$&YE/&_&\I=DMVXY7*
MQCWQ%R..5XPL5'9] F$6;<X[GVEZM[(-:'Q5Q$6OC:CL9$<G3BQ]X+LYSC+#
M SM%JQ?U@S_$O5O7UZH,\?C3C882+$Z6I BGAMA=ELRRVVGK:=D^^;D>H,V@
MMZ:(+5%&T<01L[NP"PLY.Y/T;3J[]70?2 @C,[R"EAHH#LNYS6YAJTJH:/)/
M/)JXQQL[LVNC.[N[Z,S:N@B:_D#'V8(6@J63RDUB>FV((!"P,U5M9V)R)HMH
M"[/O8]KZMH_5!HCY9P)OC(X:EZ>SD[DV,:K'"+R5[M<'.2"SJ;,!,(Z^[:=?
M1!@/R'A<E9P\,D64Q]P\R6,.HPC&\5N.(S:*YM(A>*2/]0-'?=T=!OEY/XQ'
MD(JLTKQ5K 3E4R&Z,X97J \DS,P&4@Z )$SF#,^CZ();C_)8\T!R0U)X(&".
M6&Q+VRAFCEU<2BDB*0"Z-\FUU;W0?>8Y#!C9:E489+>0OD8TZ4.UI#[8[I"W
M&X (@WJY/^""D\L\DG9X[C9\!#9*6[FZ^&R<(]N*U5-Y=)H"8R9AE)FVB[:M
MH^NOHZ"VXJ >,\?LS9#(6[=:OWKAS7G[\\,+_J=G<#.4C1>@^K_BZ"F^0^=%
M9X%R=\98M8?/8BG#?:-B 9QBG?6$W<'D9AD82U'5B;WT037#KV2DY_S*A8NS
M6:=4,7)4@E)G&%[$$A2#&S,VC.XLZ"8Y=S&EQ?'0Y"]7LV(9K,-,1JQM(326
M)&BCW:D+,+F3-J@C,CY0P^,I/:R-6Q5^W$9,G!(\#34XS+:)31M*[EJWSTCW
M/MZH,F9\E8C$AD+$M:U8QV*>(,ADJX"<$<LSCLC;4A(R;>.[:+L.O5!BR?D_
M&XVMR.>Q0M__ $M)".4C%HG)XYP:0)8OU-"'8^NG1_P0;6;\BX'#V6BLN10Q
MRPP7;$91NU>2PXC&T@.;2O\ G'=L$MNO5 ;GE6P-T\;2L9"&J-IALP/$4)34
MV_4A(M^L1;FVMW&;73H@B>.>3WM<-Q&6R5(PRF1J-<;'A)7$SBVL12@YR".S
MKHS$[$[^R#+EO(&/R?'S? _>6SO8N3(QVJ(@)UH' NW(;RN+"9$+L(LSD^C]
M$$KXZR-FYX\X]D;\Y369\;6GM6#?4C,H1(S)_=W]701&;\GC#P_,9_$8Z>[%
M2H27J-INT]:<1U%G:03+1Q=MQ 6A;?9!LEY*HTL=%8RU:>L\%6O:R\I-'VZH
M67V1F;L;L6\O08]Q,WJS(,%/R+,W+>4XW)4RJ8G #3VWB.+:[V8R-MS;]WZC
M[6!F;^.B#RUY@X_4CL?<5+A6JEJI3LU*X1V# K[[:TFZ*0HW"1]6Z%KJVFB#
MR[Y=QE*/,G:P^3C?CQQCF![43]F*81()F=I-#!Q+=H+[M->B"2SOD;C^%G<+
M1N=>&2&*]:C*-QK'8<6B[D;D,KZ[QUV"^FO5!'EY<PPO/(>-R,=2GE PMVV<
M(#'%9D,0 G;?O<'*06U%GTUZL@U\7Y0FDS6<I9''25AJ95L3BA>2N/?E:N$S
MAN*068R8G-M>FG377H@O&+O_ +ACX;GV\U5YF=_M[(=N8-'=M##5]'Z((*/R
M!ARRD5!PE'[F>>G1L$+,-BS5%SFBB!W[FHL!?)Q87TZ.@C<1Y;PN3?$''CLA
M7J9JY-C:=R>$!C:U \C%&;,9&V[LEM+335M$$1R[FENYDN,'AWO5L>7(Z^.F
MNCL"I<!VD&8/5Y"!B#02T87=G]4%YY;R:EQCCMW/7H9IJ="-YIPK!W)-@^KL
M+N/I[]4$-/Y(HP43L3XZW!.(G-]A,]>.P56-M?N!8I6%P+T%M=SOJVB"!QW-
MX8N9YG)_N-FYQN;"8O(8^OHYBQW9Y8@[,;"SCW'V-\OYOH@W.3^49*>(>7%4
M9)\G!EZF(R-)RA<JTEB0-6)V/83E'(VW:3MJ_5V02V2\D8+'6X8+3&(%8BI6
MIQ*$AKV9W80BE$9-[ON)A)P$F9W]4%;YYS.U-+A_V8KU:M%R2ACK-^+8%6RQ
MSM'8AU=^X0-U'<PL.[IJZ#H^0OU<=1L7K<C0U*L9SV)2ZL$<;.1$^GT9D%7N
M^2Z-+#%F+&-NMC@EJQ_< T)@07C:.&6,QD<9 W$+%M?4=?1!7_*7-YQXURRK
MC);N,S/&?L)SGB<&[L=J9MG;(7-W$Q$F=OBZ"RS>2,-4FOULK#/BK=".*=Z]
MMHP[T5@^U$<4C&4;L\C["U)MK_FT0;,G-:T509;%2>M;EF."MCYWABEF*)F(
MBC,Y&B*/0M=^_1T&K2\D8C)5,;+B*]G(V,EWG"G"(-)$-8WCG*9S,0!HY&V:
M[OD7Y=4'QBO)F(RMC#14JMH@ST5R7&S&  )%0)QFC-B/<!:MTU;3\4"GY,P]
MS"5LG7@F[UH[(0XV0H(K#O3E*&=]3D&+03'3\_75D$9%YKX[9@O6,?C\E?@Q
M]"/*V)8H $?M#<V<@>0PW.'9/5O?1]-4&]Q;GMS/<PR^,BH2#B:=:C8JW7>/
M0AN1%,QFV[>V\=&%M.GOH@GL_P @KXLJ=;L37+^1D>*G3K,+R%M'<9ZFX (1
MCU(B=!2?'7,+08"PV1DN9+)SYW)T<=5F<'M&,$QZ 3NX1BT48]7U8606&MY)
MP=FJ+P#*65*X>-_9781MM<B'><1,Y;&VQ_/?NV[>NJ#YH>2,;>R6-Q\-&V-C
M*17#KM* 1[9L>[#8KR,1,XF+DVC_ )7]B0:=+RWA[K8-JV-R$LW('MA1A&*/
MI)0(@F"0^YL%]8WZZZ:=4'N,\MX:^V+E;&Y"O5RM\\3'9FB 0BO1N8O#)H;E
M^:(AWBSCK[H-N7R7@0R4%$6DE:X4L5"Q#VY1GG@%S.$  WD8G8"VN0L+Z/U0
M:N$\L8K,%A/M\9D(HN0PSS8B::.,!E.L#R'$_P"H[@3BVHN7Q?ZH-3B'E.?*
M<6QF3R&+G#(9+[J2"K%VG$H:LA]R3>YL C&#,S[W%R?\K.@^Y/)I6N3X.GB*
M,V1PN5Q5C*#<@[;F8 48CL R$OCW.ON[Z:,Z#9XWS;%3<=PQXJ/(96;(P2V:
ME:<@*Z\,1N,DDYR$(-H3L+:EUZ,R#'5\O8._;KT\50OY&U9J37(XX81%A^UD
M:*> RD,&&6.1]I"_O[H+-QCD='D> HYW';_LLA",\#2CL-F+IH0]='9^CH.5
M9+EMR]D<SD<U-F\32P7(:^.KOBY8FB*-^P(PV08WU&62;<9?1]&?V067CG*)
ML=FN:AE+\MJ&MF8JN+AG,&=GFI13=B)R[8"VXB?J_1O5!+5O).'O4HBI06;.
M0FN2XW]LB:,IQL0-K-N+?V=D8.Q/)OVZ.WN^B#5\0Y/)Y#"9<LA8LV9:^;R-
M:)[CL\X10S;0C/;\?@W3IT02>:YS7Q6>;"R8^U-.=&;(PS1]IHI(JSLTH"YR
M"^\=S=';W]4$58\E8ZWQF'*#C\D-'(XVQD&DK=E[$-:,>IZ#([C)\M1TUT?U
M]$$3)S?(W;<F Q\-R+'%Q<,K5S)21?<L\HOVY3<B=]= T+XN[E[:=4$AXUYZ
M^0P_%L7DXK897)X:*[%>M"+!:*((VL.+L1'N9Y&+Y"VK/JR"8\E\KO\ %N(V
MLQ0J/<L1'#$(,XL(]Z88MY;G'5FW^WN@JO\ KC(8/F_+9LC#DKF+IXW'Y$J(
M]F1J0EWON'Z&(-H(;G82)WT06;.^2^.8>![,LCV*D4<4]R>$H_T(9]'CD,#(
M9"9Q+=H N^WKH@M@&)@)B^HDS.+M[L_5!Z@(*MS_ (ID\[4Q]G#VXZ><PMP,
MAC)+ N=<Y! HRBG$?EL,)";4>K>K((ZSP_E<F4P_)BNUIN08Y[,=BF^\*1U;
MC QP1GM.47C*(2$W;J^NK=>@5?E6-_8.2<2D:6L&8RW([&4N12RD,/<DQ\D&
MT3=MS#M  8MOYO9!+3^/>2G?Q^4$J1Y$L\.>S+;Y0C?M5BJ100? ]=L)-J9:
M:NWIU09L+P7FF+8\=%:Q+XRK'8&A?>JY7INXQ-#%:W-VV$-S;B#J;-Z-JZ"0
MX'P N-9/)6X AQM&^$3?LE(S*D,\;D\EJ,#8&B*5B9G &TZ>Z#=Y-Q?)VN0X
M;DF)FC;(X@;%<ZEAW&&Q6ML/<%S$3(#$HQ(29G^C^J"!S/CO-2UH)<<U3]QG
MS\'(LGWI91B[E=A$88G:,WT<8Q;<[-]=$%TS='*W^.WJ=.TV/REJK)%!;#4F
M@G,'9C%_B[[2=!RR[XDYI9Q^?@%\5!)G\13QDVR2P^V:L1N=@C>/=)W'DUZ]
M?J_N@NG%>.<CH\NSV;R05 KYF&D Q5Y9)#C.E&4?7='&SL>_7\$&;R1QK,\A
MP5?'XMZXRQWJ=R0[)F [:=@+&UM@&^IO'M_!!&YOAO+#Y':R>&EQ;P9<8/OA
MR4!3RU)(0[;RU'%MLFX-/A)HVK:Z^R"H^3\#F>-<'YE&T].3 YB[%D(#E(PM
MA///"]B+8P]L]2#<&CMHVNK.@G.4>/>2YK_638BYCWQW,J]3LV)GE<XCKPM$
M_2-G$P,69V)GZ?1T&\7">90YR6S4GQ,E3)2PV;\UFL4EFK,  $WV>NX2&3ML
MXM(_Q?ZH/BGXTNMRDLZ;U<=;E"W'DK./W@V1"P)!"-JOH$>Z'<)]S5R=V]F0
M:-+QOS'&8K _928FUD,+0_:9*M\)9*D]<7$@GW,/<CE$@=]&9VT?37W027^A
M>44K]Z]1M4K4N;Q<..RPS =< GK#(,4U<8F-FCVS.SQZ>S/N06'A."RN"X3B
M\'<GAEOXZG'5[\ DT3O$&P29CU?VZH*4'AZX=;/A$=3#GG<3-C[M?'[_ +.S
M<E;I>.N[ ,1CU;0/77JZ#'ROQGSC/4;=26SCS@M8NO2K03'.04K%>3<<L+,&
MA=X69G/1B;^""3R/CG/W;_)9OO:U=N108\QF$2,J]O' S W;)MLD1$S:ZNSZ
M=-/=!KY3@_/<GA6KV1PM>TV1HW!K41EAKC'0F:9W>1XWD,YG;31VT!O35!]\
MA\><GR8<]BBDI@'+(:L=(CDEUB*O",)=UFC]'T=VVH-F?A/+XL]8M8^;%/1R
MDD%BY)<KE-:IRQQ!'+]H^FR03[>K=S3:_7KZ(-&]XXY59P&=I"=$;64Y%%G(
M&>25XQBCEAE[9EV]=_\ T^G1M.J#+>\;Y>Q:S<-JKB\M@\WD/W.U0N]S<Y/5
M"!HP-@+ME&<>X91Z_@R"W\)X_:X]QBEA[-R2])58A&:4BD(0(W((MY?(VB%V
M!B+J[,@I,GCGFC\EI9B2S0NR8[,6LC#;G*9K$E2Q"<455_@31M#W-&87VOZ^
MNNH>XWQORJG@N+4WDI'9P6<L9>SI)*P'%.=@FCC+MZ[F^Z]VTZ(#>-N7U\3@
M<#3M4"QO'<Q'DJ5N9IN\=>,Y#&&2,6V[Q[NF]CT+Z,@M_D/ 9+D/"LO@L>4(
M6LG6.J,LY$,8-*VUS?:)N^GT00>;X?RR6UC\MB_VN2^% ,??Q^3"2:K\"WA-
M#( L;&#N71QT)G]M-4$;E_'O.[%_+V:.1J5Y[N+H8Z&Z#RPFY49WFD<HXATC
MCG&0H] +46]-4&#_ +5\C>'-;"QU7[W,8_-4:L#R]L7HM$Q02%L'3=V?SB/O
MZ()>+A?+ZG(9K%2;%%C,A;&_9L6*Y27JTA,+S15GTV&!D'Q(]''7W01MCQIR
MV+#4^/X^U0?&8O-Q9C'V;'>[O9"T]IZ\L8MH1,1NV]B;5O9D'1<K6NV,5;@J
MG$-N:$PA*8=\3&0Z-O!]=P:^K?1!S27PY?;C_(*&*.KAQRI4IJN(A*63'16:
M5@;!SB+B)1?<;&$@C'1O7JZ#/F?&7*LY)R\[MRC5'DU2A% $(S2O#-0)S'>Y
M;-P%KH^C,_\ [0ELGPG-9>W:R^2BQTM^>I#C6QLHG/3>HTS360E<Q^;S.S;7
MV-LT]T$16\59O%XZJ>&GJ--1N6;%#!9 I;6.AJVHA Z@R./>81,.X!,/Q?IM
MT02,7$N58O-8WDP6,8=V*A-0S4!"=6J$!3?<QE6<!+;V3=V+>WR'KT=!5O&6
M%RV3XOP?.X>Q3EGP4F6AO5IB,1)KLYL[@X,;L0[1)A)NHOZH)/&^,>:8O&4#
MKV<3<RE";(,52W%*]*:OD+/W/R?0Y EB/T=FTTZ?B@VP\><M*;DTMJQ0.3-8
M&/#USB8X1&:-I_F40@[!'_U.C,+N_P ?Q02/!N%\@P&7GMVI*IU[M#'5;(Q%
M(1A)CH2@;MZB+$,F[=J_5O31_5!)<EXSE;/(L+R/$20_?8D;%>6I9W#'-6M,
M.]FD!B>,Q*,7%]KM[:(*OB/&?*\=/6RS7:99>AE\CDJU<&D:O+6RI:SP2F0D
M8FW1P,1Z:>CZH-O*>-\V=D.38BU7J<O#(ODNW-OEHR,=8:9UC=F:3:\ ]#%F
M=B]D&Y?XCRZ3.<;SXW*EG(XO[\;\4K2QQ.%\09FKN+&3-#VFT$_S-[L@A>,>
M-N8XBYQ0K,^/L0<>LY2>8XBFC(PRA&^@B0FVL?<UZOU]/Q09:'CCE,&'Q-"2
M2DYX[D\F>,QDE=CKR333=MM8^DC=_3Z=$&Y@^%\RPUS[:"7%3X>J4\E.R4)#
MD91D<WCK32;7 !#?H\H:D[-Z-U0:V \<\DQ53Q_"4E.4^)_<CD-#E9I!L1%"
MSP_#U9CW?+3Z(-:AXTYE0PV!PX6Z-G&X<[P6:4KS#%;CM.10S2"(NV^$CZ1N
MSCZ_+71!FXSXXY7@6XO9">C8N8+%6<1-$Y2A$8RR1R!*!;7+7]+1Q=O=!YQ'
MQORKC88*_!/4ERF+I3XF[4<S:M8J2SO9"0)'B[D<H2>VUV=D&[A?'F6Q7,8\
MU"]9ZSU,C]T/<D[AW<G9"T9"S@[#&)!L;KKIUT03?C;C63XWPK%X')%"=K'1
MO"\M<B*,QW.3$V\0=O7T05#)^.>:V\;R2@'[<(YW-0YF.4IYM8A@.N31$S0_
M)R^U]?;5!L2>/.73W,UD>YCH+=O*P9G'PF\EF!WBJM4DK61*.-]A@SOO#JS^
MR#>BX5RX+F%Y 4N-;.8L[0R8ZO&<-'[2X(,<,9LW<WB\0DTA!UZMMT02WCWC
M.;X_4R\65FK3'D<I;R4+56D9@&W)W' G/U<?P9!]<UX4_([&%L16?M9<7<[D
MQ==9:DH/'9K_ /[@Z,@BH/'%K'83E%#'20%^[!9KX:$W,(JE:VQ$<71C?1II
M9#^+?1NB#1J>/N5TWK3Q'1DG;C4?';,122L#% Y;9@-HW=V-B]'%M/Q09L!P
M+DN.N<%FF*F8<7QL^,O,$DNLG="*,98M8_I!JXEIZH+)Y!XS:Y-Q*[AJLP06
M)WADB.379N@F"9A+3JS%V]-?9!6<CP;EV0N<QLS/0C?DV'CQD#!+,_:EC"4&
M,]8_ROW_ &Z]/Q08H^ <UJ312T)<07WE6G7R+7H3L%5EJ1- \U-]H[]X"S[)
M&9F+W0=, 7$!%WW.S,SEHS:Z>^C(/4!!!<PY57XUBX[LT3SR6+,%*G Q#&QV
M+)M'&)2%\0'<_4G]$'N(Y!D+.5NXW)8P\?)3ABG^Y[@RUY1E<V?MFS _P[?R
MW"WJ@D!NX>Q5>\-BO-5CUW6F,"C':_74]79M/XH$F8P\,$=B2]7CKRBYQ3%*
M# 0MU<A)WT=D'V>3QS3=C[N%I^WWNT\@;NVW5SVZZ[?Q01>"YMQK,XDLM4R$
M#T!E.%YSD 19PD*/5]7Z;G!]NOJR"3MY;%TV9[=R"NSCN9Y9 #4>C:_)VZ=4
M'P.<PI57N#D*Q5&+MO8::-XV-_0=^NW7\$&ZSL[:L^K/U;1!KSY''UYXJT]F
M**S/T@A,Q$S?T^ N^I?R05/D/.[T/()N-\=@J7\]6J!>DJ6K#5V,3D<!@C=F
M+]4F$BZ]&;37U06Z2RT-,K,[/&T<;R2C^9Q81W$W3UT05#">0[F4IX;)AAI&
MPN=DVU+P3QR=J)P.09;(,S=MB&/T9RT=]'T02N&YEQ;.XR;)5KU>3'UYY(#F
MD.-A8XI"BU?5^C$0OMU]4&6]RWC^.S>-P<]N**[DPDDJ1;P9MD+,[D_7HS[F
M8?J@D),C7(K$%26.Q>K@Y'3&0-[/IJ+$VOPW/TU=!'<?Y,^0P,65RE9L,;F4
M<T$\T9@)B;A\9QT Q)V^)-ZH)J.2.0!DC)C FU$Q=G9V_!V0063Y24.;' XV
MJ^0R_8^[GBWM%%! Y;!*65V+1Y"UV"PN[Z/[=4&I_KZA4',1YJ)\;=P=7[^Y
M7(F,#K.).,L$K,+&SD#AIHSL733T05N/RQE3OXRF];& /(X/N,#:>[K&+C$\
MLD-L=NX3%MHLX]'=]/9!<>.YS(2\;BR7)1IXRYJ8VXX+(S5XG&1P8>^[ +OT
M;7Z/T02L^1Q]>*.6Q:AABF=AADDD$1-RZBPN[LSZ^VB#80>$8 +D1,(LSN[N
M^C,S>KH*B_.,K+A9\]0P<EK#QQ2SPF\X1V9HHM?G'"3;=I[=0W&SNW5!8(\W
MCOM:<]FQ%5*\ '!%-(($3FS/M'<[;G^7L@RVLMBZCFUJY!7>-A<VED -K$^@
MN^YVTU?T0>CDL<<TL(6H2F@%CFB:07( ?T(AUU9OQ=!C;-X5]^E^L_;C::32
M:/XQOZ&_7H/X^B#))E,;'3&[);A"D;,XV2D!HG8O30W?;U_B@\GRV+KF 3W(
M(CDV]L3D 7+>^@Z,[]=S]&0?%C)UMEN.M8KG=JQN9PG*+;'T=Q[NFI +O[Z(
M/*F3A^VHM>GKQ7;D8N,4<K$)FXLY-"Y;7D'5^CZ>B")X[RFYD^3<EPMFF%;]
MBEK!%*$G<>8+,/=8R;:.U_PZH-OF.?FX]QK(YP*OW@XV [,M?>T3E'&VX]I.
MQ-KHW3H@C,/SBQ9S=/#Y3'%CK.3IO?QDHS#/%-&# \L>K"!!)'W1?1QT=O1T
M%E&]2*T5-K$;W!'>59C%Y&%_ZG#7=I^*#V&]2GFE@AL1RS5W89X@,2('?T8Q
M9]1_F@QPY7%SA-)!<@E"OTG,) )HW;_.[/\ 'T]T&,LWB/MI+ 7JQ11.P')W
M@8!,FU$2+5V9WU9!6N'\VRG(J%6X56I4WY&[1MPO8<BV4S.-BKOM;NN3@SOZ
M=.J"T0Y;%33!!%=@DGD8BCB"4",F%]"<19]79G]4'H9'%SV):@6H);$/2>N,
M@$8:OI\P9]6_F@]J6<;(<D526$SB=VECB(7<2;H[$POT?^*#'FKT]#%6[T$+
M6)*L)S- Y]MCV-N=M^A:=&^B"I5?(^2?C-'E-_!E7X];KQVY[4-D9Y:\$HL0
MR20[ <A%B^>QW=FZZ(+$.>ABMVBNVZ4&-%H/LI_N!8S>47)^X):".O39H[[F
M0?>5S(Q"\-"Q3/( </<KV)VCVQ2F+.73<6KB_P .GR?1D&Z^0I=XZS68ONP'
M<4#F+&S.VK.0ZZLVB#3HY@(\-6O9FQ3JR2BW=DCG8JV]]>D<I[-S=$&Y/DL=
M782GM0PL0/(+R2"+. MJY-J_HVOJ@RP3PSPA-!(,L,C,4<@.Q"3/Z.Q-T=D%
M<YWRF_QG$U\A7IA<&6]4IS"<CQ[ M3A#W!T$MSLY^G1!)5\I()9 \A+5@JU9
M^W#*$S/I'M'^_N86C/<[_'7TT0:UKF7'ZV=Q^$DNQ??Y**6>L#&&CQQ.+:ZZ
M_P!3FS#]4$M#?I332UX;$4MF#3OP@8D8._IO%GU'^:"M#S=Y>?5N,UP@L4[%
M"Q<^_BG:0AEKRQQE"48MH/\ <]=R"V:].J#7_<<?]Y]C]U%][IN^U[@]W;IK
MKLUW::?@@^/W?%=\(/O8._(;Q1Q=T-Y&/Y@8==7)O=D&V[]-4%#S'E7'Q50L
M81H,F$>:@PM]^^P/$\THQ%*+"Q[V8CT]O1!=(,CCYZYV(;4,M>)R&68)!(!<
M/S,1,^C./N@R5K5:U ,]68)X#_)+$3&#Z=.A#JSH/FU=I5(VDMSQUXR)@8Y3
M$!<G]!U)VZN@B,AS3CE#/A@K=Z&"^=4[I!(8 PPQD(ZDY.W4G+HR#ZP?,N/9
MG"5LU5O0MC[3LT4DD@#\G=V$7U?H1::LWJ@E;5ZE48/NK$=?NDP1/*8AN-_0
M1W.VK_@@K>*YN,W*>0X3)A!CX\.=,:M@YV_ZAKD9&/0F#:7PTVMJ@L<UZC!-
M%!/8BBGG?;!$9B)F[>P"[ZE_)!6_(7./]*XC[RO'!<M--6CDIR3M%(T5B<('
ME$-"(MN_T06M 0$%5\C2U1P U[V&+.XR[9AJY*B,13.U:1W[DK1CU?MZ;NG\
MNJ#G\=#D5#$Y3'<=LY+,\,K#2LTQF$_OXA:QI;I5SG#=/&, [A$QU;\NKH,,
M\<05X^38:CF;_'X\S!=Y#7GK]B2S%%6*'N5Z#1P&0P2O&<@]OYN.K;M$&>WB
M.,S<QX88X&2'%S6\K,<%JM+(+17(':,I(S!Q@"69WVQ%HS>NC:H,^,IPS<IJ
MXO,5,P^<I9>6W7:&$1I/68C:*9[G:%G@[!,+P]W7IMVH(KCT7[9@^,8ZSB9Z
MTT-_+09"]]I/(-22224X6* 1[<Q3 ["!FQ"'\T&MP2A5O97QZ&<QDUFU!AK]
M3)%D*<I.TKRQ]@)BECVZZ"6W5!<,-Q67'<MN\1CHQ?Z4.RW)*Y;0V 4A.Q5'
MC]?_ )D>Z+Z:,/3V0=/$=J#DF:QTMH^<X7.TY3R^6D>3C%Z,)#8HG@$*C0S1
MM^B=><'<M7%_ZOQ0;6!C:MY;-LB!376X]0IRY!X)'"6]%+*4NDVS;NVNSOU]
M'0=+ORR0T;$T0=R6.(SCC_S$(N[#T^KH.0\;I_;YG$Y3B%6WAK&5L1_ZPXC9
M@E"B$<H.]BR F+!%*!::%&6T_1V01^"B;%8C!X^QBIJ\L6;RT=ZZ]6:0*G>D
ML' 10 /;F[H$(QD3$(:ZH,?#J61(/'%R]3M//3IYFA8LVJTKRQV9##[4)-P;
MA_*^U]-K()O@$$%GD.)^]JYF/DN)@LQY3[F$8JD12CMD>2RT47W8RFVZ/:9Z
M>KZ(+%Y/J2S5\2-6_/BK$$LLE>W'5:[2%QA=NW<K;2W1FQ:"[:.S^CH)S@!9
M$N'8K]QQT>*NM"PRT(->U'M=V'8S]1$A9B87ZMKHZ"%*.;COD7+YRW%(>&SU
M*I&]V("D:O8HO(/;E &(M)1FU$M--6T05[E(2YV;E')AIS!AXN-V</C^]#)W
M;EF<BD<HX''N;!(0$7<?D[].C(- 9<(.0\7RRTB^UQ]*U'E'>E*XQ&5$(F:5
MNWTUE9VZ^Z"*XU))BZ."O6<7;L\8Q^5SD>2H1593*(KUDGH62J..^6+MD[:B
M+[=VNB"4S5*GC@AHY+&YBIQ>[C?ML95IPO?.*0Y9'.O()Q3G!)(! 0%JS#IM
MU;:@Z3QG.8SN!QD&M19+%TZ[S07!-S[;@(L_W#MVYR%^DA 3_)!(\BQAY3!9
M'&!)V3OU)ZHS?Y'FC(&+I]-R"K<3Y/%1XWC\-E:-JMG,=6BI3X]H)9>X<,;1
M[H91'MR >W<Q;OXH(;)U]_(N45N4XZ22IFJ-:/CY#&5@1 8'"6L)Q"7:E&P6
M_7IKJSL_3H%8K\?:'*9JKG*CY#+APJ"G=NG7DF:?(1#-WF:5P(9)-'#T?5T'
MM7'8Z+_2,C8XPA+A]^MDW:I*VLSQUV:*;X:N?< ]!+KKKH@^^)X?$QV_%+RX
MK8T.*N5\BYTS;9.\,(B%AW#H_<8]-_OU08..]W&<4P1Y*MDH>/0GF:UB.I3*
M<J\TE\RKO)4."8GCDKEM A#I_!T$CQSCN&#GF,JCB[ A'QAX*IY2#O2A9&VT
MU=IIMA1M*,3,3-KJ+=/9!KXJM6FX7+C\WQ^ZW*<)C,A2S=Z>*5XY9YXWU,9!
M8@N_<2[3CTUV^OQ=D$-FI\@?#FJU:-ZM?BX[AOMK,=:S+-8FKFPS01Z@XUGK
MNVI[68RUUUT9!TS@MV*UY%YO8".8(;G[;)6.:&6)C&&KVY-KR"+/M/HZ"5\K
MF_\ VWY)$ '++/C[$$,40%(9R2QN("(@Q$[N[H*;QMX^*\DQ^4R45S(XK.X^
M&OCLQ)'8LST)8V'NTI18'>*"1_F)./YF=B?T0:>+I6[F2@Q]F+,Q\UQ\MZ4+
M#Q#'2 I0E".T=[M!W83$@TC[CEKI\>B##CJ62R/"9JF%P%VASG%X>;&9"S9W
MUV.?4'EC&8OTK16'8B"3<^W=KJSN@VN38[%Y:H>7PM.6K0AX_>I9K'E7F!Y9
M)8A:E7.%Q_4EBFW.Q,SZ?7J@^L/1I8^#@%ZQB].-AC=N3 *9.\66:"&**>U$
MP;]1$)8V,A?1W_F@K_'XZE6YQ>2UB[-6.ER/.RR/+1G%@HV6L=LO[;_I&YBW
M\4&;C&*J8_ >/+ 8N2M9K\BNE:D&I*,L<,CVA9Y- WB!,<7KT]$&KP\N/VLA
MQZID(K,9827(_;G+C[4=F[8G[H -BT4?V^_KN%QD+=)MT077Q77S-3/S5Y&?
M)XE\>#PYFU5^SR-<VD9VH6]& ;!,Q.7<8=>C[O5!?N53A#QO*&;$X_:3-H(D
M9.Y XLS"+.3N[O[,@YQB\R4WAO'<5Q].U9Y%<PL>,:D\$T312R5FA,IY) $(
MQCW:D[O[=$$/#P2GDY>=\4CB=IWQ^(''7'K$,<E[&5R;N@4@]MW:808NOHZ#
M)R:!\KP>ERG)8@J_(,OD\1-]O]L9V8(J5B)I!/8&YF$0D-^FFCH-VM%:CYC-
M.(EEL!<FR$F0J9*F0V\='()ZSU[+"W?KS.S",1,Y:$VGH@CO'?<H4.'R9W'S
M'QR'!R8]QEKR&U7)=[=(,T#@YMW(&81)QTZ:>_4,F!XJ-/F?"JF1J%:&M'G#
MC*>*29J]&<Q/'P2RF)"SC&Q,(D^K>B"Y>#Q[/CZM4>&2N=6U>!Z\L1PN %<E
M.-F$V'X]LA<=.FB!YGE)^)5X@CEDE+*8XQ"&.24ML-R*60M(Q)V80%R=T%'B
M@BL2\ECH6;F$>7DA9&A?BH'/6V/1 =]BO)'ME@D-B'IU8NK.R#=Q]#-/F.&W
M[^&CQMO]IRM 'JP&]>.R<L3U#'XF4(RB+R"Q_EZL@TJU3(9+&61Q-7-0\XQ^
M&MUIQLPC7KQ3RBV\'G:*)K1RF+O"0D>FNKZ()K 'B3\D\7LX7$6:E"+!6J=@
MOLI80@F>6 AAG)Q9A)MA>KOU]^J#K;^G7^:#C$6(R.0X^6$LP2T_(5;-/<CR
M3!(S$WWG=^Z"P+;.R51]CAN_Y7%!"38JA%QK-WJV*,)&YU#;K2!4E:5JHVH#
M[T;,&_MM&Q]6;335!^@8S$XV,>H$VK._T?K[H."9>C7JX7+8JSCI1FEYK'<D
MA"I*8G1^\CE:36,'$H^VSEZ^B"0OA<JY_EX8ZI<'%1Y?&7;%:C 0[Z;4Q"U)
M!&491S.,NTC$6?=H@O?C&#&#C<C<QD>0"ED+IV0DR4?VY2&0")G#6V0O#&Y#
MZ. ZOJ_N@B?*,ACE\5%]G.03T\C$.3BBEM-#*\8N$+0 Q1M)-_3(;=--&]4%
M:X;1LRY7B%W*8^>4K'$SQTDUFO(1O>":)WCE<QU$MHE\CTZ((O&!+4XCQ?%E
MB;5:S'ALA4LWAJSR/%<$1_Z9H-O;[LNG24A?TT%^J#;Q!V&KX=^4X;)9;$YC
MC%/%5!:":4X<A")?=Q2AIW(3F?8XS.W]/YFT08N28Z"</)[/C99+_P"S8^'&
M.4$T\G>KUB A@F('>0XYG'Y"^NO5!(YIX,CD+%3-09NQ'EAH28,J$&\96CBC
M=P[YPN522.<"(W.0.CZZH-'E]>Q_IOE%+)8JQ9Y5+G:]NO-%4DF*>D%V$ZYP
MR@+LXQ5QVNS.VCL_3KJX=VC-I(Q-F<6)F)F)G$FU;7JS]6=!]("#QR%O5 U%
M U'U_P"*!N!F?KHWN@\<P9G=W9F;J^OT0 ..0!DC)C F9Q(7U9V?T=G9!]/Z
M=$$-Q_BV.P36GJ%/-/=E[UJU;F.Q,;_TBYR.[[ 9] %NC,@F4! T;33V0$!
M0-$#1M--.B!HR!H@:,@:(" @(-6+'UHKLUP0?[B=F&20B(GVCZ".KOM'WT'W
M0;2!H@:,@:,@(&B!HR!HR @("!HR @:,@:,@(" @QV:\5FO+7E'=%,!1R#J[
M:B3:.VK=?1T%>PO!<;B8*=:&S=L4\>PM3J6K#S11]O\ MNVYMSN'].YW065F
MZ=?5 T0$! T0-&0$#1D! 0$! T0$! T9 T0$! T0$#1D! 0-$! T;_'U0$!
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MV8#$G9V?5D%E PD 3 F(#9B$A?5G9^K.SL@]0$! 0$! 0$! 0$! 0$! 0$!
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M=LY.C!CVO2GM@(1(=!=R+>WQ$0'4B(M>@L@AK'-Z,%BK2^PO'E+<<MB/&1Q
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MP+:$8"^HB>GYMOMKZ($V*H6+E:W8KA+8I[GJR&VYXR)M"(&?HQ:=-?5!N("
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MM^N[O6N0QV(')M'V2BQCJWL^CH*O<\HX*I:R\%FED CP,L<66M-78XH&E%I
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M:A<PCP7J-JP['!WXF,"BE9B%W8XY"'H^K>J#7^PRE7D-'G&7,:V.R'(8Y)P
M9 BC@''G0K3R-(PN(G*^KE(S::L_N@\STP'XQ\JY?OL^+RDUXL9(3N(&,=6.
MN11[M!<3EC+:X_F]4$UR7LSYW@DUV[)7XV=:R#W*\SPQM>.N#5G*8';;J#2,
M#[M-W1!5&_?,P&!I6<M-A<M6CRY8;F-HMDEJK%/V8()V)A&7OQN,IZZ/M'<.
MC]4&&(9<W5P,-)PX)EJN%MO%?8R&K;<;3PR5?U-A202D'?<]>ZS&Q,^NKN%B
ML<TXJ/CO#X:Y]AQ.UR*@T%FC9EC@:K19BBFE'NL+R-IKVF+1RW:_5!]>4AG+
MQ_F&IXV2QQJA@I!Q%B.2+8[E7<.\8F8R?IQ]!^+^Y(+C@+_-9;6/CDQ=.'CA
M587*P=DGNB799]KPC&\?Y^G23T01?B^Y4FSW/1AFCD=L^9.P&).P_:5QUZ/Z
M:B[(/KQ%:JSAR_L3!+_]2Y(GV$Q="(-K]']'TZ(+^@(" @(" @/Z(*=S'*O;
MR>+XQ0L4WR=J5KEJG:D=M:M5V-V<!U+YR.#>G5M4'.9<E^Q<+\C<)R62CJY'
M$PVLGAQK6"B(*MZ,[$,<):@?Z4S$.WZ:>SL@W*F.PDW+Z-&2[*=+)<1^\MPO
M=FVV)XY!$9B_4^1B+E\F_P#8@B\?R2*[Q#C53D.?CQ]&UQZ.:KD[W<,9+@F<
M<A1SA-"Y6(Q8'$7U=_;7J@^\G%5LS\X:UE[=Z2AQ2C<BEEL35R&VT$Y?</ )
MCV)7( )QT^+OI[H-NUEZ68IYAN2W?_EN+U[& <IRC"=YZ9O;L#M)ADE:9F!_
M=OIU0:.!?"Y6W4KR9$YJO^@JTQ50N2!&-F+42)HQ,6$@$=?3IZH,N!R%NN/
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MTVL^GIITT09HHHXHQCB 8XP;0 %F869O9F9!](" @(" @(" @(" @(" @("
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M(" @(/B:>"&(YII!CBC;<<ANPB+-[N[]&0<MY5_N(X;B#DKXD9,];C?:15M
MK"_XV#^+_P#D8D',,O\ [B_(>0,AHO4Q43]&:")[$C-^)S?'7^ H*Q<\@^3[
M C]SGLF/<;=HTHP#I[.S1B+_ ."#%!RGR-N[E7.Y29P_-MLR='_\_P =?P02
MV.\Q>5,:[FV8GL1,[;AN016!_%G)A F_Q07CCG^YV\+A%R/$#,'H5K&D[$S?
M5X)7Z_\ E-!V'B?/N)\K@>3"9&.Q(#?JUGUCGC_\<1:&W^&B"PZL@(" @("
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M*YH8Z$[1P9P1VCJ_1AM@W07_ /B-T^NB#O4<@2 )@[$!-J),^K.S^CL[(/I
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MQ]RB6L0_; 3"POJ^[0M7?_!!\V_&UN[DN36+>68ZW**$>.N0A78#C"&*2,)
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M/]1ET9!(\;R.5R.(AM97&EB+Y[FFH%(,VQQ+3I(.C$SMU9!)H" @(&J @("
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M)B:S+3.<>Z%8&;>,(MJ9D_4O9!U7RAYXQ].D.-X5,.5R5F+O6LC6<3@H5O\
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MH6TP<29B]VU0;&"X[@L#2^SP]&&C6UW%'"+#N+_,3^I/^+H)'<WU0$! 0$!
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MR9G<S?306)_?Z,@_7_C'CA\=X)AL5(VEB&NTEKZ]Z9WDD_P(]$%H0$! 0$!
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MLT8CZMM]]4$]X@X?)ROG%4)@=\=CB'(9%]/CMC+]"%_QD-M?X,Z#]>-Z:^Z
M@(" @(" @(" @(" @(" @(" @(" @(" @^'GA:3M/(/<TUV:MNT^NB#[0$!
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MGBS.'@IR53%G=H7(;.UV$] !MPZ^R"*R?D?BT9_<#D;>3[?SCK5(C.,28=A
M12=N,@_,^NGN@J&3\CYZQCK$G':<6$QK2ZV)(7:2WJ0Z;M^C, NW346_F@I%
M*Z-.\%Z4!LN)[Y!GU-I'?UWZ]70:4LEB_=&*I 1RVI-L%:$7(Y#)^@1"W5T'
MZ0\->'FXP YS. !\AF#;# /R"G$?J E_5(7]9_R;H@ZP@(" @(" @(" @("
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MA-'/MR"KBPCR@E))'(QRO$$DW]R2.!R>$#+7J0CJ@Q8GQIP/C^8_?,?C0IY
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M.8/S1FS]1)M?1T$B@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @YWQ'B'+>&39?&8L*F1P5^[/D,?+-*<,]8[1
M;I(I18#[H"75B8F?V00/,_$7*,WG\U+7M0?M_*&P[Y.V4D@3TRQ,V\_M8V$V
M=I6;XZDVCH(X/$'-FO-.X4G!N;_ZL?6<MQ56#8T+_I?W??Z(,. \.<[Q_)J.
M5F"@<-.YR"VXC8-S)LV##$+:Q:,\;C\O^"#5I>!>8GA\'A[LU.O#1X[DL%;M
M1R'([2WI"D"6.-P#<(]-VI,Z"3L>&<\6*X\]2G1K9:EE<7D,W*5NQ/\ <CBH
M7A8FDE$NI"_P#:S"WNZ"V0\#RE#R/FN00UJ62Q&=BH_]/9?8=.>AN9BC!PD$
MF+>YL[.+L7^*"@R>"^<6.+?LDAXV"263-/-<"67OL.3??"#2C&)/$Q/^K%Z$
M^G73H@N7 > <FPG-0S60&LU-N.X_".T,Q')WZ6FX]KQ@VPO;KJ@AN3^&,URC
MEG,<A?>"G5SU6G!BK<<QR2P24/1YH=@!)'-Z&#N_Q0;&;\59[D6>Q.9S=&A+
M&V'/!9C"Q69X:VWNC-'/$40@1Q[A_LEI[=4$WQ_Q_EL-R_/VSAJ9#$YNW7O5
MK<A.-FD4-?L.$8$$FKB+?IFQMI[H*/%X*YF."+$%8JN&+PF7PN)L--)OMOEI
MG-I;;=OX-&#ZNS;M2066]XNY$[<%R5)J?[IQ>A/C;]20B&&4;-)JKRA*(.[O
M&XZLSCU9_9!0)_\ ;QY"; 'B(Y<;*Y<?@P;3//*#-)%D&OD;B\1:CI\/^*"6
MYYP/D^-OY_D(4Z=H\ID\+>Q.ZR4/VL^,K/&12$\;Q_FZ#NU9V?TUT07GQ'4R
M-7QH5$,,&/M1G:&*!K?W$5DY2>0IQGV]!.20O0=&]D%>P'B+E_\ V_XOP3+G
M4K8S"W8[V4N5Y#FDLC!8*Q'#"+A'V]Q$VXW?VZ,@\K>&.4GQ._3*Q6Q_(@Y-
M-R+"9*&0S[(V)6>0"=@ F=XMP.WH_1!M\H\0Y3)\RN6X:]67CL^ @PD<!V)8
M)V*&V-KNB48/M)MOQ+7\W5V00UCPASK)&\65R<4S2\;NX.7(E*167FLVON82
MDTC%I&$1&.0NCEU=!DR?AWG.2:WD9OLHLC=R."G.@%B1ZP5L)'M<F-XF=Y9G
M=^FW1FTZH+[XXX=F..9/F$]]X3@SN;FRM%XB(B:*8!'9(SB.TAV>VJ"\(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(""H\^SO,\51EN\?QU.U7HUY+MX[LIAO&)M7KP#$SEW2%GT(OB@C
M+_DN<(K=NG3$:N%QU7*YR&SN&<([8O(T(,VC,<<0D9.^O7XZ(,U;E_+PY;BZ
MU[%5FX[GBG#&S022'<A:&/NA-:;3M-'*#>@OJ+NS/U0,_P ]R7'>:5<=E*82
M<9OQ"XY>!B8J4IR-$'WC$[CVI#?1I&T87_-]4$_QV_E[ES,1WWK]JC;>M5[
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M;A[9_J$S[]S>G1! MX9R8X7*<?')4OVF24I\1-]DS7@,[+6GCLV&+Y@Q-M^
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MM&3QC^7<(N3:LWN@FT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 04/RN^=H<6S'(<;F;.//%8VQ)!4@&/8=
M@=""61S$W?:S:;?3J@T[W+;7#Y:M,SO\FOYJ$[M2F;#N@AK0AWV:2./Y;S-M
M@N/J_KH@CJWDB7$YCE=ZV-ZW7FM8:##XB=B&6&;(56+L]O1WB^6KGT?^:#<+
MS1*$EX)N-7*[8N@^3R+SF,3M7"<H9"A$V8I69@<Q?0=S?B@U>+^0KM"_E0R
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MO(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>'Z(
M?E0>H/A_S_S9!]H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
& @("#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>s118023_ex3-1img05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 s118023_ex3-1img05.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@"UP)8 P$1  (1 0,1 ?_$ *$  0 " P$! 0$
M       $!0(#!@$'" D! 0                     0  $# P,"! ,"" 8,
M"@@!#0(! P0 $04A$@83!S%!(A11,A5A(W&!0E+2%A<(D3,DE)56H;'18G*"
M<Y.STS0VP9*R0Z-49"5U-^%38T1T-29&HL+CA+3P58/#I$5VAD<1 0
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MJ#I.QO$LMQG%G R6+EP'VH[#1.R'()LF3:*A(Q[41<VW6_WMUH/J- H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H/R5^]KSYS*\HQW X>Y['X\@EY5EA?O'7R^5JR>8MK=-/$J#XO-
MCRYC[&$Q_7GN,*8,XDA>ZBHX:$,=D!15N KO-/C>@^Z]E6>/Q.-OY*:P$+/2
M#>@Y.;*<5N3>*.U.F'3^X$0M^!4U6@^P\-+"OLM-*\CLM(^Q)!F]N=; D];9
MNB(N;;I<QH.P9DQ21M$/[QY25MW5?!=$(ATO^.@^:=W>WG&.78M^2+[<;*M-
MNI#R[*J)"9"J.-/D*%N97P-/%*#\>S(DW'9'(X[)0V6&&R)HR(R1!Z([^BT^
MJ$I;TLH_G:4'W+]U'G;F(Y9,X*\XX6*RP>_PYO"H*+R A&*(2)H8)Y>8_;0?
MK*@B9=QUK%3'6B,708=)LFPZAH2 JHH!^45_ ?.@_.^$[H]QL)@7W&.KR!UV
M5':/+S5<<A,H<<W+"G38>;,W!07&RNC:KXK0=D_W3YR29Q&(T(,A!818N&*/
M,-X'-S"(XXZB(V;1=8E3;9=/PT%+R+N3W=-GE.(89BPIF% ?^\H[#Q$/3=:0
MG0:-3W@ZV9JB^5O.@EQ.[?<?(3\OC\9 CO)&F0(>/R3D.4VR0R9!,O.FWN4E
M$!'?Y:+\*#J^!\UYGF)7(8^4AQR/C.Z"^D9"%)>0!2<56=REM:)E6K(NNXJ#
MCF.7]R.6CA64E#CV5S<%,D]CV)+!"TZRZ\]CW5=]6YE6D%PT]);D\*#WDG)N
M;P^[,^+C)TV6!BX$'$"!MM,;8!F+AM$V33[!/"B]47$)"]-J"KC]W>YLJ']+
M@DW/E)QUZ4_DVH$ALFYX1^LA(I+L-;W;L@VWI^*@Z[M;W!YYF^4/8;-1F%Q\
M6&!),!IUIQPT;:49'JN)"_O+TZ;;4'UN@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@\<,0 C);"**JJODB4'+L]R^*O-"ZR<MUIQ-S;H09A"0KX*)(U94^V@S_:
M+QKX3?YA-_U5 _:+QKX3?Z/F_P"JH'[1>-?]M_F$W_54#]HO&OA-_H^;_JJ!
M^T7C7_;?YA-_U5 _:-QK_MO]'S?]30/VB\:_[;_,)O\ JJ!^T7C7PF_S";_J
MJ!^T7C7PF_T?-_U5 _:-QKX3?Z/F_P"IH'[1>-?";_,)O^JH/![C\8(B 5FJ
M86WBD"8JI?5+_=4'J]Q>-)XI-_H^;_JJ!^T7C7PF_P!'S?\ 4T#]HO&OA-_H
M^;_JJ!^T7C7PF_T?-_U5 _:+QK_MO\PF_P"JH'[1>-?";_1\W_54#]HO&OA-
M_H^;_J:!^T7C7PF_S";_ *J@?M&XU\)O]'S?]30/VC<:_P"V_P!'S?\ 4T#]
MHW&O^V_T?-_U- _:-QK_ +;_ $?-_P!30/VC<:_[;_1\W_4T#]HW&O\ MO\
M1\W_ %- _:-QK_MO]'S?]30/VC<:^$W^CYO^IH+'!<GP^;62./=,G(B@,EIU
MIU@P5Q-P7!T0*Q(FBT%K0*!0>&2".XEL(ZDJ^"(E!_.#D_(5E<VSN>==?DR7
M,D\<2:!+MZ8N%MVG="11#;LM0=C^[\TP'=+$RGVGG'FP<?!Q2<9)'WD]*.$6
MACTR75/%*#]49XH>-S+K28\G_P!88SK8])OJ*<J,*%8D2Q)N;LM_-;K04[WO
M\I'E8C(K*Q;[735N'*<(A<,Q1=ON _(545" %32@@KRW+0)302<4K6,. 2(S
M&%YB&2QW=B;57=\R6LFEO/QH";0Y$6-Q^.R<3*RGG'Y,EXT<:1I )5D.$/W1
M 961!T):#\U=Q\2Z\XF9Z;RN./$P1"TJ!:,(D#@651;W!>][^%!!Q^5F8SD_
M'>3"CKF4BS8SK[SC_6,FT(43JH.C>[Y01%MMH/Z'B2$B*G@J(J?CH-4UU]J(
M\Y';1Y\&S)EHB0$,T&XBI+H**NE_*@^+)WOYHUCVGW\%C][12WYCS<EQ8SL2
M&ZRTXL,]MW'.I(4;JFU=JJGC0=GQ_G'))N=Y1!R$"&,3"-JY&E0WC=1"N:I'
MD*J(/6V")D@:#NLNM!R'$/WBPRS37U'%&U+]G%5W'Q44GRR$V23+##2&J#TW
M6]K@F1>=!8Y?]X''MP'WL+@LCDI$1IAZ:A"VTU&1Z2L4@>-3^<7 )+#>]OA0
M6';7FN(DY+)\?:PAX:4$B?-!6@3H2P9E*PZ\)(1$3FZV^_GX:4$'!]V\[]-<
MY%GHV-# 28KDS'QH4E/J+: _T4;?:?4 *_Y1BJ(*Z+0;W>_O'$QK>3C8?*RH
M)Q&9CDIE@%;:&0Z;+8.&II95-LO#3S\*"6UWOXF;L( C3/;2V8[SLI&P5J.4
MQ'%CM.J)JJDYT2^1%1/.@DX3NO!Y!A,Q-Q4&1'F8R"WD(\7);(POMR&B<C'O
M0B$0<4%2ZKI0<OQCOCG93;#64Q33LTL@,28S&1V,Y&9*$<LG'69%U54Z1(*B
M2B8I=*"P9_>+X>JL^Z@Y&$CL-)Z]9H+BRXT;S*J(F2_>MM*HK^"]J"1Q[O7&
MY'R#!8W$XF1[;*%-"9(D* +'*(RVZ.U!(D<0A=345TH/IM H% H% H% H% H
M% H% H% H% H-$__ &&1_DC_ .2M!\MBR<TK'"8$!V634K"O&]%BR C7)D6$
M!S<:+=1ZBZ4%ED.22XV4: 7Y+88[.>SFHKO422R.+*1\FU-MU1%VI^5KYT&:
M]P,Y,A-1VH<=B5F&G'L-)&1N;)A(JR"(]B$8.!\J::^/@BT$V#GYC?#N'RY)
M.29&2<@,OO([TR5Q\+J1JB+O%2^8=+T&[A?.)V>E Q,B-1E?@I/95EPG+)[A
MR.0E=!\V[I:@YD.>\E0HN:=5EP0@91Z5CP,@8(8>0!@3&Z$74Z:JFNE!UW'>
M73LUEG@;AMCB$5]IJ4CP]87XSG3-MQE?5ZO%%3P\_&@H<MW*R?TR=(A1VFVG
MHN5/%R%)2<;>Q5Q/W 6LB%:XV73P7QH*Q9^8B3)92,A-D1,8&(D-M!,(#(\F
MZH.HX2@N]M%U$5\M$6@Z!>X<M8:SPCQO92I*0<=N>5'1D>Y6-:2"HB .X;Z+
M_>^-!92>5Y&+Q_&RI<)MC+9*4UCQC=5'&&Y#IJ"*3H7N'IOIKY>-!20>09;D
MG(\5"<<<QL=MB:[,:C.J)%*Q\P(Z[3MZV2UT5-47XT%GR\YPQY?LRD(ZDW'[
MO;*>_I=0>K?IZ[>G?=]E!71<MS6'(G-Q(;TK'N23<PQ2T(G#!%:$F#)?4V"[
MG#;,_)*#UWEW,_:MRFL<[=PGFW8I1'=[+S>RS=[^L5]>UQ-%H, Y=SI)-UQW
M6;W^F.,9T%)%<>;0>H2V3TMMG=?SJ URSF[QQ5&(H,2$ E0H;X.)U'5;42WJ
MB"3:>KPLMOA02I!<KE8GCDN,^^&=;:-Z0PX!-,2#%OUL203T@AK?:7Y)65*"
M#^LO-H$0&F<9()?;H^VW(9<>,2-APU;=<$EN0O"@:+YT&$G-<VFF##@.,"S)
M!P93$9X$$&9 BI&.[[P#;.ZA]E!(/E?/=IM'C4C2F@81Q%CO.MEUC 5=;,%V
MZ;CW-JMQM0?0&T-&Q0RW&B(A$B615\UMK:@RH% H% H% H.8P7^_/*?\#'?Z
M)R@Z>@4"@T3@,X;X!\Y-F(VUU45MI0?S74Y4''96)(D'&V3%:=A]-M24Q54.
M^[UBHV_)H+'!2<K'RGU3#-D^Y BM2R;CB\XSL90!-31Q=ZH))ZU'THNB:4'Z
M5R?>OB^7B)!QV0EK)G,$])R41G<F,?,$Z;II957:YZ?1>X4'S+'3NZ#$G;*R
M13FU]M( I$)'3D-&X3 OLM&@.FM_F54\/&@\@9+DF#XGDY&3=DS\4[BWHC*F
MRD5MAR4^BM( E_&$ZI+ONEQH+SMQPS(O\8DY''<XDQ)K(.A)AQT;TD );6_O
M7$WE85%%_*\J#YGR:5EHWOL;F)*/-BV3S#2 3D8E5BR._<$JMN[SV^I=J+\V
ME!1O8*1$;Q".));64ZPC3;C:IO7<FY$&P[;*OI157<FM!_1^.*BPV*I94$4L
MOCX4&G++!'&2RGV]BC#BR]U[=% 7J7MK;;>@^2X0>RI8=MR9QASC^&QYL93'
MR,HP;,<^M;I.LN(;@EN0$56U7[5&@NX^5[&<9R.5D,3<9CYV1%'<JJ.KN=&7
M]XA&-U3[W?NT\:#9):['NN.XAXL2KOTYD'8^\4+Z?%3KLIN1?!L?6.NY$UH/
M#+LT'!LKE(<>%,XRU&"%D!AIU$<:CE=IC:*HJEO=]/Q4KWH(T3F'"..1RRLW
MCTGC;D)N8VXDIH1>%D!&6ZK2"9]87%)%]"KZO&@DX?$=D>2!)''P<7,/D@F[
M,8$$ZKR,$)N;P^8-AF*EX>I?C05G*<IVBXW[_A.0P@I'9QT:8F/;#T/QO=$V
M ,KN3U,NN*2I\%O06L1GL@>7B!%^DED\,GTF(($.YCTN)T$2]KHB.>/AK0;X
M>8[.QVYD2+*Q8-'C&_>M;AVKC& 46MZ+HK0@YI]BT'.\7E]@'X08[&MPHD4<
MN34 3<(5D366Q;0VC4MYCL?Z:(JVUM:@W<DS?:?CO.HV-G\?5<K%Q1-MS&F$
M)L((M.*C*!N17!1MHQN@J@^"JEZ"LP7+NU\6#@9.)X=.:]ED2B0VXS0.%!FS
MA!/O%%Y;]9IT5\22WPM0="YW\XDWC\G.<B3P8Q_3*/\ <7]XRX\4<7F-JJFQ
M'6R15.UK7H.NY5S3!\8QC&0RCA"$IYJ-%9;3<ZXZ\2"(B/V7W$ODE!S.5[T8
MK%Y3)XR7ALH$N%M2$/1'^7*<A(H^WN>B$\MA4]J*FJ4%E@NZ?'<WFL7B(+4I
M9&5@%DFG'&2!H&Q5$5LS+1745=1&]J#L:#S<6^VWTV^;[?A0>T"@4"@4"@4"
M@4"@4"@T3_\ 89'^2/\ Y*T'%821AL9PSC>9E0QD9!F"PQ#-$'K(C@)N$")4
MLB^?QH.J7!8-7EF.0F$?1[W9/$"(2/(&SJJOYZ!Z;_"@A1>%\*2 C$3%Q$@N
M/>\!&0% 5TD7[P5'XHJ^'E037,+@68$>*<5D($!1.*T0HC;*M_(0W^7;?2@B
M0F>(XY@,E";C1V$'VK<A@433J+]T.WQ^\OZ4\Z#>[Q/C+JFKF,C$KB."=VQU
M%XD-Q%T\#)+E\5H-D+CF!@Y&5DX<!F//F[4ER6P03<VI9-RI^"@P+BW'"<FN
M%CF"+(HHSK@BHZA?,A)X>JWJ^/G0>EQ;CI*:ECF%5T6@<503U"PMV47XHVOR
M_"@TN<*XFZF21S$Q23,*BY1%;&SZIK=SXK?6_P =:"6Y@,,YB1Q!PVEQ@"(!
M$VHC8H"W&R)X*BI=%H$? X:._'D,0VFWXK2L1W1%$(&B6Y *^-E75?BM!6YB
M9F(4;.RL+!3)99IMM84$G$:%UW981(UT%/-:#YD_WIYMA(G*(.;@8V=G\*>.
MCQ'L<;J0RE90]@1GU<N0FS\QV75/A07.,[J<N9PW)XN3P8Y3EG&980W(^)4D
MC/\ 79Z[3ZJ^J$TV@WZBJJVM05CO>;E#_#^"R8C>,A9KF+;[CD_)$XUC8WM@
M5PA54+=N<^44W4$>+WTY3R/$<<#BF/@#G<I$R$_()--THS88P^DX#2MV(NL:
M>@E\$\:";G^^>9;X?Q3/87 FXWR H139K^L2*,E]&":0D(2<=WWVHB:)JOPH
M/.<][,OB^X+W%\.6'8'&^T24.7?-AV8[+6_1BD/H;V-JBJ;FE]*!F>\W)8/<
MW]60BP4CIDHF.;Q3BN_4I#$IM#.<T2?=(VWKZ535$76@8KO)R:7W._5AR+ Z
M!925C3Q(*Y]28CQVU<">X2KTE:<T]*)YI03\3W#[BQ^>X?!\GQF.C1N0!,=8
M@Q'3<FP&8B7%Z62JK1 [X7&VM!+X+W7D\L[BYK"QH@M\>A0FY6+GDA(Y+17B
M9-X;K;I*8$@::VOYT&WO#W*SG"X$4\3ACFJ^]'"3D74M#C-O/BS8E0A(W"4O
M2(_A6@\[C]R\[QKD7'L3C\,;L/*9*)#G9F0EHP))(D1IFQ(1NV!5\+#Y^-!]
M&H% H%!S&"_WYY5_@8[_ $3E!T] H% H/P;^\9Q9WB_=/*Q8J(,'.(WD(X*W
MNN9DNX1)4^;J(M[?'6@X/&K-BSH^,)QR)M<5J?)472V,;Q5QMYJZ(K39(I&B
M>/G0?7^8<!PT"#^L^(S<-F2#PMDS&9?B \TK>W:UL4MBG\VB)IK02NW.$[LQ
MRD?JZC.4?B@H*^;[4ENSGW@-Q77?6C:DNXU$K72@ZCVN;AEBY'/H,1CD D\2
M',;8?BJP %L;;BH1"P9>*NV5+T%-DHV3E<.8E3</&<=>:<<)]C&,M-1B!HMQ
M@ZW='%N/C:UJ#XMSK-Q,KDG#@L(R"[68HA%]J11T3>V\2 MB)\B55NGPM0=1
MV;PN:YUW&XYA9QD[CL.H2W5VEZ(\/41)"6R(16#PO0?O>@TS(\>3%>CR40H[
MS9-O"NB*!BJ$B_B6@^,Y3A';23CY.#E]P9"N-"T;(.Y!@EC0HP$K;2,V0%;1
MMRY$2772ZT&U_@G:F7Q0,&SRII&,R['&/-%^*X[(*"P,3IMJ2$AV1$OMU0J"
M1,[2]M8^)^I2L^XQQEQE-G6D,I&]TY%]BDSK$.Y75:TMNVW\J#H(7&>WDF)F
M>)-9)F6N::9?E06GVD?!L(S++3K:!J/I9 T*WCK05Y]O>'OX'ZOE.3R<K#$)
MROYJ9*:<:()C"0S]2(C0BT(^E!MZO&@I./\ '\!$R^9=QG+\:/(\W'Q[&)G-
M/@<HH,$15QUP=!5Q\6BWJ [;(E!>\KP7:CF1,S,EFXKJY)Z,.*?9E,HO7@.$
MNV.=UNI*YM<'7^&@\_8!P\H/(H)R)*Q^0O=<[*V+D9>NLDD9<0-^KA+\RKII
M09Y#L)Q"9G\CF/<S&5R,%,:L1HQ1EIH6VVPZ2**JFSH@J)>UTH(SW[O/&Y,Z
M!D9F7R<K(09I9)9#CC7WL@S:<4C 6T'Q83Y432@O\[VIP69Y>WR>1*EM2@:1
MLF&7!%LB '&VW$514Q4!>+05VKYHM!KXWVCP&":@"S*DR7860=RSCSRMHK\I
MQE8Z$Z(  V!M?2@HGQH-4/LW@8F.S< )\TH^8:]JVA&/\DB]4GNA'L.@]1PE
MN5UUH)/*>S?;WDQNOY3&(LY[;NGM&;;Z;4%-"1;:B"(NGA05TGL?@Y,G-2'L
MSE2/-/-2"^_"\=V,:%')@E;4AZ.W:"*JI:@Z/%\#PV,?P;D0W@# 1'H<)E3N
M!"_LWFYIZC7I^/VK0='0*!0*!0*!0*!0*!0*!08JWZT/<J6OZ4\%O\:#5/\
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M4XC4:.!.ONK>P@"7(EM\$2@RBR6949J2P2&P^ N-&G@0&EQ5/PHM!R'+Y2P
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MQ7_5&O\ B)0/HV)_ZHU_Q$H'T;$_]4:_XB4#Z-B?^J-?\1*!]&Q/_5&O^(E
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MM:V7<*+?1=%H);.<Q#V7?PS4QH\K%:!^3"$D5UMIQ; 9CXHA6TH)M H% H%
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M5H.A[(%GXO>+,!F</D(^8R>'CR<W+F*TMI2NF2FB 1(+1:-M"/@@ZT'Z*H%
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ME\IMN(HD*_A1:#XF_P#N[<J#&N<3@<\EQNWKRDIX<F .2#9$I*P$A5OTUO\
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MU1>UG$E1%1/I,/1;7_B1^&E!U] H% H% H% H% H% H% H% H% H% H% H%
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M+:>T:\O\6@]8[1=L6140XIB4'=N'^2-+_;&@ZF)$C0XS46*T#$9D4;99;%!
M %+((BFB(E!NH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M!&^VKK22G5:;>DN"5A)I@D)PO):#C8^-YCQ?@G*^',-M8UQ\H,_"/X243C0
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M.*8="/(>5A1473%3 ";4.I<A15'TZT&/<'*]L.&0^.9"1QN%(Q&=DMPSF"T
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M-D3CG'H;XOQ,7$C/@JJ+K3#0&BKXV(11=:"QH% H% H% H% H% H% H% H%
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MKVYX.7(7>1KAHRYM\2%Z?M^\+J-](U76VXF_2I6O:@TIVN[>H]B'OH,17L$
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M$:6)N:?$5]P2@SN(@00ZA)Z-ZI?RH*_%]X^+Y$GWQ>"+CH93PFR)2DT8+CW
M;(@;4/6);T6Z+=-$M>@F/=W>W;&-:R+N8 (SSYQ&[M/]3W#8=0VU:0.H)("[
MM1\*"^Q/),-EE9^G2@DB_&;FLFVA;3CO*J-N"2I;U;5T\:"SH% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MB@D2C'>6Z%X;;#ZOQ4$Z+.9DFX+:$BM;=Z$*C\Z;D\?LH)% H% H% H% H%
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M?)%H,T;%%541$5?%;:Z4'BLME?<(K?QNB+X4!6&E14415%M=+)K;PH/1; ?
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ML$6VRIY^"6H/I] H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MBGV)0)>.BS5;.9CX\EQG=T5>$'%'<FNU2%;;O!;4'OL63:<9<Q[*L.;4<;5
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MLVO+TW2 M]]R?;03)':_',9*'D7>036!;EQ)LIMPV$&7.BBH-NN$0713%;*
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M..F733:V.]PB+: Z"-[(E!(AL2!S61=,51EP&$9*Z67:A;K>?G06- H% H%
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MK 85\(LMUQIQ!5PVT=1&K"JFB!JNU/M\*!GNX_'X$=YF!-CS<RL!W(8^#O)
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M+;K?RH)>9[LXB"PZY#QN0RBBZ##!1F"Z+YD^,<^D\5@7IF=EO^*@VS^[/%(
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M-.'%)M&EC#$-GVY"3=E;;%4)=4)*"^Y#V]#)CCB@Y-W'2L?%>QRO[ >ZL.0
M@ZV8EM3<O3%1)/!?+RH)/&N#1^/Y.9)B2S*%(B0X+$$A%$9:@-JTUM<3UDNT
MEO>@I&.TZ%-R4_(9EV7DI8QQASA8::>9]HXCK!N$-^NX!"B;C_)NGG03_P!F
M\<L-+Q;F0=5O(&_*G.BVV).3WW@?&6ED])-$VB"*:6\:"$_VEBO1'Q7*OAD,
MB4KZS/!MI"E-S4!'F]BHHMIM:% V_+0=%#XLD/DQ9IB8X,<H#6.'&;0Z0BP:
MD!B5M^[UJGC:@Y(>W<[.9_E*\@5UG 9"6+D*&!-*CMH:1O<;QNX"BN[:*_8M
M!;8+MU)Q<C$ON9Z3.+%N.G9UF.".BXPD<0+I ")L!+W1+DNJT$;E':['Y_/2
MIS^5>8>E17&!9:%E" 3;1I54K;W&T\4 [HA:T$3+]F(^5D/OR<[,!R0^3Y])
MMA!12:::7:) :(7\G%=_CXI02IW:9B5 Z7UJ6W/#).Y:/D4!@C;=D#L>#IDV
MK1 8JNBCI0=;A\.6-%QI)CTF.J-C':>45Z0MMH"H)(B*NY1W+?S6@YQSMU&D
MXSD.+=S$ET,[-"?)5$9WL.(39;6[#H*HR*>J]!#?[28D\I[Y,O,8R+[TEV4;
M2L"3[$IT77&%0@+:(F/I(+$E_&@M>2\,7(Y>+FV\Y(Q+D"(]#;Z0L$"-R%%7
M")7@/U?=C9?*U!38_M#Q#', Q"G/MX=@(J9& KH$T^Y!)7&77S5-PGN5%+:J
M7LE!YBNS6,QTJ-+AYS(DC$J/.!MPV7&R.,+@-W^[15NV\HDM[E\:"SP?;+'8
M;D#66B9&8K$59GLL89-K'9'(.(\^(^C>H]4=PW+2@UEVJQ"R)Y!.E-QI?O38
MB"K>R,]DAV2G6E4-VXT4K(2JB76U!NR?"(65XQ!XLWFY3*88XI>Y8-E9*K$L
M3*/(H$/Y(K\J7M0:VNUV-%'GW<I/?RTF;%R$O*N. KSA05W1V=NSIBR"JOH$
M4H-0=IL4&.Q\-O+9)H\<[*-F6T\ /$U-<ZK[!J@64%)=--R>2T&$CMIQJ.DR
M#]8G0HV7<4H./&6@-QY&]'R<A 27ZF\-^NZVNFM![+[08.3'F1BR,\8TD9",
MLHX%HY3%19)LJH70G51;WO;<MK7H+ >&X1GF<3/2)SKN6!@FX49TVD]*-"TZ
M0(@BX2;412&ZBA+>R4$65VJQ+^;DYGZC.;FOO-/"0&VB-HR^D@6QN%U'J#^4
MJJB:)9*"$UV2XR$J)*+(9(WH<CW;:^X%$)T9)RP4K!^2XX6B6NGC>@M^/=NL
M;@Y<"3'R$YXL<U*8:;>=%6R&8^LAU7!$!N74^5?*@ZN@BL.ME/DMHJ*8"VII
M:RHA7MKY^%!*H% H% H% H% H% H% H(>85!QKQ+?THB^DMB_,G@5!\BC<XR
MW',GR=4F1'<6>7R@L-RS><>9>CQ&G_%"+[E#].P1TO02('=GE;V#:RCL:&8!
MD9F#DMLH1F4W:B8\A0#<$1<<)!<3<MO&]!;\=Y_R:?S]WC\M,6,**;L24V#R
MC.Z[+(.=5N.JD:M&I%JJ(B#;55H*7.\@Y:O(-C>5B')@\B>8@PSWL@$1,<3R
M!)1LMSB+XBJIXZT$CC'=OD&>Y1C(P1\=%QC[<5)D=Y_;+(YD5) O1A75P$-=
MB6'R555+4&WD?=#.0>=2L##=@I&%J0VSU!7J!)8A>\%#NX!&I_+M$+6_*OI0
M0I7<?,93),L,9K'P<8UDL>S,=;1#4F)^/-]8YGOLA=4=J$EO+SH('$^X?(L5
MQ7'8Z5)@F3[&,2%DR)QWVK4^0['ZDW>=SVJTEBW"BJ6M!->[@\RR#<Z,1XT8
ML'!S9TY%!V\E8[[T5#9,'!5MIWI(:+JJ>2^=!ZQSOE>*>RDQ9D*3Q[#EC'Y6
M.V$4J/B9$1HWGVR$U(^F1+\R+NLM!T')N0<H;X1A,NLUK#RI>1A>])&D,?9R
M9""C:]1?0JMD.Y?CI0."\]S.=Y"D:0L8X,N-*D#'9 A?@G$E^V1J0JDN[JIZ
MDN(^"VTH*B5W!S&,R LLE#&)];E1<L\T)/.((NM-MDK*N[Q0NIM,@W;2MZ;4
M$2%W8Y%[QQK)3,=#;23*8-P@16&Q2*\]%,9(NJVXBDRET])>**B+02>']UN0
M9WD6%BD[C B28L0Y<?>227SE15>5Z*'J+8+B*.J;42]RO05W<CF>5DS.5<=D
MR([4)B.#F*Z.[?U6'HZDKKH&A 8D[JV0HA"J;576@W3^\.>QRQ694C'*]%RS
M^/R;JBK;;[#,EECJM;G%Z:H+ZW%%-;I\*#";W1YPS"CR&)^$),A/R$:*_(O'
MC@&-<44;)U7"W&^/J2VJ6T1:#K>&\WRV6Y=F,1/5A6H[?N(#<4=R$T)""JKV
M]50T(K$#@ 2>5TH."S_<SDF6X?/7WT: ,W'.2'2:!4>QKS60;B^V>4CU5X#5
M+KM6Z+Y4'8<SRF5X9B\!!XY,Q\*'+62#TJ<+CC6]N,<H%;^]2R.DVH[=R_,E
MJ#F5[I<[?C9B>4B#C&(CN*BE'=95?9%DF&W7'I+Q$NC1%MU%$UU\*"-GN19%
MW(L9Z?E(,W(8C ,3VH+ .>V"2Y,Z13FU51<Z:!]YJ*IM3\V@D+W&Y\0OJ/(<
M*H8[#RLJ^ZQ'-YN1[:0K0*)D;5A,52Y"BI=/303)?<;G..Y(..*=BYZ0XS+Q
MP.FXS+R/N(QOHY#;#J:":('S;=%W>5!/[69E9_(^6SUR[&5>D1,9*)UD=K+9
M%'/<"@!'\BI8K:_'6@YUKN5S=][#3?>K()AW+-RH$=EM&)C\>$+T:.+P*X)B
M9EZ%2Q>2IN2@GM]T>1^U8ZV8B,XV6<??RDHZ*Q#<>AG(6*XW= 5>J"!N5=-U
ME]5!YQ'ETAKN9D,2<T(D3)2(\MZ<K1JU-E+":0XC(NK>-N_C/5JORIK>@MN4
M<JGXSDV8B0<C#Q<ER=AF3E/1NH2L2P-LT*YBA$UMW(O@B:+0;UY]G3[:8_-#
M(:26YD6\=E,NTTA-QV$EJPY,Z*W'Y!0K>";K^%!S$CN;S2.I/.9N&D:!]Y<H
M?^WQTRB1!?NA>@7&24O0GB-TTH.N[?\ ,.19OF&<ASYT-R%%)X&L4RTX,J(K
M3ZMMJ\XHH"BZW8DU6_BFE!R\KNCS3Z?D94>9'%]IEXIK!,"2XJ2W/",TP8(J
M&?5:(B]?PW)I0=GR_)<EQ3'&L>UR%J-*GO/,3LHY# ^J@1G'1(&D78VNX$^R
M@XS%=R^7G"B+D<LP Y-G&2G9XPT#Z>$HG6Y%Q*XJ*$T'J/Y=VNE!B7<;N$K3
MYC-94X&'>G]((:D4I!FG&"59+J(^W1']@IK^"@OH?*^5+VPGY+ZS$GY!F5T8
M69;:-EEQ@G 1+DX" A[24.KLV(7CX+044?N+S:7)C*F3'& &."2S%FPE5^<A
M,NDZX/316D)IUL=4/;;6WJ2@U2N7\P@K$R!S0R$R5QH)[F02 (G&ZTQD7=J-
MB2J+39&NQ;KZ;JE!.Q/<#DK.:P'U'.-Y+%R.J+[\*,K2&T).DDAUMX!,FNF"
M(3K2HB$GRV*@Z/N;S:7$XOBLGQJ;Z<HYNBS&6T>;<#H&\VF[:Y9'%%+6%5+P
MT\:#GBY[RD<RLV)E2GPWIJ18^'6%L#8YBUE)9S:CEQDH@(JK;6U!*[<95QW(
M\SR+.0=G2WX<"4,R1&)M$=&*>X.F !NZ1Z**>KRH./=Y5R65'@<C6<\UR##0
M<V2R#B@\V^+81R:9;40$3:<<OM)10_R?%*"TG<YS.6+D>/S'6/$2\1,5F"Y$
M<L$EI&U;!%%OS0UVW)5+QTH.@Q@1BP?<X28W,NJ9]/I'9S?BVDN@JGJ522WI
M\Z#B%YYSW"\:+'P\C(-8#4<L?)=A:F(XH7U8(D;*Z"^B@B(&XOENGC0=N>:[
MDG.EC!]PZV]C4S\%XF@5FY0U;3&H*B)(:RK.(B^K;YT&[ S^1YCMAR)5S$J9
MD/;/C"FC$<B2FG%C(73%' !7"%R_J0/L\J#D\1D,WCN31)V(R$UT)2X>#-8>
MBDHRU+'/=1Y\B:$^H+@-CN141/.@Z?MWR+E3W&<]D<ED)N2?8BH^W'/'DP_&
ME(T2O1PZ@M=8D-$L-MJ:>I;T'*8WGO.@Q\AR7.R)QQ3(,,/I#,G5=<@MO0K?
M<!O)'^H**@;;Z?"@26\UE\]#.7.R[4J3.Q,UM_VQJD-LL6X,EQG<THM??*H$
MB_'PH+3$\J[BRI.,5U^6$C;C49C'%(&941P3'(R7[MW;=;45)$NEK)HNZ@K9
M'ZVY'BV--_.969)S6*S1/ <46WVU9;NRC+C;(&P1*">E5]=!U'&I7,AY3B\*
M&0ER\1-B1LTLN9L%^/'9;Z3L)UO8![GGC$[DE[73RH(_*7.28[EV=>&1EF<1
M-E8SW,B,CKC<?'(P0ON1D$303]P@H>U%5!NMJ#O^WS^;?X?C7<V1GD2 NHX\
M.QTVT<)&3<%$2QDUM4M/&@Z&@A1F(X928Z *CSHL]4];*@H2#;\%UH)M H%
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MGIOK06<K*-IA7<I#VR6QC%)CV*PN(@;P]5ELA?&@Y7%]U<&;"2LQ*B8Z.4>
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M^0K3L;"=)L>M(81D!$G&Q7:IDYNT2VGDE!&PG;"<<Z)GLA.9]](/K9*.U%Z
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MPRD)B('M\@Y.CPWW!>.3CY@1U)MQ$VFT7Y*$G@I7UH(_).4<Z_6IAB++A@_
MS;\2+ %UQII^(6-*2'O$]1$J+J.U/&@LL!W6S.9S^-BM8Z(WC9#<1)Y.2A&0
MV],C>X#HA_SHW]&@ZV5;T&>7[E\F@<NF8AO%Q'<?'F,X]M_KG[@GI40I33BM
M[=J-ALLYK]J>%!7P.ZG,G'\$U)@XD"R<:+D91>Z-H!BRWNB@,$Y_&O-VN2"*
MHMT2@J,/S3E4"04]IR/E,CD9&1<E-2IQ1X@PX.0]LB, X1"+PBOY/Y-DM=;T
M%[CNX?<'(/P28BX3VL^?,A,IUI*N[8'4)Q;(-E(Q:]*>2KK01L;W:SV6B,B3
M>+BIF%!O'R@EJ?0%QMXS24(+N;-.EM#U)<KZ:4$MCF^:P_9W 9Q@V\C/=992
M2^^1/7%!(G7+"0FZHH'J05W6NMEM:@K&.XF7P4K)2SD19V$R4UY83\B2\1LO
M?36YB"EQ6T:_I 43=K0;\?W<Y9.;B!'@X]922LG'R#1N.(:AC6@?^Y!M7+&X
M!VVJ2V6@C#WEY4F'#)&SBC:?-A]LHKZRC;AO-*X9/,-EO3IGZ25%4D'U;*#I
M.Y/<R9Q29BVXS<:0W(1MV:VX1":,NR&X^\"51%$3JJOY2JJ6V^*T$G@?.,ER
M!_.PLC[9B;CB0FF&D+8C+BN(VYUD(P< MFA"J+XHJ)05?;KD^9FYW'P'<A'7
M$/X&/.8@W)Q]7R><;<(7S)3<%-GGX)0<K+[H99G/N<B23&57,/);9PXND@QC
M;R;4=')8J:IN;$U(EVC9+IX4%TSW5Y6N4QV-(\(+R #L^04DD8D@Y**-_)"3
MYB!$15$=WJ7;X:T%?"[S<P??57"PJ1FHP9%Y0)[=T5R!0":&YVW^G?N\$\+4
M':\)YQD<[G>08Z644/IQJ4(6MQ(K"N.-@ZKJ$0."73U^4A*Z*GG0<5#[V<G+
M$H_,#%=>8W'>B2&'#1B,#\UR&1RE<*R"BMHJ%=$NMEH+?']SL^\\VDR5B DQ
M6 <D8Q@G'G)ZF+J[X#B*BDFYI!T$A^;7PH*4>]7*QQD6>Z]AGHSSC3[[D%PY
M+C$9UL24'&-P*IMN%M- 531-=M!)R7>3D#,?,])R$S*CRP9QHF&YMQDR>V&+
MW51OUHQKU-B@M]%TH)$/N5SO,0YN2PQ8EV+C<=CLE*A@CCKYC+:ZTD )#045
ML1+9=-=$H.@F\XS3/;Y[E0 "MSI#98QPVB#VV/DO"VU(D@2W50;+JEX:4%;A
M><<PR'),7@VIV-=8.1/"1D>FJE,CP595'(P >T5+K*!+=1116WPH-'*N[^2P
MG.I>':&/)AQ&7KQK*#Y/A"64V"*I;B4E3Q$-MO/=04^+YSF<9-Y!GPR<3+PP
MDXM_+-Q!-U$CRX>P4B@CA[520H(OQ3Q1%H-^?YWR7CTO**XY!#--M8H\D274
MT!QEXWD:8<=0#(-F@BJ*0WM<K4$;E'<F;EI>?X_[Z,$,8CKL!UI38?"7#>CE
MM4=_54$1Q2)2$45$LGG0;<MS/*IDL/DY4F+D,EBIN8CP7H).-1IK36-5U/N]
MY[E!Q4$K*NJ:4'7<;Y1RK,\%S&0B3L7/R\;JKC94/>Y$*S0N@#W@F_7:6PM/
MPT'&3>Y?+<OQOD1/1VV($+&OY7JR8[C;<K'OQT2(U<30@<-X7$+5%VHGQH-,
MK.YB9E\>U^L,6)-B9IA,5'?!$;8B/XA74$A$QZH$ORJ:^*7O06>,[L<IR+L1
M6W8B27',:P&* +G-;G-_?38YD5]K1[E1-4L"[O&@KP[I\BR3,01Y!&@^U7$G
MFG68XDK)ORG8\ID]RJ*>H054\1O:@Z;GO<G)X'G6'P\:9&"&^<,)[+X()=.8
M\3*O"1*BELLBV!+#^4NJ4'/XGN1SW(8J7(BYC'SYD2+]4<C1HR(7MHTUQB2R
M-W"N9L-[P7\[[%H.LG\RS\?MLO)7'QCOY&0#F-(V+*S#EOHD='A)=@GT212,
M_2BKJE!P4WGF4Y)@L*6<G-P7&'<;-",VRNZ>^&0)I_IK;<'1%L;[?SKKI083
M>82)TC(YK(9"-]07$R&)V%>87IQ"9R+:!%=VJ)D:@2V4EOYII03VN6YJ+R>?
M[E],W/QN7S0XB"^WM>;!K'"[%:8(-J;7=42Z+?RUH)<?N7R>4N/;;Y# "!-6
M$;^:2,A P<B.ZX_$)-W30FR;%44ENE[%K0:HO<_+Y;)8Z+-G,EALEC>GD8Z1
MU!%=>B.EU .Q'M5P$&]T%/EU6@LY7*LGA.RW&9N$E=&4['C,-/DUUAN+!+M/
M<A;;D%K[56^B:K05+_<+EN8@S0#-EB,B6+!^!C&8)$[+%W'*\<AAPDW 024(
M==!VV5+JE!N:Y;DX@.O-9/T2F<$.0SRQ$]PQ'D-.HZ^Z1#M.SB"FXAL&[5*"
M,G</GK<UER5F$!IB/!>2*,%$&6DC(E%ZA%92!'8VUZP_+?X4'W:@C,"GOI)6
M)%5&[JORK9%\/^&@DT"@4"@4"@4"@4"@4"@4$/,.BUCW'"<Z2"H7<UT]8IY7
M6@Y;'\9[;9V1DIZ8*,4IN:^Q/.2P@N+(!1ZI+N\1)4$K^"^-!8S.%<!DQ'F9
MF(@N14=<EOBXV"BCKH6==-5\-X)ZE7Q2@UPW^&Y;.-8]F(#LSC;4>3CGE;LT
MVU+;(6SC&BV5%!M16U!O:X)P< ?!K"P@!^2$R0+;0"A26BW@X6W\H26Z?;0<
MS$R/:B4ZK$3!@<#)3 @?5&H"^S?E-.J0!UQ'U(+P^D_DW>"T':Q,)QZ$P+,:
M%&99;D%)$  $$9*WW.I\'-5]7C0>1./<=B9>3EXF.C,Y6:B>[FMM@CSB)X;S
M1+KX4&AGB?$V&5!C'1FFRE%/11 -)9Z+(%5O]Y_?>-!R.![9\0XXYORTUC(I
M)<")$24U'917>JKH(6Q$ZTC=X&7J^%!T$;C'!I\)M7,%'9;4GV6F),<&S];N
MYW:):_>&._3Q\:#?GPX?CN,/1<A#8/!QT;!R"#0N *&X@!9H?[\DU_'02XO'
M>,,28TB+ C!)QK:QHCK8 ALMK>[8JFHHM]4H(LS&\&E9=GW<: ]EI>]UE3%L
MGG.D'2,D7YEV@6U?LTH-\+!<2A''G0H,)AR*U[6+*;;:%6VK_P 4!IX)=?!%
MH.2AQ^*1<US3F4IEZ=,C&466R[%;ZS80XHJXW%_*=!QI46_G0=+$C<*E8S$9
M@8<)N)$:![$O.MM![87P141M5T:545-$H*X3X#(S.0P[N(C-O<<Z&04WH[(,
M"4M"47F37T[E5M4)=-:"9Q69P[,X?'9?'06(S4HG9<%MQEIIX3W*#KJ"GRDN
MWU*GXZ"6.&X7L<A#!QVR:YUG(R-,6>='53(+>LDOX^-!+>X]@7L<WC7<=&/'
M-*A-0U9#HBHK=%%NVU-?@E!&/A?$3=)T\-#-PW">,B8;6[ACL(ENGBH>G\%!
MG'XCQ:-)8E1L1#8D15(H[K3#8$!&*"2BHHEE(4LM!Y^I_$T;Z:8:$C:2%F;$
MCMHGN%T5VR#\Z_&@E3\'A<BZT]/@1Y;K"*C)OM XH(2HJ[5)%M=12@]@X;$0
M%?6#"8B^Z-7)/1;$.H:_E'M1-R_AH,F<3BF7FGF8;#;S *TPZ#0"0-DMR "1
M+B*KJJ)0:PP&"!Y]\,=%%Z5N]TZ++:$[OT+J$@W+=YWH"8'!(,44QT5!@W]B
M/1;LQ?QZ7I]'^+0:1XIQ<?EP\$;CTUM&:3T;MVWY?#=K;XT&^%A</ 60L*"Q
M&666^5T6@#J%:USVHF[\=!I:XQQIEIQIK$PFVG6U9=;".T(DTI;E;)$&RCNU
MMX7H) XC%"_'D#"81^("M1'D:!#:;5+*#96N V\DH,!P.#!$0<=%%$=60B(R
MVB(\7BYX?.OYWC0>-\?P31/DWCHH+*<1Z2HLMIU'!\#/3U$GQ6@AYCB.*R,!
MR$WOQH/J'N'<>HQG7&P_YHS ;J!)HJ?"@MABQAC)%1H?;""-(RJ(H;$2VVRZ
M6MI0:VL7C629)F(RV4<5".0-B*MB7B(63THOP2@]7'P%D^Z6,TLI;(KZ@/4L
MFB>JU]+T&N)AL/# PB08\8'%17!:: $)46Z7042^NM!D]BL6^X3KT-AUTU%3
M,VP(E4/ENJI?T^5!Z6,QI...%$9)QY%1XU;%2-%3:J$MM=--:#UG&XYEIEIF
M*RVU'2S#8-B(MHOCL1$L/XJ#8S&CL-])AH&FM5V *"-U\=$TUH/288-M6R;$
MFU2R@J(HJB>5J#64""2W*,T2I9$50%?!+)Y?"@R&'$$FS%AL2:3:T2"**(KY
M"MM$H"0X@H2"PVB&NXD01U6][KI\:#UR+&<-#<9 S1+(1"BK:][77[:"LS?%
ML7EL<4!U'(T=PD5[V9K'(P1?4V1!95 _ A\Z"S&.P+ L(V*,B* +=DVH(Z(E
MO@E!ETF]PEL3<-]I62Z7\;?AH,5C1UW7:!=ZHIW%/4J>"K\:#WH,[MW3'<FN
MZR7O:WC08A$B@V30,@+9*I$""B"JKXJJ6H,T::%+( HEK61$\/A0$:;04% 1
M!'441$LGX*#W8&Y#VIO1+(5M;?AH"@)(J*B*A:*BIXWH/;(B6MHE H-#6SW3
M]CW'8-P:^E++;^&@WT"@4"@4"@4"@4"@4"@4$+,FK>.=-% 5%1LKBJ@?.GBJ
M4'RO.\ BMYK-Y7D45N'@'GILG)9L9!J;L.5&%D&.B";A5MQ$.]K)M2WC07/"
M>*9"9V^R3V41MS.<FADV^Z0*V),@PL:'O!?E^Y02+[26@H<)VWY!&R&.R;N
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MNM,I,85Y\.JPVCH;C;M?> WN0V3Q2@K\1S;BN6QD3*0\I&*%.,FHCAN@'4<
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MQ8>+>2%%G+AV\2JX=UX4:E^Q22+C.\D(1Z?N )M22UTH)R]K<S+B922_@\5
MR,B)"'%1XRH3<1UB8<@@ U%%%10D4B&R*7AI0=7W#XOELQE,!/QT1B6L IK4
M@7C%LVPF129%YM20KJ![=*#C,UV>RWZO8V)AX,9AV%!PXS8T<VXZRI&/<,WF
MU-0,-R[[B;@JBKXT'2\/X+E(/;[.86;#::?RYS'&\<_)5]L4DAM0'760:$=R
MZETALE]*#FN*]M^;P(6/&3CX@M0<JR_'B2'6'7V8_LCBNO)(9:;1P@(A)I"'
M?8=2O05R=H>82<>+;F&QD)[$0VX8,@_N;S1,S6Y*E)V@.P' 97^,W+N-;Z4%
MOD^VG*<N[CLX.+QV%FXIR1,B\>9<0X;SIOM&C4Q1%&S4P BWB-A/:M!)R?:+
M)3VY+H-Q(63G9C)3G9XZO!&G0W& %3%$(K$8W&]K)0:(O;#E$YMR1*Q^/P<@
MDQD18T)U3 VH"N;Y3BH#:*?WEFQM=!2RK04Z=H^;3\?)A/XO&X;VF&CXJ,[#
MD+NG.0YC<@3<40%6@=%M43=N(576@N^-=I\I'R,+(SX$5M!F9&6]&D2#G$*R
MX@1VU-Q0;%2(@N>P4T^V@M>T7"N4<:F9!,FQ'AXPH[#$2(T\DLM[1&I$#RMM
M.BP@DB VXI*/QH*R=V>RTEME&78T&2XYR%9<UO1U1RXF,==PHBGMW#NNM!7Q
M>T?*,DRKDR+"X^XX>-8=BP75<3HP&7FG)2*( /6/K)L2WRI95H-D?M1S*3 E
M1ID?%P2&!B,9&6*9EUDQ<U)!OO?=CM4VQ](ZV^-!NY3VSG1^.G(!IKJQ<=EV
MY:Q&B>>?.;+"2R"M@@DZ'H^\2]_&UZ"W[-M95^9RG/S\<QC6<Q+C+$:B@X#)
MC'B@T;@BZ#1ZDEKJ"4'.1>SW+D;R\(FX#&)EFPH0!=-YMSIY 91$!.-HZPWT
M]UVE,T4ETM0;.2=H^6O.Y%K$A".#D<ADG^BKGM2:;G,- !]0&G#VB0%U&PMO
MTUH)LSM#F9/$Y$!5A_5@C89MAU", =+%-B+C1.BG5; U1;*GA>]J"KG]F.4.
M86/[.)CX^661*><(9TLG&ED-@V*^X< T?'[O[ULV[%I0?2\]QO*Y##X&)UF7
M9>-FP)4QXQV XD5;ND "B[5+\E*"JX?V]F8'D&.R).1U8AX/Z2Z#(J)$][KK
M[TT1-ME_#>@\C\%ROZV3)D@(1XEW*KE6;HI.KO@+%43;(=NX7/4BW\*#A"["
M\B8;@1VW(<]LHD.'/)Z1)8!CV4@G4)MII/O@43](D0V-+^%!]'[@<;SV2EX;
M*X-J%+FXDI(^PR6Y([H3&>B1*0B:HK?C:VJ73SH.8+MERY9Y1W3Q18J5+BY2
M5,:;<9D-R8T<6598;1%%&U,$VKN](W2U!6Y+MYRL9/'\#BXL)09XO)P^3G2&
MR]LUUR: BCD"7ZNA%M7YDH+/(]J>1/2W,6S(@?JVY,CY-)C@N?41=C1A81FZ
M>E14FT7>I7055+4%;G.S?+YG&,+@H4V&W'B85<5+;4G66QD70E?3HBAO"5K=
M,U0;^K6@M,EVES62R,EN1)BM8F3,2:3S6_W*;\2N.=!--NAV,5^%![C^UW)W
MYL6?FWL<LB%])BM,1 /I%$Q;Q/*;BF-R=<5?2GRC07..[=21[=YWB,R2 %EW
M<FH2&46P!/><<"Z+;Y4<3<E!S_&NSV7@(V[,* $D)^*D.*P<M_>QC%)5W'*,
MUW$I7 $1!"@\G]GL\]#E0HTN$U&F1YT=RXN7#W.2&>TH62UD%%$D7S\*#R;V
M8S<IC)1_J,5L)3F3]LYL-21O)2F)**:?G!T2'33PH)F2[726>.3&.J+Q(F;<
MV1&45XDR?J &Q,D15&WJ15]2T$CM+$Y$]E^0\@S$;V@9 ($:*"Q7(6Y(;)"9
M=%TB/Q.UU^&FB4'K/:[*K]4;E3XY,R6<W&@J#9J0AF74=0G-RVW-K=%V^*4%
M+#[$28N?8DI)A2<<KL*9)=D-R#E!)A, U]P*."QM)6T(2,=P:^-!?0>U\F/Q
MYK%%(CJX& DX0G1;6RN27$/J6_-TU3XT'09?C>0DP\ S#?:$\1(:.0KJ%M<8
M1@X[J!M6XFHN7&^E_&@I^'< S>)S,.9EI\65'PD%S%X4(K!,FK#C@DKDE5)4
M4T%L1L/I\5\Z"J'M-E8G+W\O >QQQ"GOY=AR4W).2$IYM40+"XC&P7"OOV[]
MOI^V@@1^Q>0B8)_'LY6/)</)L9]KKQR;;7(HA#*$^@39)'<W_=B*[@^*T%MC
M>SZ,XE^#(EL,^\QD['2DA,JVV+D]]'R=!'",EV[;+O55+Q6@QE]MN99EJ&6>
MS&/-Z"X7MH[$+=&Z2PSC7<%PMSA&KFXA)=J)HE!3)V)RI8Z$3^0AOSX$IQ^)
M ="6YCFV7V19=:!"?]PER!#3UV1=+6H/I_$>/AQ[C>/PP*TJ0FD;56&^BUN5
M5(MC=RVC==$NM!<4"@4"@4"@4"@4"@4"@4!5M0?(^0=]38',P<=AG$RL.%-F
M0.J\PX)^R(1+K T9*UNW;A0ENJ?"@['E?(\IC>*P,H I$DOR((2VS1'.FV^Z
M"/C=-%5!4M4H.8Q'?S!91):Q<9*,6X;T^"2&U9]I@D%1,E) 8,D7<B&7R_P4
M&A?W@,?] =R0X5UV1'R"XR4TW(9*,#G11\2]YHUM,5VA>US]/VT'4<<YAELO
MS3*XLX'1P\6! F0Y:F"D1RQ(B D%2\+6TTT^U*"('=F%^O[7#G<<XV\_(=BL
M2NLP:D3+/64R9 B<!LD140B\_*@W<S[E_JY/.)'PLG+)'QKN8F/QW&0;:BLG
ML);N$FXE_)%/&@J7>]*-0'GG^/28\MLXNR,_(C-B3$UHG67U=4]J)8%%12Y(
MOE081^[[$AJ)DXT26^.3QT9^!A11E%*1)FE$$>LJIJI#K?TH*7\:#>YW9EOB
MS$BX!\<FJ9!,HT3S*)!+&[4=525%%Z_4%0VZ%]E!6<3[NY1Z21Y>)OP1EBF6
MLLI--FT60AH^KDD!T1%<5$NFB72@ZX.XD']0GN9O0WFX @;L:/HKKS?5Z3!(
MFB#UO2HW\$76@X[D_<3G,ES'86#AW<'F#S42%E;2(SZA%D,D^!-.$)-KU4;(
M5]-QVJGFE!:]T>;\IX]*<8Q#37MAP63R2RCVD8R(?2Z5@7YD3J:IYW^R@BKW
MHEP<:#>6P!QL\3[,=J$4II6G!=C))60KXB0@"!>Z;;WTH.G@\_"?V_=Y?%QC
MY]%AUYS&%87KQR5'!%52Q?(JBMO4GX:"J/NN<R6</CN#=S+Q/=&$HOM,-O"W
M&"3(<WFBH*-=8&[>9+Y6H.;3O!F<CR!4CQRB\>=#"G$=!6O<H[D))M.@\)H0
M[;MD!;=4VW3QH+-CO1/*$Y)D<8>CI(C)(P0>Z:)9AE*&(C161.BN]P2]5_3_
M  4'3\$YAE.0%F(N6Q'T;)8:4,23'1\9($I-"ZA@X(CZ5$_A>@Y=KO5-;:Z^
M1XT]%9FQ9$K [)+3IRUC/ R39HB"C.\G0(5)5TH,I?>>5B3DQL[QYR-D(0/C
M(88D ^)219!^*PR:(.\I(&NVZ(J*GA0:<IWXQ\=L"@X[W*R'TCQ'#>4&B)J,
M$F2AF#;I"K2NBW;:MR^%J#H^*\_F\ERT9F%AG(^*/'1\A)G27$ P.3O0&!8V
M[B45:+<5T2@LN8\FEX6/!8QT%,AELI)2)CXKCJ,-J>PG")QU4+:(@"KHBJOA
M0<Y@.Y^7SV8P^.Q^"1$DQWI.;>>DH*1/;2BAN@VB"O67J@NU4LBI02>2=QY>
M%YK!P)XT$QDCH"]EI+ZL!NDFH(+/H)LB"R;A,Q5;IMO00YW>.-!BL27<8:@]
M"R4Q %P=RECI0Q1;2Z(GWIFB[ET'SH*_.<U[F1LE@@7#QHV3-R>DO#I- XSS
M#,47P=60C:F!-^&Q02ZZ_+0=.[W$9_9Q$YG'@FZL]B,[$QQ&($KTLA;;:)Q?
M2B;SLI?"@H6^Z'+'YS6('C\:/F4RCV.E-.S%-@&H\,9I/@XVW<E4#L@;4UH(
MF)[Z'D8$_(#@CCX]N&Y-QLR0Z33+G3<1M&Y#AMH+1GN11V*?P\:"-C.ZG,\M
M*A(W"B16\=E7HG(!$GK.QVX"S!6.+K;;B%M\B1/4B>2T&[']Z^12\3(G+Q8D
M-X8;F&!'C%MY)SZ,M@ZZZT B0[D-=FY+>=!UG,N6Y[CW'<5*;QC$O.9*;$QO
ML?<*# ORUVWZR@JJ(K_>T%$/=7/;H[3F#8!^.F3+/"DJXLIB5%'?;EL^]ZF]
M-N[;;SH(SO=SE+ !#D\<CCFIGTYW%L!-0X[D?)NJR'5>0/NW&R'5-JH7Y*T&
M9]W>0&#L.)Q]ES.8P9[V<CN2^G';:QQB#BQW5!5=5SJ)MN*6_*M01\CW3Y9D
M7FG>-XZ,WBO?X:.DF6Z0R'!R8M/$WT4 D"P/;5+=^"@U1>[/(&8#BP\6DYG%
MMOY#-O39:"\D7WST<!C((6,]K)%ZK(B(@WNM!=8;N9GIO*VH4G#,L\?F9*7B
M8,\)"E)5Z(VKJ&XRH(@@: 0Z%=%H)/.NX.:P>5D1,3C8TUG$P!R^9*2^K!>U
M)PF]D9$$D)S[LE]5D\$\Z"/VLD<FR4[E^7RTQ7@<RCL7$Q>J9,L1V '8"-*B
M"*^OU*FJ_P %!PF&[E]RX$&-FIRQLLRSA"R&68-TF!0 R3K*.,"@:O$VEK%8
M?30=EA.[66RO*FX;6%+]7WY[^+;G7<1T'6!5>HXI"C2B1"J;!)23QH+3F?<6
M3QO+EC%QJ27I<=D\&J.;?=2G)(QW(_AHK?4%S2_IO\*#G,]W1Y;[+*% B0F&
M'@RT7#2>L3C[4K% 2FY(:V[>F73*VV^U=N[QH-[/,^=MHU"Q\>),SDLV4?*8
M^ZD,$'%A+,FD =X[CTV_%;T$:1WHY">/:R<'$0TA1F<4>6;DR2!Y'<J:"@QT
M$51P6[^=MWEX4'8\YY7G,/DN/XG"Q(TJ?GY#T<#F.FTTTC#!/J2[!(B^2VU*
M#CG^\O(CA-Y*+C((Q,?$C3,_&>D$KY)(DG&48)"FP]JM*J*7S:"FM!A)[Z3H
MV0+!N8QE<R/6@?.8L_6/<HW%B>9?>L+UE7X4&<3O-R1R=/=<P;:81E,FW&D*
M1-FC^*;,C5PC7:0NFTJ;03<*65:#K&.79^'VS/E.;9@-9!8B308:=<&*(NBA
M,@;AB1W]2(5AU7PH.(;[T<Q/'Y%M,5$7+8R>,626V0C?0*)[OJ>VO[G3Y2M?
M:GJ5/*@^@9;E\QGM\/)L6PQ+EOQXSL1@G"1@CDF #]Y9"V(KE[VO0<;([G<\
MQ;LB1F8F'3%X[(KB9[S+D@"5U8_7%\%-"0&QT$A6Z^*I01<+WFY.XF0=S$&$
MU#Q(X^;D9#8O,J..GJ8N.BVZ2G]SM$MRHB$-]$H.DR_(\Y/[-9?D,A$Q4Y_'
MRI</I*2$RS8BC$1>*$K>TB5/"]!R\KNOSO'--X0HL#(9UYV,W&GX\'9$9 D1
MBD;3:5P#)U$;TL:;D7=]E!],X+GYW(.*X_+SX@P9LD"]Q% T<$3 U!=I"I)9
M=M[7T\%H+^@4"@4"@4"@4"@4"@4"@+0?/8W8O@T=R40+-(9,>7#%HI)*VS'G
M+=YMD41$'U>I%U6_G0=9)XSCI>'B8J8KLF/#*.8&Z:DX91E0@)PD^954?5\:
M#E%[.\&A0<@$E^9]*>CN,I&D3#6+"8)Q'B]N)6%M!,45%*]K?"@R:[,\+/&2
M8[3T]0R+_O)4L9KO5?,V>B2F:+8A-O14M;PM07N+X?@..S#RL,W(C#./8QYL
M$[_)0C0D56C42\" 55%*_A048]M."Q>51N4%)D!-D3CG0&BE*,99DEM4<)IM
M+(2O!>Z*J_90=#DN%X#(+)60PJ#+QYXEX&R4!]HX2D0"B>"W7QH*',=MN Y*
M9%"2XZSD?N@@.,2B:D#[!HFMK*BMTLTXJ.6H($3LUCTFS8DDD:XVW"CP,'&C
M.O>[85F04PI!R#7<CJ/G<++HGC0=)B^WG&\?'::!MU\VV93!R)#IN/.I.)#D
MF\:_.;A#J7\%!SW(^SV.>X]D<-QY&HC6:9A8_)C+)UUI(4,4;$F01?X\6Q1!
M)5_#0=K,X[AYF + 28H.X@V$B'%*^U61%!0=+*ED1+*E!3XKMMQG&M1P;&1(
M<C31R0R94AU]\I+;2L@3CAJJD(-EM$5T2@U\ZP/"IR1I7)WO;@0/8QDE?)D7
M1GH@&PJ"J;]^Q%1/LO0;\OVZXUE6B1YMZ.^ILNM3(K[C$AHX[2L@33@*BA]V
MJB7Q3QH+;"8'&X3#LXB !>S8%1%'C)XRW*JDIFXI$2DJJJW6@YXNT_#&\#$P
ML1E['0\>Z\_$=B2'6'VRDJ2OIUA7?M<0U0DOX?@H,HW;C@4DH60AQ )EAB(Q
M$5ATU85J"XKL9=HEL-6S550O'6@@\G[?\>?PK7'X!QXV5.$]$Q S=SX*UU0?
M=NVA 16(1]8KN'Q2@F=L^!N<1QL\9+K3V1RLHILU8_5Z(DH"V( KYN.E80U(
MRNJT$+C'9SC&*Q;T>>T60E3&'8LHW773;%MYU77!C@9+T4,[$NRVJ)03<)P/
M@#^&BC"CADH03@RC4UYXY+CDZ.J@+YO&1$9!MVZK;2U!D_VKX4>&8Q,>&Y!C
M17WI45V&^ZP^T[)5>L0/ 2']YN5"2]E2@DO=O\(&&EXW%=3%+*A-8\9,<SZC
M;+%^EL52^8=Y>KQUUH)_(.*X7D.,;QV59)YIDP=9=$S:>;=;^1UMUM1,#3XH
MM!AA>'<=PCL=W&0TCE%B>P9VD2V8ZBO**W5;JKBJ2DNJK01<UV^XIFLPSE\C
M#)V6TK2DB.N@T[T"ZC/79$D;=Z1^H-R+9:"/'[5\%CY&?D!QB.2,DV^S*1UQ
MQQOI2EW/M-MD2@ .%ZE04376@VXKM_PW QD.-!1/;J^\LE]QU]U.LTC3BDXX
M1&J=(4!+KH*:4&&2XQB<SV]7 8)8\;%28K;>/WLJ]'%I+$"*T2B2C9/BBIXI
M00^"=LH'&XZNRT9E90ICT\'V0-MMEU]D8YHTCANGJT-E4R55H)3?:S@K8S6Q
MQ0JU/;-A]HG'2;%IP^H8,@1*+**XF[[M$UH-D+MIPJ$B)&QJ J2V\@3BNO&9
MRF@5L73,C4B782B5UU3QH,<?VPX3CFW B8Y6P<<9=05=>- ]LYU61;WF73 #
MU01LE!*YKPS'<N@0\?D25(<6:Q.=:2_WO0NJ-J2*)#=5ON%;I0;,=PCBV.8C
M,1,:T#<1EZ,RA;G%Z4E4)\24U)3ZA)<E*ZK0<Y.[*\+=Q'TJ#%]G$>FQ)DWU
MNN&ZW#-3;CHX1[VP&]@053;Y4%CD.V' )&*AX^7B6R@XWJFPF]U"1'5W/[W!
M)#<1U=7$-5W>=!*C\=X;G<2Y*BQVW\?F2C3%>94P1Q8X@D=P%114-@M#MVV\
M*#&9VWX3,.$<C$M*6/,CC(*F*?>.=8A<023J KOKVG=+T%BSQC LOMO!";1U
MJ6]/:+55&5($D==&Z_,0D5!%Y#P;B7(9L6=F<8W,E0M&'#4D].[>@&@JB.!O
M1"VG=+T$L0P> ;<,&DB#D9F]U6P(NI+D*@[B04*REM2Z^%! A\ X;"CR8K6+
M9%B:!LR&S4C0VW7">)OUJOI5PE+:FE!%E\4[?8KDD?D<B"RQF9;X,1GUWJBR
M7A5L2%JZMBX0CMZFV]O.@LIT?BV6S\:-+:9E9K![9\43%5./UT)H717P]6TD
MH,!X+Q ,G/R@XEA)^3:-B>_M_C6W4LX*C?:G4MZU1$W>=!&B8_@F'DPH,9J/
M'E"[[2&T.XC1Y(MNG>Y:^V&WJ_)H*'D'9O%YC/P99/LL8F$,9 QHQ6U<%(;G
M4 69%T( (E]2**K^:J7H+_E_!<#RN3BG,V*/1<6XZZ,4E41<)UM6D7<*B0[+
MW2RT&Q[@G"'I&,5W$1"=PX(&,!03[D LHH(^"H*IN3<BV77QH)A\8XT_)2:6
M-BN2/<A/&0C8*2RFPZ8/[D34Q#TH7PH*ICBO '<]EIP8B,.5<W1LI)-I0ZGN
M6T4T12L!=0%1#(?'P6@M":P,V',X\]%$X$5IN+(BO-JC"MN FP!4O22(.FGA
M052]N>W(1%Q:X6"++SHO+'5$0C=$%%#O?>I;%5%6^J>-!?GC<6] 3&$PT4)I
M&Q2(B(@ C2H3:(*>""HI:@C3,'QLVY"2X<8FS<6;*1P1VJX@;%>-%\T#2]!P
M?TSM?D^!/RL.K?'L#E#;Q\G(C'1HY,<WD#HH3J*1 \I;1/ROI0=SBLGQK.XQ
M^+!)J5 9)V!(C$GI3H$K+C9 7Y***C\%H(D?@G GL&[AX^'@GAGW>L[%:;!6
MB>%?G]/Y0VLFNGA07T"!"Q\-F%!8;BPXXHVQ'9%  !3P01&R(E!OH% H% H%
M H% H% H% H"^5!^=L\O-X_&\3.=R^4:8RLK)NY64X<PB9>9=,(#+8Q0)UL-
MHW$43:9(FZ@V2<QRUC,XU>29;,1<J<C!-8MI@'8\.3&>4$FE( 4(!,G-R.(X
M2*FB)09YCD/-WX;^':/)NY&&YR7ZFG1=)M&E;<7'"IJ/3.Z**M(EZ#;G,9S!
MK%Y/,^_R@H68C0,B"N2>DSA@C-$9LLQ[&*=9?O#;]5KT%3FI/('.(PX?),IG
MBQ,S'Y5G$/0F)#;\F63UH;4@+./&)1ULWUK;D\=:#ZAS1,XSQWB XUE[W#<V
M*DI&ANH-C$<W;TLMDW62@C]M8'(,9GECRYV3FX^7@X$QQ<F9N[)YFXCXB1HF
MTMNVX)X4'"O\,]WR)Z"P[EV%CY?D4J0\VY(;<0G(S9Q^F^GRMG>Z;5L2I:@A
M0\GW0E<AP99+(38F0<:Q)XYH6IA]:.38+.ZC3:>U4B+<CJOJA#Y4'?\ =1YX
M.2X\<C)S<;!+"<* N!ZJN'E1=%0 ^DA77I_Q:.?=KK>@Y"3D^:/=T0>A?68P
M>XE1,E&_E#W38*$2QS4508([G40FT!57=\Q4%7$E\T_4T&O=Y)S$1<HQ]<RC
MJ9+J.-%'+<BLKMEMH+^WKHR:CN^72]!] @KSDNQ\I6I$Z9G%!SVCJM%'GE$]
MQ^0#I$?4]ONZ:GZETOK0<]A>+1<IG<&^Q%S2\;Q^;%[!!D"DB;2>Q(I+A=5>
MLC77$4'J+X[D31:#/O1DN6!S",U@QR;<F(W">C.1O=FRX)2K2.FVPB,(H-I]
MZKZK<53:E!V'=@N61Q@/<<;DOGE4=P<H8Y$GM_>[>E-LGR] A*Y^5Z#D5CY]
MSF[^%1W,GE!F.1W!<5[Z<?'4A* JA7Z74)RWJ1>IU+^5!Q>-#FD+$<9@0'\G
MCF6<=%:PC3#$UTO?M232>V8"0-(7@B]?T=/Y:#Z5WJBB6:XY-E1<J_#8BY(#
M=PJ/=9N0ZVU[=#5CUH)&.GE>U]*"/B YJWS# <;GS)#B9&/$Y!ER-S<3!PV$
M9DQBVKH+\A6SLFFA4$_FK<G]H;!Y)G-/L$U#3C/T@G!9"2+Y++]PH_=#<=FY
M7O3T[VUH/G<^-S6*QAL?&QF2CS8C3;T+I!,,2)<DZ;_3!@FV&2%JV\GMVX5T
M2@N!;Y<G).6QHK.<=.5'R*NRT!]M^/<D*.+:&:PY.Y-&>EM-!NBZT%5)9YS*
MXSC$Z&1C<=C2)P$;3&1?===5L%C/C%5YN6TTA;Q;0C41/7PH.CQ+',XW<K"N
MS&<K,-P(C<PGQ?::!M(FUUX76G#BJWOU<9<'?U/!:"R[JPL[(Y,Z#$#*RY+T
M.,/%)F/)Q(T6>#Y*\<C80B&FPE)Q%1014H.G[?<;EXN-GY\YE_ZS.R$U5><<
M(C<8%TO;])#(A +:@B(B4'R7'8KN WQS*0XD?+>R;EPG<M(E-2QF/-(;GN&A
MC=9>J:(HDZ<=P1--$2@Z/#<8STZ'A@E%EGHD:#FI,4'$D0MKY.MI#;-E77#L
M(J71%TU6WC05>%Q'. SN!'(!EVLN+>,6.ZTPXXRW&",*2&WI!/#'#U[T=0FU
M)572@NNULO,\:?S4C-0\HN,58X',G \DE9;LDFD;5LG'6G51'$(GV=HJEM*"
M^[NQICF2Q1RH66R/'O;3&WHV%)Q'1GF@>U<-&B [)8T OE$O&@W=N.-YYGD$
MW*<D&2[DV\?C(S4EYPE:4DC_ ,JV A=-3ZED<*WC0?/CP7.S[AY62&+S,*/(
M3,M3),53)3;=9M#-F2\]TS6XW; 6Q%M=+T'<=EH6>@X;,PYN/E1& =;7'ORP
M>CF^I,)U%]L\X^K2B:>I1+:175$H.1B=K9_TB.\_%ROU1>/.R'S67(W_ %D7
MA)DE3J65X454!/#;I0:X?'^6Y'N"#F3Q>2QT>4YD(^9FIUE9]L[%4&7#E$]T
MR3>B& -MHC:^=!V7:)G.93#97-9>0K\I]/H\)P3WMFQC1)CW#:WVK[AW>Y>@
M^=83AO+&>,/0L/@LOAG8V(&/GP?(E6?(24!*D4%=L9(R+FHJ.A;:#Z'V_P +
MR"%V]Y+&VSVRDE,+"Q)C21GFQ-BP"RUU'C;!7/D$CNE!PW(.W6?AR<.Q%A9<
MH2XV$,%8">Y.+D^KU)CKKCSX*RX?INX6X;(J4$I,/DF>>XV'(Q>1C<AEO9H)
M>==>+V4[JPW5B=-4/;Z14=H[$V66@G!!YUEI++PX7)8YJ(YQR+LDD@J:PGG2
MFN"@F5VQ0DN2_,E!4\J[8\BC)CPB0LD]CG<:\)L0D;E/MY9UY2-\UDO!TB,-
MJ Z-]EK6H+,>(<C+FN*6=@Y\S,QLW&GO<F)Y"BIC CH'2)=Z(1@:;5;$/F]:
M>-!-[F<;R<GGDV?'P&2R,B5BXD; Y*"XK;,:<W)<)3>(3'9L0Q+<2*FVX^=!
M<<-B3GNY66Q_7)[#<85QYAP75,3F99$<<;)+V3VR XB"OAO2@A9_M]#RW-'6
M7,+(*"]G(^1RDL2,&GVEQQMBN]#150'?28C\:#AW>!=P%CXQO)0\P\^$!F)B
MWX1,NNPG69;BEU3?=#IW;Z9(YZKHEEH.U[P01E<PX@S,PDODL1N)DBDXV(:"
M1GTVA!PT4VA6Q+\=%6Z4%:_VXY4YA93\R"[,S3>%Q,3>,A1>>;9>,YT1M[<E
MC-FS:G^5\:#2?%N<,XR7E.+8J9B69$Y^)C< ^Z@FS"GQ08<DDWO-&^G('K("
M%\:#WF_;OD.V;%B8R9D8;3T8<839,O@2,XL(Y$\R^ZTJB3HJFX30A7U)03<K
MQ3D93PGYK /Y?#H40IN$B.(:FZ.,1A"!#<'>++]Q]1>>[6U!JA=K\^4*+.R.
M/Z_(H08)(4HGE-Q@(TPG)#8N*7J)I@D$R_*336@L>W_%N3XON9E)[N)=C8N4
M4Y9,N431DJN2$<92.\TYN= ]5LZTB@FB+05P\$Y"]RR2,S"O/S'LQ-F2^1D\
M*QI&'>8,6X2AOW+N0A:Z:AM&VZ]!<2N!R6^RV$P'T479>-/'2)&*#81;F)(.
MOH*W02/9N\]:"HB]J\W'C394/'##S4\N1([*;<$#)J<>Z&+A(OFB(@_FT'2]
MF>*R<$.5(L;/Q4:5[?IQ9[D1;FVVJ.$VS#38"76VY5N=KT'TJ@4"@4"@4"@4
M"@4"@4"@4!;4%&'.>%F<T S<$CQPD<]$D-KT0!=IDYKZ4$M%7RH*%ON1V^Y-
M,?P^/D,9@X4F%UD$P1I#?<NRXV9*B.*V8(MAUO:U!9/]Q^*;7PQT]C*28DJ/
M"EQHKP$;1R7A912U\!(M?X/&@EQ^<<.?.>#.9B.'BQ,\@B/#]R+:V,BU^45T
M5?CI03L1GL+F,<F2Q4UF9 )23W+1H0(H:$BKY*/FB^%!S&<[O<(QW&9^?AY!
MC*,P76HQ,QG14B??- ;"ZZ)NO?<NED6@N<CRJ#BWHB9-6HD:1&>E/RG7VQ!D
M6$!3O=44D]?S)HE!@7<'A X9<RN;B?2Q=]NLKJBH=;QZ?QW6UM\-:#8G..'%
M,@0DS,-9.5 7,<TCP*KX'\BMV6R[K>GX^5!#?[G]OHXF3^>B-BV\Y%)2<M]\
MSJZVGQ(/RD3PH)I\WX@&0AXTLQ$2=D  X3'5%2=%U+MJ%EMZT^7\[RH-#_</
M@[ 2#=S441B/K$?]=U%\452:LFJD*"JDB>'G00'^YW'/JSN,A.#,DMMP9"&+
M@ R;.0=Z39MNKZ2MXV\[Z4$\.XG!S+*".:BJN%%3RB[[(R +M(R5=%$2]*JE
MT1=*"DSG>;B&/Q<3)X_W&<BRIPXXEQK:NJT\ME7JHNU0]*W2_C07?).;8+C4
MK'MYEX84;("\J2G2V@"L")*))KXH7XK4&U[G/#F<BQC'<Q%&=) 76(ZN#N(7
M!4P5/+UBEQ3S3PH-LGF/%(T,)C^6BA&=924TZKHJALJ2 C@66Y(I$@I;SH \
MNXRN"//#D&5P[5T=FHJJ *A[%0M+BJ$MENFE!79#E';W SLID9DN+#G-+'8R
MDA47JW,%<8;)112+T7)!&]DUH(I]UN&MYV3BW9@@U&QK.7+(ZK&-B0:@&PQ1
M=RKI:WC>R:T$G(=S>#PL"&;<R\?V3RN!'+<J$;C*7,-MMXJ'Y6Y/3YT$F3RV
M*S@L/F'  &<L<40!QU V>Z'<EBLJ&HIY)XT&WCO-^)<C=?:P>39GNQA WQ:5
M;H!WV'JB7%;+JFE!S.([U\-F-Y25,D# Q\&:]!COFIN'(]LEWGD: -X-AYJO
M@FJVH.I#F/%C C#),$ R6H2J)7_E$@1)IO3S,314^R@K@[H]ORC9*2F992/B
M1$YSBH:(#9'TQ<&X^MM7/3O"XW\Z"?D>9\9QV$CYN9,1O'2]B1'-CBFZ3J7
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M&F,.Y%PII!8<,7P?EY H[Q(ZB6(%Z:Z>8V^V@LR[L\O9Q+N2?QF/,)V.F9+
MQV)!FXGM70;%N4ED^='1]0:(NE!E+[J\KB19$"1%QP\DB9,\>ZRTLI]MX!B#
M+W1VFP5XS03L2+9!\;T%0'<G/Y/!N\N;>.%[;$XO+KC /<PI'*=;DM:I<D=
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M)SO$^/ND9.0Q)3**975=2@KNC+X_\VOA01<)V_XEA,J[E,9!Z$UU'!W]1TQ
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M0;,841(3IPNB>W8I;A%?22K>^Z@EXWDO*\YAP48^4%R$''X\KW<8V]TU)/\
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MQ\599E.J\.X8[9HCA@*:]2UE\J#[!C?_ )=%_P BW_R4H)% H% H% H% H%
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MVBB#KI0='"[FO)CHQ,<2S\EM66E;=;B@H&) BH0JKGA0;/VH3_ZD\B_FK?\
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MQW!+\"MT'9T"@4"@4"U M0+4"U H% H% H% H% H% H% H% H% H% H% H%
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M.QTL5%G&"&8&\ZJ'* /F?%M 2]!S2X;G^5R?2EN9R-*C9%]^1+1QD8:"(O\
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M<CCN_P!R&4,85AP.NHNN])>N)S$!UEL68@^K[Q>LOC=-/PT%SB^Z7,,L][:
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M8/:*7(E0394]H#I:]DH->/C=LI7(<+)Q4QE7&!DY.# CBI 3BMI&<DEZ24%
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?!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6765628976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>May 08, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ANAVEX LIFE SCIENCES CORP.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001314052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVXL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,115,137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6765531376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 19,457,845<span></span>
</td>
<td class="nump">$ 22,930,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_GeneralSalesTaxRecoverable', window );">Sales tax recoverable</a></td>
<td class="nump">76,160<span></span>
</td>
<td class="nump">40,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">849,642<span></span>
</td>
<td class="nump">1,251,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred costs</a></td>
<td class="nump">151,133<span></span>
</td>
<td class="nump">101,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermInvestments', window );">Deposits - short term</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">20,549,780<span></span>
</td>
<td class="nump">24,323,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">52,396<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">20,549,780<span></span>
</td>
<td class="nump">24,376,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">6,370,604<span></span>
</td>
<td class="nump">3,884,626<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Liabilities</a></td>
<td class="nump">6,370,604<span></span>
</td>
<td class="nump">3,884,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments - Note 5</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Capital stock Authorized: 100,000,000 common shares, par value $0.001 per share Issued and outstanding: 48,173,241 common shares (September 30, 2018 - 45,933,472)</a></td>
<td class="nump">48,175<span></span>
</td>
<td class="nump">45,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">138,696,975<span></span>
</td>
<td class="nump">129,377,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesSubscriptions', window );">Subscriptions receivable</a></td>
<td class="num">(292,700)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(124,273,274)<span></span>
</td>
<td class="num">(108,931,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">14,179,176<span></span>
</td>
<td class="nump">20,491,510<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 20,549,780<span></span>
</td>
<td class="nump">$ 24,376,136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_GeneralSalesTaxRecoverable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to general sales tax recoverable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_GeneralSalesTaxRecoverable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesSubscriptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesSubscriptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6762088368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Capital shares, authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Capital shares, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Capital shares, issued</a></td>
<td class="nump">48,173,241<span></span>
</td>
<td class="nump">45,933,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Capital shares, outstanding</a></td>
<td class="nump">48,173,241<span></span>
</td>
<td class="nump">45,933,472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6765611472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">$ 2,061,251<span></span>
</td>
<td class="nump">$ 1,489,450<span></span>
</td>
<td class="nump">$ 3,822,559<span></span>
</td>
<td class="nump">$ 2,887,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">6,078,786<span></span>
</td>
<td class="nump">3,245,023<span></span>
</td>
<td class="nump">11,790,996<span></span>
</td>
<td class="nump">5,939,335<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(8,140,037)<span></span>
</td>
<td class="num">(4,734,473)<span></span>
</td>
<td class="num">(15,613,555)<span></span>
</td>
<td class="num">(8,826,588)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_NonOperatingIncomeFromGrant', window );">Grant income</a></td>
<td class="nump">74,527<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">149,055<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income, net</a></td>
<td class="nump">51,465<span></span>
</td>
<td class="nump">28,647<span></span>
</td>
<td class="nump">130,265<span></span>
</td>
<td class="nump">59,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange gain (loss), net</a></td>
<td class="nump">54,199<span></span>
</td>
<td class="num">(18,337)<span></span>
</td>
<td class="nump">49,693<span></span>
</td>
<td class="num">(6,358)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income, net</a></td>
<td class="nump">180,191<span></span>
</td>
<td class="nump">10,310<span></span>
</td>
<td class="nump">329,013<span></span>
</td>
<td class="nump">52,665<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before provision for income taxes</a></td>
<td class="num">(7,959,846)<span></span>
</td>
<td class="num">(4,724,163)<span></span>
</td>
<td class="num">(15,284,542)<span></span>
</td>
<td class="num">(8,773,923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(48,048)<span></span>
</td>
<td class="num">(27,861)<span></span>
</td>
<td class="num">(56,765)<span></span>
</td>
<td class="num">(37,266)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">$ (8,007,894)<span></span>
</td>
<td class="num">$ (4,752,024)<span></span>
</td>
<td class="num">$ (15,341,307)<span></span>
</td>
<td class="num">$ (8,811,189)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.17)<span></span>
</td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average number of shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Basic and diluted (in shares)</a></td>
<td class="nump">47,134,686<span></span>
</td>
<td class="nump">44,545,523<span></span>
</td>
<td class="nump">46,726,649<span></span>
</td>
<td class="nump">44,210,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_NonOperatingIncomeFromGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_NonOperatingIncomeFromGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6755931584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows used in Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (15,341,307)<span></span>
</td>
<td class="num">$ (8,811,189)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,960,139<span></span>
</td>
<td class="nump">2,347,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in non-cash working capital balances related to operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Sales tax recoverable</a></td>
<td class="num">(35,989)<span></span>
</td>
<td class="nump">4,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and deposits</a></td>
<td class="nump">402,156<span></span>
</td>
<td class="nump">185,268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposits</a></td>
<td class="nump">37,396<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">2,485,978<span></span>
</td>
<td class="num">(167,597)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(8,491,627)<span></span>
</td>
<td class="num">(6,441,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows provided by Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common shares</a></td>
<td class="nump">5,068,834<span></span>
</td>
<td class="nump">4,688,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred financing charges</a></td>
<td class="num">(50,000)<span></span>
</td>
<td class="num">(30,943)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">5,018,834<span></span>
</td>
<td class="nump">4,657,427<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashPeriodIncreaseDecrease', window );">Decrease in cash and cash equivalents during the period</a></td>
<td class="num">(3,472,793)<span></span>
</td>
<td class="num">(1,783,673)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">22,930,638<span></span>
</td>
<td class="nump">27,440,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 19,457,845<span></span>
</td>
<td class="nump">$ 25,656,584<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6769887872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Common Shares to be Issued [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Sep. 30, 2017</a></td>
<td class="nump">$ 43,332<span></span>
</td>
<td class="nump">$ 115,689,221<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (91,478,558)<span></span>
</td>
<td class="nump">$ 24,253,995<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Beginning (in shares) at Sep. 30, 2017</a></td>
<td class="nump">43,330,817<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued under purchase agreement - purchase shares</a></td>
<td class="nump">$ 1,234<span></span>
</td>
<td class="nump">4,687,136<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,688,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued under purchase agreement - purchase shares (in shares)</a></td>
<td class="nump">1,233,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares (in shares)</a></td>
<td class="nump">8,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedUponExerciseOfWarrantsCashless', window );">Shares issued pursuant to cashless exercise of options</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares', window );">Shares issued pursuant to cashless exercise of options (in shares)</a></td>
<td class="nump">970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,347,681<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,347,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(8,811,189)<span></span>
</td>
<td class="num">(8,811,189)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Mar. 31, 2018</a></td>
<td class="nump">$ 44,575<span></span>
</td>
<td class="nump">122,724,029<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(100,289,747)<span></span>
</td>
<td class="nump">22,478,857<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Ending (in shares) at Mar. 31, 2018</a></td>
<td class="nump">44,573,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2017</a></td>
<td class="nump">$ 44,423<span></span>
</td>
<td class="nump">121,038,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95,537,723)<span></span>
</td>
<td class="nump">25,545,335<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Beginning (in shares) at Dec. 31, 2017</a></td>
<td class="nump">44,421,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued under purchase agreement - purchase shares</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">459,699<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">459,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued under purchase agreement - purchase shares (in shares)</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares (in shares)</a></td>
<td class="nump">826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedUponExerciseOfWarrantsCashless', window );">Shares issued pursuant to cashless exercise of options</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares', window );">Shares issued pursuant to cashless exercise of options (in shares)</a></td>
<td class="nump">970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,225,696<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,225,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,752,024)<span></span>
</td>
<td class="num">(4,752,024)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Mar. 31, 2018</a></td>
<td class="nump">$ 44,575<span></span>
</td>
<td class="nump">122,724,029<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(100,289,747)<span></span>
</td>
<td class="nump">22,478,857<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Ending (in shares) at Mar. 31, 2018</a></td>
<td class="nump">44,573,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Sep. 30, 2018</a></td>
<td class="nump">$ 45,935<span></span>
</td>
<td class="nump">129,377,542<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(108,931,967)<span></span>
</td>
<td class="nump">$ 20,491,510<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Beginning (in shares) at Sep. 30, 2018</a></td>
<td class="nump">45,933,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,933,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued under purchase agreement - purchase shares</a></td>
<td class="nump">$ 2,229<span></span>
</td>
<td class="nump">5,359,305<span></span>
</td>
<td class="num">(292,700)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5,068,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued under purchase agreement - purchase shares (in shares)</a></td>
<td class="nump">2,229,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares (in shares)</a></td>
<td class="nump">9,631<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants', window );">Shares issued pursuant to cashless exercise of warrants</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares', window );">Shares issued pursuant to cashless exercise of warrants (in shares)</a></td>
<td class="nump">546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,960,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,960,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,341,307)<span></span>
</td>
<td class="num">(15,341,307)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Mar. 31, 2019</a></td>
<td class="nump">$ 48,175<span></span>
</td>
<td class="nump">138,696,975<span></span>
</td>
<td class="num">(292,700)<span></span>
</td>
<td class="num">(124,273,274)<span></span>
</td>
<td class="nump">$ 14,179,176<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Ending (in shares) at Mar. 31, 2019</a></td>
<td class="nump">48,173,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,173,241<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Beginning at Dec. 31, 2018</a></td>
<td class="nump">$ 46,888<span></span>
</td>
<td class="nump">133,438,276<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(116,265,380)<span></span>
</td>
<td class="nump">$ 17,219,784<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Beginning (in shares) at Dec. 31, 2018</a></td>
<td class="nump">46,887,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Shares issued under purchase agreement - purchase shares</a></td>
<td class="nump">$ 1,279<span></span>
</td>
<td class="nump">3,365,555<span></span>
</td>
<td class="num">(292,700)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,074,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued under purchase agreement - purchase shares (in shares)</a></td>
<td class="nump">1,279,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement', window );">Shares issued under purchase agreement - commitment shares (in shares)</a></td>
<td class="nump">6,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants', window );">Shares issued pursuant to cashless exercise of warrants</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares', window );">Shares issued pursuant to cashless exercise of warrants (in shares)</a></td>
<td class="nump">546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,893,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,893,152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,007,894)<span></span>
</td>
<td class="num">(8,007,894)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance Ending at Mar. 31, 2019</a></td>
<td class="nump">$ 48,175<span></span>
</td>
<td class="nump">$ 138,696,975<span></span>
</td>
<td class="num">$ (292,700)<span></span>
</td>
<td class="num">$ (124,273,274)<span></span>
</td>
<td class="nump">$ 14,179,176<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance Ending (in shares) at Mar. 31, 2019</a></td>
<td class="nump">48,173,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,173,241<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to commitment under terms of purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_CommitmentSharesIssuedSharesUndertermsOfPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of stock issued pursuant to commitment under terms of purchase agreement during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_CommitmentSharesIssuedValueUndertermsOfPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the pursuant to cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_SharesIssuedPursuantToCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the pursuant to cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_SharesIssuedUponExerciseOfWarrantsCashless">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents amount of shares issued upon exercise of cashless warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_SharesIssuedUponExerciseOfWarrantsCashless</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents number of shares issued upon exercise of cashless warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_SharesIssuedUponExerciseOfWarrantsCashlessInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6758730928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Description and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Business Description and Basis of Presentation</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 42pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Note 1</font></td>
    <td style="text-decoration: underline"><font style="font: 10pt Times New Roman, Times, Serif"><u>Business
    Description and Basis of Presentation</u></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Business</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Anavex
Life Sciences Corp. (the &#8220;Company&#8221;) is a clinical stage biopharmaceutical company engaged in the development of differentiated
therapeutics by applying precision medicine to central nervous system (&#8220;CNS&#8221;) diseases with high unmet need. Anavex
analyzes genomic data from clinical studies to identify biomarkers, which select patients that will receive the therapeutic benefit
for the treatment of neurodegenerative and neurodevelopmental diseases. The Company&#8217;s lead compound ANAVEX&#174;2-73 is
being developed to treat Alzheimer&#8217;s disease, Parkinson&#8217;s disease and potentially other central nervous system diseases,
including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked
gene, methyl-CpG-binding protein 2 (&#8220;MECP2&#8221;).</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basis
of Presentation</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify; text-indent: 42.55pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These
unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;) and accounting principles generally accepted in the United States of America
(&#8220;US GAAP&#8221;) for interim reporting. Accordingly, certain information and note disclosures normally included in the
annual financial statements in accordance with US GAAP have been condensed or omitted pursuant to such rules and regulations.
In the opinion of management, the disclosures are adequate to make the information presented not misleading.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These
accompanying unaudited interim condensed consolidated financial statements reflect all adjustments, consisting of normal recurring
adjustments, which in the opinion of management are necessary for fair presentation of the information contained herein. The consolidated
balance sheet as of September 30, 2018 was derived from the audited annual financial statements but does not include all disclosures
required by US GAAP. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction
with the audited consolidated financial statements and notes thereto included in the Company&#8217;s annual report on Form 10-K
for the year ended September 30, 2018 filed with the SEC on December 12, 2018. The Company follows the same accounting policies
in the preparation of interim reports.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Operating
results for the six months ended March 31, 2019 are not necessarily indicative of the results that may be expected for the year
ending September 30, 2019.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Liquidity</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">All
of the Company&#8217;s potential drug compounds are in the clinical development stage and the Company cannot be certain that its
research and development efforts will be successful or, if successful, that its potential drug compounds will ever be approved
for sales to pharmaceutical companies or generate commercial revenues. To date, we have not generated any revenues from our operations.
The Company expects the business to continue to experience negative cash flows for the foreseeable future and cannot predict when,
if ever, our business might become profitable.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company believes that its existing cash and cash equivalents, along with existing financial commitments from third parties, will
be sufficient to meet its cash commitments for at least the next eighteen months after the date that these condensed consolidated
interim financial statements are issued. The process of drug development can be costly, and the timing and outcomes of clinical
trials is uncertain.&#160;The assumptions upon which the Company has based its estimates are routinely evaluated and may be subject
to change.&#160;The actual amount of the Company&#8217;s expenditures will vary depending upon a number of factors including but
not limited to the design, timing and duration of future clinical trials, the progress of the Company&#8217;s research and development
programs and the level of financial resources available. The Company has the ability to adjust its operating plan spending levels
based on the timing of future clinical trials.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company will need to raise additional capital in order to continue to fund operations and fully fund later stage clinical development
programs. Such capital may not be available on commercially acceptable terms, if at all. The Company believes that it will be
able to obtain additional working capital to fund future operations through current financing commitments from third parties,
or through other arrangements; however, there can be no assurance that such additional financing, if available, can be obtained
on terms acceptable to the Company.&#160;&#160;If the Company is unable to obtain such additional financing, future operations
would need to be scaled back.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use
of Estimates</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and
expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset
valuations, asset impairment, stock-based compensation and loss contingencies. The Company bases its estimates and assumptions
on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the
results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs
and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially
and adversely from the Company&#8217;s estimates. To the extent there are material differences between the estimates and the actual
results, future results of operations will be affected.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Principles
of Consolidation</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">These
consolidated financial statements include the accounts of Anavex Life Sciences Corp. and its wholly-owned subsidiaries, Anavex
Australia Pty Limited, a company incorporated under the laws of Australia, Anavex Germany GmbH, a company incorporated under the
laws of Germany, and Anavex Canada Ltd., a company incorporated under the laws of the Province of Ontario, Canada. All inter-company
transactions and balances have been eliminated.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair
Value Measurements</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
fair value hierarchy under GAAP is based on three levels of inputs, of which the first two are considered observable and the last
unobservable, that may be used to measure fair value which are the following:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 72pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 0.55in; white-space: nowrap; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
    1 -&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">quoted prices (unadjusted) in active markets
    for identical assets or liabilities;</font></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 63pt"></td><td style="width: 40.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: justify"></td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 72pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 0.55in; white-space: nowrap; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">Level
    2 -&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">observable inputs other than Level 1, quoted
    prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities
    in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are
    observable; and</font></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 63pt"></td><td style="width: 40.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: justify"></td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0px; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 72pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 0.55in; white-space: nowrap; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
    3 -&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">assets and liabilities whose significant value
    drivers are unobservable by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 63pt"></td><td style="width: 40.5pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: justify"></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
book value of cash and cash equivalents and accounts payable and accrued liabilities approximate their fair values due to the
short-term maturity of those instruments.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
March 31, 2019 and September 30, 2018, the Company did not have any Level 3 assets or liabilities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Basic
and Diluted Loss per Share</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Basic
loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common
shares outstanding during the period. Diluted loss per common share is computed similar to basic loss per common share except
that the denominator is increased to include the weighted average number of all potentially dilutive securities convertible into
shares of common stock that were outstanding during the period.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of March 31, 2019, loss per share excludes 7,655,850 (September 30, 2018 &#8211; 7,185,296) potentially dilutive common shares
related to outstanding options and warrants, as their effect was anti-dilutive.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6626807136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 42.55pt"><font style="font: 10pt Times New Roman, Times, Serif">Note 2</font></td>
    <td style="text-decoration: underline"><font style="font: 10pt Times New Roman, Times, Serif"><u>Recent
    Accounting Pronouncements</u></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recently
Adopted Accounting Pronouncements</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2014, the FASB and the International Accounting Standards Board (IASB) issued a converged standard on revenue recognition
from contracts with customers, ASU 2014-09 (Topic 606 and IFRS 15). This standard superseded nearly all existing revenue recognition
guidance. ASU 2014-09 is effective for the Company on a prospective basis beginning on October 1, 2018. The adoption of this standard
did not have a material impact for any period presented and the Company will apply this standard to all future revenues.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2017, the FASB issued ASU No. 2017-09, &#8220;Compensation&#8211;Stock Compensation (Topic 718): Scope of Modification Accounting,&#8221;
clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The
new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the
same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company
on a prospective basis beginning on October 1, 2018. The adoption of this standard did not have a material impact for any period
presented.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements Not Yet Adopted</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases</i>. The guidance would require lessees to recognize
most leases on their balance sheets as lease liabilities with corresponding right &#8211;of use assets. The guidance is effective
for annual and interim reporting periods beginning on or after December 15, 2018. The new guidance is effective for the Company
on a prospective basis beginning on October 1, 2019. The Company is currently evaluating the impact this guidance will have on
its financial condition, results of operations and cash flows.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments
(&#8220;ASU 2018-07&#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring
goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after
December 15, 2018, with early adoption permitted, but no earlier than the Company&#8217;s adoption date of Topic 606. The new
guidance is effective for the Company beginning on October 1, 2019. The new guidance is required to be applied retrospectively
with the cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07
will have on the consolidated financial statements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">Other
than noted above, the Company does not expect the adoption of recently issued accounting pronouncements to have a significant
impact on its results of operations, financial position or cash flow.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6758758256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>Component of Operating Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_OtherIncomeDisclosureTextBlock', window );">Other Income</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt; margin-top: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 42.55pt"><font style="font: 10pt Times New Roman, Times, Serif">Note 3</font></td>
    <td style="text-decoration: underline"><font style="font: 10pt Times New Roman, Times, Serif"><u>Other
    Income </u></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Grant
Income</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Clinical
Study Grant</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the year ended September 30, 2017, the Company was awarded grant funding in the amount of $597,886. The grant is being received
in equal quarterly installments over a period of two years beginning during the year ended September 30, 2018 in exchange for
a commitment to complete clinical testing for a therapeutic drug candidate for the treatment of Rett syndrome.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
grant income is deferred when received and amortized to other income as the related research and development expenditures are
incurred. During the three and six months ended March 31, 2019, the Company recognized $74,527 and $149,055, respectively (2018:
$Nil and $Nil, respectively) of this grant on its statement of operations within grant income.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_OtherIncomeDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other income disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_OtherIncomeDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6625940784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Offering Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_EquityOfferingAgreementsAbstract', window );"><strong>Number of shares issued for commitment</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_EquityOfferingAgreementsTextBlock', window );">Equity Offering Agreements</a></td>
<td class="text"><table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 42.55pt"><font style="font: 10pt Times New Roman, Times, Serif">Note 4</font></td>
    <td style="text-decoration: underline"><font style="font: 10pt Times New Roman, Times, Serif"><u>Equity
    Offering Agreements</u></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Controlled
Equity Offering Sales Agreement</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
July 6, 2018, the Company entered into a Controlled Equity Offering&#160;Sales Agreement (the &#8220;Sales Agreement&#8221;) with
Cantor Fitzgerald&#160;&#38; Co., as agent (&#8220;Cantor Fitzgerald&#8221;), pursuant to which the Company may offer and sell
shares of common stock, for aggregate gross sale proceeds of up to $50,000,000 from time to time through Cantor Fitzgerald (the
&#8220;Offering&#8221;).&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Upon
delivery of a placement notice based on the Company&#8217;s instructions and subject to the terms and conditions of the Sales
Agreement, Cantor Fitzgerald may sell the Shares by methods deemed to be an &#8220;at the market offering&#8221; offering, in
negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices,
or by any other method permitted by law, including negotiated transactions, subject to the prior written consent of the Company.
The Company is not obligated to make any sales of Shares under the Sales Agreement. The Company or Cantor Fitzgerald may suspend
or terminate the offering of Shares upon notice to the other party, subject to certain conditions.&#160; Cantor Fitzgerald will
act as sales agent on a commercially reasonable efforts basis consistent with its normal trading and sales practices and applicable
state and federal law, rules&#160;and regulations and the rules&#160;of Nasdaq.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company has agreed to pay Cantor Fitzgerald commissions for its services of acting as agent of up to 3.0% of the gross proceeds
from the sale of the Shares pursuant to the Sales Agreement.&#160; The Company has also agreed to provide Cantor Fitzgerald with
customary indemnification and contribution rights. At March 31, 2019, the Company had incurred $151,133 in legal and accounting
fees associated with the Sales Agreement. This amount is included in deferred financing charges at March 31, 2019 and is expected
to be reclassified to share capital upon issuance of shares under the Sales Agreement. At March 31, 2019, no shares have been
sold pursuant to the Offering.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Purchase
Agreement</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 21, 2015, the Company entered into a $50,000,000 purchase agreement (the &#8220;2015 Purchase Agreement&#8221;) with Lincoln
Park Capital Fund, LLC (&#8220;Lincoln Park&#8221;), pursuant to which the Company may sell and issue to Lincoln Park, and Lincoln
Park is obligated to purchase, up to $50,000,000 in value of its shares of common stock from time to time over a 36-month period
starting from the effective date of the respective registration statement, to September 6, 2019.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company may direct Lincoln Park, at its sole discretion, and subject to certain conditions, to purchase up to 50,000 shares of
common stock on any business day, provided that at least one business day has passed since the most recent purchase. The amount
of a purchase may be increased under certain circumstances provided, however that Lincoln Park&#8217;s committed obligation under
any single purchase shall not exceed $2,000,000. The purchase price of shares of common stock related to the future funding will
be based on the then prevailing market prices of such shares at the time of sales as described in the 2015 Purchase Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
consideration for entering into the 2015 Purchase Agreement, the Company issued to Lincoln Park 179,598 shares of common stock
as a commitment fee and agreed to issue up to 89,799 shares pro rata, when and if, Lincoln Park purchases at the Company&#8217;s
discretion the $50,000,000 aggregate commitment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
the three months ended March 31, 2019, the Company issued to Lincoln Park an aggregate of 2,239,223 (2018: 1,242,001) shares of
common stock under the Purchase Agreement, including 2,229,592 (2018: 1,233,580) shares of common stock for an aggregate purchase
price of $5,361,534 (2018: $4,688,370) and 9,631 (2018: 8,421) commitment shares. At March 31, 2019, an amount of $7,836,072 remained
available under the 2015 Purchase Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
March 31, 2019, an amount of $292,700 (September 30, 2018: $0) was receivable under the Purchase Agreement in respect of 100,000
purchase shares and 526 commitment shares issued and outstanding. This amount was received subsequent to March 31, 2019.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_EquityOfferingAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_EquityOfferingAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_EquityOfferingAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to equity offering agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_EquityOfferingAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6758727088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Commitments</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: left; width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Note
    5</font></td>
    <td style="text-decoration: underline"><font style="font: 10pt Times New Roman, Times, Serif"><u>Commitments</u></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">a)&#160;&#160;
Litigation</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">The
Company is subject to claims and legal proceedings that arise in the ordinary course of business. Such matters are inherently
uncertain, and there can be no guarantee that the outcome of any such matter will be decided favorably to the Company or that
the resolution of any such matter will not have a material adverse effect upon the Company&#8217;s consolidated financial statements.
The Company does not believe that any of such pending claims and legal proceedings will have a material adverse effect on its
consolidated financial statements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">b)
&#160;&#160;Share Purchase Warrants</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">A
summary of the status of the Company&#8217;s outstanding share purchase warrants is presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 60%">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Average</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Number
    of Shares</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Exercise
    Price</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 53%"><font style="font: 10pt Times New Roman, Times, Serif">Balance,
    October 1, 2017</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 20%"><font style="font: 10pt Times New Roman, Times, Serif">1,609,309</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 20%"><font style="font: 10pt Times New Roman, Times, Serif">2.66</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Issued</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">350,000</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.19</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(756,143</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.96</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(524,787</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.00</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance, September
    30, 2018</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">678,379</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.87</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,250</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.68</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(307,129</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.47</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance,
    March 31, 2019</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">370,000</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.03</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="margin-top: 0pt; margin-bottom: 0pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">During
the six months ended March 31, 2019, the Company issued 546 shares in connection with the exercise of 1,250 share purchase warrants
on a cashless basis.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">c)&#160;&#160;
Stock&#8211;based Compensation Plan</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">2015
Stock Option Plan</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">On
September 18, 2015, the Company&#8217;s board of directors approved a 2015 Omnibus Incentive Plan (the &#8220;2015 Plan&#8221;),
which provides for the grant of stock options and restricted stock awards to directors, officers, employees and consultants of
the Company.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">The
maximum number of our common shares reserved for issue under the plan is 6,050,553 shares, subject to adjustment in the event
of a change of the Company&#8217;s capitalization. As a result of the adoption of the 2015 Plan, no further option awards will
be granted under any previously existing stock option plan. Stock option awards previously granted under the previously existing
stock option plans remain outstanding in accordance with their terms.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">The
2015 Plan provides that it may be administered by the board of directors, or the board of directors may delegate such responsibility
to a committee. The exercise price will be determined by the board of directors at the time of grant shall be at least equal to
the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be
less than 110% of fair market value of the Company&#8217;s shares of common stock on the grant date. Stock options may be granted
under the 2015 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may
be determined by the board, subject to earlier termination in accordance with the terms of the 2015 Plan.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">A
summary of the status of Company&#8217;s outstanding stock purchase options is presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 90%">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Number
    of</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Average</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Average
    Grant</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Aggregate</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Shares</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Exercise
    Price</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Date
    Fair Value</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">intrinsic
    value</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 35%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at October 1, 2017</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">5,092,030</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">4.13</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">5,280,544</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,730,000</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.71</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.09</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(164,280</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.66</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(150,833</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.18</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at September 30, 2018</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,506,917</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.83</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,353,088</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,030,399</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.45</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.97</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(238,966</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.86</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at March 31, 2019</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,298,350</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.67</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,642,978</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable
    at March 31, 2019</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,240,285</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.73</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,976,021</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="margin-top: 0pt; margin-bottom: 0pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted market
price of the Company&#8217;s stock for the options that were in-the-money at March 31, 2019.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">During
the three and six months ended March 31, 2019, the Company recognized stock-based compensation expense in connection with the
issuance and vesting of stock options in exchange for services. These amounts have been included in general and administrative
expenses and research and development expenses on the Company&#8217;s statement of operations as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 90%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Three
    months ended March 31,</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Six months
    ended March 31,</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 36%"><font style="font: 10pt Times New Roman, Times, Serif">General
    and administrative</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">950,999</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">625,679</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">2,006,587</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; width: 13%"><font style="font: 10pt Times New Roman, Times, Serif">1,197,041</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Research and development</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">942,153</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">600,017</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,953,552</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,150,640</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total share based compensation</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,893,152</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,225,696</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,960,139</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,347,681</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">An
amount of approximately $4,546,000 in stock-based compensation is expected to be recorded over the remaining term of such options
through June 2021.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">The
fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following
weighted average assumptions:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left; width: 54%"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free
    interest rate</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 20%"><font style="font: 10pt Times New Roman, Times, Serif">2.91</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; width: 20%"><font style="font: 10pt Times New Roman, Times, Serif">2.43</font></td>
    <td style="text-align: left; width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected life of options
    (years)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5.59</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6.57</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="background-color: rgb(204,238,255); vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Annualized volatility</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">105.96</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112.23</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="background-color: white; vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividend rate</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6758720560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="text-align: left; width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Note
    6</font></td>
    <td style="text-decoration: underline"><font style="font: 10pt Times New Roman, Times, Serif"><u>Subsequent
    Events</u></font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">Subsequent
to March 31, 2019,</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">i)</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The Company filed
    a Certificate of Amendment with the Secretary of State of Nevada to amend the Company&#8217;s articles of incorporation to
    authorize the issuance of 10,000,000 shares of preferred stock having a par value of $0.001 per share. The Board of Directors
    of the Company shall have the authority to issue shares of preferred stock in one or more series and shall have the authority
    to establish by duly appointed resolution such voting powers, designations, preferences, limitations and restrictions and
    relative rights of the preferred shares it deems necessary or advisable.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">ii)</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On January 15, 2019,
    the Board approved, subject to stockholder approval, the 2019 Omnibus Incentive Plan (the &#8220;2019 Plan&#8221;) and, on
    April 5, 2019, the 2019 Plan was approved the Company&#8217;s stockholders. Under the terms of the 2019 Plan, 6,000,000 additional
    shares of Common Stock are available for issuance under the 2019 Plan, in addition to the shares available under the 2015
    Plan. Any awards outstanding under the 2015 Plan or the Company&#8217;s 2007 Stock Option Plan (the &#8220;2007 Plan&#8221;)
    will remain subject to and be paid under the 2015 Plan or the 2007 Plan, respectively, and any shares subject to outstanding
    awards under the 2015 Plan or the 2007 Plan that subsequently cease to be subject to such awards (other than by reason of
    settlement of the awards in shares) will automatically become available for issuance under the 2019 Plan.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.3pt 0pt 0.5in; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0px; margin-bottom: 0pt; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 0.5in"><font style="font: 10pt Times New Roman, Times, Serif">i)</font></td>
    <td style="text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On May 3, 2019 (the
    &#8220;Effective Date&#8221;), the Company entered into a Second Amendment to the Employment Agreement (the &#8220;Amendment&#8221;)
    with the Company&#8217;s Chief Executive Officer (the &#8220;CEO&#8221;) in his continuing capacity as Chief Executive Officer
    of the Company. The Amendment amends the Employment Agreement by and between the Company and the CEO, effective July 5, 2013
    (the &#8220;Employment Agreement&#8221;), as amended, and extends the term of the Employment Agreement through July 5, 2022,
    unless earlier terminated as provided in the Amendment. Pursuant to the terms of the Amendment, the CEO shall receive an annual
    base salary of $550,000 and is eligible to earn an annual cash target bonus for each whole or partial calendar year of twenty
    percent of his base salary. Subject to the terms of the Amendment, the CEO will also receive on the Effective Date 750,000
    options for shares of the Company&#8217;s common stock, one-third of which shall vest on each of July 5, 2020, July 5, 2021
    and July 5, 2022. The options shall have an exercise price equal to the closing price of the Company&#8217;s common stock
    on the Effective Date.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6758824208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recent Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recently
Adopted Accounting Pronouncements</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2014, the FASB and the International Accounting Standards Board (IASB) issued a converged standard on revenue recognition
from contracts with customers, ASU 2014-09 (Topic 606 and IFRS 15). This standard superseded nearly all existing revenue recognition
guidance. ASU 2014-09 is effective for the Company on a prospective basis beginning on October 1, 2018. The adoption of this standard
did not have a material impact for any period presented and the Company will apply this standard to all future revenues.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2017, the FASB issued ASU No. 2017-09, &#8220;Compensation&#8211;Stock Compensation (Topic 718): Scope of Modification Accounting,&#8221;
clarifying when a change to the terms or conditions of a share-based payment award must be accounted for as a modification. The
new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the
same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company
on a prospective basis beginning on October 1, 2018. The adoption of this standard did not have a material impact for any period
presented.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements Not Yet Adopted</i></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued Accounting Standards Update No. 2016-02, <i>Leases</i>. The guidance would require lessees to recognize
most leases on their balance sheets as lease liabilities with corresponding right &#8211;of use assets. The guidance is effective
for annual and interim reporting periods beginning on or after December 15, 2018. The new guidance is effective for the Company
on a prospective basis beginning on October 1, 2019. The Company is currently evaluating the impact this guidance will have on
its financial condition, results of operations and cash flows.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
June 2018, the FASB issued ASU 2018-07, Compensation-Stock Compensation (Topic 718), Improvements to Nonemployee Share-based Payments
(&#8220;ASU 2018-07&#8221;). This ASU expands the scope of Topic 718 to include share-based payment transactions for acquiring
goods and services from nonemployees. The effective date for the standard is for interim periods in fiscal years beginning after
December 15, 2018, with early adoption permitted, but no earlier than the Company&#8217;s adoption date of Topic 606. The new
guidance is effective for the Company beginning on October 1, 2019. The new guidance is required to be applied retrospectively
with the cumulative effect recognized at the date of initial application. The Company is currently evaluating the effect ASU 2018-07
will have on the consolidated financial statements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 42.55pt; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">Other
than noted above, the Company does not expect the adoption of recently issued accounting pronouncements to have a significant
impact on its results of operations, financial position or cash flow.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6749798016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Schedule of exercisable share purchase warrants outstanding</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">A
summary of the status of the Company&#8217;s outstanding share purchase warrants is presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 45.75pt 0 14.2pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 80%">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Average</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Number
    of Shares</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Exercise
    Price</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance,
    October 1, 2017</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,609,309</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.66</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Issued</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">350,000</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.19</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(756,143</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.96</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(524,787</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.00</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance, September
    30, 2018</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">678,379</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.87</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,250</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.68</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(307,129</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.47</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Balance,
    March 31, 2019</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">370,000</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.03</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of outstanding stock purchase options</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">A
summary of the status of Company&#8217;s outstanding stock purchase options is presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 45.75pt 0 18.95pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 90%">
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Weighted</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Number
    of</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Average</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Average
    Grant</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Aggregate</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Shares</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Exercise
    Price</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Date
    Fair Value</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">intrinsic
    value</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at October 1, 2017</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,092,030</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.13</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,280,544</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="white-space: nowrap; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,730,000</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.71</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.09</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(164,280</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.66</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(150,833</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.18</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at September 30, 2018</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,506,917</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.83</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,353,088</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,030,399</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.45</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1.97</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(238,966</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.86</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding
    at March 31, 2019</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,298,350</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.67</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,642,978</font></td>
    <td style="border-bottom: black 2.5pt double; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Exercisable
    at March 31, 2019</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,240,285</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3.73</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,976,021</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of general and administrative expenses and research and development expenses</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">These
amounts have been included in general and administrative expenses and research and development expenses on the Company&#8217;s
statement of operations as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.3pt 0 57.4pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.7in; width: 80%">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Times New Roman, Times, Serif"></font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Three
    months ended March 31,</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="6" style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">Six months
    ended March 31,</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="white-space: nowrap; border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 20%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">General
    and administrative</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">950,999</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">625,679</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,006,587</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,197,041</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Research and development</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">942,153</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">600,017</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,953,552</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,150,640</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Total share based compensation</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,893,152</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,225,696</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">3,960,139</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,347,681</font></td>
    <td style="border-bottom: black 1pt solid; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of weighted average assumptions for fair value of each option award</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-bottom: 0; margin-left: 0.7in"><font style="font: 10pt Times New Roman, Times, Serif">The
fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following
weighted average assumptions:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 64.7pt 0 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1pt"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: black 1pt solid"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 54%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Risk-free
    interest rate</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.91</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 20%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2.43</font></td>
    <td style="width: 1%; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Expected life of options
    (years)</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5.59</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6.57</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Annualized volatility</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">105.96</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">112.23</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">Dividend rate</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td style="text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6758718208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Description and Basis of Presentation (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Loss per share for potentially dilutive common shares</a></td>
<td class="nump">7,655,850<span></span>
</td>
<td class="nump">7,185,296<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6756466208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_NonOperatingIncomeFromGrant', window );">Grant income</a></td>
<td class="nump">$ 74,527<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 149,055<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avxl_ClinicalStudyGrantMember', window );">Clinical Study Grant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_NonOperatingIncomeFromGrant', window );">Grant income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 597,886<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_NonOperatingIncomeFromGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_NonOperatingIncomeFromGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avxl_ClinicalStudyGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avxl_ClinicalStudyGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6766148432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Offering Agreements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 06, 2018</div></th>
<th class="th"><div>Oct. 21, 2015</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross sale proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,068,834<span></span>
</td>
<td class="nump">$ 4,688,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=avxl_EquityOfferingSalesAgreementMember', window );">Equity Offering Sales Agreement [Member] | Cantor Fitzgerald &amp; Co [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Gross sale proceeds</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_PercentageOfGrossProceedsFromSales', window );">Percentage of gross proceeds from sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Legal and accounting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 151,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=avxl_PurchaseAgreementMember', window );">2015 Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_StockIssuedDuringPeriodSharesNewIssues4', window );">Number of shares issued for aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_StockIssuedDuringPeriodSharesNewIssues3', window );">Number of shares issued for commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=avxl_PurchaseAgreementMember', window );">2015 Purchase Agreement [Member] | Lincoln Park Capital Fund, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ValueOfSharesObligatedToPurchase', window );">Total number of shares obligated to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_AgreementTerm', window );">Agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDescription', window );">Description of purchases price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company may direct Lincoln Park, at its sole discretion, and subject to certain conditions, to purchase up to 50,000 shares of common stock on any business day, provided that at least one business day has passed since the most recent purchase. The amount of a purchase may be increased under certain circumstances provided, however that Lincoln Park&#8217;s committed obligation under any single purchase shall not exceed $2,000,000. The purchase price of shares of common stock related to the future funding will be based on the then prevailing market prices of such shares at the time of sales as described in the 2015 Purchase Agreement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179,598<span></span>
</td>
<td class="nump">2,239,223<span></span>
</td>
<td class="nump">1,242,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_NumberOfSharesObligatedToPurchaseProrataBasic', window );">Pro rata basic number of shares obligated to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_StockIssuedDuringPeriodSharesNewIssues4', window );">Number of shares issued for aggregate purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,229,592<span></span>
</td>
<td class="nump">1,233,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_StockIssuedDuringPeriodValueNewIssues3', window );">Number of shares issued for aggregate purchase price, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,361,534<span></span>
</td>
<td class="nump">$ 4,688,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_StockIssuedDuringPeriodSharesNewIssues3', window );">Number of shares issued for commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,631<span></span>
</td>
<td class="nump">8,421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_StockIssuedDuringPeriodValueNewIssues4', window );">Amount of shares remain available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,836,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_AgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Terms of the agreement under agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_AgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_NumberOfSharesObligatedToPurchaseProrataBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to number of shares obligated to purchase prorata basic.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_NumberOfSharesObligatedToPurchaseProrataBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_PercentageOfGrossProceedsFromSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to percentage of gross proceeds from sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_PercentageOfGrossProceedsFromSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_StockIssuedDuringPeriodSharesNewIssues3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_StockIssuedDuringPeriodSharesNewIssues3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_StockIssuedDuringPeriodSharesNewIssues4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_StockIssuedDuringPeriodSharesNewIssues4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_StockIssuedDuringPeriodValueNewIssues3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_StockIssuedDuringPeriodValueNewIssues3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_StockIssuedDuringPeriodValueNewIssues4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_StockIssuedDuringPeriodValueNewIssues4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ValueOfSharesObligatedToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to value of shares obligated to purchase initially.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ValueOfSharesObligatedToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the nature of an unconditional purchase obligation that is not recognized as a liability on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77896938&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=avxl_EquityOfferingSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=avxl_EquityOfferingSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=avxl_CantorFitzgeraldAndCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=avxl_CantorFitzgeraldAndCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=avxl_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=avxl_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=avxl_LincolnParkCapitalFundLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=avxl_LincolnParkCapitalFundLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6769948880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod', window );">Exercised</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=avxl_PurchaseWarrantsMember', window );">Purchase Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance, at beginning</a></td>
<td class="nump">678,379<span></span>
</td>
<td class="nump">1,609,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod', window );">Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod', window );">Exercised</a></td>
<td class="num">(1,250)<span></span>
</td>
<td class="num">(756,143)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod', window );">Expired</a></td>
<td class="num">(307,129)<span></span>
</td>
<td class="num">(524,787)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance, at end</a></td>
<td class="nump">370,000<span></span>
</td>
<td class="nump">678,379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice', window );">Balance, at beginning</a></td>
<td class="nump">$ 2.87<span></span>
</td>
<td class="nump">$ 2.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice', window );">Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="nump">1.68<span></span>
</td>
<td class="nump">2.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice', window );">Expired</a></td>
<td class="nump">1.47<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice', window );">Balance, at end</a></td>
<td class="nump">$ 4.03<span></span>
</td>
<td class="nump">$ 2.87<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of exercised in period made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to share based compensation arrangement by share based payment award equity instruments other than options expired in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpiredInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to share based compensation arrangement by share based payment award equity instruments other than options expired in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to share based compensation arrangement by share based payment award equity instruments other than options outstanding weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information related to share based compensation arrangements by share based payment award equity instruments other than options exercised in period weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to share based compensation arrangements by share based payment award equity instruments other than options exercised in period weighted average expired price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageExpiredPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents information related to share based compensation arrangements by share based payment award equity instruments other than options exercised in period weighted average issued price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageIssuedPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=avxl_PurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=avxl_PurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6768762336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details 1) - 2015 Omnibus Incentive Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning</a></td>
<td class="nump">6,506,917<span></span>
</td>
<td class="nump">5,092,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">1,030,399<span></span>
</td>
<td class="nump">1,730,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited</a></td>
<td class="num">(238,966)<span></span>
</td>
<td class="num">(164,280)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150,833)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at ending</a></td>
<td class="nump">7,298,350<span></span>
</td>
<td class="nump">6,506,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at ending</a></td>
<td class="nump">5,240,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning</a></td>
<td class="nump">$ 3.83<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted</a></td>
<td class="nump">2.45<span></span>
</td>
<td class="nump">2.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited</a></td>
<td class="nump">2.86<span></span>
</td>
<td class="nump">3.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at ending</a></td>
<td class="nump">3.67<span></span>
</td>
<td class="nump">3.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at ending</a></td>
<td class="nump">3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted</a></td>
<td class="nump">$ 1.97<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate intrinsic value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at beginning</a></td>
<td class="nump">$ 2,353,088<span></span>
</td>
<td class="nump">$ 5,280,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding at ending</a></td>
<td class="nump">3,642,978<span></span>
</td>
<td class="nump">$ 2,353,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at ending</a></td>
<td class="nump">$ 2,976,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueRollForwardAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=avxl_StockOptionPlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=avxl_StockOptionPlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6757656096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details 2) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share based compensation</a></td>
<td class="nump">$ 1,893,152<span></span>
</td>
<td class="nump">$ 1,225,696<span></span>
</td>
<td class="nump">$ 3,960,139<span></span>
</td>
<td class="nump">$ 2,347,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share based compensation</a></td>
<td class="nump">950,999<span></span>
</td>
<td class="nump">625,679<span></span>
</td>
<td class="nump">2,006,587<span></span>
</td>
<td class="nump">1,197,041<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share based compensation</a></td>
<td class="nump">$ 942,153<span></span>
</td>
<td class="nump">$ 600,017<span></span>
</td>
<td class="nump">$ 1,953,552<span></span>
</td>
<td class="nump">$ 1,150,640<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6757628496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details 3)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.91%<span></span>
</td>
<td class="nump">2.43%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of options (years)</a></td>
<td class="text">5 years 7 months 2 days<span></span>
</td>
<td class="text">6 years 6 months 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Annualized volatility</a></td>
<td class="nump">105.96%<span></span>
</td>
<td class="nump">112.23%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6752073504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_RemainingAllocatedShareBasedCompensationExpense', window );">Remaining stock based compensation | $</a></td>
<td class="nump">$ 6,020,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares', window );">Shares issued pursuant to cashless exercise of warrants</a></td>
<td class="nump">546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod', window );">Shares issued pursuant to cashless exercise of warrants</a></td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=avxl_StockOptionPlan2015Member', window );">2015 Omnibus Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Maximum number of common shares reserved for future issuance</a></td>
<td class="nump">6,050,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Description of grant option</a></td>
<td class="text">The exercise price will be determined by the board of directors at the time of grant shall be at least equal to the fair market value on such date. If the grantee is a 10% stockholder on the grant date, then the exercise price shall not be less than 110% of fair market value of the Company&#8217;s shares of common stock on the grant date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_RemainingAllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>It represents as a remaining stock based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_RemainingAllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of exercised in period made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the pursuant to cashless exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avxl_SharesIssuedPursuantToCashlessExerciseOfWarrantsInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avxl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=avxl_StockOptionPlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=avxl_StockOptionPlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6765810608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>May 03, 2019</div></th>
<th class="th"><div>Apr. 05, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Issuance of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Employment Agreement [Member] | CEO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Annual base salary</a></td>
<td class="nump">$ 550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights', window );">Vesting period</a></td>
<td class="text">one-third of which shall vest on each of July 5, 2020, July 5, 2021 and July 5, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Omnibus Incentive 2019 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=avxl_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=avxl_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=avxl_OmnibusIncentive2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=avxl_OmnibusIncentive2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>43
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M'WX78>NTV9E_;'P6[#OX=1?]%U!+ P04    " !,H:A.F5R<(Q &  "<)P
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M[YT=2BF%?_G$):H+U@GOMBV@?0\XKDN&=7%$JX1FBLFP+"P46285OU05[:6
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M47,^=H=Q(5D_-3XT=]_\#U!+ P04    " !,H:A.I"I_+NP#   .$   &
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MDUZKJHU)@+A/H>]2<WY^*.)KV]VZ=%\/'>KPT%;'L?O.SC\!S/\%4$L#!!0
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MFQ:,74NPF0QIVX()W^*A+A*QI8 )@4DH*P82A^-SJM*^!6G,*?J>T+B"%
M0DH)' :2S!@'3#LA3%BA#!G%'D<!3%4I!A)&.4%S3V3:#2&/.,GPBS-B/JHG
M''&)0U()).0",SY7J;3'PMAD)0Q9Q?:)D,2 X>CE32 YL39(YVJ5=EL8VZV,
M[$U&'UTH">6"T)!5C$24V=_$P@=6Q:2#:E1W\,UFGVWUN36N69FL7AO:>^0Z
ML&!][1I=WYF]IQFZY.]E=ZC:/GO2QO9WO@O;:VV4)0IN;>&.MC&_3FJU-V[(
M[;@;NM-A8O1I[+R+:_N_^@=02P,$%     @ 3*&H3K5KUOT,!P  ]"@  !@
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M=@<&)Y92,#:;=4=+D<5&8\)J1%@^X;7$9U<'&[.V.G+:B-C'9Y.6NS5^MZ^
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M@B9$\PW:;EJSR0FVGU\06YYQ^0M02P,$%     @ 3*&H3BT6QTNT 0  T@,
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M/-MQS$;#FV[Z06S^QOD'4$L#!!0    ( $RAJ$[+:RE_M $  -(#   8
M>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL?5-A;]P@#/TKB!]0+ERVWDY)I%ZG
M:9,VZ=1IW6<N<1)4B#,@E^[?#TB:96O4+X"-W_.S,=F(YLFV (X\:]79G+;.
M]4?&;-F"%O8&>^C\38U&"^=-TS#;&Q!5!&G%^&[WGFDA.UIDT7<V18:#4[*#
MLR%VT%J8WR=0..8TH2^.!]FT+CA8D?6B@>_@?O1GXRVVL%120V<E=L1 G=.[
MY'A*0WP,>)0PVM69A$HNB$_!^%+E=!<$@8+2!0;AMRO<@U*!R,OX-7/2)64
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MS5C0/7UW/(FV\\'!RKSG+7P#_[T_6[38PE(+!=H)HXF%IJ!W^^,I"_$QX(>
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M G/ H#)N^FCG:KP*8V!D-]UR/#\UV3]02P,$%     @ 3*&H3O?PXZ@R @
M;@8  !D   !X;"]W;W)K<VAE971S+W-H965T,38N>&ULC55A;YLP$/TKB!]0
M,&"21@2I21IMTB95G;I]=L@EH!K,;"=T_WZV<0D!E/0+ML_OO;OSV4?2,/XN
M<@#I?)2T$DLWE[)>>)[(<BB)>& U5&KGP'A)I%KRHR=J#F1O2"7U M^/O9(4
ME9LFQO;"TX2=)"TJ>.&..)4EX?]60%FS=)'[:7@MCKG4!B]-:G*$7R#?ZA>N
M5EZGLB]*J$3!*H?#8>D^H<46:[P!_"Z@$;VYHS/9,?:N%]_W2]?7 0&%3&H%
MHH8SK(%2+:3"^&LUW<ZE)O;GG^I;D[O*94<$K!G]4^QEOG3GKK.' SE1^<J:
M;V#SP:YCD_\!9Z *KB-1/C)&A?DZV4E(5EH5%4I)/MJQJ,S8M#M1:&G3A, 2
M@HZ \$U": GAA1#=)$26$'W5 [8$_%4/L27$%T)LZM$>ECG]#9$D33AK'-[>
MGYKH:XH6L:IOIHVFG&9/%4 HZSE%.$R\LQ:RF%6+"7J8V+^&;,80=(W83B#P
M!>.I(+M(@ZE(5\%((+AVL1XCXD$4F[LBS_=%MF,(PM%T*N'DH8=&(.K[F W.
MO(7$!E(9R"S"P0"U'@M%P\J,A5#TZ&,\2/NFTE5*T61*T8B/>CZN!/"D +Y[
M)EL\2@4_SN;S>.#&Z]W]$OC1="[A9.Q425V1GK5KCD^!?CL#^PHMUFC"OD&+
MY[;W7>3;3OR3\&-1"6?'I'JQYET=&).@HO<?5/BY:O[=@L)!ZNE,S7G; MN%
M9+7M[E[WBTG_ U!+ P04    " !,H:A.==+U B0#   <#0  &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q-RYX;6R-5W]OFS 0_2J(#U"PP3^HDDAKTZZ3-JGJ
MM.UOFC@)*F &3M)]^]G@HL0^TE1*P?#>O3O[[FQF1]F^=3LA5/!>E74W#W=*
M-;=1U*UVHLJ[&]F(6K_9R+;*E1ZVVZAK6I&O>U)51CB.:53E11TN9OVSYW8Q
MDWM5%K5X;H-N7U5Y^^].E/(X#U'X\>"EV.Z4>1 M9DV^%3^%^M4\MWH4C5;6
M127JKI!UT(K-//R";I]P; @]XG<ACMW)?6!">97RS0R^K>=A;#P2I5@I8R+7
MEX.X%V5I+&D__EJCX:AIB*?W']8?^^!U,*]Y)^YE^:=8J]T\Y&&P%IM\7ZH7
M>7P2-B 2!C;Z[^(@2@TWGFB-E2R[_G^PVG=*5M:*=J7*WX=K4??7X_"&$4N#
M"=@2\$A Z45"8@G)2.#Q14)J">FU"L02R+4$:@GT6@*S!'8M@5L"=PC1L!S]
M^BYSE2]FK3P&[9"B36XJ =URG4$K\[!/F/Z=7N)./STL$*&SZ& ,6<S=@,%G
M&':.N8<P_!RS]#'X'/'@(R@ZASQ^:N3KYT:>?$B2C)!(3]@X:QB<-=SST[-H
M,\?1 4-[3-UC2$PY3U+'71^7&AB+88<2T*'$=XA.&$A! ^GG$=VE0$3#'ZQ$
M0"4"N.HN,H3!L @%12A@('%$J!<.(@A-)0(#=1B@D\(&.&B  P:(X^B (2>.
MX@RSDUD?DMJ'3:Q+!GJ2 9XXG> Q\R30A?5',=QR8E\I\<H\]J0(IA,Z$ZT-
M 1&Q"1-PG2.@T"EW6Q]4Z9?J L$UC* BSEPQ #35*A!<Z@BH=89<'0@T48((
M+G0$53%Q=8B?4BPCF;=W^#B,DTS_W"T$,(A3?9A#$\[##00!'80EKO/4T^(9
MR[());B%(*B'4#=\!H2/]3QY.Z@/1#A)")_*$;@M(: OL=1UBON)GU!$W"WN
M 0!>W.,0W*$0T*+<QK%$?H_*J(MZ % \Q1,I@N$^AH$^QIS\7EK0:>B,)S3V
M:BDZ.;&9[X8?>;LMZBYXE4H?_OHCVD9*);31^$;[O=.?*N.@%!ME;O7).FB'
M\_HP4+*QWR+1^$&T^ ]02P,$%     @ 3*&H3BM/8071 @  9@H  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&ULC59M;YLP$/XKB.\+?@%#JB12FVG:
MI$VJ.G7[3!,G007,;"?I_OUL0RG@8TH^!&R>NWL>WW'<ZBKDJSIQKH.WJJS5
M.CQIW=Q%D=J=>)6KA6AX;9X<A*QR;9;R&*E&\GSOC*HR(@BQJ,J+.MRLW-ZC
MW*S$69=%S1]EH,Y5E<N_#[P4UW6(P_>-I^)XTG8CVJR:_,A_<OW</$JSBGHO
M^Z+BM2I$'4A^6(?W^&Z+4VO@$+\*?E6#^\!*>1'BU2Z^[=<ALHQXR7?:NLC-
MY<*WO"RM)\/C3^<T[&-:P^']N_<O3KP1\Y(KOA7E[V*O3^LP"X,]/^3G4C^)
MZU?>"4K"H%/_G5]X:>"6B8FQ$Z5R_\'NK+2H.B^&2I6_M=>B=M=KY__=##8@
MG0'I#4SL_QG0SH!^&# GOF7FI'[.=;Y927$-9)NM)K=%@>^H.<R=W71GYYX9
MM<KL7C8X9:OH8AUUF(<60X:8,6(+()(/3&08]#0(1..!> [()(2/H!2.0$&A
MU-G3D= 4=A"##F+G(!XYR"8GU6(2AZE;#$D0'"4!HR1 E"7L@($.V.TZ4]!!
MZC/(T$1GZNED:48'1-N<^3#,T)*B&4$9R"<#^$SK+_,"T029'QQG"<99WI#?
MI1?GTRC!+1L E28,QS/UBA'\9B) .)F^FLB/15&*R305$# A<9K-U :>:1<8
M($6GI+"?CG24CHZ3CYN4T9@2V#KN,?$K/HMG7,"] =,;:KX#90.V9#$XODX3
MA&)LA@[<:3#0:KR2[T VKWVD>('GS@[N-AAJ-].B[T"C2'C!LBDA $86RSGI
M</?"[):B9Q"AV$L%\\MPA@S<"3'4"KUB3[V$QPM$IUQ\U*AX6CK1X*M=<7ET
M XX*=N)<N^EJL-L/4??$??4_X.T$]B.7QZ)6P8O09G9P7_B#$)H;,FAACN1D
MAKY^4?*#MK>IN9?MY-,NM&BZJ2[J1\O-/U!+ P04    " !,H:A.U>:H%$(#
M    #0  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6R-5UUOFS 4_2N(
M]X$_^+"K)%+#-&W2)E6=MCW3Q$E0 6= FN[?SQB7@GVIDH> G7/O.=?Q/9C5
M53;/[4F(SGNMRKI=^Z>N.]^%8;L[B2IO WD6M?KE()LJ[]2P.8;MN1'Y7@=5
M94@02L(J+VI_L])S#\UF)2]=6=3BH?':2U7ES;^M*.5U[6/_;>*Q.)ZZ?B+<
MK,[Y4?P4W:_S0Z-&X9AE7U2B;@M9>XTXK/U[?)<1T@=HQ.]"7-O)O=>7\B3E
M<S_XME_[J%<D2K'K^A2YNKR(3)1EGTGI^&N2^B-G'SB]?\O^11>OBGG*6Y')
M\D^Q[TYKG_G>7ASR2]D]RNM780J*?<]4_UV\B%+!>R6*8R?+5G][NTO;R<ID
M45*J_'6X%K6^7DW^MS X@)@ ,@8H[H\"J F@[P&)+GY0IDO]G'?Y9M7(J]<,
M_]8Y[S<%OJ-J,7?]I%X[_9NJME6S+QO,XE7XTB<RF.V (5/,')$!B/@=$RH%
MHPP"R=@2)P&Q*%P$I3 #!0NE.I[."DW@!!&8(-()HEF"U%JI 1-K3*TQ28P2
MCBU<YN)BQ FB"!84@X)B0!"S!,4.$58LE'-+$(!+*5(?6% ""DH 01;1-G&(
M/A'*>))8@@ <3B+"%@2EH*#4%91:*Y2E %&,V-+F8B 1<XDXLBIG#E%*.*.Q
MA<M<G+V'9H(X*(@#@JRFW7)W$Y((D4G[SX@P@@T$N8W%R4**!0_"-[26 ;&)
M7!HP:AN1BXH"O/!?8M"+[C&YH;$,J*]^9")!%-MZ0%BZX(T8MBY,;V@L [*8
MF-U7$(P&R8(38M@*,>"%3F,9T(P)!Y@M,,$>AP&3<SK+@.R:;-.%86QI<\ >
MAP&3<SK+@"RF=(D)-B^< HVUE *V)0SXDKN3F=,R..#.XKDH$B"^( <V)<R!
MBJ*%8P+L-@3=8!4&E$RUTI@BN_0, ,;J$1-'2Z)@_R* ?SF;U("F=DO5 XT[
M?6. 'ZF?BX)=C  NYFQ4 YIQ\31!Q#:H<'*>K$1SU$?OUMO)2ZW/_9/9\7A_
MKT_WX3M\>#?XD3?'HFZ])]FI4ZT^>QZD[(32@P*U/"?U.C(.2G'H^MM4W3?#
MF7P8=/)LWC?"\:5G\Q]02P,$%     @ 3*&H3JXG#T!S @  FP<  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C N>&ULC571;ILP%/T5Q <4&[ )48+4A$R;
MM$E5IV[/#G$"*F!F.TGW][,-I8EQL[Q@^W+.\3W7X+LX,_XJ2DJE]];4K5CZ
MI93=/ A$4=*&B ?6T5:]V3/>$*F6_!"(CE.R,Z2F#D( <-"0JO6SA8D]\6S!
MCK*N6OK$/7%L&L+_KFC-SDL?^N^!Y^I02AT(LD5'#O0GE2_=$U>K8%3950UM
M1<5:C]/]TG^$\TVB\0;PJZ)G<3'WM),M8Z]Z\6VW](%.B-:TD%J!J.%$U[2N
MM9!*X\^@Z8];:N+E_%W]B_&NO&R)H&M6_ZYVLESZ,]_;T3TYUO*9G;_2P0_R
MO<'\=WJBM8+K3-0>!:N%>7K%44C6#"HJE8:\]6/5FO'<OXGP0',3PH$0C@2U
M]RU"-!"B#T)\DQ /A/C>'=! 0-8.0>_=%#,GDF0+SLX>[S^'CNBO#LZ1.JY"
M!\WIF'>JGD)%3QE,T2(X::$!L^HQX04&@VM(/H7 $1&H!,8L0E<6JW!"#Z\W
M6$\1&%HY_%=D<U/D*LW(6:S(\..K8F&K6#T&&TS;8V9I!)%MR($+0X1MO7R*
MBU(,8)1:WJ:X,(H3//O$8.PT&#L,)FX!Y!1 =U2HQZ"+3%,$TM0RM)["L*I/
M8L'R*4Q?DFB66/69XJ#R!N)/ZH.=]K##WLPMD#@%DCOJDTQ.,HU#B"*K/E,8
M!@! RW<^A:D?/$+V][AQX" ". :6O>#B9FDH/YAK7G@%.[92_S<7T;&3/(;Z
M9K+B*SA?0T<\5YVG;Q0?\GW;^D'XH6J%MV52W8?FUMHS)JE*'SRHDRU5IQP7
M-=U+/4W4G/?]HE](U@VM,!C[<?8/4$L#!!0    ( $RAJ$[S>Y5O# (  /T%
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;'U4[6Z<,!!\%<0#Q'S>
M)2= RA%5K=1*IU1-?_NX/4"Q,;5]1_KVM0TAE&SR!]OKF=E9&V\V"/FL&@#M
MO7#6J=QOM.YWA*BJ 4[5C>BA,SMG(3G59BEKHGH)].1(G)$H"#:$T[;SB\S%
M#K+(Q$6SMH.#]-2%<RK_[H&)(?=#_S7PV-:-M@%29#VMX2?H7_U!FA6954XM
MATZUHO,DG'/_/MR56XMW@*<6!K68>[:2HQ#/=O'ME/N!-00,*FT5J!FN4 )C
M5LC8^#-I^G-*2US.7]6_N-I-+4>JH!3L=WO23>[?^MX)SO3"]*,8OL)43^I[
M4_'?X0K,P*T3DZ,23+FO5UV4%GQ2,58X?1G'MG/C,.ZDT43#"=%$B&9"E'Q*
MB"="_$9(7?&C,U?J ]6TR*08/#E>5D_M/Q'N8G.8E0VZLW-[IEIEHM<BO+O+
MR-4*39C]B(F6F!E!C/J<(L)2[*-W].C_!.5[Q.:###%:1.SX\=)@G. ""2J0
M.(%D:3$(5J> 8<)5(1@FPHVDJ)$4$8A71C!,LC*"85+<R 8ULD$$-BLC&&:[
M,H)A;G$C6]3(%A%8_Z ()EQ=7_DY9C1"%J^&@ZQ=@U%>)2Z=MO_G(CKWL'OW
MKE?QO>EM8RMZDQD;XP\JZ[93WE%H\Z;=RSL+H<%8#&[,K36F%\\+!F=MIULS
MEV-'&A=:]%.S)7/'+_X!4$L#!!0    ( $RAJ$[Z/@6M#@(  -8%   9
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MOOPE<Y#2<"N*GZQ<:1^J<2#XP;AN9ONJOZW[@9'M\!*A\3DL_@-02P,$%
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M528@+BY(B@);:]%Z@"':7\KS&F]Z%O><S^^^D^^N;O[^1.XA,^%=E#QDLL@
M#@"CY(KY$BB]5;>9(VAJA^^+3.N\/"&+ @0<*-78G!G\BG\GJ\2\47,#J(E7
M37D)DOMDX6>*CQK.N=7I.2?JS7"U.(E/:/F')/T!MZ'UDUSX$8A;A;J(M0W
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M,9-@N ;.%9YC8--R^:>8=DE"C-X_!\*!\Q#F!9_NY+?S^:U]"8<I&">I2<P
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M1PGW"+@XL<LS]55VAN*OD\+%KT_A\ED4+BR%]QX7>2 :Y3_!/# 2#TCZG5J
M[Y\274]:Z+I-FGW:4;!)T_ODI#_TP-*AT JL^.<B5HYM5.<2?'+2GWH5#C@Y
MS!2>O-Q2^LQV$5PGL=KNHF0/GM2=0\ZW3,Z9K>%P7EF6OY HQ"?J,QQBH'.Q
MAN_L>UV[HHUG*@XD'<L2F0#3L>LD"9C0T,YFKP-E>%S"K0,E)6D14FW^UE"#
M#OB8K ^?.BG&%;>B8OK5)3BB?%$FH<?&4N6\%\MZ0WRP'!>(>%09 .8_#@B-
M#]::-3=S3<31*AS+/%95'-8.!YADUL*(829M80)'U%!\APHK6/*2 T&CVXR\
MKF7'EVMC1BNTGU C5 .G(:HYGW6"*^?<8+0.#);13F/JZ=4=:A.D8(B'=9[D
MT:!/3U*'ER#4Q^2Q^HOD7M6<#%.]P5E;EEV.,$FU76/M#+<LJB(. (E:QCAN
MG=!B!A8+J:*F)>;E.>#O3)LB*AJ3#VY8B-RZ=MG:DX8; [;@]%W9::2;OAXQ
M]$8:9WHT];Z9?YR;E.5=7@1[?B;?DGTN'BONF%:13C8P*@@8NZ9U,#U#>HT/
MMTQ 'HUG4^_L3',##R:-P'85U55B%A?]7< ?_"\%AJ7R"R"%*.*SP:YKU"QL
MQJ".>$@:K.[X&H<+54*GFP^X4/AN=3][AV!5YV[J3NMF$FL4334EH%SE@!Y$
M16!5*D$KI8]L+:R=KD3$AXW_D^UB\,*Z>XL)AY^TOY([38\Z9VG<F>Y2#C?A
MBV$4F(^LBUYJB3,.Q)&0/EPM4Z4%1X0<34^]\7!*:QP-3F=>'UPW!,O*(GF,
M!_!*'%V'W#**?ZD.>6%- ,:1YKS,;0NNQ)MA;"Q=?#;OY^!^EQL,>%/3F.GK
M:+IB]19%+3562>K02"OKG>JV&M'R&HQZ@TR.(B#U.C!\NX =*V_09@!,3=I"
M*HH:5JG$#.QR9UGYV+)N=7CMF:WH1%R*<T D[/9=F/^TQE+10/[1W^Y>P[MZ
MY S[:UK.6/3UT68QKU)CV:Q]P&AL0FD.-@NBJ".PX#'3K0':-7+8.L5( =8,
M<3F'"FA*L</W'(W+.P$X2Q)NV=RE/W6^M[E%Q([06S(H+ VD3R"01: B#!GN
MV6G813[K#=0]8-#(2@U W4C@8)H36]?E&T\QQ.FPA#TLKP5ZQ"5BD,<S%K%4
M6N4;-(X"G&F-A-A0@5;X.L"95'=M_^T!\.#;K!,N]Z]:>115I^DZQ OF-X;9
M=(^'+H<@>X(.C$N ]%@G"D-);&=N95%*U6-C06R*T7ECI;5&05O_P7/J4SH@
M]NJ8AU=@Z#G%=:CF,E.-PIEJ=9CVN))%%*X-_)3.QH=<RH9%JGP*96:FQG-5
M6RI)NTZUH%H3*E; W<8ZJ&N/QWT75NUH:M2[8W1AR<.^LG-3!5A26Z\% *KP
M0N/'S_3&F/?)R:O4@CBY7%,VR(Z?+C3&662%HB37Y<:YOL&(V(%6WZ%=0Z1!
M:H\-3UA3D.SGXA85T&T#=-KME?,VL5_HH[CVL\#_L5IVLR%!ENI""/!@6K:_
MM#7VVN= +63<%Q0"2VY>MF@Q0FC4Z__!D!!+*R.HA,W<,CNL7(ZM-P8<I!C:
M0)0E[BZX*;GU($&N<X ,?=L0B'(;.V$)ECMY&H+3@S^D&#"FL/]!S;^A0F6V
M)$#?CP?>8#1"XRH"21W5FA#$2N%A95FR9+8LZX2;^\1V);8@0YO[I;KEH+-7
M6W>AU7,4868K=(6I.S#Q%"U[*-YL*HV(B4*G=3Q[E)%;L!0G9I[-G0IP=IK-
M'T;7].2M;CH5%4O N(%#7GI\T!IPE5]+#ZMK >!:]I4=EH"\0G,JB@7V"MGF
MZG> "4]>79U;$T /HY:BYVA_TEA\1ADGI=R5.(]8 0'[XERI:_;HM2A_H!6;
M5R/&;4]:-&T$[6F,)B=D 9NX$H@@KOJQ'%R+5)0EXB;TE>KKY8BEK/GJX9M*
MGV3B^/?"Q4X CCV(WAI*N!P12(D;3\#3IR[%FDG1%.^>BR^-+L96B1E1P0S)
MA7U9AQSXH$+LO0>< 375O."N5@:2=-IAE@]]"2Z5 T,CR7+MCEM0=/"/>%VP
M866 U.GZ,JW%+&CWYE8*6< \4[?'$-9)DXPQMN-S*AX@:L+SH<4%J7!L75*5
M;G0LT:0( PIQ>30T5*:+BLU(,E?<ZTUJQ.88/!3[Y9"Z\9Q-/76UF'3#K6.M
MAA&]"BTG_;X6BPLE+A;E+D&VEYT?'=Q/07U36\%H0;U'4H9]>PUYQ_RJ<-*>
M4XVMY6 Z\\:SLPX<"0JN.][X2KNDI9IC:<$D?#;SIK.960N(0 +<OJ<3 "A:
M5E[U]>:P++9JIKHHV8H>NS*E]$%* 'MN!(4]Z"=[SAT8 @N]?!/@9^@-1S-O
M.!QIYUD.O.$ITN#@11?SEMJJ[91**QF6'N)Q#)VE1R-O?-9_T2DQ*=[N0&@P
M*BSY'XV]T63@C4>G9MFC4V]R=N:-IGWN39QYD]' /#SS3H>PE<8%"ZV:%5]=
MQI:FWMEHXO6G0^"M+9?5EFG^$@F=]-ZH:ZB_8#@;>M-^:^X9=@6[P4A8>7';
M0<0C]VGU@&OKZ^M$_=H+Q,]X.&FY<")LO;JN:B^5\.AJ-_5CH:-:U9TV@B3.
M97R'[NFC=+1;4BK?VE:Y1Z*38BPK*[T05Z"=UK824#@NEJO-(C_4WC$;EMJ:
M!@AL!5*8V;8H:CY%,Q<LSY2O0S"Z29>Y;WV0_JGII=HHCF$+V[]AFS\J==_K
MPL<8DRJ;4DQ#"#D#J#G*Q6T99*"6I#!7_GV"]T;N:S7>G./S39DS:/;"1*Y;
MEVS+A.G"4!-U)Q.V+0KQ>,2]XNC:R+HNW-6XCO=6[Y@VB(,G5 ;^NT'F&-_C
M=: ]N7@AN!;(\M??S5T7<Y$56W)PM"V6\1VQ'?TD;N4'^P"6$^WU&6'FI,P!
M#<G#*V&N-1-S+J<1'#,4I2-^H6_B$+<H$86^S,(3U9S.%/Z<]&?>J#^31W+8
MFTR$OHQHI"VS(WG:&\R$62Z0Q]/QQ!N<CN0+FC&;P+,=)8".Q\-3;WHVI2?@
M?_;M6TM;4]CX]V2*LIA?>S9U7P#R?]RG10:]R5FY_*@_]0;#F7YR.BTW5?.Y
M0,1;V/LC5SD^*ZBL1=WX=&*%'YFSL:(X3ND\NK>>,/ =9\FI:7M;"H4G>G()
MY(1J31<CL.U5R;O>8L,/*A >*&]VY<_@H)5Z87#6XJ)9:EM0R0O=GH%V/=;%
MFQY( (L4U WXY""I,-.#!4S ,/22IML&OUH_2[!OI>W?LO%0Q\Y7QIIW2IOP
MPD,@3*H\HX>4R:'\EP4.RV]70+SX-YNA-8$"3('Y7( MW# 9R?"M_SG<%ENG
MR S;&2OU5U)?7LMA=6W/6<5)'5; >*#7@0_&XY&]/]/1"66'NA'[6)BB70B=
MV>G@>^WIZQM>L!P-[Z*@O)ZM?:@4(QC[ > BSWY5I!16TV,T]HSY3HBWW@I5
M)H#YCFT1F"8U!47NJ=".>_JZL^JBSM3JNARZ;*PK&NMFVC*JB+N6?ATN<:,X
M-)^CW7-)6Z:10WMFYK9/E99=#$TR]TP52PL'D)^K(K8C^1H&L(_0 >$N/$%A
M#>.O:6?1<CS;FZ6BY0#I(5CJ'A(S"3MXN"'CSW(J,D^$+='1?I<.*>BN*]13
MMD=KK8T#NFEGT/^#6UMJO#E^'S<JDV>7-_=3NIL+)4A44?Y[,."88@LT[63>
M8;XW(*D27F8.5Y.;J!O12!#:!2@!MUE9]LHPDLZY61LL,2$2*Y;(?-J93#FA
M$S>+T6I=TN$3+*+[:"L"P=9IZ"@Y+MQ.YJ80K,;:O4/VPT';@=!G]8W!XR'3
M05H;HK0=M#5A_A2<GI\;-TNTVA9TA;[ 3@S)G1@A1G%CK)+F,G?G!G@!Y%VW
M0,9>'QR<_DC;&B/X8^P-ST#LGIXR! #LP)N.C%(?]J8#^J,_$^^2=*6H^?=X
M,#G%:=KZF$PJ)@5(\;/12)L.@[,Z3"WY^8DW[D^\&0"(RYTA6$-O-!YY_;,S
M!RR VQO-V(PY'=/RLZD+UG!TYLTF$VTNG4WJKZ[9+E-O. /#:-SG7=#;O0FX
MVK/IF=D1Y2.:4P%KIWU P9BF3AGBV11TV'! XK3TE^T1:?[%+(D?+?4EDSJE
M7S9G57NSJK)"TRGQ*-^YI?6&R8'H1@^6%Z(RJ2$OK'=?LJ:Y DN1HW0"#S H
MJO;-6'M+&.27%!)T=C7J-KP.:U#8P#UU(RI[PTW5"*J5?]BDCKZ!QW:"EGU/
M;@IBW7GAM:C<@WNX&@-'=;AI794.?F8N2WD%?AJ@6'2@]LYB7=0>"2)6XC'[
M-Z%O\!;-#0$5SX![9\1CD^'8F[#3 ,( 6/0,&63@#693KW\Z$%W7>\L9<-
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MIBA<A[J=&6",RYG<>)!C612<0!(7'!8F4Q-OPR!M2O<@T=A(86L-E\Q393U
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ML5(LSEIC<=8:B[/66)RUOJ"SYK'23)J_2#ZM7>SKD_PW8/H-4$L! A0#%
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $RAJ$X^1Q)6AP(  *8)   8
M          "  ?<(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !,H:A.1)1'ZC8#   L#0  &               @ &T"P  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 3*&H3G7J'0WT 0  B04
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M965T-RYX;6Q02P$"% ,4    " !,H:A.+1;'2[0!  #2 P  &
M    @ $!(@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M3*&H3LMK*7^T 0  T@,  !@              ( !ZR,  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( $RAJ$[=P'Z LP$  -(#   9
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M970Q-"YX;6Q02P$"% ,4    " !,H:A.4Y1[MMT!  !V!   &0
M    @ &5+P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M $RAJ$[W\..H,@(  &X&   9              "  :DQ  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ 3*&H3G72]0(D P  ' T  !D
M             ( !$C0  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !,H:A.*T]A!=$"  !F"@  &0              @ %M-P  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( $RAJ$[5YJ@40@,
M   -   9              "  74Z  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ 3*&H3JXG#T!S @  FP<  !D              ( !
M[CT  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !,H:A.
M\WN5;PP"  #]!0  &0              @ &80   >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $RAJ$[Z/@6M#@(  -8%   9
M      "  =M"  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ 3*&H3AE;T:8M @  &@<  !D              ( !($4  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !,H:A.,>,&/+XH   ?FP
M%               @ &$1P  >&PO<VAA<F5D4W1R:6YG<RYX;6Q02P$"% ,4
M    " !,H:A.A9OKQ$D"  !^"P  #0              @ %T<   >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( $RAJ$[IZ_(7KP(  !\0   /
M  "  >AR  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !,H:A.AVJFH$<!
M   :#P  &@              @ '$=0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " !,H:A.!DM[X7,!   5$   $P
M@ %#=P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     (  @ )((  #G>
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>81</ContextCount>
  <ElementCount>125</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>17</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/InterimCondensedConsolidatedBalanceSheets</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/InterimCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/InterimCondensedConsolidatedStatementsOfOperations</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/InterimCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/InterimCondensedConsolidatedStatementOfChangesInStockholdersEquity</Role>
      <ShortName>INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Business Description and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation</Role>
      <ShortName>Business Description and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Recent Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/RecentAccountingPronouncements</Role>
      <ShortName>Recent Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Other Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/OtherIncome</Role>
      <ShortName>Other Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Equity Offering Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/EquityOfferingAgreements</Role>
      <ShortName>Equity Offering Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Recent Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/RecentAccountingPronouncementsPolicies</Role>
      <ShortName>Recent Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://anavex.com/role/RecentAccountingPronouncements</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/CommitmentsTables</Role>
      <ShortName>Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://anavex.com/role/Commitments</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Business Description and Basis of Presentation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/BusinessDescriptionAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>Business Description and Basis of Presentation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/BusinessDescriptionAndBasisOfPresentation</ParentRole>
      <Position>15</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Other Income (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/OtherIncomeDetailsNarrative</Role>
      <ShortName>Other Income (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/OtherIncome</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Equity Offering Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/EquityOfferingAgreementsDetailsNarrative</Role>
      <ShortName>Equity Offering Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/EquityOfferingAgreements</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/CommitmentsTables</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Commitments (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/CommitmentsDetails1</Role>
      <ShortName>Commitments (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/CommitmentsTables</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Commitments (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/CommitmentsDetails2</Role>
      <ShortName>Commitments (Details 2)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/CommitmentsTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Commitments (Details 3)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/CommitmentsDetails3</Role>
      <ShortName>Commitments (Details 3)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/CommitmentsTables</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Commitments (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/CommitmentsDetailsNarrative</Role>
      <ShortName>Commitments (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/CommitmentsTables</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="avxl-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://anavex.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://anavex.com/role/SubsequentEvents</ParentRole>
      <Position>23</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>avxl-20190331.xml</File>
    <File>avxl-20190331.xsd</File>
    <File>avxl-20190331_cal.xml</File>
    <File>avxl-20190331_def.xml</File>
    <File>avxl-20190331_lab.xml</File>
    <File>avxl-20190331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>48
<FILENAME>0001615774-19-007324-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001615774-19-007324-xbrl.zip
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M.WCU"XK0MYO0_>E-X<A9J-X4@U4!WPSVX9OA$?B&#K+S.2P$.@TZ+ 2=#60
M=4QTIL^:&N_/KY$_78 Z>CGW&4/&XXP9__S9!MW<<;^:_A]7YLH.3>=3Y%J@
M>+=[%PME\NUWT&YN9I<^;-0Y89_9RALH\_Q.W@4 4*O??F9ST_E(!,M,^PS%
M3RI(!!^58W#!<+4R.!QR(*^,^*"'SX.8@S_^.P)T;V8S&-^=WYI@#FS@]2N0
MUI[_R0[_G#/?=*Q+U[KRSI_/GR=0W2R_A? G97?!5:7U+62_FMG]B9'5L7O'
M[F=GZVY6$W?43Y[1<MK*YS5J#R?7GFID\,;JYZ,,@X\Z!N\8?'^%I3R#CX[
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MO4 1OOO @JEODSPZ,BK?%TR*M:RE^2A9-H <2N(]"5^4)1,,-1#9@><P> !
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MJ+Y1!Z76>6K#B;=+I)6N]_615L>F7^>Q0X!\<L;7Q7,' *D:@]%8T];;Q];
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MJ(*_^N/!. -EB=DK!KPT$_;5;&VPTP%>EE4OU)&>%;:G@[PL1U\,].PMX0&
M?_%<+Y:JN0U1B46AC95L,Y&-DQT$5?E:??"<6C=4I>T&1<^&%M8#5&G)J0VR
MY\O.0/$?D?%PXBL Q'8C>$D<X)XK&)(_!VS)@H\/8'1X/MB^IO]X';(E)6?
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M]B:LUMRZIT*JTBYZ**0/8T!J+H0SV]1/)5N'AG_^W;68C_W<@IO9U\B?+LR
M7<Y]1@VY]O0@;=KCU0.S@V?H>,#LX/$Y'C 'W$X>99GV5%N&HE_6WN =E>)[
M(CEJ+I+U.'4N6KJL!V#<LC6NT$H[SA(U&N#Z'#W'Y?^FP5I+IL5QP:PDUO\X
M(#=ZB]7GQSF*2KVO[U)I[K%2C[_GHFTH-WS7U.7?V0(K>9Z.9E-L,+4'2G^[
M$OH\E+6A6K$#:-37U*:B6K%7:(1-'IN*::6NHO% ;_"B'B[Y8[2WRI<LJ  9
M1DR&WSV,KG)8$'Q\8/[4#MC-[.\F-IW?.YRT=A@.=6O5!,.^2HG@R[)0'16E
M0S20)N-7M;I1]SI4H&74) 7:SOUUZ=]-QJ^)W%^SCIT%\?>5YSX%*@:WCFN#
MRF>O<-=MA^=(:%2\TTZ*4YV[JUJJGWQ?51B>=DHNJ"<T[;2<?0S79GU4/RIG
M7PM:',%),1XJI9DB!J\&["KV2U2!71P3<FG]"[B54@6_>QLV(;TY6:\J\(WQ
M@!%VR_P[>\IX,,DW-O7F+HWR--NIJKH+=0/=!"*5K[0[UE5#>UE$*EWX5].,
M03;E_R40Z>"J(B^!2+66K&S(JK<;H7K\;R]2;-9C8KY(N7&DQ+"F;;AJPO6;
MLF#MQZK6*K%-0^B0-MXO4/\[4MY<0RS)MK-]'=<L)S>@;_RYZ=I_T@A7GAMX
MCFW1'Y>N]15X#P"A/V]FHGH.3(]=H0G"#W8P=;P@\MEWH-9[!Q9T5Z_"+W]U
MPG<A+Q+('"=8F5B8!VE"?Z],RXK_#L)'A_W\:@8#OY54915*W^TE"Z0O[%[Z
MYBU-5^9?R!)@;L_>24O3G]ONQ<0+82>]E>"-Y+O06^$7#^^D>]L*%SB>\I=7
M?YV'[_[Z7ZK^CH#RXQGOF!_:4].Y,!U[[KZ5X.7T4:0B/6[%CXL1^QK.AS2(
MWW/8+.0OPO.(1EF4Z.4O7L@D%8=X@^_%X[T)K2TP$1C <1YO-?$6>-%BO@-'
MZ>$ X<L1?G@?!3!@$"0P?&#!U+=7.*-DNI:$=4$#R9M)68XBX*,$C2*<Z*.?
M6YTWQ#.YKU;[<@AP0AT+]5=SN7KW7^I *4!LE4)>!?CTW[[6,XQUGD,I8L\>
M#\<F6=PSP.7X*U,;*I>N><<>"-3/]HQ)MU.;N5-XZ<KS5SWI=;A@$D=WI&G*
M.SPH3/<Q^49]]Z,$6]*4IB +4,8!$.:<21/;6\'ILC2G+"+9!_*<WI28.X<'
M+,EV)1S;2EN4XL:V[-F,^?"'#6>#16!AE4US1<,$TN11,E<K!VM?22L?3L
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M*A'H1;(/!($?.0 ,BC"?S2-'2 G@&_B1(+AET\CG54OQJ8\/TX7ISDD2+^V
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MZ*61[N$74)9  [6X;HS3Q13<ML4G42A9'@F),)8/1+;,GB- ?/11^5P1$T*
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M",.O!K+WM%L0PSSB;$T9"^%&6S](RS%,/9<4*>Y?"+T<&68YBHJ*/1@0LIU
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MS.+I(H?STGR4/$1+!/LZO P_A0Q39!V<@4O/!8+#82;S2.$YH#/'>"NPN8-
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M\ +DJ[^4SZOE>C42#T1YBO%\J3+!8JQ,AR^DRD52A7F,!>YFH+;/*_[3G%1
MJ Q2A%-KJ;=;*:F 'Q;.4@,S_$ 6DG[ETGE=.D0<XA+FWWK<;9$)#AP(Y_<
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M$,Z+9O@OS2E_@$30C\*#-^$&=CV+%E:#,DO(;^VP6%L^:G=[[7[W<B_,5N@
MSX(.M\@#62+Y]_%!>ZD5,[PC>VGOCOQ79\2-K4V8.V#FF+G4?=;8DCNV!Q7@
M>[K6#EG>M/!N;T&5W>NKOE_A#RJR[O,&XD-0>V.!.3IOPJ@QESC4'G)F$B:(
M"1\$MZ@I0^P66]+2^IH05Q0!+JWHK.COL0/&7!.7&M@Z&954K57STEWX+4-#
MS):S#7&\D#C*/?D:S\EGB,7ZSN)/)Z.34'@V-E#W&K,5$1K376[\N>:6"7E_
M_-<6&O-)Z"G5< J^MUM!&1%B1(3AT(V,#DA+MUA0L/"]0P2 44IJI16= OT#
M,60>-0R^A43*5O<.9_#1\$.D"+*:]"EPSB"1.!H,!FQ2!"JEZ"D0^)$S6RXA
M]MAJL'*(FHV*Y$Z!;<AMF[I*<%**G@*!OET(\M<6U(YW*C"RRE<?T_>0*@Q*
MCHSMN)83>W&.%U8QQ$R!L^:U$7$QM<04.[)OW!6VSZ,5GSB?E,6O(%IEOBD+
MMZR>$T=R4$V)4(Y)5(.G6QY0MUI$O?*(>M4BZI='U*\6D7+0*XA6T>N5A:DJ
MGX<5)E?&UO(2Y@2^1R3(WB4P2#9#/1+T41-R>"PU7/D_7=1&H=3A1\Q,Y*M
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M%5=C5525I^^B8Z.#(B$5KRE235+UZ$]_>) 4'WB1(H&4[(U9MTK*!!+ +Q-
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M1CZ=R3K\!"WP*HQI"#Y='>G[W*["T_<%R7\N=@+/B-5+TQ<BK_*]/C->VV;
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MHI"](G2?E#F51)$3>AYKT2FFXE?!*3H&YT:[CY1ML-W3%TY0W(YW2LH":$*
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M3[36-SR)TJYBM*L9+5C5)?Y8Y2>H61DJ:W,$RF))575/H2.?<(R7H1!7:@Y
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M7UH>8@7^)Z 7%D9[+</]T^&#Q!6>7^KY#^U9>>V]XB])_(BS' <3/#??MW(
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M<&,QKA!*QLD0,YY#MC.[HP>NA'8E\/B5H8._S* H$XYS:!9J-\BRI=;P6U6
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MH-\6/JD4NGY\6#!%]9 N"D7\UI(PN_:G%/I9E"-:BK+^$Y$8 2Q*?/P\(&8
MN\1 :A*^8B:G8@J3>2,L=0I](Z']S&\=B:XK:QE-^B*!4K ?R>9\(HI(D=4#
MO^6@9U2KB6'7W10\W,3L60\*P;*S60S\PH/F#JF)R:X/U%58U.K$CCXN$E!'
M3!0OB6K)-\+*#8!?9-!#6U,P;IB"$J);H^C W09=/+30[!2*[++W590%<9HM
ML<IA3.L&P>\\&!VS,L&Y@?X7L@N=48VF.4FFZ'8Y?T!X.&$,5<Y]E8=VV_;
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MK>3>U!$[7:5*BC)NSLTU^4W%@0'@RI8'01,/:[/$:/X%4B0*J(FQ#)\_44M
MG!N06QS,Y226VG8(C(QC2[=S;]/U$V'%*D2?^&']<V0MK %]MBM-""?EP!%S
MDQ<1I69[;MV/X8?=&;-$.Q&*]ZHMSC;1>4?;$]H"VKOMJ8W"F'0PG/3HAGW*
M2!2GA^<4[Q 6' [<2 =?(8M:'F2Q\]??C,FGC QSZF61IKS6;<@-!(7:6,][
MH,NB'6MW<U(>^30<934S"^U>E8K0AZXM]9$?'BZ2CR4K>2LWF1 5;FGHTR0#
M4$@D8>*T,5O-@1D*WD[3Q],0173Z>T\_4'#>5V8]\M77&S3UXWZ2T]=NFE<>
M4FJKD!NSE7B]::*[<JJ]/Q$7!'#='*3(9@E@X3;);4NRFQ1;\F.0/66*KZ/\
MSRG9<,8A.\05NS)$-<#F\BUQ-3@PY*Q:FIV)11RD<7+GX]_+7$77RR2\N;D4
M"EI:"VRV5A"V(LN6!,YR.I7A!-GP(8[8"[_C=+4X<"0NK]8)]Y$J]Y:$_[+R
MCA&><R1=*P-M JK)M9$Q-\*7/B<8!51*X6<R[I*7_&@EXJ42L%B3EU@1_L:J
M76O0T6[*CVWL(BPWX!;F&K]%W]B?VB9GK]2'W@\H0ZHG$%M'%4NZM DFWCN<
M8C_W:7Q6P)D8-=N ?B1!\3RCC6!L97M5TI3O.? HUX9^TT -&$UA[!<29L:\
M$'&AA\A69>BW"'8"A",*T"&B"<AV;>B7 TP.D29(3%RGV]OPTISPMBI#OQE@
M<'@9F^[,V'ID;0P0"C,: D )]). ;.XJ23CY9IY"5>@' 90M/&4Q.#@"B9;1
M2^O^E%#\":=95F6&G1;P'/4*%<'? E ;>NHR<&/8,??L-1+MHBI%P-/X*X^C
M+;[ (XFJV5Z*2)\7TC9BAK:26F[<XBZK'J]Q[],-T7!Q:^,R8.4X[^-S\^4N
M6822N2[<.$^S=6&NI5!<B9.2\<%C8VNZ:U A VV[H3O&QUM=KPQ(RI&0KX)7
MTHLXU*M6['7 7&/:C:BP]JRNV4G"N]A/;OTYX@8"J&IZJ][<4)]&U=<=Z:WX
MMQ.BL'(2KVY<*H4VU0N#GS!:5.^F\*=F8;FQM6J]S!1A=H.$&$=+)C-V-W$\
M\Y/R7NYMFCRB+$=APRLF!@V#EG1 !P\8L[%,F0T[X?EJ=+DX/0-5XQ4)SL^B
M=C1M[^J^"7EKCV;QE-(H]W%NXUS!FAP*#_T@*;SSO).)O74/'M@"JO7[E;7=
M@TUK;*R>/(53V@8*P*-W#EAON8!W4'47$095W%K_X#%-!ZVVC6 ?;>E]VW8:
M[X':BQ%[5=:T*R_4[GV"KSS/^@5%TQF12.\187^*5HO8'8X"1*&:<%TF=J>E
M-B2"!_09=Z>X)^..FC2*K+JJYH"AD4[PWZ2"+@V1KOMEN$<-^KN>FIB*W?Q.
M@VM/Q('%JSJAP;N.L+UJD(,!G8 ",K*"[8T\L/#BXS#3UZ+C0-L4$7.5.#O.
MJM3!Q8 ?QYFV$G5QF+W6K9B&F\Y";+\3(G!]-V;1KP=]#^*L^2+$!Y6+$-[9
M\2K$/L\NNIEQU>2EA&,&5HLAX1W/P+H*7!5'XV^6ZI#D-PEW(Z!>-13>S2#V
M)H7A"-UN]'GE\3':(2GP@S  75 >.GI2'CTN9;;C@0+;EJ7=0'%)?] !X<K9
ME:S*^^!TREJ0";\KZ*G%LH984T>W JW=T&3VSDBV<FBQ7 WV=+FQL\X&7$-H
MLP"NPYA9B?@F*,K)#C03!*D:DF9C9YT-I(;01P%<^O/KAV)^31!+&.C W"K*
M!E9]I_CE8$#D;=!OJ[.QT:TTL;6P#T#1.FR.=CJVV0F#U)5893=TN1S>U/]F
M6Y<;NNILG#&$)G.A.NJQH4!\\UIA.N(>,&$KH' .:<?5/FACOP XD'863M-
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M"_U!0Q/)-_\/4$L! A0#%     @ 3*&H3NBOH?=]7   ^=,$ !$
M     ( !     &%V>&PM,C Q.3 S,S$N>&UL4$L! A0#%     @ 3*&H3JG5
M66.0"0  ]UH  !$              ( !K%P  &%V>&PM,C Q.3 S,S$N>'-D
M4$L! A0#%     @ 3*&H3K4Y3J(5"0  [%\  !4              ( !:V8
M &%V>&PM,C Q.3 S,S%?8V%L+GAM;%!+ 0(4 Q0    ( $RAJ$[]>S;@O1(
M '(W 0 5              "  ;-O  !A=GAL+3(P,3DP,S,Q7V1E9BYX;6Q0
M2P$"% ,4    " !,H:A.ROJX+IHO  #5T ( %0              @ &C@@
M879X;"TR,#$Y,#,S,5]L86(N>&UL4$L! A0#%     @ 3*&H3JAQ(5S_'
MW?$! !4              ( !<+(  &%V>&PM,C Q.3 S,S%?<')E+GAM;%!+
4!08     !@ & (H!  "BSP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
